Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA single nuclei brain specificity"	"RNA single nuclei brain distribution"	"RNA single nuclei brain specificity score"	"RNA single nuclei brain specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA tissue cell type enrichment"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Secretome function"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Brain expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	Interactions	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Cancer prognostics - Bladder Urothelial Carcinoma (TCGA)"	"Cancer prognostics - Breast Invasive Carcinoma (TCGA)"	"Cancer prognostics - Breast Invasive Carcinoma (validation)"	"Cancer prognostics - Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA)"	"Cancer prognostics - Colon Adenocarcinoma (TCGA)"	"Cancer prognostics - Colon Adenocarcinoma (validation)"	"Cancer prognostics - Glioblastoma Multiforme (TCGA)"	"Cancer prognostics - Glioblastoma Multiforme (validation)"	"Cancer prognostics - Head and Neck Squamous Cell Carcinoma (TCGA)"	"Cancer prognostics - Kidney Chromophobe (TCGA)"	"Cancer prognostics - Kidney Renal Clear Cell Carcinoma (TCGA)"	"Cancer prognostics - Kidney Renal Clear Cell Carcinoma (validation)"	"Cancer prognostics - Kidney Renal Papillary Cell Carcinoma (TCGA)"	"Cancer prognostics - Liver Hepatocellular Carcinoma (TCGA)"	"Cancer prognostics - Liver Hepatocellular Carcinoma (validation)"	"Cancer prognostics - Lung Adenocarcinoma (TCGA)"	"Cancer prognostics - Lung Adenocarcinoma (validation)"	"Cancer prognostics - Lung Squamous Cell Carcinoma (TCGA)"	"Cancer prognostics - Lung Squamous Cell Carcinoma (validation)"	"Cancer prognostics - Ovary Serous Cystadenocarcinoma (TCGA)"	"Cancer prognostics - Ovary Serous Cystadenocarcinoma (validation)"	"Cancer prognostics - Pancreatic Adenocarcinoma (TCGA)"	"Cancer prognostics - Pancreatic Adenocarcinoma (validation)"	"Cancer prognostics - Prostate Adenocarcinoma (TCGA)"	"Cancer prognostics - Rectum Adenocarcinoma (TCGA)"	"Cancer prognostics - Rectum Adenocarcinoma (validation)"	"Cancer prognostics - Skin Cuteneous Melanoma (TCGA)"	"Cancer prognostics - Stomach Adenocarcinoma (TCGA)"	"Cancer prognostics - Testicular Germ Cell Tumor (TCGA)"	"Cancer prognostics - Thyroid Carcinoma (TCGA)"	"Cancer prognostics - Uterine Corpus Endometrial Carcinoma (TCGA)"
ABCB1	"ABC20, CD243, CLCS, GP170, MDR1, p-170, P-gp, PGY1"	ENSG00000085563	"ATP binding cassette subfamily B member 1"	P08183	7	87503017-87713323	"Cancer-related genes, CD markers, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 98.7;intestine: 68.8"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 101.1;Microglial cells: 544.8;Proximal enterocytes: 247.2"	"Cell type enriched"	"Detected in many"	23	"endothelial cell: 4738.8"	"Cancer enhanced"	"Detected in many"		"Kidney Renal Papillary Cell Carcinoma (TCGA): 35.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 27.2;NK-cell: 17.9"	"Group enriched"	"Detected in many"	9	"NK-cells: 17.9;T-cells: 27.2"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 26.0;liver cancer: 17.4"	"Adrenal gland - Adrenal cortex cells, Prostate - Endothelial cells, Spleen - NK-cells (Spleen)"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001716, HPA002199, HPA074614"	Enhanced		Supported	"Plasma membrane"			NA	NA			"Cluster 24: Non-specific - Transcription"	"Cluster 55: Kidney & Intestine - Metabolism"	"Cluster 47: Endothelial cells - Vasculature"	"Cluster 70: DU4475 - Unknown function"	"Cluster 22: Proximal enterocytes - Digestion"	10	"Plasma membrane"		"CAB001716: , HPA002199: AB_1844428, HPA074614: "		"unprognostic (5.03e-2)"	"unprognostic (1.00e-1)"		"unprognostic (8.89e-2)"	"unprognostic (7.32e-3)"	"unprognostic (8.80e-3)"	"unprognostic (1.58e-1)"			"potential prognostic favorable (2.30e-8)"	"unprognostic (9.76e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.06e-2)"	"unprognostic (7.36e-2)"		"unprognostic (2.74e-2)"		"unprognostic (7.12e-2)"			"unprognostic (3.61e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.54e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.33e-2)"		"unprognostic (1.21e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.90e-1)"	
ABCG2	"ABCP, BCRP, CD338, EST157481, MXR"	ENSG00000118777	"ATP binding cassette subfamily G member 2 (Junior blood group)"	Q9UNQ0	4	88090150-88231628	"Cancer-related genes, CD markers, Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 85.9"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 198.2;Distal enterocytes: 98.5;Extravillous trophoblasts: 89.8;Hofbauer cells: 125.1;Microglial cells: 177.1;Proximal enterocytes: 212.5"	"Cell type enriched"	"Detected in many"	17	"endothelial cell: 1911.5"	"Cancer enhanced"	"Detected in many"		"Glioblastoma Multiforme (TCGA): 17.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 2.2"	"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Liver - Hepatocytes"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB037299, HPA054719"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"			NA	NA			"Cluster 15: NK-cells - Unknown function"	"Cluster 25: Small intestine - Absorption"	"Cluster 47: Endothelial cells - Vasculature"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 3: Basal prostatic cells - Lipid metabolism"	6	"Plasma membrane"	Nucleoplasm	"CAB037299: AB_476804, HPA054719: "	"unprognostic (9.74e-2)"	"unprognostic (1.82e-1)"	"unprognostic (5.75e-2)"		"unprognostic (4.47e-1)"	"unprognostic (1.39e-1)"	"potential prognostic favorable (2.42e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.98e-3)"	"validated prognostic favorable (3.55e-15)"	"validated prognostic favorable (5.94e-5)"	"unprognostic (1.76e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.82e-2)"	"unprognostic (7.57e-2)"	"unprognostic (4.10e-1)"	"unprognostic (2.17e-1)"	"unprognostic (3.04e-1)"			"unprognostic (4.54e-3)"	"unprognostic (4.03e-2)"	"unprognostic (7.26e-2)"	"unprognostic (2.56e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.73e-2)"	"unprognostic (9.90e-2)"	"unprognostic (2.80e-1)"	"unprognostic (9.01e-2)"
ACE	"ACE1, CD143, DCP1"	ENSG00000159640	"Angiotensin I converting enzyme"	P12821	17	63477061-63498380	"Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Calmodulin-binding, Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 257.7;testis: 99.0"	"Group enriched"	"Detected in many"	20	"Early spermatids: 373.5;Late spermatids: 1317.0;Proximal enterocytes: 1039.2"	"Cell type enhanced"	"Detected in many"		"endothelial cell: 5.9;medium spiny neuron: 7.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"memory B-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cancer enhanced"	"Detected in many"		"Neuroblastoma: 17.2"	"Adipose subcutaneous - Adipose progenitor cells, Kidney - Proximal tubular cells, Kidney - Proximal tubular cells, Pituitary gland - Corticotropes, Skin - Fibroblast_1, Testis - Late spermatids, Thyroid gland - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002426, CAB002921, HPA029298, HPA069790"	Enhanced		Approved	Vesicles	"Secreted to blood"	Enzyme	NA	NA	104000000	130000000	"Cluster 14: Non-specific - Unknown function"	"Cluster 25: Small intestine - Absorption"	"Cluster 33: Neurons - Mixed function"	"Cluster 11: Neuronal - Sensory perception"	"Cluster 22: Proximal enterocytes - Digestion"	4	Vesicles		"CAB002426: AB_442052, CAB002921: , HPA029298: AB_10960255, HPA069790: AB_2686197"	"unprognostic (2.23e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.07e-2)"	"unprognostic (4.01e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.68e-1)"	"unprognostic (4.46e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.90e-1)"	"validated prognostic favorable (2.65e-5)"	"validated prognostic favorable (2.01e-4)"	"unprognostic (4.85e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.62e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.69e-3)"	"unprognostic (1.32e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.71e-1)"	"unprognostic (6.94e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.92e-2)"
ACKR1	"CCBP1, CD234, DARC, Dfy, FY, GPD"	ENSG00000213088	"Atypical chemokine receptor 1 (Duffy blood group)"	Q16570	1	159203307-159206500	"Blood group antigen proteins, CD markers, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"Blood group antigen, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 310.2"	"Group enriched"	"Detected in many"	10	"Adipocytes: 571.8;Endothelial cells: 840.3"	"Cell type enhanced"	"Detected in many"		"endothelial cell: 48.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"Bile duct cancer: 5.8;Brain cancer: 1.7;Leukemia: 1.5;Neuroblastoma: 2.2;skin cancer: 2.2"	"Breast - Endothelial cells, Colon - Endothelial cells, Minor Salivary Gland - Endothelial cells, Pancreas - Endothelial cells, Prostate - Endothelial cells, Skeletal muscle - Endothelial cells, Testis - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016421, HPA017672"	Enhanced						NA	NA				"Cluster 7: Adipose tissue - Mixed function"	"Cluster 35: Non-specific - DNA binding"	"Cluster 47: Leukemia - Hemostasis"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"				"HPA016421: AB_1849219, HPA017672: AB_1849221"	"unprognostic (5.81e-2)"	"unprognostic (2.83e-2)"		"potential prognostic favorable (6.37e-5)"	"unprognostic (6.93e-2)"	"unprognostic (6.41e-2)"	"unprognostic (2.62e-2)"	"unprognostic (4.36e-2)"	"unprognostic (6.62e-3)"	"unprognostic (5.11e-2)"	"unprognostic (4.55e-3)"	"potential prognostic favorable (9.58e-4)"	"unprognostic (2.70e-1)"	"potential prognostic favorable (9.81e-5)"		"unprognostic (2.15e-3)"	"unprognostic (1.58e-1)"	"unprognostic (7.69e-2)"	"unprognostic (5.53e-2)"	"unprognostic (7.40e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.25e-3)"	"unprognostic (9.70e-2)"	"unprognostic (9.11e-2)"	"unprognostic (2.69e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.97e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.04e-2)"	"unprognostic (3.05e-1)"
ADAM10	"CD156C, HsT18717, kuz, MADM"	ENSG00000137845	"ADAM metallopeptidase domain 10"	O14672	15	58588809-58749791	"Cancer-related genes, CD markers, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Notch signaling pathway"	"Hydrolase, Metalloprotease, Protease"	"Alzheimer disease, Amyloidosis, Cancer-related genes, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 351.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001709, HPA050670"	Approved		Supported	"Vesicles,Plasma membrane"	"Intracellular and membrane"	Enzyme	NA	NA		670000	"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 16: Non-specific - Transcription"	"Cluster 13: Oligodendrocytes - Mixed function"	"Cluster 58: Non-specific - Nuclear processes"	"Cluster 51: Oligodendrocytes - Unknown function"	40	"Vesicles, Plasma membrane"		"CAB001709: , HPA050670: "	"unprognostic (4.08e-2)"	"unprognostic (5.03e-2)"	"unprognostic (5.15e-2)"	"potential prognostic unfavorable (3.94e-4)"	"unprognostic (1.00e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.96e-1)"	"unprognostic (9.59e-2)"	"unprognostic (7.17e-3)"	"unprognostic (1.11e-1)"	"potential prognostic favorable (5.99e-6)"	"unprognostic (1.15e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.23e-1)"	"potential prognostic unfavorable (9.44e-4)"	"unprognostic (2.43e-3)"	"unprognostic (5.70e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.74e-2)"	"unprognostic (5.46e-3)"	"potential prognostic unfavorable (2.06e-4)"	"unprognostic (1.13e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.69e-1)"	"unprognostic (6.59e-3)"	"unprognostic (9.67e-3)"
ADAM17	"CD156B, cSVP, TACE"	ENSG00000151694	"ADAM metallopeptidase domain 17"	P78536	2	9488486-9556732	"CD markers, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Notch signaling pathway"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"monocytes: 248.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010738, HPA051575"	Approved		Approved	Cytosol			NA	NA		530000	"Cluster 42: Non-specific - Vesicular transport"	"Cluster 58: Placenta - Pregnancy"	"Cluster 30: White matter - Myelination"	"Cluster 7: Liver cancer - Metabolism"	"Cluster 58: Macrophages - Innate immune response"	22	Cytosol		"HPA010738: AB_1078100, HPA051575: AB_2681539"	"unprognostic (4.40e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.15e-2)"	"unprognostic (5.00e-2)"	"unprognostic (8.72e-3)"	"unprognostic (2.47e-1)"	"potential prognostic favorable (2.98e-5)"	"unprognostic (5.49e-2)"	"unprognostic (4.94e-2)"	"potential prognostic unfavorable (6.27e-4)"	"unprognostic (2.49e-2)"	"unprognostic (4.73e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.79e-2)"	"unprognostic (4.49e-3)"	"potential prognostic unfavorable (5.32e-7)"	"unprognostic (1.24e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.51e-1)"	"unprognostic (9.03e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.75e-2)"
ADAM8	"CD156, CD156A, MS2"	ENSG00000151651	"ADAM metallopeptidase domain 8"	P78325	10	133262420-133276868	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 67.8;lymphoid tissue: 47.3"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 105.8;Langerhans cells: 163.3;NK-cells: 68.3;T-cells: 36.5"	"Cell type enriched"	"Detected in many"	7	"leukocyte: 57.8"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebral cortex: 44.4"	"Group enriched"	"Detected in many"	5	"basophil: 107.8;eosinophil: 259.4;neutrophil: 139.8"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 259.4"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 53.8"	"Adipose visceral - Neutrophils, Breast - T-cells, Heart muscle - Neutrophils, Spleen - Neutrophils, Thyroid gland - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA064637	Approved				"Intracellular and membrane"	Enzyme	NA	NA		4000	"Cluster 21: Neutrophils - Unknown function"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 12: Non-specific - Vasculature"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 14: Langerhans cells - Innate immune response"	4			"HPA064637: AB_2685306"	"unprognostic (2.31e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.49e-3)"	"unprognostic (4.25e-3)"	"unprognostic (1.94e-2)"	"unprognostic (2.45e-1)"	"unprognostic (8.06e-3)"	"unprognostic (1.08e-1)"	"unprognostic (6.14e-2)"	"unprognostic (5.25e-2)"	"potential prognostic unfavorable (3.37e-8)"	"unprognostic (3.28e-2)"	"unprognostic (7.71e-2)"	"unprognostic (4.30e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.85e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.91e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.36e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.25e-2)"
ADGRE2	"CD312, EMR2"	ENSG00000127507	"Adhesion G protein-coupled receptor E2"	Q9UHX3	19	14732392-14778560	"CD markers, Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins"	"Cell adhesion, Inflammatory response"	"G-protein coupled receptor, Receptor, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 18.8"	"Cell type enhanced"	"Detected in many"		"granulocytes: 72.9;Kupffer cells: 72.1;Macrophages: 72.3;monocytes: 238.9"	"Cell type enhanced"	"Detected in some"		"leukocyte: 43.5;oligodendrocyte: 21.8;pericyte: 23.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 70.2;eosinophil: 74.8;intermediate monocyte: 46.9;neutrophil: 55.8;non-classical monocyte: 90.2"	"Group enriched"	"Detected in many"	9	"granulocytes: 74.8;monocytes: 90.2"	"Cancer enhanced"	"Detected in many"		"Leukemia: 7.7"	"Lung - Neutrophil_2"					"Low region specificity"	"Detected in many"			HPA055200			Uncertain	Vesicles,Cytosol			NA	NA			"Cluster 37: Monocytes & Neutrophils - Innate immune response"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 6: Non-specific - Immune response"	"Cluster 71: Lymphoma - Inflammatory response"	"Cluster 29: Monocytes - Innate immune response"	18	Vesicles	Cytosol	"HPA055200: "	"unprognostic (2.68e-1)"	"unprognostic (7.32e-2)"		"potential prognostic unfavorable (6.87e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.26e-2)"	"unprognostic (4.01e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.19e-1)"	"unprognostic (6.61e-2)"			"unprognostic (7.02e-3)"	"unprognostic (1.14e-3)"	"unprognostic (5.34e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.77e-1)"		"unprognostic (2.34e-1)"	"unprognostic (3.50e-3)"	"unprognostic (7.29e-2)"	"unprognostic (2.15e-1)"	"unprognostic (7.23e-3)"	"unprognostic (6.68e-2)"	"unprognostic (5.94e-2)"	"unprognostic (6.74e-3)"	"unprognostic (1.91e-1)"	"unprognostic (3.25e-1)"
ADGRE5	"CD97, TM7LN1"	ENSG00000123146	"Adhesion G protein-coupled receptor E5"	P48960	19	14380501-14408725	"CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Cell adhesion"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 209.5"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 152.0;monocytes: 445.8;NK-cells: 300.7;T-cells: 188.2"	"Cell type enriched"	"Detected in many"	7	"leukocyte: 256.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Adipose progenitor cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013707	Enhanced		Approved	"Golgi apparatus,Plasma membrane"	"Secreted to blood"	Receptor	NA	Yes	10000000	3800000	"Cluster 7: Non-specific - Innate immune response"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 11: White matter - Signal transduction"	"Cluster 23: Non-specific - Transcription"	"Cluster 78: NK-cells & T-cells - Immune system & Transcription"	3	"Plasma membrane"	"Golgi apparatus"	"HPA013707: AB_1846345"	"unprognostic (2.90e-1)"	"unprognostic (5.56e-1)"		"unprognostic (9.50e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.93e-3)"	"unprognostic (8.66e-2)"	"potential prognostic unfavorable (1.02e-4)"	"unprognostic (3.26e-2)"	"unprognostic (6.14e-3)"	"unprognostic (1.08e-2)"	"unprognostic (9.06e-2)"	"unprognostic (8.73e-2)"	"potential prognostic unfavorable (3.63e-5)"		"unprognostic (2.30e-1)"	"unprognostic (3.54e-1)"	"potential prognostic unfavorable (7.31e-4)"	"unprognostic (3.01e-1)"	"unprognostic (1.19e-2)"	"unprognostic (5.29e-1)"	"unprognostic (8.35e-3)"	"unprognostic (6.34e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.05e-2)"	"potential prognostic favorable (2.47e-5)"	"unprognostic (1.14e-1)"	"unprognostic (5.49e-2)"	"unprognostic (5.05e-2)"	"unprognostic (4.08e-2)"	"unprognostic (6.02e-2)"
ALCAM	"CD166, MEMD"	ENSG00000170017	"Activated leukocyte cell adhesion molecule"	Q13740	3	105366909-105576900	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Adaptive immunity, Cell adhesion, Immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"parathyroid gland: 424.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 292.6;Oligodendrocyte precursor cells: 638.2;Oligodendrocytes: 913.2"	"Cell type enhanced"	"Detected in all"		"mammillary body: 2102.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 29.6"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 29.6"	"Low cancer specificity"	"Detected in all"			"Breast - Breast glandular cells, Colon - Enteric glia cells, Liver - Hepatocytes, Pituitary gland - Lactotropes, Skin - Sebaceous gland cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002148, HPA010926"	Enhanced		Uncertain	Vesicles	"Secreted to blood"	Immunity	NA	NA	60000000	840000000	"Cluster 2: Dendritic cells - Unknown function"	"Cluster 24: Parathyroid gland - Vesicular transport"	"Cluster 28: Oligodendrocytes - Mixed function"	"Cluster 3: Rhabdoid - Membrane components"	"Cluster 69: Neurons - Neuronal signaling"	13	Vesicles		"CAB002148: AB_442053, HPA010926: AB_1078449"	"unprognostic (1.05e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.59e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.00e-1)"	"unprognostic (7.08e-3)"	"potential prognostic favorable (6.10e-4)"	"unprognostic (3.17e-2)"	"unprognostic (1.93e-2)"	"potential prognostic favorable (7.99e-7)"	"unprognostic (2.59e-3)"	"unprognostic (1.72e-1)"	"potential prognostic unfavorable (9.77e-4)"	"unprognostic (2.25e-1)"	"unprognostic (1.73e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.70e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.51e-1)"	"unprognostic (2.68e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.90e-2)"	"unprognostic (7.77e-3)"	"unprognostic (9.45e-2)"
ALK	"ALK1, CD246"	ENSG00000171094	"ALK receptor tyrosine kinase"	Q9UM73	2	29192774-29921586	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.7;pituitary gland: 1.2;testis: 1.2"	"Group enriched"	"Detected in some"	5	"Inhibitory neurons: 262.0;Oligodendrocyte precursor cells: 407.0"	"Cell type enhanced"	"Detected in all"		"LAMP5-LHX6 and Chandelier: 876.2"	"Group enriched"	"Detected in some"	4	"Glioblastoma Multiforme (TCGA): 2.1;Ovary Serous Cystadenocarcinoma (TCGA): 1.2;Skin Cuteneous Melanoma (TCGA): 2.9;Thyroid Carcinoma (TCGA): 1.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	9	"Neuroblastoma: 84.2"	"Colon - Enteric glia cells, Pituitary gland - Lactotropes, Testis - Early spermatids, Testis - Late spermatids"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA010694	Approved		Supported	"Plasma membrane"			NA	NA				"Cluster 17: Neuronal - Synaptic function"	"Cluster 41: Monoamines - Neurotransmitter signalling"	"Cluster 17: Neuroblastoma - Neuronal signaling"	"Cluster 65: Neurons - Synaptic function"	36	"Plasma membrane"		"HPA010694: AB_1078133"							"unprognostic (8.98e-2)"	"unprognostic (9.10e-2)"												"unprognostic (1.61e-1)"	"unprognostic (2.25e-1)"						"unprognostic (2.65e-3)"			"unprognostic (2.35e-1)"	
ANPEP	"AP-N, CD13, gp150, hAPN, LAP1, p150, PEPN"	ENSG00000166825	"Alanyl aminopeptidase, membrane"	P15144	15	89784895-89815401	"CD markers, Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Angiogenesis, Differentiation, Host-virus interaction"	"Aminopeptidase, Developmental protein, Host cell receptor for virus entry, Hydrolase, Metalloprotease, Protease, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"intestine: 2318.1;pancreas: 655.5"	"Cell type enriched"	"Detected in many"	12	"Proximal enterocytes: 5896.8"	"Cell type enriched"	"Detected in some"	4	"pericyte: 83.6"	"Cancer enhanced"	"Detected in all"		"Kidney Renal Papillary Cell Carcinoma (TCGA): 311.1"	"Group enriched"	"Detected in many"	5	"cerebral cortex: 19.2;thalamus: 38.8"	"Immune cell enriched"	"Detected in many"	4	"neutrophil: 227.8"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 227.8"	"Cancer enhanced"	"Detected in many"		"Adrenocortical cancer: 455.0"	"Kidney - Proximal tubular cells, Liver - Hepatocytes, Prostate - Prostate glandular cells, Skeletal muscle - Macrophages, Spleen - Neutrophils"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"spinal cord: 19.5"	"CAB002417, HPA004625"	Enhanced		Supported	"Plasma membrane"			NA	NA		840000000	"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 25: Small intestine - Absorption"	"Cluster 12: Non-specific - Vasculature"	"Cluster 44: Connective tissue cells - ECM organization"	"Cluster 22: Proximal enterocytes - Digestion"	14	"Plasma membrane"		"CAB002417: AB_563491, HPA004625: AB_2667199"	"unprognostic (9.29e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.64e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.31e-1)"	"unprognostic (1.97e-2)"	"potential prognostic favorable (5.54e-7)"	"unprognostic (1.25e-2)"	"unprognostic (3.78e-3)"	"unprognostic (2.63e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.45e-1)"	"potential prognostic unfavorable (4.98e-4)"	"unprognostic (7.80e-3)"	"unprognostic (4.92e-2)"	"unprognostic (7.48e-2)"	"unprognostic (3.83e-1)"	"unprognostic (7.37e-3)"	"unprognostic (7.63e-2)"	"unprognostic (4.32e-1)"	"unprognostic (1.49e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.55e-2)"	"unprognostic (6.63e-2)"
ART1	"ART2, ARTC1, CD296"	ENSG00000129744	"ADP-ribosyltransferase 1"	P52961	11	3645128-3664416	"CD markers, Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	56	"skeletal muscle: 45.7;tongue: 35.3"	"Cell type enhanced"	"Detected in single"		"Microglial cells: 1.8"	"Cell type enriched"	"Detected in single"	21	"endothelial cell: 6.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"				"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA051148	Uncertain						NA	NA				"Cluster 14: Skeletal muscle - Muscle contraction"	"Cluster 15: Non-specific - Transcription"	"Cluster 70: DU4475 - Unknown function"	"Cluster 47: Astrocytes - Unknown function"				"HPA051148: AB_2681363"																															
ART4	"ARTC4, CD297, DO, DOK1"	ENSG00000111339	"ADP-ribosyltransferase 4 (inactive) (Dombrock blood group)"	Q93070	12	14825569-14843526	"Blood group antigen proteins, CD markers, Enzymes, Metabolic proteins, Predicted membrane proteins, Predicted secreted proteins"		"Blood group antigen, Glycosyltransferase, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 51.6;lymphoid tissue: 18.5"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 11.4;Endothelial cells: 15.2;Erythroid cells: 36.2;Hepatocytes: 27.2;Lymphatic endothelial cells: 52.6;Rod photoreceptor cells: 12.6"	"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in some"		"Liver Hepatocellular Carcinoma (TCGA): 8.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	4	"Rhabdoid: 11.7"	"Adipose subcutaneous - Smooth muscle cells, Liver - Hepatocytes, Thyroid gland - Fibroblasts"	"Region enhanced"	"Detected in single"		"olfactory bulb: 1.8"	"Low region specificity"	"Detected in all"			HPA075664			Approved	"Rods & Rings"	"Secreted to blood"	Enzyme	NA	NA		8800000		"Cluster 83: Liver - Metabolism"	"Cluster 28: Oligodendrocytes - Mixed function"	"Cluster 47: Leukemia - Hemostasis"	"Cluster 54: Lymphatic endothelial cells - Lymph vessel development"		"Rods & Rings"		"HPA075664: "	"unprognostic (1.20e-1)"	"unprognostic (1.38e-1)"	"potential prognostic favorable (1.48e-4)"								"potential prognostic favorable (7.63e-4)"	"unprognostic (3.78e-2)"		"unprognostic (2.76e-1)"	"unprognostic (1.08e-3)"		"unprognostic (1.32e-2)"		"unprognostic (5.38e-2)"			"unprognostic (1.37e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.56e-1)"							
ATP1B3	"CD298, FLJ29027"	ENSG00000069849	"ATPase Na+/K+ transporting subunit beta 3"	P54709	3	141876124-141926549	"CD markers, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"dendritic cells: 967.3;Late spermatids: 993.4;monocytes: 2234.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Heart muscle - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020697, HPA048963"	Enhanced		Supported	"Plasma membrane"			NA	NA		15000	"Cluster 33: Non-specific - ATP binding"	"Cluster 60: Choroid plexus - Transmembrane transport"	"Cluster 44: Non-specific - Mixed function"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 29: Monocytes - Innate immune response"	38	"Plasma membrane"		"CAB020697: , HPA048963: AB_2680574"	"unprognostic (9.23e-2)"	"unprognostic (4.56e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.47e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.56e-1)"	"potential prognostic unfavorable (1.99e-4)"	"unprognostic (3.59e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.09e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.96e-3)"	"validated prognostic unfavorable (6.92e-6)"	"validated prognostic unfavorable (1.04e-6)"	"unprognostic (3.01e-2)"	"unprognostic (2.73e-3)"	"unprognostic (2.03e-1)"	"unprognostic (8.78e-2)"	"unprognostic (3.55e-2)"	"unprognostic (6.63e-2)"	"unprognostic (5.87e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.27e-1)"	"unprognostic (8.81e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.29e-3)"	"unprognostic (3.63e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.05e-2)"	"unprognostic (6.01e-2)"
BCAM	"CD239, LU"	ENSG00000187244	"Basal cell adhesion molecule (Lutheran blood group)"	P50895	19	44809071-44821421	"Blood group antigen proteins, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Blood group antigen, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 308.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 358.1;Basal respiratory cells: 432.6;Collecting duct cells: 488.2;Cytotrophoblasts: 688.0;Secretory cells: 548.9;Syncytiotrophoblasts: 406.4"	"Group enriched"	"Detected in many"	9	"endothelial cell: 121.2;pericyte: 138.1;vascular associated smooth muscle cell: 296.0"	"Cancer enhanced"	"Detected in all"		"Ovary Serous Cystadenocarcinoma (TCGA): 1417.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Lung - Alveolar cells type 1, Prostate - Prostate glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005654	Enhanced		Approved	"Nucleoli fibrillar center"			NA	NA		13000000		"Cluster 51: Thyroid gland - Unknown function"	"Cluster 42: Choroid plexus - Mitochondria"	"Cluster 16: Thyroid cancer - Neuronal signaling"	"Cluster 24: Cytotrophoblasts - Mitochondria"	10	"Nucleoli fibrillar center"		"HPA005654: AB_2667378"	"unprognostic (1.39e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.03e-1)"	"unprognostic (5.44e-2)"	"unprognostic (4.88e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.59e-1)"	"unprognostic (6.32e-3)"	"unprognostic (1.98e-3)"	"unprognostic (7.15e-2)"	"validated prognostic favorable (5.04e-6)"	"validated prognostic favorable (8.13e-4)"	"unprognostic (3.91e-1)"	"unprognostic (4.04e-1)"	"unprognostic (9.15e-2)"	"unprognostic (7.98e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.75e-2)"	"unprognostic (5.92e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.65e-1)"	"potential prognostic favorable (9.20e-4)"	"unprognostic (1.82e-2)"	"unprognostic (4.75e-2)"	"unprognostic (3.96e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.55e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.69e-2)"
BMPR1A	"ACVRLK3, ALK3, CD292"	ENSG00000107779	"Bone morphogenetic protein receptor type 1A"	P36894	10	86756601-86932825	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 135.3;Inhibitory neurons: 76.7;Oligodendrocyte precursor cells: 114.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Kidney - Fibroblasts, Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB019398	Approved		Approved	Cytosol			NA	NA				"Cluster 51: Thyroid gland - Unknown function"	"Cluster 39: Astrocytes - Mixed function"	"Cluster 5: Rhabdoid - Unknown function"	"Cluster 76: Oligodendrocyte precursor - Unknown function"	42	Cytosol		"CAB019398: "	"unprognostic (4.53e-3)"	"unprognostic (3.26e-2)"	"unprognostic (8.39e-3)"	"unprognostic (2.82e-1)"	"unprognostic (3.15e-2)"	"unprognostic (5.05e-2)"	"unprognostic (1.64e-3)"	"potential prognostic favorable (5.70e-5)"	"unprognostic (2.37e-1)"	"unprognostic (1.26e-3)"	"unprognostic (2.56e-3)"	"unprognostic (7.22e-2)"	"unprognostic (5.16e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.88e-1)"	"unprognostic (4.24e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.59e-1)"	"unprognostic (5.14e-2)"	"unprognostic (3.46e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.22e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.34e-3)"	"unprognostic (2.51e-2)"	"unprognostic (4.92e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.64e-3)"	"unprognostic (2.74e-2)"
BMPR1B	"ALK6, CDw293"	ENSG00000138696	"Bone morphogenetic protein receptor type 1B"	O00238	4	94757955-95158448	"CD markers, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Chondrogenesis	"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 23.8;prostate: 21.7"	"Cell type enriched"	"Detected in many"	4	"Astrocytes: 455.8"	"Group enriched"	"Detected in all"	5	"astrocyte: 814.4;bergmann glia: 1335.1;ependymal cell: 596.0"	"Group enriched"	"Detected in many"	5	"Breast Invasive Carcinoma (TCGA): 70.4;Kidney Chromophobe (TCGA): 41.1;Prostate Adenocarcinoma (TCGA): 39.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"prostate cancer: 14.0"	"Adipose subcutaneous - Smooth muscle cells, Liver - Hepatic stellate cells, Lung - Respiratory ciliated cells, Prostate - Prostate glandular cells, Testis - Spermatogonia"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"										NA	NA				"Cluster 64: Neuronal - Transcription"	"Cluster 39: Astrocytes - Mixed function"	"Cluster 27: Breast cancer - Unknown function"	"Cluster 47: Astrocytes - Unknown function"	6				"unprognostic (2.56e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.96e-2)"		"unprognostic (4.05e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.88e-1)"	"unprognostic (9.63e-2)"	"unprognostic (3.94e-3)"		"unprognostic (1.36e-2)"			"unprognostic (1.39e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.95e-1)"	"unprognostic (9.62e-2)"	"unprognostic (2.94e-3)"	"unprognostic (3.31e-1)"		"unprognostic (1.07e-1)"	"unprognostic (7.86e-2)"	"unprognostic (7.69e-3)"	"unprognostic (9.69e-2)"		"unprognostic (1.77e-2)"
BSG	"CD147, EMMPRIN, EMPRIN, OK"	ENSG00000172270	"Basigin (Ok blood group)"	P35613	19	571277-583494	"Blood group antigen proteins, CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Angiogenesis, Host-virus interaction"	"Blood group antigen, Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 1413.1;Distal enterocytes: 1719.0;Syncytiotrophoblasts: 1570.2"	"Cell type enhanced"	"Detected in all"		"endothelial cell: 700.9;pericyte: 477.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Adipocytes (Subcutaneous), Heart muscle - Cardiomyocytes, Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002427, HPA036048, HPA074870"	Enhanced		Approved	"Vesicles,Mid piece,Principal piece,End piece"			NA	NA		330000	"Cluster 7: Non-specific - Innate immune response"	"Cluster 30: Heart muscle - Heart development"	"Cluster 23: Choroid plexus - Mixed function"	"Cluster 23: Non-specific - Transcription"	"Cluster 5: Enterocytes - Absorption"	91	Vesicles	"Mid piece, Principal piece, End piece"	"CAB002427: AB_563501, HPA036048: AB_2674917, HPA074870: AB_2686719"	"unprognostic (2.38e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.83e-1)"	"unprognostic (3.85e-3)"	"unprognostic (6.30e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.57e-2)"	"unprognostic (7.39e-2)"	"potential prognostic favorable (6.16e-4)"	"unprognostic (7.22e-2)"	"potential prognostic favorable (3.62e-5)"	"validated prognostic unfavorable (2.30e-6)"	"validated prognostic unfavorable (8.85e-5)"	"potential prognostic unfavorable (3.20e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.80e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.87e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.42e-2)"
BST1	"BST-1, cADPR2, CD157"	ENSG00000109743	"Bone marrow stromal cell antigen 1"	Q10588	4	15703065-15738313	"CD markers, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"bone marrow: 138.1;intestine: 47.2"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 61.4;Kupffer cells: 31.0;Proximal enterocytes: 79.1"	"Cell type enhanced"	"Detected in some"		"fibroblast: 14.5;pericyte: 19.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 258.3;neutrophil: 294.2"	"Group enriched"	"Detected in many"	94	"dendritic cells: 79.0;granulocytes: 294.2;monocytes: 258.3"	"Low cancer specificity"	"Detected in many"			"Prostate - Fibroblasts, Skin - Fibroblast_2, Spleen - Neutrophils, Stomach - Fibroblasts, Thyroid gland - Fibroblasts"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA050121	Uncertain				"Intracellular and membrane"	Enzyme	NA	NA		130000000	"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 77: Bone marrow - Cell proliferation"	"Cluster 48: Non-specific - Mixed function"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 29: Monocytes - Innate immune response"				"HPA050121: AB_2681025"	"unprognostic (7.12e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.33e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.55e-2)"	"potential prognostic favorable (1.66e-5)"	"unprognostic (4.49e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.83e-1)"	"unprognostic (6.64e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.35e-2)"	"unprognostic (4.75e-1)"	"unprognostic (2.09e-1)"	"unprognostic (4.43e-1)"	"unprognostic (6.22e-2)"	"unprognostic (2.92e-1)"	"unprognostic (7.84e-3)"	"unprognostic (3.98e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.67e-2)"	"potential prognostic unfavorable (2.62e-4)"	"unprognostic (2.83e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.84e-2)"
BST2	"BST-2, CD317, HM1.24, tetherin"	ENSG00000130303	"Bone marrow stromal cell antigen 2"	Q10589	19	17402939-17405630	"CD markers, Plasma proteins, Predicted membrane proteins, Transporters"	"Antiviral defense, B-cell activation, Host-virus interaction, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 672.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 1191.1;Ovarian stromal cells: 1315.0"	"Cell type enhanced"	"Detected in some"		"endothelial cell: 258.9;fibroblast: 79.5;leukocyte: 71.9;pericyte: 71.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Adipose subcutaneous - Endothelial cells, Breast - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017060, HPA073472"	Enhanced		Supported	"Golgi apparatus,Vesicles"			NA	NA		3600000	"Cluster 10: Non-specific - Membrane trafficking"	"Cluster 41: Smooth muscle tissue - ECM organization"	"Cluster 43: Hindbrain - Mixed function"	"Cluster 31: Non-specific - Antiviral immune response"	"Cluster 6: Ovarian stromal cells - Transcription"	4	"Golgi apparatus, Vesicles"		"HPA017060: AB_1845467, HPA073472: "	"unprognostic (1.71e-1)"	"unprognostic (1.51e-3)"	"unprognostic (8.32e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.90e-2)"	"unprognostic (3.17e-2)"	"unprognostic (4.55e-1)"	"unprognostic (3.71e-2)"	"unprognostic (3.13e-2)"	"unprognostic (9.59e-3)"	"unprognostic (1.37e-3)"	"unprognostic (1.72e-1)"	"unprognostic (8.03e-2)"	"unprognostic (7.26e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.39e-1)"	"unprognostic (4.31e-1)"	"unprognostic (1.26e-3)"	"unprognostic (4.09e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.34e-1)"	"unprognostic (6.25e-2)"	"potential prognostic unfavorable (6.45e-4)"	"unprognostic (1.33e-1)"	"unprognostic (2.94e-1)"
BTLA	"BTLA1, CD272"	ENSG00000186265	"B and T lymphocyte associated"	Q7Z6A9	3	112463966-112499472	"CD markers, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"lymphoid tissue: 27.8"	"Cell type enhanced"	"Detected in some"		"B-cells: 63.4;dendritic cells: 18.2;Plasma cells: 21.0;Schwann cells: 20.4;T-cells: 9.0"	"Cell type enriched"	"Detected in some"	13	"leukocyte: 16.7"	"Cancer enhanced"	"Detected in some"		"Testicular Germ Cell Tumor (TCGA): 2.8"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	5	"memory B-cell: 65.3;naive B-cell: 96.8;plasmacytoid DC: 24.9"	"Group enriched"	"Detected in many"	4	"B-cells: 96.8;dendritic cells: 24.9"	"Cancer enhanced"	"Detected in some"		"lymphoma: 3.6;Myeloma: 13.3"	"Breast - Plasma cells, Minor Salivary Gland - Plasma cells"	"Not detected"	"Not detected"							"HPA047211, HPA062029, CAB080456"	Enhanced				"Secreted to blood"	Receptor	NA	NA		4000	"Cluster 34: B-cells - Unknown function"	"Cluster 36: Lymphoid tissue - Cytokine signaling"	"Cluster 37: Neurons - Mixed function"	"Cluster 55: Lymphoma - Immune response"	"Cluster 73: B-cells - B-cell function"				"CAB080456: , HPA047211: AB_2679983, HPA062029: AB_2684665"			"unprognostic (4.45e-2)"			"unprognostic (5.62e-2)"						"unprognostic (4.33e-2)"				"potential prognostic favorable (4.16e-4)"	"unprognostic (6.56e-2)"		"unprognostic (1.96e-1)"			"unprognostic (1.25e-1)"	"unprognostic (1.69e-2)"			"unprognostic (2.91e-2)"			"unprognostic (4.08e-2)"		
BTN3A1	"BT3.1, BTF5, BTN3.1, CD277"	ENSG00000026950	"Butyrophilin subfamily 3 member A1"	O00481	6	26402237-26415208	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cells: 71.1;Plasma cells: 34.4;T-cells: 41.9"	"Cell type enriched"	"Detected in many"	4	"leukocyte: 54.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Breast - T-cells, Heart muscle - T-cells, Prostate - T-cells, Thyroid gland - T-cells"	"Not detected"	"Not detected"							HPA012565	Approved		Uncertain	Vesicles			NA	NA			"Cluster 1: T-cells - Unknown function"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 43: Hindbrain - Mixed function"	"Cluster 31: Non-specific - Antiviral immune response"	"Cluster 19: NK-cells - Adaptive immune response"	10	Vesicles		"HPA012565: AB_1845494"	"unprognostic (2.38e-2)"	"unprognostic (4.80e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.90e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.57e-1)"	"unprognostic (8.94e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.40e-2)"	"unprognostic (4.75e-3)"	"unprognostic (2.23e-2)"	"unprognostic (3.61e-1)"	"unprognostic (4.00e-2)"	"potential prognostic favorable (1.71e-4)"	"unprognostic (3.26e-2)"	"unprognostic (9.18e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.92e-2)"	"unprognostic (4.22e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.49e-3)"	"unprognostic (1.98e-1)"	"unprognostic (3.56e-2)"	"unprognostic (4.59e-1)"	"unprognostic (2.49e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.98e-1)"
C5AR1	"C5A, C5AR, C5R1, CD88"	ENSG00000197405	"Complement C5a receptor 1"	P21730	19	47290023-47322066	"CD markers, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 124.0;lymphoid tissue: 82.5"	"Cell type enriched"	"Detected in many"	7	"monocytes: 3492.2"	"Group enriched"	"Detected in many"	5	"choroid plexus epithelial cell: 147.9;ependymal cell: 192.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 393.7"	"Group enriched"	"Detected in many"	42	"granulocytes: 393.7;monocytes: 116.2"	"Low cancer specificity"	"Detected in many"			"Adipose subcutaneous - Macrophages, Adrenal gland - Macrophages, Breast - Macrophages, Colon - Neutrophils, Heart muscle - Macrophages, Kidney - Macrophages, Minor Salivary Gland - Macrophages"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB002720, HPA014520, HPA048012"	Approved		Approved	"Golgi apparatus,Vesicles"			NA	NA			"Cluster 28: Neutrophils - Unknown function"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 12: Non-specific - Vasculature"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 29: Monocytes - Innate immune response"	41	"Golgi apparatus"	Vesicles	"CAB002720: , HPA014520: AB_1846337, HPA048012: "	"unprognostic (2.00e-2)"	"unprognostic (7.55e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.13e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.64e-2)"	"unprognostic (2.08e-3)"	"unprognostic (5.45e-2)"	"unprognostic (7.28e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.00e-1)"	"unprognostic (8.75e-3)"	"unprognostic (5.35e-2)"	"unprognostic (7.23e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.30e-1)"	"potential prognostic unfavorable (3.62e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.72e-2)"	"unprognostic (9.68e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.05e-2)"	"unprognostic (9.83e-3)"	"unprognostic (6.92e-3)"	"unprognostic (5.28e-2)"	"unprognostic (5.03e-2)"	"unprognostic (4.42e-2)"
CCR1	"CD191, CKR-1, CMKBR1, MIP1aR, SCYAR1"	ENSG00000163823	"C-C motif chemokine receptor 1"	P32246	3	46201711-46208313	"CD markers, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 41.4"	"Group enriched"	"Detected in some"	4	"Extravillous trophoblasts: 95.7;Hofbauer cells: 120.2;Kupffer cells: 154.3;Macrophages: 88.9"	"Cell type enriched"	"Detected in some"	5	"central nervous system macrophage: 44.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cancer enriched"	"Detected in some"	7	"Myeloma: 57.7"	"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Breast - Macrophages, Colon - Macrophages, Heart muscle - Macrophages, Liver - Kupffer cells, Minor Salivary Gland - Macrophages, Pituitary gland - Macrophages, Prostate - Macrophages, Skeletal muscle - Macrophages, Skin - Macrophages, Spleen - Macrophages, Stomach - Macrophages, Testis - Macrophages, Thyroid gland - Macrophages"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"										NA	NA			"Cluster 35: Neutrophils - Protein binding"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 58: Macrophages - Innate immune response"	235				"unprognostic (3.66e-1)"	"unprognostic (3.92e-1)"	"unprognostic (6.55e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.59e-1)"	"unprognostic (4.80e-2)"	"unprognostic (2.53e-1)"	"unprognostic (8.00e-2)"	"unprognostic (1.80e-1)"	"unprognostic (7.18e-2)"	"unprognostic (4.61e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.04e-3)"	"unprognostic (3.75e-2)"	"unprognostic (3.87e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.77e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.78e-2)"
CCR2	"CC-CKR-2, CD192, CKR2, CMKBR2, FLJ78302, MCP-1-R"	ENSG00000121807	"C-C motif chemokine receptor 2"	P41597	3	46353864-46360940	"CD markers, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"	"Host-virus interaction, Inflammatory response"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 23.8"	"Group enriched"	"Detected in some"	4	"dendritic cells: 60.6;Kupffer cells: 47.0;Langerhans cells: 16.5;Macrophages: 21.7;Plasma cells: 31.6"	"Cell type enriched"	"Detected in single"	60	"leukocyte: 30.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"basophil: 557.4"	"Low lineage specificity"	"Detected in all"			"Cancer enriched"	"Detected in some"	4	"Myeloma: 29.9"	"Breast - Plasma cells, Minor Salivary Gland - Plasma cells, Pituitary gland - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB003793, HPA063255"	Approved		Supported	"Nucleoli fibrillar center,Plasma membrane"			NA	NA			"Cluster 41: Basophils - Unknown function"	"Cluster 70: Lymphoid tissue - Immune response"		"Cluster 20: Myeloma - Immune response"	"Cluster 29: Monocytes - Innate immune response"	1	"Plasma membrane"	"Nucleoli fibrillar center"	"CAB003793: AB_344889, HPA063255: "	"unprognostic (1.86e-1)"	"unprognostic (1.05e-2)"	"unprognostic (7.54e-2)"	"unprognostic (2.92e-3)"		"unprognostic (1.45e-1)"		"unprognostic (2.66e-2)"			"unprognostic (6.41e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.21e-2)"		"unprognostic (8.66e-3)"	"potential prognostic favorable (5.21e-6)"	"unprognostic (1.77e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.19e-1)"		"unprognostic (4.11e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.18e-1)"			"unprognostic (7.17e-2)"	"unprognostic (1.09e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.22e-1)"	
CCR3	"CC-CKR-3, CD193, CKR3, CMKBR3"	ENSG00000183625	"C-C motif chemokine receptor 3"	P51677	3	46130890-46266706	"CD markers, G-protein coupled receptors, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 2.5;skeletal muscle: 1.7"	"Cell type enriched"	"Detected in some"	8	"Oocytes: 11.0"	"Cell type enhanced"	"Detected in single"		"central nervous system macrophage: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	25	"basophil: 3400.3;eosinophil: 2516.4"	"Lineage enriched"	"Detected in many"	109	"granulocytes: 3400.3"	"Cancer enriched"	"Detected in single"	4	"Myeloma: 3.2"		"Not detected"	"Not detected"							"CAB003795, HPA069514"	Uncertain		Approved	"Plasma membrane"			NA	NA			"Cluster 41: Basophils - Unknown function"	"Cluster 25: Small intestine - Absorption"		"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 74: Neutrophils - Degranulation"	3	"Plasma membrane"		"CAB003795: AB_562259, HPA069514: "						"unprognostic (1.24e-1)"											"unprognostic (1.73e-1)"		"unprognostic (2.05e-2)"							"unprognostic (4.53e-2)"					
CCR4	"CC-CKR-4, CD194, ChemR13, CKR4, CMKBR4, k5-5"	ENSG00000183813	"C-C motif chemokine receptor 4"	P51679	3	32951644-32956349	"CD markers, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 12.6;urinary bladder: 5.2"	"Cell type enriched"	"Detected in some"	5	"T-cells: 11.9"	"Cell type enriched"	"Detected in single"	5	"leukocyte: 2.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"T-reg: 60.8"	"Lineage enriched"	"Detected in many"	41	"T-cells: 60.8"	"Cancer enriched"	"Detected in some"	4	"lymphoma: 18.7"	"Adipose subcutaneous - T-cells, Breast - T-cells, Skin - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA031613	Approved		Supported	"Plasma membrane"			NA	NA			"Cluster 9: T-regs - Cell cycle regulation"	"Cluster 36: Lymphoid tissue - Cytokine signaling"	"Cluster 48: Non-specific - Mixed function"	"Cluster 59: Leukemia - T-cell receptor"	"Cluster 78: NK-cells & T-cells - Immune system & Transcription"	1	"Plasma membrane"		"HPA031613: AB_10601096"	"unprognostic (4.81e-3)"	"unprognostic (5.27e-3)"	"unprognostic (3.82e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.34e-1)"			"potential prognostic favorable (7.29e-7)"		"unprognostic (6.70e-3)"	"unprognostic (6.17e-2)"				"potential prognostic favorable (7.41e-4)"	"unprognostic (4.98e-1)"	"unprognostic (1.61e-2)"	"unprognostic (4.97e-2)"			"unprognostic (1.63e-1)"	"unprognostic (7.34e-3)"	"unprognostic (9.45e-2)"		"unprognostic (2.11e-2)"		"unprognostic (1.23e-1)"	"unprognostic (4.17e-3)"		"unprognostic (1.13e-2)"
CCR5	"CC-CKR-5, CD195, CKR-5, CKR5, CMKBR5, IDDM22"	ENSG00000160791	"C-C motif chemokine receptor 5"	P51681	3	46370946-46376206	"CD markers, Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"	"Host-virus interaction"	"G-protein coupled receptor, Host cell receptor for virus entry, Receptor, Transducer"	"Diabetes mellitus, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 15.0"	"Cell type enhanced"	"Detected in some"		"Kupffer cells: 7.3;Langerhans cells: 40.9;Macrophages: 14.3;T-cells: 13.0"	"Cell type enriched"	"Detected in some"	5	"leukocyte: 26.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 40.8"	"Low lineage specificity"	"Detected in many"			"Cancer enhanced"	"Detected in some"		"lymphoma: 1.5;Myeloma: 1.2"	"Lung - T-cells, Prostate - T-cells, Skin - T-cells, Spleen - T-cells, Stomach - T-cells"					"Low region specificity"	"Detected in all"										NA	NA			"Cluster 5: Non-specific - Cell proliferation"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 59: Leukemia - T-cell receptor"	"Cluster 29: Monocytes - Innate immune response"	10				"unprognostic (5.40e-2)"	"unprognostic (6.68e-3)"	"unprognostic (7.59e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.78e-1)"	"unprognostic (7.60e-2)"	"unprognostic (6.10e-2)"	"potential prognostic favorable (3.32e-4)"	"unprognostic (7.23e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.08e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.48e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.14e-2)"	"unprognostic (7.07e-2)"
CCR6	"BN-1, CD196, CKR-L3, CMKBR6, DCR2, DRY-6, GPR-CY4, GPR29, STRL22"	ENSG00000112486	"C-C motif chemokine receptor 6"	P51684	6	167111807-167139141	"CD markers, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 32.9"	"Group enriched"	"Detected in some"	6	"B-cells: 15.7;T-cells: 13.7"	"Cell type enhanced"	"Detected in many"		"leukocyte: 26.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"MAIT T-cell: 70.3;memory B-cell: 64.1;memory CD4 T-cell: 27.4;naive B-cell: 73.4;T-reg: 52.1"	"Group enriched"	"Detected in many"	5	"B-cells: 73.4;T-cells: 70.3"	"Cancer enhanced"	"Detected in some"		"liver cancer: 5.2"	"Adipose subcutaneous - T-cells, Prostate - T-cells, Spleen - B-cells (Spleen), Testis - Early spermatids, Testis - Late spermatids"	"Region enriched"	"Detected in single"	7	"basal ganglia: 1.8"	"Not detected"	"Not detected"			"CAB006820, HPA014488"	Approved						NA	NA			"Cluster 16: Non-specific - Cell proliferation"	"Cluster 36: Lymphoid tissue - Cytokine signaling"		"Cluster 18: Liver cancer - Metabolism"	"Cluster 7: T-cells - T-cell receptor"	8			"CAB006820: , HPA014488: AB_1846639"		"unprognostic (1.26e-1)"	"unprognostic (1.45e-1)"	"potential prognostic favorable (3.30e-4)"	"unprognostic (3.92e-2)"	"unprognostic (2.71e-2)"			"potential prognostic favorable (1.07e-4)"		"unprognostic (7.47e-2)"	"unprognostic (3.29e-1)"		"unprognostic (4.17e-1)"	"unprognostic (3.10e-1)"	"potential prognostic favorable (7.48e-4)"	"unprognostic (1.92e-1)"	"unprognostic (3.69e-2)"	"unprognostic (7.23e-2)"			"unprognostic (1.32e-1)"	"unprognostic (1.07e-1)"		"unprognostic (9.65e-3)"	"unprognostic (1.18e-1)"		"unprognostic (1.05e-1)"	"unprognostic (2.32e-2)"	"unprognostic (6.21e-2)"	
CCR7	"BLR2, CD197, CDw197, CMKBR7, EBI1"	ENSG00000126353	"C-C motif chemokine receptor 7"	P32248	17	40553769-40565472	"Cancer-related genes, CD markers, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 20.7;lymphoid tissue: 82.0"	"Cell type enhanced"	"Detected in some"		"B-cells: 167.8;Cytotrophoblasts: 150.8;Langerhans cells: 549.3;Syncytiotrophoblasts: 515.0;T-cells: 89.8"	"Cell type enriched"	"Detected in single"	27	"leukocyte: 12.9"	"Cancer enhanced"	"Detected in many"		"Bladder Urothelial Carcinoma (TCGA): 18.1"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"naive CD4 T-cell: 4611.8"	"Lineage enriched"	"Detected in all"	4	"T-cells: 4611.8"	"Cancer enriched"	"Detected in some"	7	"lymphoma: 140.8"		"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB003796, HPA031383, HPA074467"	Enhanced		Enhanced	Mitochondria			NA	NA			"Cluster 43: Non-specific - Transcription & Translation"	"Cluster 36: Lymphoid tissue - Cytokine signaling"	"Cluster 11: White matter - Signal transduction"	"Cluster 21: Lymphoma - Adaptive immune response"	"Cluster 14: Langerhans cells - Innate immune response"		Mitochondria		"CAB003796: AB_562261, HPA031383: AB_2673854, HPA074467: AB_2686693"	"unprognostic (1.99e-2)"	"unprognostic (2.21e-3)"	"unprognostic (2.26e-3)"	"potential prognostic favorable (1.71e-5)"	"unprognostic (1.70e-1)"	"unprognostic (1.42e-1)"		"unprognostic (2.03e-2)"	"potential prognostic favorable (3.90e-6)"		"unprognostic (8.97e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.06e-2)"	"validated prognostic favorable (5.23e-4)"	"validated prognostic favorable (7.77e-4)"	"potential prognostic favorable (5.37e-4)"	"unprognostic (7.34e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.02e-3)"		"unprognostic (4.25e-3)"	"unprognostic (7.77e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.62e-2)"	"unprognostic (5.29e-2)"	"unprognostic (5.01e-2)"	"unprognostic (3.80e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.57e-1)"
CCR8	"CDw198, CKR-L1, CMKBR8, CMKBRL2, CY6, GPR-CY6, TER1"	ENSG00000179934	"C-C motif chemokine receptor 8"	P51685	3	39329709-39333680	"CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"lymphoid tissue: 7.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	6	"T-reg: 25.8"	"Lineage enriched"	"Detected in single"	32	"T-cells: 25.8"	"Group enriched"	"Detected in some"	8	"Leukemia: 2.9;lymphoma: 4.4;testis cancer: 2.7"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA042383	Enhanced						NA	NA			"Cluster 9: T-regs - Cell cycle regulation"	"Cluster 71: Thymus - Adaptive immune response"		"Cluster 59: Leukemia - T-cell receptor"	"Cluster 78: NK-cells & T-cells - Immune system & Transcription"				"HPA042383: AB_2732497"		"unprognostic (2.09e-1)"	"unprognostic (1.38e-1)"			"unprognostic (3.80e-1)"			"unprognostic (1.10e-3)"								"unprognostic (1.01e-1)"		"unprognostic (6.27e-2)"				"unprognostic (5.04e-2)"			"unprognostic (4.96e-3)"			"unprognostic (1.99e-2)"		
CCR9	"CDw199, GPR-9-6, GPR28"	ENSG00000173585	"C-C motif chemokine receptor 9"	P51686	3	45884425-45903174	"CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"lymphoid tissue: 126.5"	"Group enriched"	"Detected in some"	5	"B-cells: 1.2;T-cells: 3.4"	"Cell type enriched"	"Detected in single"	15	"fibroblast: 8.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"memory B-cell: 24.3;naive B-cell: 15.7;T-reg: 8.2"	"Group enriched"	"Detected in many"	43	"B-cells: 24.3;T-cells: 8.2"	"Cancer enriched"	"Detected in single"	8	"Leukemia: 6.4"		"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB006839, HPA066879"	Uncertain		Approved	"Endoplasmic reticulum,Plasma membrane"			NA	NA			"Cluster 14: Non-specific - Unknown function"	"Cluster 71: Thymus - Adaptive immune response"	"Cluster 30: White matter - Myelination"	"Cluster 59: Leukemia - T-cell receptor"	"Cluster 78: NK-cells & T-cells - Immune system & Transcription"		"Plasma membrane"	"Endoplasmic reticulum"	"CAB006839: , HPA066879: "																															
CD101	"IGSF2, V7"	ENSG00000134256	"CD101 molecule"	Q93033	1	117001750-117036552	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 4.7;intestine: 6.1;lung: 6.5"	"Cell type enhanced"	"Detected in some"		"Kupffer cells: 5.9;Langerhans cells: 4.7;Macrophages: 7.8;monocytes: 24.7;T-cells: 6.0"	"Cell type enhanced"	"Detected in many"		"leukocyte: 18.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 97.1"	"Group enriched"	"Detected in many"	18	"dendritic cells: 33.8;granulocytes: 97.1;monocytes: 53.4"	"Low cancer specificity"	"Detected in some"				"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA049527, HPA057763"	Approved		Uncertain	Mitochondria			NA	NA		5600000	"Cluster 25: Non-specific - Unknown function"	"Cluster 25: Small intestine - Absorption"	"Cluster 53: Neurons - Mixed function"	"Cluster 49: HMC-1 - Innate immune response"	"Cluster 58: Macrophages - Innate immune response"	1	Mitochondria		"HPA049527: , HPA057763: AB_2683519"		"unprognostic (1.58e-1)"	"unprognostic (3.42e-2)"	"unprognostic (8.00e-2)"		"unprognostic (2.93e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.94e-3)"	"unprognostic (1.58e-1)"			"unprognostic (2.50e-1)"				"unprognostic (2.79e-3)"	"unprognostic (2.06e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.28e-1)"			"unprognostic (2.90e-1)"	"unprognostic (1.68e-1)"			"unprognostic (2.09e-2)"		"unprognostic (3.23e-1)"			"unprognostic (3.42e-1)"
CD109	"CPAMD7, DKFZp762L1111, FLJ38569"	ENSG00000156535	"CD109 molecule"	Q6YHK3	6	73695785-73828316	"CD markers, Plasma proteins, Predicted membrane proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	17	"parathyroid gland: 319.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 63.9;Basal keratinocytes: 40.5;Basal respiratory cells: 56.5;Basal squamous epithelial cells: 51.2;Squamous epithelial cells: 46.6"	"Group enriched"	"Detected in many"	6	"astrocyte: 107.9;endothelial cell: 116.4;ependymal cell: 153.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Endothelial cells, Liver - Hepatic stellate cells, Prostate - Endothelial cells, Testis - Early spermatids, Thyroid gland - Fibroblasts"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA008992, HPA015723"	Enhanced		Supported	"Plasma membrane,Cytosol"			NA	NA		170000000		"Cluster 24: Parathyroid gland - Vesicular transport"	"Cluster 39: Astrocytes - Mixed function"	"Cluster 69: Skin cancer - ECM organization"	"Cluster 12: Squamous epithelial cells - Keratinization"	4	"Plasma membrane"	Cytosol	"HPA008992: , HPA015723: AB_2732415"	"unprognostic (1.68e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.81e-2)"	"unprognostic (6.52e-3)"	"unprognostic (1.34e-2)"	"potential prognostic unfavorable (3.99e-4)"	"unprognostic (2.36e-1)"	"unprognostic (2.64e-1)"	"unprognostic (9.11e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.29e-3)"	"unprognostic (2.23e-2)"	"potential prognostic unfavorable (1.21e-6)"	"unprognostic (6.69e-3)"	"unprognostic (7.59e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.11e-2)"	"potential prognostic unfavorable (8.91e-4)"	"unprognostic (1.52e-3)"	"unprognostic (7.55e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.70e-3)"	"unprognostic (1.88e-1)"	"potential prognostic unfavorable (2.81e-4)"	"unprognostic (1.86e-1)"	"unprognostic (1.31e-1)"	"unprognostic (6.75e-2)"
CD14		ENSG00000170458	"CD14 molecule"	P08571	5	140631728-140633700	"Cancer-related genes, CD markers, Human disease related genes, Plasma proteins, Predicted secreted proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 347.3"	"Cell type enriched"	"Detected in many"	4	"Hofbauer cells: 2936.8"	"Cell type enriched"	"Detected in many"	12	"central nervous system macrophage: 162.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"classical monocyte: 3500.8"	"Group enriched"	"Detected in all"	6	"granulocytes: 935.1;monocytes: 3500.8"	"Cancer enhanced"	"Detected in many"		"breast cancer: 11.9;head and neck cancer: 9.9"	"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Colon - Macrophages, Heart muscle - Macrophages, Kidney - Macrophages, Liver - Hepatocytes, Pancreas - Macrophages, Pituitary gland - Macrophages, Prostate - Macrophages, Skeletal muscle - Macrophages, Spleen - Macrophages, Stomach - Macrophages, Thyroid gland - Macrophages"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001887, HPA002127, CAB033631, CAB072865, CAB072866"	Enhanced		Approved	Vesicles	"Secreted to blood"	Immunity	NA	NA	2750000000	5800000000	"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 11: Liver - Plasma proteins"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 27: Breast cancer - Unknown function"	"Cluster 58: Macrophages - Innate immune response"	7	Vesicles		"CAB033631: AB_781932, CAB072865: AB_2665714, CAB072866: AB_2665715, HPA001887: AB_1078442, HPA002127: AB_1078440"	"unprognostic (1.54e-1)"	"unprognostic (2.46e-1)"	"unprognostic (4.70e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.55e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.46e-2)"	"unprognostic (5.41e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.04e-3)"	"unprognostic (4.92e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.78e-3)"	"potential prognostic favorable (5.22e-5)"	"unprognostic (1.08e-1)"	"unprognostic (3.00e-2)"	"potential prognostic unfavorable (5.06e-4)"	"unprognostic (6.18e-2)"	"unprognostic (4.14e-3)"	"unprognostic (2.80e-1)"	"unprognostic (4.39e-2)"	"unprognostic (5.05e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.35e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.77e-3)"	"unprognostic (7.17e-2)"	"unprognostic (8.64e-2)"
CD151	"PETA-3, RAPH, SFA-1, TSPAN24"	ENSG00000177697	"CD151 molecule (Raph blood group)"	P48509	11	832887-839831	"Blood group antigen proteins, CD markers, Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Blood group antigen"	"Deafness, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"endothelial cell: 72.8;pericyte: 165.3;vascular associated smooth muscle cell: 190.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Spleen - Fibroblast_1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002428, HPA011906"	Supported						NA	NA			"Cluster 25: Non-specific - Unknown function"	"Cluster 41: Smooth muscle tissue - ECM organization"	"Cluster 12: Non-specific - Vasculature"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 45: Non-specific - Mixed function"	38			"CAB002428: AB_564129, HPA011906: AB_1846245"	"unprognostic (2.89e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.06e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.08e-1)"	"unprognostic (9.24e-3)"	"potential prognostic unfavorable (9.68e-5)"	"unprognostic (1.95e-2)"	"unprognostic (5.89e-2)"	"unprognostic (5.69e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.33e-1)"	"potential prognostic unfavorable (2.34e-4)"	"unprognostic (1.76e-2)"	"unprognostic (7.63e-2)"	"unprognostic (3.47e-2)"	"potential prognostic unfavorable (1.51e-5)"	"unprognostic (3.53e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.09e-3)"	"unprognostic (3.12e-1)"	"unprognostic (2.39e-1)"	"unprognostic (5.69e-2)"	"unprognostic (4.82e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.50e-1)"
CD160	"BY55, NK1, NK28"	ENSG00000117281	"CD160 molecule"	O95971	1	145719471-145739288	"CD markers, Predicted secreted proteins"	"Adaptive immunity, Angiogenesis, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 5.1;brain: 14.5;intestine: 4.5;liver: 4.9;lymphoid tissue: 13.1"	"Cell type enriched"	"Detected in some"	4	"NK-cells: 216.3"	"Cell type enriched"	"Detected in many"	9	"leukocyte: 30.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"gdT-cell: 108.0;MAIT T-cell: 44.6;memory CD8 T-cell: 73.0;naive CD8 T-cell: 83.2;NK-cell: 86.1"	"Group enriched"	"Detected in all"	8	"NK-cells: 86.1;T-cells: 108.0"	"Low cancer specificity"	"Detected in many"			"Liver - NK-cells (Liver)"	"Not detected"	"Not detected"												"Secreted to blood"	Receptor	NA	NA	3130000		"Cluster 15: NK-cells - Unknown function"	"Cluster 16: Non-specific - Transcription"	"Cluster 15: Non-specific - Transcription"	"Cluster 59: Leukemia - T-cell receptor"	"Cluster 19: NK-cells - Adaptive immune response"	8						"unprognostic (7.98e-2)"	"unprognostic (1.61e-1)"		"unprognostic (5.65e-2)"					"unprognostic (5.74e-2)"	"unprognostic (4.54e-2)"	"unprognostic (2.34e-1)"		"unprognostic (1.03e-1)"		"unprognostic (4.90e-2)"		"unprognostic (1.36e-1)"							"unprognostic (1.62e-2)"		"unprognostic (3.73e-2)"	"unprognostic (5.94e-2)"		
CD163	"M130, MM130, SCARI1"	ENSG00000177575	"CD163 molecule"	Q86VB7	12	7470811-7503893	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Acute phase, Inflammatory response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 234.7"	"Group enriched"	"Detected in many"	4	"Kupffer cells: 1630.5;Macrophages: 624.9"	"Cell type enriched"	"Detected in some"	6	"central nervous system macrophage: 33.5"	"Cancer enhanced"	"Detected in all"		"Glioblastoma Multiforme (TCGA): 100.8"	"Region enhanced"	"Detected in all"		"thalamus: 112.0"	"Group enriched"	"Detected in many"	11	"classical monocyte: 76.1;myeloid DC: 65.3"	"Group enriched"	"Detected in many"	40	"dendritic cells: 65.3;monocytes: 76.1"	"Cancer enriched"	"Detected in single"	9	"lymphoma: 6.1"	"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Breast - Macrophages, Colon - Macrophages, Heart muscle - Macrophages, Kidney - Macrophages, Liver - Kupffer cells, Lung - Macrophages, Minor Salivary Gland - Macrophages, Pancreas - Macrophages, Pituitary gland - Macrophages, Prostate - Macrophages, Skeletal muscle - Macrophages, Skin - Macrophages, Spleen - Macrophages, Stomach - Macrophages, Thyroid gland - Macrophages"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB002432, HPA046404, HPA051974"	Enhanced		Supported	"Plasma membrane"	"Secreted to blood"	"Acute phase"	NA	NA	903000000	970000000	"Cluster 26: Monocytes - Plasma membrane proteins"	"Cluster 57: Lung - Lung function"	"Cluster 12: Non-specific - Vasculature"	"Cluster 71: Lymphoma - Inflammatory response"	"Cluster 58: Macrophages - Innate immune response"	2	"Plasma membrane"		"CAB002432: AB_563510, HPA046404: AB_2679655, HPA051974: AB_2681678"	"unprognostic (3.36e-1)"	"unprognostic (3.58e-1)"	"unprognostic (2.24e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.11e-1)"	"unprognostic (4.46e-2)"	"unprognostic (2.02e-3)"	"unprognostic (3.39e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.50e-1)"	"unprognostic (5.02e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.71e-2)"	"unprognostic (8.19e-2)"	"potential prognostic unfavorable (7.35e-5)"	"unprognostic (2.18e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.10e-2)"	"unprognostic (3.43e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.06e-2)"	"unprognostic (5.84e-3)"	"unprognostic (1.95e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.67e-2)"
CD163L1	"CD163B, M160, SCARI2, WC1"	ENSG00000177675	"CD163 molecule like 1"	Q9NR16	12	7346685-7479897	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 21.3;lymphoid tissue: 31.0"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 28.5;Breast myoepithelial cells: 17.9;Excitatory neurons: 18.2;Inhibitory neurons: 15.9;Lymphatic endothelial cells: 13.8;Melanocytes: 24.0"	"Cell type enhanced"	"Detected in many"		"lower rhombic lip: 50.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Minor Salivary Gland - Macrophages, Spleen - Macrophages, Stomach - Macrophages, Testis - Early spermatids"									HPA015663	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol	"Intracellular and membrane"	"No annotated function"	NA	NA		430000		"Cluster 25: Small intestine - Absorption"	"Cluster 52: Neurons & Synapses - Synaptic function"	"Cluster 72: Neuronal - Signal transduction"	"Cluster 17: Breast glandular cells - Lactation"		"Centrosome, Cytosol"	Nucleoplasm	"HPA015663: AB_2072575"	"unprognostic (1.51e-1)"	"potential prognostic unfavorable (1.07e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.18e-2)"	"unprognostic (5.16e-3)"	"unprognostic (1.93e-1)"		"unprognostic (1.60e-1)"	"unprognostic (4.27e-1)"		"unprognostic (2.20e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.64e-2)"	"unprognostic (3.12e-1)"		"unprognostic (1.86e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.62e-2)"	"unprognostic (3.60e-2)"		"unprognostic (5.89e-2)"	"unprognostic (2.20e-1)"		"unprognostic (5.96e-3)"
CD164	"DFNA66, MGC-24, MUC-24"	ENSG00000135535	"CD164 molecule"	Q04900	6	109366514-109382467	"CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Myogenesis"		"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 751.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010636	Approved				"Intracellular and membrane"	"Cell adhesion"	NA	NA			"Cluster 5: Non-specific - Cell proliferation"	"Cluster 55: Kidney & Intestine - Metabolism"	"Cluster 21: Non-specific - Metabolism"	"Cluster 28: Non-specific - Nuclear processes"	"Cluster 58: Macrophages - Innate immune response"	3			"HPA010636: AB_1078447"	"unprognostic (1.70e-2)"	"potential prognostic unfavorable (9.91e-4)"	"unprognostic (2.61e-3)"	"unprognostic (3.17e-2)"	"unprognostic (8.70e-2)"	"unprognostic (3.42e-3)"	"unprognostic (9.90e-2)"	"potential prognostic unfavorable (2.60e-4)"	"unprognostic (1.52e-2)"	"unprognostic (5.28e-3)"	"potential prognostic favorable (1.09e-7)"	"unprognostic (1.05e-2)"	"unprognostic (1.10e-1)"	"potential prognostic unfavorable (7.57e-4)"	"unprognostic (6.16e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.95e-2)"	"unprognostic (8.61e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.96e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.60e-1)"
CD180	"LY64, Ly78, RP105"	ENSG00000134061	"CD180 molecule"	Q99467	5	67179613-67196799	"CD markers, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 22.7"	"Cell type enhanced"	"Detected in some"		"B-cells: 55.8;Hofbauer cells: 68.8;Kupffer cells: 22.8;Macrophages: 19.6;Plasma cells: 52.2"	"Group enriched"	"Detected in some"	5	"central nervous system macrophage: 17.2;leukocyte: 5.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 77.2;naive B-cell: 79.2"	"Group enriched"	"Detected in many"	25	"B-cells: 79.2;dendritic cells: 23.5;monocytes: 34.7"	"Group enriched"	"Detected in some"	4	"lymphoma: 19.2;Myeloma: 11.7"	"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Breast - Plasma cells, Colon - Macrophages, Heart muscle - Macrophages, Liver - Kupffer cells, Lung - Macrophages, Skeletal muscle - Macrophages, Thyroid gland - Macrophages"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA003740	Enhanced		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Mitotic spindle"			Yes	NA			"Cluster 23: B-cells - Immunoglobulins"	"Cluster 36: Lymphoid tissue - Cytokine signaling"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 73: B-cells - B-cell function"	3	"Plasma membrane"	"Nucleoplasm, Nucleoli, Mitotic spindle"	"HPA003740: AB_1078450"	"unprognostic (1.08e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.27e-2)"		"unprognostic (3.61e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.15e-1)"			"unprognostic (6.05e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.91e-1)"		"unprognostic (3.30e-1)"	"unprognostic (1.16e-2)"	"unprognostic (4.80e-2)"	"unprognostic (3.87e-2)"	"unprognostic (9.02e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.29e-1)"	"unprognostic (2.07e-1)"	"unprognostic (5.95e-2)"			"unprognostic (2.19e-2)"		"unprognostic (1.21e-1)"	"unprognostic (2.83e-2)"		"unprognostic (3.22e-1)"
CD19		ENSG00000177455	"CD19 molecule"	P15391	16	28931965-28939342	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins"	"Adaptive immunity, Immunity"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"intestine: 32.1;lymphoid tissue: 73.1"	"Cell type enhanced"	"Detected in some"		"B-cells: 128.5;Early spermatids: 52.8;Plasma cells: 27.6"	"Cell type enhanced"	"Detected in some"		"central nervous system macrophage: 1.0;endothelial cell: 1.2;leukocyte: 1.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	81	"memory B-cell: 138.6;naive B-cell: 172.5"	"Lineage enriched"	"Detected in many"	90	"B-cells: 172.5"	"Group enriched"	"Detected in some"	13	"Leukemia: 37.8;lymphoma: 71.1"	"Liver - T-cells, Lung - B-cells (Lung), Minor Salivary Gland - Plasma cells, Spleen - B-cells (Spleen), Testis - Early spermatids, Testis - Late spermatids"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB016110	Enhanced						NA	NA			"Cluster 23: B-cells - Immunoglobulins"	"Cluster 70: Lymphoid tissue - Immune response"		"Cluster 6: Leukemia - Signal transduction"	"Cluster 73: B-cells - B-cell function"	7			"CAB016110: AB_626952"	"unprognostic (3.23e-1)"	"potential prognostic favorable (7.75e-5)"	"unprognostic (3.31e-2)"			"unprognostic (1.01e-1)"			"potential prognostic favorable (1.36e-5)"						"unprognostic (3.05e-1)"	"potential prognostic favorable (1.29e-4)"	"unprognostic (4.37e-2)"	"unprognostic (3.62e-1)"	"unprognostic (3.03e-1)"			"unprognostic (1.93e-1)"						"unprognostic (2.59e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.38e-1)"	
CD1A	CD1	ENSG00000158477	"CD1a molecule"	P06126	1	158254424-158258269	"CD markers, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"lymphoid tissue: 309.8"	"Cell type enriched"	"Detected in some"	15	"Langerhans cells: 204.7"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Lung Adenocarcinoma (TCGA): 8.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	25	"classical monocyte: 6.4;intermediate monocyte: 4.2;memory B-cell: 10.2;myeloid DC: 11.4;naive B-cell: 5.3"	"Group enriched"	"Detected in many"	37	"B-cells: 10.2;dendritic cells: 11.4;monocytes: 6.4"	"Cancer enriched"	"Detected in single"	16	"Leukemia: 13.5"						"Not detected"	"Not detected"			"CAB000009, HPA010734"	Enhanced						NA	NA		10000	"Cluster 2: Dendritic cells - Unknown function"	"Cluster 71: Thymus - Adaptive immune response"		"Cluster 59: Leukemia - T-cell receptor"	"Cluster 28: Dendritic cells - Antigen presentation"	1			"CAB000009: AB_2073290, HPA010734: AB_1078452"	"unprognostic (1.19e-1)"	"potential prognostic favorable (6.98e-5)"	"unprognostic (2.53e-2)"	"unprognostic (1.02e-3)"					"unprognostic (1.40e-2)"							"unprognostic (2.09e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.10e-2)"		"unprognostic (2.35e-2)"	"unprognostic (2.55e-2)"				"unprognostic (1.36e-1)"			"unprognostic (2.40e-1)"	
CD1B	CD1	ENSG00000158485	"CD1b molecule"	P29016	1	158327951-158331531	"CD markers, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	157	"lymphoid tissue: 515.3"	"Cell type enriched"	"Detected in some"	35	"Langerhans cells: 200.2"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	6	"myeloid DC: 19.2"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 19.2"	"Cancer enriched"	"Detected in single"	487	"Leukemia: 48.7"						"Low region specificity"	"Detected in all"			HPA021824	Approved		Approved	"Golgi apparatus,Vesicles,Cytosol"			NA	NA		20000	"Cluster 2: Dendritic cells - Unknown function"	"Cluster 71: Thymus - Adaptive immune response"		"Cluster 59: Leukemia - T-cell receptor"	"Cluster 28: Dendritic cells - Antigen presentation"	21	"Golgi apparatus, Vesicles"	Cytosol	"HPA021824: AB_1846262"			"unprognostic (2.65e-3)"													"unprognostic (3.00e-3)"	"unprognostic (3.68e-2)"		"unprognostic (9.40e-2)"										"unprognostic (2.78e-1)"		
CD1C	CD1	ENSG00000158481	"CD1c molecule"	P29017	1	158289923-158294774	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"lymphoid tissue: 126.9"	"Cell type enriched"	"Detected in some"	9	"Langerhans cells: 743.3"	"Cell type enriched"	"Detected in single"	20	"leukocyte: 2.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"memory B-cell: 84.5;myeloid DC: 325.4"	"Group enriched"	"Detected in many"	8	"B-cells: 84.5;dendritic cells: 325.4"	"Group enriched"	"Detected in some"	46	"Leukemia: 5.3;lymphoma: 7.2"	"Liver - T-cells, Skin - Langerhans cells, Spleen - B-cells (Spleen), Thyroid gland - T-cells"									HPA068359			Approved	"Endoplasmic reticulum,Golgi apparatus,Vesicles"			NA	NA		250000	"Cluster 2: Dendritic cells - Unknown function"	"Cluster 71: Thymus - Adaptive immune response"		"Cluster 59: Leukemia - T-cell receptor"	"Cluster 28: Dendritic cells - Antigen presentation"	2	"Golgi apparatus, Vesicles"	"Endoplasmic reticulum"	"HPA068359: "	"unprognostic (9.36e-3)"	"unprognostic (2.16e-3)"	"unprognostic (1.12e-3)"	"unprognostic (6.73e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.73e-1)"			"unprognostic (3.13e-2)"		"potential prognostic favorable (9.51e-5)"	"unprognostic (3.24e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.38e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.35e-3)"	"unprognostic (3.40e-2)"	"unprognostic (9.56e-2)"	"unprognostic (2.10e-1)"			"unprognostic (8.10e-2)"	"unprognostic (4.92e-2)"	"unprognostic (3.67e-1)"	"unprognostic (6.64e-2)"	"unprognostic (2.01e-2)"	"unprognostic (3.33e-1)"	"unprognostic (8.25e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.34e-1)"	"unprognostic (8.04e-2)"
CD1D		ENSG00000158473	"CD1d molecule"	P15813	1	158178030-158186427	"Cancer-related genes, CD markers, Predicted membrane proteins"	"Immunity, Innate immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"intestine: 17.7;liver: 15.0;lymphoid tissue: 23.4"	"Cell type enhanced"	"Detected in some"		"B-cells: 20.3;Hofbauer cells: 30.4;Kupffer cells: 50.2;Macrophages: 33.8;monocytes: 13.2"	"Group enriched"	"Detected in some"	6	"central nervous system macrophage: 2.0;leukocyte: 4.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"classical monocyte: 139.1;intermediate monocyte: 63.8;myeloid DC: 139.4"	"Group enriched"	"Detected in many"	8	"dendritic cells: 139.4;monocytes: 139.1"	"Cancer enhanced"	"Detected in some"		"Leukemia: 3.3;lymphoma: 2.1"		"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB016107, HPA072662"	Enhanced		Supported	"Endoplasmic reticulum"			NA	NA		600000	"Cluster 26: Monocytes - Plasma membrane proteins"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 8: Immune cells - Immune response"	"Cluster 59: Leukemia - T-cell receptor"	"Cluster 29: Monocytes - Innate immune response"		"Endoplasmic reticulum"		"CAB016107: AB_626960, HPA072662: AB_2686545"			"unprognostic (1.37e-3)"			"unprognostic (1.42e-1)"	"unprognostic (4.25e-2)"	"unprognostic (4.24e-2)"			"unprognostic (1.82e-2)"	"unprognostic (3.93e-2)"	"unprognostic (7.10e-2)"	"unprognostic (3.40e-1)"	"unprognostic (3.09e-3)"	"potential prognostic favorable (9.72e-5)"	"unprognostic (3.34e-1)"		"unprognostic (4.01e-2)"			"unprognostic (2.09e-2)"	"unprognostic (2.57e-2)"			"unprognostic (1.97e-1)"			"unprognostic (8.45e-2)"	"unprognostic (1.97e-2)"	
CD1E		ENSG00000158488	"CD1e molecule"	P15812	1	158353696-158357553	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	69	"lymphoid tissue: 937.7"	"Cell type enriched"	"Detected in some"	19	"Langerhans cells: 750.6"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	14	"myeloid DC: 62.6"	"Lineage enriched"	"Detected in many"	14	"dendritic cells: 62.6"	"Cancer enriched"	"Detected in single"	433	"Leukemia: 66.8"	"Skin - Langerhans cells"					"Not detected"	"Not detected"			"HPA057769, HPA070634"	Uncertain		Supported	"Nucleoli,Golgi apparatus"	"Intracellular and membrane"	Immunity	NA	NA			"Cluster 2: Dendritic cells - Unknown function"	"Cluster 71: Thymus - Adaptive immune response"		"Cluster 59: Leukemia - T-cell receptor"	"Cluster 28: Dendritic cells - Antigen presentation"		"Golgi apparatus"	Nucleoli	"HPA057769: AB_2683522, HPA070634: "	"unprognostic (3.02e-1)"	"unprognostic (5.66e-3)"	"unprognostic (1.69e-3)"	"potential prognostic favorable (9.58e-5)"		"unprognostic (9.36e-2)"			"unprognostic (2.47e-2)"		"potential prognostic favorable (1.69e-5)"	"unprognostic (7.09e-3)"	"unprognostic (7.12e-2)"		"unprognostic (1.12e-1)"	"unprognostic (1.36e-3)"	"unprognostic (3.02e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.09e-2)"	"unprognostic (2.42e-1)"		"unprognostic (3.01e-1)"	"unprognostic (2.05e-2)"	"unprognostic (4.71e-2)"	"unprognostic (5.37e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.56e-1)"
CD2	SRBC	ENSG00000116824	"CD2 molecule"	P06729	1	116754430-116769229	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"lymphoid tissue: 243.3"	"Group enriched"	"Detected in many"	11	"NK-cells: 199.5;T-cells: 483.9"	"Cell type enriched"	"Detected in some"	242	"leukocyte: 345.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	6	"gdT-cell: 422.7;MAIT T-cell: 403.9;memory CD4 T-cell: 611.9;memory CD8 T-cell: 713.9;naive CD4 T-cell: 317.2;naive CD8 T-cell: 487.5;NK-cell: 1110.8;T-reg: 656.9"	"Group enriched"	"Detected in all"	10	"NK-cells: 1110.8;T-cells: 713.9"	"Group enriched"	"Detected in some"	66	"Leukemia: 11.8;lymphoma: 12.5"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Adrenal gland - T-cells, Breast - T-cells, Colon - T-cells, Kidney - T-cells, Liver - T-cells, Lung - T-cells, Minor Salivary Gland - T-cells, Pancreas - T-cells, Pituitary gland - T-cells, Prostate - T-cells, Skin - T-cells, Spleen - T-cells, Stomach - T-cells, Testis - Early spermatids, Testis - Late spermatids, Thyroid gland - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB002430, HPA003883"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane"			NA	NA			"Cluster 1: T-cells - Unknown function"	"Cluster 71: Thymus - Adaptive immune response"	"Cluster 8: Immune cells - Immune response"	"Cluster 59: Leukemia - T-cell receptor"	"Cluster 78: NK-cells & T-cells - Immune system & Transcription"	15	"Plasma membrane"	"Nucleoplasm, Golgi apparatus"	"CAB002430: AB_442057, HPA003883: AB_1846263"	"unprognostic (7.62e-3)"	"unprognostic (1.57e-3)"	"unprognostic (3.33e-2)"	"unprognostic (3.23e-3)"	"unprognostic (8.33e-2)"	"unprognostic (9.51e-2)"	"unprognostic (3.03e-2)"	"unprognostic (9.52e-2)"	"potential prognostic favorable (3.95e-4)"	"unprognostic (3.29e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.54e-2)"	"unprognostic (8.61e-3)"	"unprognostic (4.64e-3)"	"unprognostic (3.01e-3)"	"unprognostic (6.71e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.74e-2)"	"unprognostic (4.93e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.87e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.49e-1)"	"potential prognostic favorable (1.87e-4)"	"unprognostic (1.35e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.15e-1)"
CD200	"MOX1, MOX2, MRC, OX-2"	ENSG00000091972	"CD200 molecule"	P41217	3	112332347-112362812	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 63.8"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 52.6;Inhibitory neurons: 53.2;Lymphatic endothelial cells: 79.1;Mesothelial cells: 88.0;Syncytiotrophoblasts: 72.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	16	"memory B-cell: 30.8;naive B-cell: 83.8"	"Lineage enriched"	"Detected in many"	23	"B-cells: 83.8"	"Cancer enhanced"	"Detected in many"		"Neuroblastoma: 21.0;skin cancer: 31.2"	"Adipose visceral - Mesothelial cells, Breast - Breast myoepithelial cells, Kidney - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031149	Approved						NA	NA		12000	"Cluster 34: B-cells - Unknown function"	"Cluster 64: Neuronal - Transcription"	"Cluster 56: Hypothalamus - Neuropeptide signaling"	"Cluster 69: Skin cancer - ECM organization"	"Cluster 54: Lymphatic endothelial cells - Lymph vessel development"	1			"HPA031149: AB_10600694"	"unprognostic (8.08e-2)"	"unprognostic (3.72e-1)"	"unprognostic (9.64e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.97e-1)"	"unprognostic (9.31e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.26e-1)"	"potential prognostic favorable (1.29e-4)"	"unprognostic (3.00e-2)"	"unprognostic (1.93e-2)"	"unprognostic (7.66e-2)"	"unprognostic (4.69e-2)"	"unprognostic (6.45e-2)"	"unprognostic (9.30e-2)"	"unprognostic (7.03e-2)"	"unprognostic (4.07e-2)"	"unprognostic (8.57e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.34e-2)"	"unprognostic (4.49e-1)"	"unprognostic (7.27e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.80e-1)"	"unprognostic (5.61e-2)"	"unprognostic (3.87e-3)"	"unprognostic (2.23e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.51e-2)"
CD207	"CLEC4K, Langerin"	ENSG00000116031	"CD207 molecule"	Q9UJ71	2	70830211-70835816	"CD markers, Disease related genes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skin 1: 85.4"	"Group enriched"	"Detected in some"	4	"Langerhans cells: 15.1;Macrophages: 13.7"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Lung Adenocarcinoma (TCGA): 10.7"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	12	"myeloid DC: 1.1"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 1.1"	"Cancer enhanced"	"Detected in some"		"Bone cancer: 1.3"	"Testis - Early spermatids, Testis - Late spermatids"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002222, HPA011216"	Enhanced		Uncertain	Cytosol			No	NA				"Cluster 13: Skin - Cornification"		"Cluster 12: Bone cancer - Neuronal signaling"	"Cluster 28: Dendritic cells - Antigen presentation"	8	Cytosol		"CAB002222: AB_563850, HPA011216: AB_1078453"	"unprognostic (3.24e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.47e-2)"				"unprognostic (2.17e-3)"	"unprognostic (1.76e-1)"		"potential prognostic favorable (9.63e-7)"	"unprognostic (3.17e-3)"	"unprognostic (2.39e-2)"			"unprognostic (1.39e-3)"	"unprognostic (2.60e-1)"	"unprognostic (9.94e-2)"	"unprognostic (2.63e-1)"	"unprognostic (6.87e-2)"	"unprognostic (9.69e-3)"	"unprognostic (2.28e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.21e-1)"		"unprognostic (4.94e-2)"	"unprognostic (4.60e-1)"			"unprognostic (2.99e-1)"	"unprognostic (1.31e-1)"
CD209	"CDSIGN, CLEC4L, DC-SIGN, DC-SIGN1, hDC-SIGN"	ENSG00000090659	"CD209 molecule"	Q9NNX6	19	7739993-7747564	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Cell adhesion, Endocytosis, Host-virus interaction, Immunity, Innate immunity"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 33.0;placenta: 22.0"	"Group enriched"	"Detected in some"	4	"Kupffer cells: 12.9;Langerhans cells: 14.9;Macrophages: 22.9"	"Cell type enhanced"	"Detected in single"		"central nervous system macrophage: 1.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 1.4;intermediate monocyte: 1.4;myeloid DC: 1.2"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.2;monocytes: 1.4"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 1.0"	"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Breast - Macrophages, Colon - Macrophages, Heart muscle - Macrophages, Kidney - Macrophages, Liver - Kupffer cells, Minor Salivary Gland - Macrophages, Skeletal muscle - Macrophages, Thyroid gland - Macrophages"									"CAB032436, CAB033831"	Supported				"Intracellular and membrane"	Receptor	NA	NA		16000000	"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 57: Lung - Lung function"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 58: Macrophages - Innate immune response"	6			"CAB032436: AB_639039, CAB033831: AB_1121347"	"unprognostic (2.52e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.46e-3)"	"unprognostic (1.64e-2)"	"unprognostic (5.23e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.23e-1)"	"unprognostic (3.52e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.70e-1)"	"unprognostic (9.00e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.55e-2)"		"unprognostic (1.13e-1)"	"unprognostic (3.25e-3)"		"unprognostic (7.59e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.12e-2)"		"unprognostic (1.26e-1)"
CD22	"SIGLEC-2, SIGLEC2"	ENSG00000012124	"CD22 molecule"	P20273	19	35319261-35347361	"CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 223.3;ovary: 123.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 155.6;granulocytes: 71.4;Granulosa cells: 52.3;Oligodendrocytes: 85.2;Ovarian stromal cells: 46.7;Secretory cells: 34.6"	"Group enriched"	"Detected in many"	30	"committed oligodendrocyte precursor: 159.9;oligodendrocyte: 290.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	24	"memory B-cell: 97.9;naive B-cell: 120.7"	"Lineage enriched"	"Detected in many"	26	"B-cells: 120.7"	"Group enriched"	"Detected in many"	9	"Leukemia: 48.4;lymphoma: 193.5"	"Colon - Mast cells, Spleen - B-cells (Spleen)"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB002418, HPA024353, HPA066523"	Enhanced						NA	NA		4400	"Cluster 23: B-cells - Immunoglobulins"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 11: White matter - Signal transduction"	"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 73: B-cells - B-cell function"	9			"CAB002418: AB_563529, HPA024353: AB_10600695, HPA066523: "	"unprognostic (6.63e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.65e-2)"	"unprognostic (9.99e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.33e-2)"	"unprognostic (8.98e-3)"	"unprognostic (5.14e-2)"	"unprognostic (4.21e-2)"	"unprognostic (6.39e-2)"	"unprognostic (7.23e-2)"	"unprognostic (3.04e-1)"	"unprognostic (8.42e-2)"	"unprognostic (2.48e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.32e-1)"	"unprognostic (6.57e-2)"	"unprognostic (8.29e-3)"	"potential prognostic favorable (9.77e-4)"	"unprognostic (1.09e-3)"	"unprognostic (1.52e-2)"	"unprognostic (1.88e-1)"	"unprognostic (8.74e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.93e-2)"
CD226	"DNAM-1, DNAM1, PTA1, TLiSA1"	ENSG00000150637	"CD226 molecule"	Q15762	18	69831158-69961803	"CD markers, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"lymphoid tissue: 19.7;parathyroid gland: 60.5"	"Cell type enhanced"	"Detected in many"		"Microglial cells: 21.5;NK-cells: 101.6;Oligodendrocytes: 24.7;Schwann cells: 29.5;T-cells: 54.6"	"Cell type enhanced"	"Detected in all"		"leukocyte: 317.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"gdT-cell: 36.7;MAIT T-cell: 13.4;memory CD4 T-cell: 28.9;memory CD8 T-cell: 22.5;naive CD4 T-cell: 15.8;naive CD8 T-cell: 17.4;NK-cell: 29.7;T-reg: 11.3"	"Group enriched"	"Detected in many"	11	"NK-cells: 29.7;T-cells: 36.7"	"Group enriched"	"Detected in some"	6	"Leukemia: 8.2;lymphoma: 10.3"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Colon - T-cells, Minor Salivary Gland - T-cells, Prostate - T-cells, Stomach - T-cells, Thyroid gland - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA015715, HPA015865"	Supported		Supported	"Nucleoplasm,Plasma membrane,Centriolar satellite"			NA	No		9500000	"Cluster 15: NK-cells - Unknown function"	"Cluster 24: Parathyroid gland - Vesicular transport"	"Cluster 38: Sub-cortical - Mixed function"	"Cluster 59: Leukemia - T-cell receptor"	"Cluster 78: NK-cells & T-cells - Immune system & Transcription"	2	"Plasma membrane"	"Nucleoplasm, Centriolar satellite"	"HPA015715: AB_1846278, HPA015865: "		"unprognostic (1.93e-3)"	"unprognostic (2.18e-1)"	"unprognostic (5.26e-2)"		"unprognostic (1.02e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.15e-1)"			"potential prognostic favorable (1.08e-4)"	"unprognostic (1.85e-1)"				"unprognostic (2.08e-3)"	"unprognostic (2.37e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.06e-1)"				"unprognostic (3.96e-2)"			"unprognostic (8.63e-2)"		"unprognostic (2.82e-1)"	"unprognostic (4.43e-2)"		
CD24	CD24A	ENSG00000272398	"CD24 molecule"	P25063	6	106969831-106975627	"Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 1581.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 2800.6;Exocrine glandular cells: 2217.6;Glandular and luminal cells: 1467.2;Suprabasal keratinocytes: 1440.9"	"Cell type enriched"	"Detected in many"	4	"ependymal cell: 145.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	29	"eosinophil: 86.4;memory B-cell: 61.3;naive B-cell: 39.9"	"Group enriched"	"Detected in many"	240	"B-cells: 61.3;granulocytes: 86.4"	"Cancer enhanced"	"Detected in all"		"breast cancer: 1239.9"	"Adrenal gland - Adrenal medulla cells, Colon - Colon enterocytes, Lung - Respiratory ciliated cells, Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 159.0"	"HPA045879, CAB078471"	Approved		Enhanced	Vesicles	"Intracellular and membrane"	"No annotated function"	NA	NA			"Cluster 29: Non-specific - Unknown function"	"Cluster 38: Salivary gland - Salivary secretion"	"Cluster 29: Forebrain - Mixed function"	"Cluster 27: Breast cancer - Unknown function"	"Cluster 3: Basal prostatic cells - Lipid metabolism"	2	Vesicles		"CAB078471: AB_10983158, HPA045879: AB_2732523"	"unprognostic (1.35e-1)"	"potential prognostic unfavorable (2.01e-7)"	"unprognostic (3.01e-1)"	"unprognostic (1.79e-3)"	"unprognostic (7.39e-2)"	"unprognostic (1.88e-3)"	"unprognostic (2.76e-2)"		"unprognostic (6.97e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.94e-2)"	"unprognostic (9.58e-2)"	"unprognostic (9.50e-2)"	"potential prognostic unfavorable (8.15e-5)"	"unprognostic (2.69e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.25e-2)"	"unprognostic (4.44e-1)"	"unprognostic (7.10e-2)"	"unprognostic (2.64e-1)"		"unprognostic (2.25e-2)"		"unprognostic (9.01e-2)"	"potential prognostic favorable (8.25e-4)"	"unprognostic (1.33e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.06e-1)"
CD244	"2B4, NAIL, NKR2B4, Nmrk, SLAMF4"	ENSG00000122223	"CD244 molecule"	Q9BZW8	1	160830160-160862887	"CD markers, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 9.8;lymphoid tissue: 16.4"	"Cell type enhanced"	"Detected in some"		"Kupffer cells: 19.0;monocytes: 19.1;NK-cells: 39.7;T-cells: 17.7"	"Cell type enriched"	"Detected in some"	8	"leukocyte: 62.6"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	4	"basophil: 473.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 473.6"	"Cancer enriched"	"Detected in single"	17	"Leukemia: 15.3"	"Adipose subcutaneous - T-cells, Adipose visceral - Mesothelial cells, Adrenal gland - T-cells, Breast - T-cells, Heart muscle - T-cells, Kidney - T-cells, Lung - NK-cells (Lung), Minor Salivary Gland - T-cells, Pituitary gland - T-cells, Prostate - T-cells, Thyroid gland - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"										NA	NA		3500000	"Cluster 41: Basophils - Unknown function"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"		"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 19: NK-cells - Adaptive immune response"	9				"unprognostic (4.31e-2)"		"unprognostic (1.14e-1)"	"unprognostic (2.98e-2)"		"unprognostic (1.01e-1)"		"unprognostic (9.44e-2)"			"unprognostic (7.28e-3)"	"unprognostic (1.70e-1)"			"unprognostic (2.16e-2)"	"unprognostic (7.87e-3)"	"unprognostic (3.34e-1)"		"unprognostic (9.95e-2)"							"unprognostic (2.00e-1)"			"unprognostic (1.95e-1)"		
CD247	"CD3-ZETA, CD3H, CD3Q, CD3Z, CD3ZETA, TCRZ"	ENSG00000198821	"CD247 molecule"	P20963	1	167425027-167518640	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Adaptive immunity, Host-virus interaction, Immunity"	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"bone marrow: 39.7;lymphoid tissue: 157.1"	"Group enriched"	"Detected in many"	22	"NK-cells: 775.2;T-cells: 240.6"	"Cell type enriched"	"Detected in many"	41	"leukocyte: 1073.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	20	"gdT-cell: 336.7;MAIT T-cell: 189.2;memory CD4 T-cell: 181.3;memory CD8 T-cell: 205.8;naive CD4 T-cell: 227.8;naive CD8 T-cell: 184.5;NK-cell: 213.0;T-reg: 242.5"	"Group enriched"	"Detected in all"	25	"NK-cells: 213.0;T-cells: 336.7"	"Group enriched"	"Detected in some"	11	"Leukemia: 23.4;lymphoma: 21.4;Myeloma: 16.1"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Adrenal gland - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Kidney - T-cells, Liver - NK-cells (Liver), Lung - NK-cells (Lung), Minor Salivary Gland - T-cells, Pancreas - T-cells, Pituitary gland - T-cells, Prostate - T-cells, Skin - T-cells, Thyroid gland - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB004651, HPA008750"	Enhanced						NA	NA			"Cluster 27: T-cells - Unknown function"	"Cluster 71: Thymus - Adaptive immune response"	"Cluster 52: Neurons & Synapses - Synaptic function"	"Cluster 59: Leukemia - T-cell receptor"	"Cluster 19: NK-cells - Adaptive immune response"	19			"CAB004651: AB_425347, HPA008750: AB_1857863"	"unprognostic (4.54e-2)"	"potential prognostic favorable (3.28e-4)"	"unprognostic (2.84e-2)"	"unprognostic (2.63e-3)"	"unprognostic (4.65e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.15e-3)"	"unprognostic (5.40e-2)"	"potential prognostic favorable (4.82e-4)"	"unprognostic (1.22e-1)"	"unprognostic (2.09e-1)"	"unprognostic (9.98e-2)"	"unprognostic (2.79e-2)"	"unprognostic (9.49e-3)"	"unprognostic (4.73e-3)"	"unprognostic (6.01e-3)"	"unprognostic (9.34e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.68e-3)"	"unprognostic (3.61e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.05e-1)"
CD248	"CD164L1, TEM1"	ENSG00000174807	"CD248 molecule"	Q9HCU0	11	66314494-66317044	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 229.8;breast: 150.5"	"Group enriched"	"Detected in many"	5	"Endometrial stromal cells: 157.0;Fibroblasts: 195.1;Leydig cells: 75.3;Mesothelial cells: 52.3;Smooth muscle cells: 57.9"	"Group enriched"	"Detected in some"	6	"fibroblast: 42.7;pericyte: 51.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	7	"naive CD8 T-cell: 21.9"	"Lineage enriched"	"Detected in single"	145	"T-cells: 21.9"	"Group enriched"	"Detected in many"	6	"Bone cancer: 137.0;Neuroblastoma: 39.8;Sarcoma: 67.1"	"Adrenal gland - Fibroblasts, Colon - Fibroblasts, Liver - Hepatic stellate cells, Pituitary gland - Fibroblasts, Prostate - Fibroblasts, Skeletal muscle - Fibroblasts, Skin - Fibroblast_2, Spleen - Fibroblast_1, Stomach - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051856	Enhanced		Approved	"Plasma membrane"			NA	NA		30000000	"Cluster 43: Non-specific - Transcription & Translation"	"Cluster 7: Adipose tissue - Mixed function"	"Cluster 47: Endothelial cells - Vasculature"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 53: Fibroblasts - ECM organization"	4	"Plasma membrane"		"HPA051856: AB_2681640"	"unprognostic (2.03e-2)"	"unprognostic (2.07e-1)"	"unprognostic (6.90e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.25e-2)"	"unprognostic (9.31e-3)"	"unprognostic (3.84e-1)"	"unprognostic (9.96e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.69e-3)"	"unprognostic (1.08e-3)"	"unprognostic (7.18e-3)"	"unprognostic (3.33e-1)"	"unprognostic (2.46e-2)"	"unprognostic (6.04e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.25e-2)"	"unprognostic (5.28e-2)"	"unprognostic (2.49e-1)"	"unprognostic (8.49e-2)"	"unprognostic (4.82e-2)"	"unprognostic (5.92e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.59e-1)"
CD27	"S152, TNFRSF7, Tp55"	ENSG00000139193	"CD27 molecule"	P26842	12	6444955-6451718	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	Apoptosis	Receptor	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 144.3"	"Cell type enriched"	"Detected in some"	4	"Plasma cells: 455.7"	"Cell type enriched"	"Detected in some"	19	"leukocyte: 37.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"T-reg: 642.1"	"Group enriched"	"Detected in all"	7	"B-cells: 294.3;T-cells: 642.1"	"Cancer enriched"	"Detected in some"	7	"lymphoma: 88.8"	"Adipose subcutaneous - T-cells, Breast - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Thyroid gland - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB002420, HPA038936, HPA069501, CAB080304"	Enhanced		Approved	Vesicles			NA	NA		110000	"Cluster 43: Non-specific - Transcription & Translation"	"Cluster 36: Lymphoid tissue - Cytokine signaling"	"Cluster 11: White matter - Signal transduction"	"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 77: Plasma cells - Protein processing"	42	Vesicles		"CAB002420: AB_563539, CAB080304: , HPA038936: AB_2676278, HPA069501: "	"unprognostic (1.29e-2)"	"unprognostic (4.14e-3)"	"unprognostic (4.96e-3)"	"unprognostic (2.73e-3)"	"unprognostic (9.54e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.19e-2)"		"potential prognostic favorable (4.01e-6)"		"unprognostic (1.26e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.19e-3)"	"unprognostic (4.65e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.66e-2)"	"unprognostic (7.30e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.99e-2)"	"unprognostic (7.52e-3)"	"unprognostic (7.49e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.80e-1)"	"potential prognostic favorable (7.76e-4)"	"unprognostic (6.41e-2)"	"potential prognostic favorable (7.12e-5)"	"unprognostic (4.50e-1)"	"unprognostic (4.84e-2)"	"unprognostic (9.72e-2)"	"unprognostic (3.19e-1)"
CD274	"B7-H, B7-H1, B7H1, PD-L1, PDCD1LG1, PDL1"	ENSG00000120217	"CD274 molecule"	Q9NZQ7	9	5450503-5470566	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Adaptive immunity, Immunity"	Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 16.3"	"Group enriched"	"Detected in many"	4	"Extravillous trophoblasts: 31.3;granulocytes: 43.8;Langerhans cells: 62.7;Syncytiotrophoblasts: 54.7"	"Cell type enriched"	"Detected in many"	5	"central nervous system macrophage: 36.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 6.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.7"	"Low cancer specificity"	"Detected in many"			"Kidney - Endothelial cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003528, CAB076385, CAB080537"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Actin filaments"	"Secreted - unknown location"	Receptor	NA	NA			"Cluster 35: Neutrophils - Protein binding"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 56: Hypothalamus - Neuropeptide signaling"	"Cluster 71: Lymphoma - Inflammatory response"	"Cluster 14: Langerhans cells - Innate immune response"	54	"Plasma membrane, Actin filaments"	Nucleoplasm	"CAB076385: AB_2687655, CAB080537: , HPA003528: "	"unprognostic (1.57e-1)"	"unprognostic (6.40e-2)"	"unprognostic (9.65e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.98e-2)"	"unprognostic (4.77e-2)"	"unprognostic (9.07e-2)"	"unprognostic (8.18e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.06e-1)"	"potential prognostic favorable (5.33e-4)"	"unprognostic (9.06e-2)"	"unprognostic (1.18e-1)"		"unprognostic (3.02e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.70e-3)"	"unprognostic (3.49e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.51e-3)"	"unprognostic (3.35e-3)"	"unprognostic (9.49e-3)"	"unprognostic (3.27e-3)"		"unprognostic (3.46e-2)"	"unprognostic (3.48e-2)"	"unprognostic (5.88e-2)"	"unprognostic (6.88e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.49e-1)"	
CD276	"B7-H3, B7H3, B7RP-2"	ENSG00000103855	"CD276 molecule"	Q5ZPR3	15	73683966-73714514	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 242.7;Hofbauer cells: 68.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Adipose progenitor cells, Adipose visceral - Adipose progenitor cells, Breast - Fibroblasts, Skin - Fibroblast_2, Spleen - Fibroblast_1, Thyroid gland - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009285, HPA017139, CAB017826"	Enhanced		Approved	Vesicles			NA	NA		18000000		"Cluster 7: Adipose tissue - Mixed function"	"Cluster 23: Choroid plexus - Mixed function"	"Cluster 58: Non-specific - Nuclear processes"	"Cluster 4: Extravillous trophoblasts - Unknown function"	2	Vesicles		"CAB017826: , HPA009285: AB_1078258, HPA017139: AB_1845246"	"unprognostic (7.52e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.60e-1)"	"unprognostic (7.74e-3)"	"unprognostic (8.31e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.15e-2)"	"unprognostic (5.03e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.25e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.68e-2)"	"potential prognostic unfavorable (2.76e-4)"	"unprognostic (7.89e-3)"	"potential prognostic unfavorable (4.79e-4)"	"unprognostic (7.82e-3)"	"unprognostic (8.01e-2)"	"unprognostic (2.03e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.15e-2)"	"potential prognostic unfavorable (2.02e-4)"	"unprognostic (3.07e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.25e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.39e-1)"
CD28		ENSG00000178562	"CD28 molecule"	P10747	2	203706475-203738912	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"lymphoid tissue: 29.9;placenta: 14.3"	"Group enriched"	"Detected in some"	10	"Hofbauer cells: 31.1;T-cells: 60.5"	"Cell type enriched"	"Detected in some"	19	"leukocyte: 55.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"T-reg: 102.2"	"Lineage enriched"	"Detected in many"	7	"T-cells: 102.2"	"Cancer enriched"	"Detected in some"	13	"Myeloma: 98.6"	"Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Kidney - T-cells, Skin - T-cells, Testis - Macrophages, Thyroid gland - T-cells"	"Region enhanced"	"Detected in single"		"olfactory bulb: 1.0"	"Low region specificity"	"Detected in all"			"HPA041233, HPA070003"	Enhanced		Supported	"Plasma membrane"			NA	NA			"Cluster 31: T-cells - T-cell receptor"	"Cluster 36: Lymphoid tissue - Cytokine signaling"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 20: Myeloma - Immune response"	"Cluster 78: NK-cells & T-cells - Immune system & Transcription"	5	"Plasma membrane"		"HPA041233: , HPA070003: AB_2686226"	"unprognostic (2.55e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.70e-2)"			"unprognostic (3.29e-1)"		"unprognostic (4.51e-2)"	"potential prognostic favorable (6.76e-4)"		"unprognostic (2.28e-1)"	"unprognostic (2.26e-1)"	"unprognostic (5.95e-2)"		"unprognostic (9.28e-3)"	"unprognostic (5.33e-3)"	"unprognostic (1.67e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.38e-1)"			"unprognostic (1.10e-1)"	"unprognostic (4.10e-3)"	"unprognostic (4.00e-2)"		"unprognostic (9.82e-2)"		"unprognostic (1.11e-1)"	"unprognostic (1.46e-2)"		
CD300A	"CMRF-35-H9, CMRF35H, IGSF12, IRC1, IRC2, Irp60"	ENSG00000167851	"CD300a molecule"	Q9UGN4	17	74466399-74484794	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 92.9"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 55.9;Hofbauer cells: 135.8;Kupffer cells: 95.5;Macrophages: 76.0;monocytes: 132.3;NK-cells: 138.7"	"Group enriched"	"Detected in some"	42	"central nervous system macrophage: 63.4;leukocyte: 75.1"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebral cortex: 59.6"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in some"		"Leukemia: 40.9;Myeloma: 12.0"	"Adrenal gland - Macrophages, Liver - Kupffer cells, Pituitary gland - Macrophages, Spleen - Macrophages, Stomach - Macrophages, Testis - Macrophages, Thyroid gland - T-cells"									"HPA010971, HPA011645"	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"	"Intracellular and membrane"	Receptor	NA	NA			"Cluster 42: Non-specific - Vesicular transport"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 12: Non-specific - Vasculature"	"Cluster 59: Leukemia - T-cell receptor"	"Cluster 29: Monocytes - Innate immune response"	6	"Plasma membrane"	"Vesicles, Cytosol"	"HPA010971: , HPA011645: AB_1846988"	"unprognostic (1.86e-1)"	"unprognostic (2.92e-1)"	"unprognostic (3.38e-1)"	"unprognostic (9.06e-2)"	"unprognostic (4.15e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.23e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.87e-1)"	"unprognostic (4.54e-2)"	"unprognostic (4.71e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.63e-2)"	"unprognostic (2.50e-2)"	"potential prognostic unfavorable (7.08e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.34e-2)"	"unprognostic (5.97e-3)"	"unprognostic (9.09e-2)"	"unprognostic (8.92e-2)"	"unprognostic (3.60e-2)"	"unprognostic (6.56e-2)"	"unprognostic (4.72e-2)"	"unprognostic (3.76e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.20e-1)"
CD300C	"CMRF-35A, CMRF35, CMRF35A, IGSF16, LIR"	ENSG00000167850	"CD300c molecule"	Q08708	17	74541073-74546115	"CD markers, Predicted membrane proteins"	Immunity	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 9.6;lung: 8.1;lymphoid tissue: 7.1"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 42.5;Kupffer cells: 17.8;Langerhans cells: 16.1;Macrophages: 28.0;monocytes: 31.4"	"Group enriched"	"Detected in some"	8	"central nervous system macrophage: 4.9;leukocyte: 3.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 228.5;non-classical monocyte: 243.7"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Leukemia: 5.2;lymphoma: 5.0;thyroid cancer: 1.5"	"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Breast - Macrophages, Colon - Macrophages, Heart muscle - Macrophages, Kidney - Macrophages, Lung - Macrophages, Minor Salivary Gland - Macrophages, Pituitary gland - Macrophages, Prostate - Macrophages, Skeletal muscle - Macrophages, Spleen - Macrophages, Stomach - Macrophages"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA014523, HPA060349"	Approved		Uncertain	"Golgi apparatus,Vesicles,Mitochondria"			NA	NA			"Cluster 40: Monocytes - Innate immune response"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 12: Non-specific - Vasculature"	"Cluster 71: Lymphoma - Inflammatory response"	"Cluster 29: Monocytes - Innate immune response"	10	"Golgi apparatus"	"Vesicles, Mitochondria"	"HPA014523: AB_1846293, HPA060349: "	"unprognostic (2.04e-1)"	"unprognostic (5.85e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.51e-1)"	"unprognostic (3.42e-2)"		"unprognostic (3.49e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.19e-1)"		"unprognostic (6.48e-2)"	"unprognostic (9.39e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.30e-1)"	"unprognostic (9.67e-2)"	"unprognostic (1.66e-2)"	"unprognostic (3.79e-1)"	"unprognostic (9.02e-2)"	"unprognostic (1.73e-1)"		"unprognostic (5.91e-2)"	"unprognostic (7.46e-3)"	"unprognostic (7.99e-3)"	"unprognostic (7.86e-2)"	"unprognostic (4.96e-3)"	"potential prognostic unfavorable (2.96e-4)"	
CD300E	"CD300LE, CLM2, IREM2"	ENSG00000186407	"CD300e molecule"	Q496F6	17	74609885-74623738	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	Immunity	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 47.4;lymphoid tissue: 36.4"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 50.0;Kupffer cells: 73.0;Macrophages: 103.8;monocytes: 291.0"	"Cell type enriched"	"Detected in some"	13	"leukocyte: 20.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"classical monocyte: 87.9;intermediate monocyte: 135.0;non-classical monocyte: 149.1"	"Lineage enriched"	"Detected in many"	7	"monocytes: 149.1"	"Not detected"	"Not detected"			"Adrenal gland - Neutrophils, Colon - Neutrophils, Thyroid gland - Neutrophils"	"Not detected"	"Not detected"							HPA015570	Uncertain						NA	NA			"Cluster 40: Monocytes - Innate immune response"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 48: Non-specific - Mixed function"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 29: Monocytes - Innate immune response"	5			"HPA015570: AB_1846294"	"unprognostic (1.22e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.89e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.97e-1)"		"unprognostic (3.78e-3)"	"unprognostic (1.13e-1)"		"unprognostic (1.09e-2)"	"unprognostic (7.86e-2)"			"unprognostic (1.05e-1)"	"unprognostic (2.07e-2)"	"potential prognostic unfavorable (5.43e-4)"	"unprognostic (1.14e-2)"	"unprognostic (7.27e-2)"			"unprognostic (2.57e-2)"	"unprognostic (1.78e-3)"		"unprognostic (1.39e-1)"	"unprognostic (8.57e-2)"		"unprognostic (2.00e-2)"	"potential prognostic unfavorable (3.54e-4)"		"potential prognostic unfavorable (9.81e-4)"
CD300LB	"CLM7, TREM5"	ENSG00000178789	"CD300 molecule like family member b"	A8K4G0	17	74521174-74531475	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	Immunity	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 7.6;lymphoid tissue: 8.0"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 14.7;Hofbauer cells: 13.1;Kupffer cells: 11.8;Langerhans cells: 9.4;Macrophages: 18.7;monocytes: 4.6"	"Cell type enriched"	"Detected in some"	4	"leukocyte: 6.1"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in some"	5	"cerebral cortex: 34.0"	"Immune cell enhanced"	"Detected in many"		"eosinophil: 76.1"	"Group enriched"	"Detected in many"	53	"dendritic cells: 25.1;granulocytes: 76.1;monocytes: 31.7"	"Cancer enriched"	"Detected in single"	5	"Leukemia: 1.8"	"Adipose visceral - Macrophages, Thyroid gland - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA060449			Approved	"Plasma membrane"			NA	NA			"Cluster 29: Non-specific - Unknown function"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 12: Non-specific - Vasculature"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 29: Monocytes - Innate immune response"	5	"Plasma membrane"		"HPA060449: "			"unprognostic (4.72e-2)"			"unprognostic (6.30e-2)"					"unprognostic (9.70e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.56e-2)"		"unprognostic (2.32e-2)"		"unprognostic (1.04e-2)"		"unprognostic (1.66e-1)"			"unprognostic (9.63e-2)"				"unprognostic (1.98e-3)"					
CD300LD	"CD300D, CMRF35A4"	ENSG00000204345	"CD300 molecule like family member d"	Q6UXZ3	17	74579365-74592283	"CD markers, Predicted membrane proteins"	Immunity	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	6	"neutrophil: 5.1"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 5.1"	"Not detected"	"Not detected"			"Testis - Late spermatids"									HPA027756	Uncertain						NA	NA			"Cluster 35: Neutrophils - Protein binding"		"Cluster 48: Non-specific - Mixed function"	"Cluster 57: Stomach & Colon cancer - Digestion"	"Cluster 63: Late spermatids - Spermatogenesis"	2			"HPA027756: AB_10601097"						"unprognostic (1.18e-1)"																				"unprognostic (1.76e-1)"					
CD300LF	"CD300f, CLM1, IGSF13, IREM1, NKIR"	ENSG00000186074	"CD300 molecule like family member f"	Q8TDQ1	17	74694311-74712978	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	Immunity	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 26.7;lung: 17.1;lymphoid tissue: 28.2"	"Group enriched"	"Detected in some"	4	"Hofbauer cells: 41.0;Kupffer cells: 27.4;Macrophages: 37.8;monocytes: 59.2"	"Cell type enhanced"	"Detected in many"		"central nervous system macrophage: 24.1;lower rhombic lip: 20.3;upper rhombic lip: 24.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 234.8"	"Group enriched"	"Detected in many"	43	"dendritic cells: 63.8;granulocytes: 234.8;monocytes: 193.8"	"Cancer enriched"	"Detected in single"	78	"Leukemia: 19.2"	"Adrenal gland - Macrophages, Lung - Macrophages"									HPA013712	Supported						NA	NA			"Cluster 25: Non-specific - Unknown function"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 25: Non-specific - Transcription"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 58: Macrophages - Innate immune response"	1			"HPA013712: AB_2668874"	"unprognostic (1.03e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.57e-1)"	"unprognostic (9.42e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.12e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.36e-2)"	"unprognostic (3.45e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.66e-3)"	"unprognostic (1.92e-1)"	"unprognostic (8.41e-2)"	"potential prognostic favorable (7.85e-4)"	"unprognostic (6.87e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.92e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.05e-1)"	"unprognostic (3.67e-2)"	"unprognostic (4.38e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.23e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.61e-2)"	"unprognostic (7.28e-2)"	"unprognostic (3.98e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.62e-1)"
CD300LG	"CLM9, Trem4"	ENSG00000161649	"CD300 molecule like family member g"	Q6UXG3	17	43847148-43863639	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	Immunity	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 127.2;breast: 108.2;placenta: 57.0"	"Cell type enriched"	"Detected in some"	12	"Adipocytes: 505.1"	"Cell type enhanced"	"Detected in single"		"endothelial cell: 1.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Testis - Sertoli cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA004131			Approved	Calyx			NA	NA		1700000		"Cluster 7: Adipose tissue - Mixed function"	"Cluster 19: Astrocytes - Mixed function"	"Cluster 16: Thyroid cancer - Neuronal signaling"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	6	Calyx		"HPA004131: AB_1078459"		"unprognostic (8.68e-3)"	"unprognostic (5.65e-2)"							"unprognostic (1.83e-2)"	"potential prognostic favorable (4.39e-7)"		"unprognostic (1.76e-1)"																"unprognostic (1.62e-1)"		
CD302	"BIMLEC, CLEC13A, DCL-1, KIAA0022"	ENSG00000241399	"CD302 molecule"	Q8IX05	2	159768628-159798255	"CD markers, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 188.0"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 313.8;Kupffer cells: 303.9;Langerhans cells: 129.3;Macrophages: 190.4;monocytes: 181.9"	"Cell type enhanced"	"Detected in all"		"central nervous system macrophage: 154.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	215	"dendritic cells: 24.5;granulocytes: 32.3;monocytes: 33.0"	"Low cancer specificity"	"Detected in many"			"Kidney - Fibroblasts, Liver - Hepatocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"										NA	NA		94000	"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 83: Liver - Metabolism"	"Cluster 21: Non-specific - Metabolism"	"Cluster 44: Connective tissue cells - ECM organization"	"Cluster 29: Monocytes - Innate immune response"	9				"unprognostic (6.14e-2)"	"unprognostic (1.75e-2)"	"unprognostic (9.19e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.17e-1)"	"potential prognostic unfavorable (5.12e-4)"	"unprognostic (2.10e-2)"	"unprognostic (2.83e-2)"	"potential prognostic favorable (2.78e-5)"	"unprognostic (1.43e-2)"	"unprognostic (1.30e-2)"	"unprognostic (5.39e-3)"	"potential prognostic favorable (9.76e-4)"	"potential prognostic favorable (3.69e-4)"	"unprognostic (1.93e-1)"	"unprognostic (1.50e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.33e-2)"	"unprognostic (8.30e-2)"	"unprognostic (5.24e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.53e-3)"	"unprognostic (2.09e-1)"	"unprognostic (2.27e-2)"	"unprognostic (5.26e-2)"
CD320	"8D6, 8D6A, TCblR"	ENSG00000167775	"CD320 molecule"	Q9NPF0	19	8302127-8308358	"CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins"		"Growth factor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 411.2"	"Cell type enriched"	"Detected in all"	11	"endothelial cell: 323.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Testis - Early spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014500, HPA014522"	Approved		Uncertain	Vesicles			NA	NA		140000	"Cluster 5: Non-specific - Cell proliferation"	"Cluster 43: Non-specific - Mitochondrial translation"	"Cluster 45: Non-specific - Mixed function"	"Cluster 23: Non-specific - Transcription"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	2	Vesicles		"HPA014500: AB_1846295, HPA014522: "	"unprognostic (1.39e-1)"	"unprognostic (4.77e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.48e-3)"	"unprognostic (2.73e-1)"	"unprognostic (7.93e-2)"	"unprognostic (3.22e-1)"	"unprognostic (3.31e-1)"	"unprognostic (3.72e-2)"	"unprognostic (5.37e-3)"	"unprognostic (3.36e-3)"	"unprognostic (3.13e-3)"	"unprognostic (1.93e-1)"	"validated prognostic unfavorable (1.47e-4)"	"validated prognostic unfavorable (2.73e-5)"	"unprognostic (3.33e-1)"	"unprognostic (9.66e-2)"	"unprognostic (4.87e-2)"	"unprognostic (7.12e-2)"	"unprognostic (4.41e-3)"	"unprognostic (2.02e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.84e-1)"	"unprognostic (4.66e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.67e-1)"
CD33	"FLJ00391, p67, SIGLEC-3, SIGLEC3"	ENSG00000105383	"CD33 molecule"	P20138	19	51225064-51243860	"CD markers, FDA approved drug targets, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.0;lymphoid tissue: 23.4"	"Group enriched"	"Detected in some"	6	"granulocytes: 78.7;Hofbauer cells: 90.4;Kupffer cells: 95.7;Langerhans cells: 50.2;Macrophages: 55.2;monocytes: 29.3"	"Cell type enriched"	"Detected in some"	7	"central nervous system macrophage: 37.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"classical monocyte: 166.7;intermediate monocyte: 122.1;myeloid DC: 213.7;non-classical monocyte: 58.0"	"Group enriched"	"Detected in many"	9	"dendritic cells: 213.7;monocytes: 166.7"	"Cancer enriched"	"Detected in many"	8	"Leukemia: 53.6"	"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Breast - Macrophages, Colon - Macrophages, Heart muscle - Macrophages, Kidney - Macrophages, Liver - Kupffer cells, Lung - Macrophages, Minor Salivary Gland - Macrophages, Pancreas - Macrophages, Prostate - Macrophages, Skeletal muscle - Macrophages, Spleen - Macrophages, Testis - Macrophages, Thyroid gland - Macrophages"									"CAB011442, HPA035832, CAB079996, CAB080305"	Enhanced		Supported	"Plasma membrane,Cytosol"			NA	NA		12000000	"Cluster 26: Monocytes - Plasma membrane proteins"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 29: Monocytes - Innate immune response"	24	"Plasma membrane"	Cytosol	"CAB011442: , CAB079996: , CAB080305: , HPA035832: AB_2674808"	"unprognostic (1.63e-1)"	"unprognostic (1.82e-2)"	"unprognostic (5.32e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.81e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.52e-1)"	"unprognostic (5.05e-3)"	"unprognostic (3.40e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.17e-2)"	"unprognostic (7.35e-3)"	"unprognostic (1.02e-2)"	"unprognostic (9.04e-3)"	"unprognostic (8.70e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.68e-2)"	"unprognostic (6.54e-2)"	"unprognostic (2.02e-2)"	"unprognostic (5.50e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.19e-3)"	"unprognostic (6.67e-2)"	"unprognostic (1.37e-1)"
CD34		ENSG00000174059	"CD34 molecule"	P28906	1	207880972-207911402	"CD markers, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 297.5;Endothelial cells: 252.1;Fibroblasts: 121.6;Leydig cells: 141.8;Mesothelial cells: 167.7;Peritubular cells: 117.9"	"Cell type enriched"	"Detected in some"	14	"endothelial cell: 241.9"	"Cancer enhanced"	"Detected in all"		"Kidney Renal Clear Cell Carcinoma (TCGA): 124.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"Leukemia: 63.7;Rhabdoid: 115.9;Sarcoma: 87.6"	"Breast - Fibroblasts, Pancreas - Endothelial cells, Prostate - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000018, HPA036722, HPA036723"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"			NA	NA		43000000		"Cluster 7: Adipose tissue - Mixed function"	"Cluster 47: Endothelial cells - Vasculature"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	2	"Plasma membrane, Cell Junctions"	Nucleoplasm	"CAB000018: AB_2063006, HPA036722: AB_2675271, HPA036723: AB_2675272"	"unprognostic (2.23e-1)"	"unprognostic (8.14e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.89e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.10e-3)"	"unprognostic (2.42e-1)"	"validated prognostic favorable (1.17e-7)"	"validated prognostic favorable (3.94e-4)"	"potential prognostic unfavorable (1.29e-4)"	"unprognostic (9.78e-3)"	"unprognostic (3.33e-3)"	"unprognostic (7.61e-2)"	"unprognostic (3.53e-1)"	"unprognostic (8.50e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.88e-1)"	"unprognostic (3.65e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.57e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.28e-1)"	"unprognostic (8.34e-2)"	"unprognostic (6.05e-2)"
CD36	"FAT, GP3B, GP4, GPIV, SCARB3"	ENSG00000135218	"CD36 molecule"	P16671	7	80369575-80679277	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Lipid transport, Transport"	Receptor	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 1480.0"	"Group enriched"	"Detected in many"	4	"Adipocytes: 2837.3;Cardiomyocytes: 872.7;Hofbauer cells: 1253.8"	"Group enriched"	"Detected in all"	8	"deep-layer near-projecting: 201.4;ependymal cell: 542.2"	"Cancer enhanced"	"Detected in all"		"Kidney Renal Clear Cell Carcinoma (TCGA): 87.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 965.2;intermediate monocyte: 271.3;myeloid DC: 507.9"	"Group enriched"	"Detected in all"	46	"dendritic cells: 507.9;monocytes: 965.2"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 57.4"	"Adipose visceral - Endothelial cells, Colon - Endothelial cells, Liver - Sinusoid Endothelial cells, Stomach - Endothelial cells"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"spinal cord: 13.2"	"HPA002018, CAB025866, HPA071026"	Enhanced		Enhanced	"Golgi apparatus"			NA	NA		6700000	"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 7: Adipose tissue - Mixed function"	"Cluster 46: Brainstem - Mixed function"	"Cluster 47: Leukemia - Hemostasis"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	4	"Golgi apparatus"		"CAB025866: , HPA002018: AB_1078464, HPA071026: AB_2732170"	"unprognostic (4.57e-2)"	"unprognostic (2.13e-2)"	"potential prognostic favorable (7.86e-4)"	"unprognostic (7.58e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.27e-1)"	"potential prognostic favorable (3.23e-5)"	"unprognostic (8.57e-3)"	"unprognostic (2.91e-3)"	"unprognostic (2.92e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.66e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.77e-3)"	"potential prognostic favorable (6.58e-4)"	"unprognostic (4.28e-3)"	"unprognostic (9.80e-2)"	"unprognostic (2.19e-1)"	"unprognostic (8.32e-2)"	"unprognostic (6.56e-3)"	"potential prognostic unfavorable (8.64e-4)"	"unprognostic (8.82e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.15e-1)"
CD37	TSPAN26	ENSG00000104894	"CD37 molecule"	P11049	19	49335171-49343335	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 153.6;intestine: 113.2;lymphoid tissue: 230.0"	"Cell type enhanced"	"Detected in many"		"B-cells: 1676.3;dendritic cells: 531.6;granulocytes: 571.4;Hofbauer cells: 478.9;Langerhans cells: 410.3;monocytes: 820.9;NK-cells: 377.0;T-cells: 380.7"	"Group enriched"	"Detected in some"	34	"central nervous system macrophage: 120.8;leukocyte: 131.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"Leukemia: 77.0;lymphoma: 248.0"	"Adrenal gland - Macrophages, Breast - T-cells, Prostate - T-cells, Skeletal muscle - Macrophages, Skin - T-cells, Spleen - B-cells (Spleen), Testis - Late spermatids, Thyroid gland - T-cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002492, HPA032120, HPA032121"	Enhanced		Approved	"Golgi apparatus,Plasma membrane"			NA	NA			"Cluster 7: Non-specific - Innate immune response"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 55: Lymphoma - Immune response"	"Cluster 73: B-cells - B-cell function"	8	"Golgi apparatus"	"Plasma membrane"	"CAB002492: AB_563554, HPA032120: AB_2674162, HPA032121: AB_2674163"	"unprognostic (1.12e-1)"	"unprognostic (9.68e-3)"	"unprognostic (1.49e-2)"	"unprognostic (3.07e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.59e-2)"	"unprognostic (4.12e-1)"	"unprognostic (1.89e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.87e-2)"	"unprognostic (2.39e-2)"	"unprognostic (5.78e-3)"	"unprognostic (1.00e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.27e-1)"	"unprognostic (6.54e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.16e-2)"	"unprognostic (7.67e-2)"	"unprognostic (2.45e-3)"	"unprognostic (9.56e-2)"	"unprognostic (9.96e-3)"	"unprognostic (2.33e-2)"	"unprognostic (4.47e-2)"
CD38	cADPR1	ENSG00000004468	"CD38 molecule"	P28907	4	15778275-15853232	"Cancer-related genes, CD markers, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Receptor, Transferase"	"Cancer-related genes, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 61.7"	"Cell type enriched"	"Detected in many"	4	"Plasma cells: 364.6"	"Group enriched"	"Detected in many"	4	"astrocyte: 240.4;leukocyte: 63.7;pericyte: 120.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 18.3"	"Group enriched"	"Detected in all"	5	"B-cells: 9.9;dendritic cells: 5.8;NK-cells: 18.3"	"Group enriched"	"Detected in some"	15	"Leukemia: 25.9;lymphoma: 43.3;Myeloma: 35.3"	"Lung - Alveolar cells type 2, Skeletal muscle - Skeletal myocytes, Skeletal muscle - Skeletal myocytes, Stomach - Macrophages"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002493, HPA022132, CAB025255, HPA052381"	Enhanced		Supported	"Plasma membrane"			NA	NA			"Cluster 14: Non-specific - Unknown function"	"Cluster 71: Thymus - Adaptive immune response"	"Cluster 46: Brainstem - Mixed function"	"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 61: Plasma cells - Immunoglobulins & histones"	3	"Plasma membrane"		"CAB002493: AB_563556, CAB025255: , HPA022132: AB_1846300, HPA052381: AB_2681807"	"unprognostic (1.95e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.40e-2)"	"potential prognostic favorable (1.51e-4)"		"unprognostic (1.18e-3)"	"unprognostic (1.31e-1)"	"unprognostic (6.14e-3)"	"unprognostic (1.00e-1)"	"unprognostic (8.73e-2)"	"unprognostic (4.05e-2)"	"unprognostic (5.33e-3)"	"unprognostic (4.45e-1)"	"unprognostic (2.37e-1)"	"potential prognostic favorable (3.86e-5)"	"unprognostic (1.97e-2)"	"unprognostic (3.98e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.03e-1)"	"unprognostic (6.26e-3)"	"unprognostic (2.70e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.28e-1)"
CD3D	"CD3-DELTA, CD3DELTA, T3D"	ENSG00000167286	"CD3 delta subunit of T-cell receptor complex"	P04234	11	118339075-118342705	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor	"FDA approved drug targets, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	29	"lymphoid tissue: 846.9"	"Cell type enriched"	"Detected in many"	6	"T-cells: 663.2"	"Cell type enriched"	"Detected in single"	427	"leukocyte: 121.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in all"	53	"gdT-cell: 1434.7;MAIT T-cell: 971.2;memory CD4 T-cell: 1184.7;memory CD8 T-cell: 1338.7;naive CD4 T-cell: 1071.7;naive CD8 T-cell: 1320.2;T-reg: 1629.7"	"Lineage enriched"	"Detected in all"	68	"T-cells: 1629.7"	"Cancer enriched"	"Detected in some"	8	"Leukemia: 223.2"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Adrenal gland - T-cells, Breast - T-cells, Colon - T-cells, Kidney - T-cells, Liver - T-cells, Lung - T-cells, Minor Salivary Gland - T-cells, Pancreas - T-cells, Pituitary gland - T-cells, Prostate - T-cells, Skin - T-cells, Spleen - T-cells, Thyroid gland - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB013055, HPA071778"	Enhanced		Uncertain	"Endoplasmic reticulum,Vesicles"			NA	NA			"Cluster 11: T-cells - Unknown function"	"Cluster 71: Thymus - Adaptive immune response"	"Cluster 8: Immune cells - Immune response"	"Cluster 59: Leukemia - T-cell receptor"	"Cluster 78: NK-cells & T-cells - Immune system & Transcription"	12	"Endoplasmic reticulum, Vesicles"		"CAB013055: , HPA071778: "	"unprognostic (2.77e-3)"	"potential prognostic favorable (3.36e-4)"	"unprognostic (7.81e-2)"	"unprognostic (7.80e-3)"	"unprognostic (1.81e-1)"	"unprognostic (5.22e-2)"	"unprognostic (2.93e-3)"	"unprognostic (3.59e-2)"	"potential prognostic favorable (1.09e-4)"	"unprognostic (4.86e-1)"	"unprognostic (7.80e-2)"	"unprognostic (3.65e-2)"	"unprognostic (8.36e-2)"	"unprognostic (3.98e-1)"	"unprognostic (4.81e-2)"	"unprognostic (3.94e-2)"	"unprognostic (3.27e-1)"	"unprognostic (3.02e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.63e-2)"	"unprognostic (4.30e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.32e-1)"	"unprognostic (3.32e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.91e-1)"	"unprognostic (9.92e-2)"	"unprognostic (2.65e-2)"	"unprognostic (4.68e-2)"
CD3E	"CD3-epsilon, CD3epsilon"	ENSG00000198851	"CD3 epsilon subunit of T-cell receptor complex"	P07766	11	118304730-118316175	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Adaptive immunity, Immunity"	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	17	"lymphoid tissue: 623.6"	"Group enriched"	"Detected in many"	18	"NK-cells: 214.7;T-cells: 646.6"	"Cell type enriched"	"Detected in some"	179	"leukocyte: 199.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	26	"gdT-cell: 491.6;MAIT T-cell: 421.5;memory CD4 T-cell: 415.6;memory CD8 T-cell: 463.4;naive CD4 T-cell: 493.3;naive CD8 T-cell: 502.8;NK-cell: 203.3;T-reg: 427.4"	"Group enriched"	"Detected in all"	21	"NK-cells: 203.3;T-cells: 502.8"	"Cancer enriched"	"Detected in some"	8	"Leukemia: 125.7"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Adrenal gland - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Kidney - T-cells, Liver - T-cells, Lung - T-cells, Minor Salivary Gland - T-cells, Pancreas - T-cells, Pituitary gland - T-cells, Prostate - T-cells, Skin - T-cells, Spleen - T-cells, Stomach - T-cells, Thyroid gland - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB000010, HPA040957, HPA043955, CAB072863, CAB072864"	Enhanced		Supported	"Endoplasmic reticulum,Golgi apparatus,Plasma membrane"			NA	NA			"Cluster 11: T-cells - Unknown function"	"Cluster 71: Thymus - Adaptive immune response"	"Cluster 8: Immune cells - Immune response"	"Cluster 59: Leukemia - T-cell receptor"	"Cluster 7: T-cells - T-cell receptor"	38	"Endoplasmic reticulum, Plasma membrane"	"Golgi apparatus"	"CAB000010: AB_2631163, CAB072863: AB_2665707, CAB072864: AB_2665708, HPA040957: AB_2677222, HPA043955: AB_2678747"	"unprognostic (2.34e-2)"	"potential prognostic favorable (1.61e-4)"	"unprognostic (2.89e-2)"	"potential prognostic favorable (2.43e-4)"	"unprognostic (1.49e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.05e-3)"	"unprognostic (8.41e-2)"	"potential prognostic favorable (3.77e-4)"	"unprognostic (2.18e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.67e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.25e-1)"	"unprognostic (5.00e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.79e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.26e-1)"	"unprognostic (8.54e-3)"	"unprognostic (1.20e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.39e-2)"
CD3G	"CD3-GAMMA, CD3GAMMA"	ENSG00000160654	"CD3 gamma subunit of T-cell receptor complex"	P09693	11	118344344-118355161	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"lymphoid tissue: 92.2"	"Group enriched"	"Detected in many"	14	"NK-cells: 95.2;T-cells: 331.9"	"Cell type enriched"	"Detected in single"	470	"leukocyte: 168.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	21	"gdT-cell: 228.7;MAIT T-cell: 135.3;memory CD4 T-cell: 187.4;memory CD8 T-cell: 196.4;naive CD4 T-cell: 192.7;naive CD8 T-cell: 241.8;T-reg: 200.1"	"Lineage enriched"	"Detected in many"	26	"T-cells: 241.8"	"Cancer enriched"	"Detected in some"	6	"Leukemia: 19.9"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Adrenal gland - T-cells, Colon - T-cells, Kidney - T-cells, Liver - T-cells, Lung - T-cells, Minor Salivary Gland - T-cells, Pancreas - T-cells, Pituitary gland - T-cells, Prostate - T-cells, Skin - T-cells, Spleen - T-cells, Stomach - T-cells, Thyroid gland - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB017520, HPA038494"	Enhanced		Supported	"Plasma membrane,Cytosol"			NA	NA			"Cluster 11: T-cells - Unknown function"	"Cluster 71: Thymus - Adaptive immune response"	"Cluster 6: Non-specific - Immune response"	"Cluster 59: Leukemia - T-cell receptor"	"Cluster 78: NK-cells & T-cells - Immune system & Transcription"	10	"Plasma membrane, Cytosol"		"CAB017520: AB_831094, HPA038494: AB_2676044"	"unprognostic (3.30e-2)"	"unprognostic (1.87e-2)"	"unprognostic (4.46e-1)"	"unprognostic (3.75e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.84e-1)"		"unprognostic (4.89e-2)"	"unprognostic (2.41e-3)"		"unprognostic (3.93e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.55e-2)"		"unprognostic (4.77e-3)"	"unprognostic (9.31e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.98e-1)"	"unprognostic (5.39e-2)"	"unprognostic (5.38e-3)"		"unprognostic (7.48e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.90e-2)"	"unprognostic (2.59e-1)"	"unprognostic (5.30e-2)"	"unprognostic (8.32e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.07e-2)"	"unprognostic (8.94e-2)"
CD4		ENSG00000010610	"CD4 molecule"	P01730	12	6786858-6820799	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Adaptive immunity, Host-virus interaction, Immunity"	"Host cell receptor for virus entry, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 148.3;lymphoid tissue: 213.7;parathyroid gland: 168.4"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 227.5;Hofbauer cells: 152.0;Kupffer cells: 190.2;Langerhans cells: 99.7;Macrophages: 116.7;monocytes: 150.0"	"Cell type enhanced"	"Detected in many"		"central nervous system macrophage: 162.0;fibroblast: 71.2;pericyte: 48.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	18	"classical monocyte: 247.4;intermediate monocyte: 241.4;memory CD4 T-cell: 153.8;myeloid DC: 166.4;naive CD4 T-cell: 128.5;non-classical monocyte: 205.2;plasmacytoid DC: 264.3;T-reg: 154.9"	"Group enriched"	"Detected in many"	20	"dendritic cells: 264.3;monocytes: 247.4;T-cells: 154.9"	"Group enriched"	"Detected in some"	35	"Leukemia: 40.6;lymphoma: 27.6;Myeloma: 23.9"	"Adrenal gland - Macrophages, Colon - Macrophages, Minor Salivary Gland - Macrophages, Pituitary gland - Macrophages, Skeletal muscle - Macrophages, Spleen - Macrophages, Stomach - Macrophages"	"Region enriched"	"Detected in many"	14	"basal ganglia: 46.2"	"Low region specificity"	"Detected in many"			"CAB000011, HPA004252, HPA004472, CAB068180"	Enhanced		Supported	"Plasma membrane"			NA	NA			"Cluster 2: Dendritic cells - Unknown function"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	10	"Plasma membrane"		"CAB000011: AB_442062, CAB068180: AB_2665653, HPA004252: AB_1078466, HPA004472: AB_1078465"	"unprognostic (2.67e-3)"	"unprognostic (8.77e-3)"	"unprognostic (1.16e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.78e-2)"	"unprognostic (4.32e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.83e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.49e-1)"	"unprognostic (5.33e-2)"	"unprognostic (4.32e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.59e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.52e-3)"	"unprognostic (5.86e-2)"	"unprognostic (3.27e-1)"
CD40	"Bp50, p50, TNFRSF5"	ENSG00000101017	"CD40 molecule"	P25942	20	46118271-46129863	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins"	Immunity	Receptor	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"B-cells: 126.2;Basal respiratory cells: 118.9;Langerhans cells: 237.0"	"Cell type enhanced"	"Detected in many"		"central nervous system macrophage: 29.2;pericyte: 32.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 108.3;naive B-cell: 123.7"	"Group enriched"	"Detected in all"	6	"B-cells: 123.7;monocytes: 34.9"	"Cancer enhanced"	"Detected in many"		"lymphoma: 97.7"	"Spleen - B-cells (Spleen)"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002495, HPA031567, HPA031568, CAB072868, CAB080468"	Enhanced		Approved	"Vesicles,Plasma membrane"	"Secreted to blood"	Receptor	NA	NA	705000		"Cluster 23: B-cells - Immunoglobulins"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 42: Choroid plexus - Mitochondria"	"Cluster 55: Lymphoma - Immune response"	"Cluster 14: Langerhans cells - Innate immune response"	76	Vesicles	"Plasma membrane"	"CAB002495: AB_563562, CAB072868: AB_2665719, CAB080468: , HPA031567: AB_2673936, HPA031568: AB_2673937"	"unprognostic (3.20e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.59e-2)"	"unprognostic (5.71e-2)"	"potential prognostic unfavorable (6.62e-4)"	"unprognostic (7.05e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.11e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.55e-2)"	"unprognostic (8.70e-3)"	"unprognostic (3.46e-1)"	"unprognostic (2.31e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.00e-1)"	"unprognostic (9.95e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.59e-3)"	"unprognostic (5.10e-2)"	"unprognostic (3.74e-2)"	"unprognostic (5.05e-2)"	"unprognostic (6.57e-2)"	"unprognostic (4.03e-2)"
CD40LG	"CD154, CD40-L, CD40L, gp39, hCD40L, HIGM1, IMD3, T-BAM, TNFSF5, TRAP"	ENSG00000102245	"CD40 ligand"	P29965	X	136648158-136660390	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 3.7;lymphoid tissue: 14.7"	"Cell type enriched"	"Detected in some"	9	"T-cells: 78.4"	"Cell type enriched"	"Detected in single"	20	"leukocyte: 19.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	5	"gdT-cell: 26.4;MAIT T-cell: 64.4;memory CD4 T-cell: 80.5;naive CD4 T-cell: 76.3"	"Lineage enriched"	"Detected in many"	34	"T-cells: 80.5"	"Cancer enriched"	"Detected in single"	7	"Leukemia: 2.6"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Adrenal gland - T-cells, Colon - T-cells, Kidney - T-cells, Liver - T-cells, Lung - T-cells, Minor Salivary Gland - T-cells, Skin - T-cells, Spleen - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA045827, HPA072480"	Enhanced		Approved	"Golgi apparatus,Plasma membrane"	"Secreted to blood"	Cytokine	NA	NA	776000	18000	"Cluster 11: T-cells - Unknown function"	"Cluster 36: Lymphoid tissue - Cytokine signaling"	"Cluster 6: Non-specific - Immune response"	"Cluster 59: Leukemia - T-cell receptor"	"Cluster 78: NK-cells & T-cells - Immune system & Transcription"	1	"Golgi apparatus, Plasma membrane"		"HPA045827: AB_10959606, HPA072480: "		"potential prognostic favorable (2.15e-4)"	"unprognostic (7.50e-3)"			"unprognostic (2.87e-1)"					"unprognostic (2.42e-1)"	"unprognostic (2.12e-1)"			"unprognostic (4.01e-3)"	"unprognostic (1.10e-3)"	"unprognostic (1.70e-2)"		"unprognostic (2.76e-1)"			"unprognostic (1.26e-1)"				"unprognostic (1.73e-1)"		"unprognostic (6.40e-2)"	"unprognostic (2.64e-2)"		
CD44	"CD44R, CSPG8, HCELL, IN, MC56, MDU2, MDU3, MIC4, Pgp1"	ENSG00000026508	"CD44 molecule (Indian blood group)"	P16070	11	35138882-35232402	"Blood group antigen proteins, Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Cell adhesion"	"Blood group antigen, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 484.4"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 983.9;Exocrine glandular cells: 928.7;granulocytes: 1083.6;Langerhans cells: 2343.8;monocytes: 1059.3"	"Cell type enhanced"	"Detected in many"		"astrocyte: 403.2;leukocyte: 474.2;vascular associated smooth muscle cell: 152.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"Adrenocortical cancer: 1400.7"	"Adipose subcutaneous - Adipose progenitor cells, Prostate - Urothelial cells, Skin - Keratinocyte (other)"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000112, CAB000316, HPA005785"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"	"Secreted to blood"	Receptor	NA	NA	260000000	660000000	"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 48: Stomach - Proteolysis"	"Cluster 39: Astrocytes - Mixed function"	"Cluster 72: Neuronal - Signal transduction"	"Cluster 29: Monocytes - Innate immune response"	26	"Plasma membrane"	"Golgi apparatus"	"CAB000112: , CAB000316: AB_2076596, HPA005785: AB_1078467"	"unprognostic (1.93e-3)"	"unprognostic (1.85e-1)"	"unprognostic (3.84e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.90e-2)"	"unprognostic (3.00e-2)"	"unprognostic (3.19e-1)"	"potential prognostic unfavorable (1.71e-4)"	"unprognostic (1.76e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.08e-3)"	"unprognostic (1.73e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.77e-3)"	"unprognostic (1.44e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.58e-2)"	"unprognostic (5.89e-3)"	"unprognostic (8.97e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.97e-2)"	"unprognostic (8.74e-2)"
CD46	"MCP, MGC26544, MIC10, TLX, TRA2.10"	ENSG00000117335	"CD46 molecule"	P15529	1	207752037-207795513	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Complement pathway, Fertilization, Host-virus interaction, Immunity, Innate immunity"	"Host cell receptor for virus entry, Receptor"	"Cancer-related genes, Disease variant, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Mucus glandular cells: 507.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 301.2;eosinophil: 387.4;neutrophil: 404.1"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 404.1"	"Low cancer specificity"	"Detected in all"			"Minor Salivary Gland - Minor salivary glandular cells"	"Low region specificity"	"Detected in single"							"CAB010401, HPA016903"	Enhanced		Approved	"Plasma membrane"			NA	NA		1100000	"Cluster 35: Neutrophils - Protein binding"	"Cluster 24: Parathyroid gland - Vesicular transport"	"Cluster 36: Choroid plexus - Mixed function"	"Cluster 57: Stomach & Colon cancer - Digestion"	"Cluster 74: Neutrophils - Degranulation"	4	"Plasma membrane"		"CAB010401: AB_2291289, HPA016903: AB_1846309"	"unprognostic (8.50e-2)"	"unprognostic (3.35e-3)"	"unprognostic (5.19e-2)"	"potential prognostic unfavorable (1.33e-4)"	"unprognostic (3.68e-1)"	"unprognostic (3.78e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.26e-1)"	"potential prognostic favorable (1.32e-6)"	"unprognostic (9.93e-3)"	"unprognostic (4.11e-2)"	"unprognostic (4.21e-2)"	"unprognostic (3.94e-2)"	"unprognostic (2.33e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.57e-3)"	"unprognostic (1.19e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.20e-2)"	"unprognostic (2.46e-1)"	"unprognostic (8.72e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.51e-1)"
CD47	"IAP, MER6, OA3"	ENSG00000196776	"CD47 molecule"	Q08722	3	108043091-108091862	"CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Angiogenesis, Apoptosis, Cell adhesion, Inflammatory response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 484.0;Ductal cells: 550.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Adipose progenitor cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016055, HPA044659"	Approved		Supported	"Vesicles,Plasma membrane"			NA	NA			"Cluster 12: Non-specific - Mitochondrial translation"	"Cluster 40: Non-specific - Transcription"	"Cluster 34: Non-specific - Mixed function"	"Cluster 30: Non-specific - Gene expression regulation"	"Cluster 45: Non-specific - Mixed function"	4	"Plasma membrane"	Vesicles	"CAB016055: AB_627086, HPA044659: AB_2679040"	"unprognostic (2.73e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.14e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.18e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.25e-2)"	"unprognostic (8.57e-3)"	"unprognostic (4.16e-1)"	"unprognostic (2.95e-2)"	"potential prognostic unfavorable (1.03e-5)"	"unprognostic (1.09e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.44e-1)"	"potential prognostic unfavorable (9.98e-5)"	"unprognostic (1.61e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.95e-2)"	"unprognostic (2.77e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.32e-2)"	"unprognostic (6.42e-2)"	"unprognostic (2.16e-1)"	"potential prognostic favorable (4.20e-4)"	"unprognostic (2.13e-2)"
CD48	"BCM1, BLAST, hCD48, mCD48, SLAMF2"	ENSG00000117091	"CD48 molecule"	P09326	1	160678746-160711831	"CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 146.6;lymphoid tissue: 277.0"	"Cell type enhanced"	"Detected in many"		"B-cells: 357.1;granulocytes: 236.4;Hofbauer cells: 222.8;Kupffer cells: 212.1;Macrophages: 183.5;monocytes: 953.3;NK-cells: 402.1;Schwann cells: 198.4;T-cells: 432.3"	"Cell type enriched"	"Detected in some"	144	"leukocyte: 159.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in some"		"lymphoma: 243.2;Myeloma: 458.6"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Kidney - T-cells, Pituitary gland - T-cells, Prostate - T-cells, Skin - T-cells, Thyroid gland - T-cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002497, HPA055146"	Enhanced		Approved	"Nucleoli fibrillar center,Plasma membrane,Cytosol"	"Secreted to blood"	"No annotated function"	NA	NA	1770000	1600000	"Cluster 33: Non-specific - ATP binding"	"Cluster 36: Lymphoid tissue - Cytokine signaling"	"Cluster 12: Non-specific - Vasculature"	"Cluster 55: Lymphoma - Immune response"	"Cluster 19: NK-cells - Adaptive immune response"	1	"Plasma membrane"	"Nucleoli fibrillar center, Cytosol"	"CAB002497: AB_563586, HPA055146: AB_2682716"	"unprognostic (5.07e-2)"	"potential prognostic favorable (5.81e-4)"	"unprognostic (4.94e-2)"	"unprognostic (1.10e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.56e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.77e-2)"	"potential prognostic favorable (3.12e-4)"	"unprognostic (1.06e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.35e-1)"	"unprognostic (3.75e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.85e-1)"	"unprognostic (4.10e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.82e-2)"
CD5	"LEU1, T1"	ENSG00000110448	"CD5 molecule"	P06127	11	61102489-61127852	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 45.2"	"Cell type enriched"	"Detected in some"	4	"T-cells: 57.0"	"Cell type enriched"	"Detected in some"	19	"leukocyte: 34.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 138.6"	"Lineage enriched"	"Detected in many"	33	"T-cells: 138.6"	"Group enriched"	"Detected in some"	7	"Leukemia: 17.3;lymphoma: 23.1"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Adrenal gland - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Kidney - T-cells, Liver - T-cells, Lung - T-cells, Prostate - T-cells, Spleen - T-cells, Thyroid gland - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB015392, CAB020308, HPA043416, HPA060839"	Enhanced						NA	NA			"Cluster 6: T-cells - T-cell receptor"	"Cluster 36: Lymphoid tissue - Cytokine signaling"	"Cluster 32: Cerebral cortex - Mixed function"	"Cluster 59: Leukemia - T-cell receptor"	"Cluster 7: T-cells - T-cell receptor"	1			"CAB015392: AB_2075324, CAB020308: , HPA043416: AB_2678472, HPA060839: AB_2684376"	"unprognostic (4.36e-2)"	"unprognostic (1.50e-3)"	"unprognostic (7.81e-2)"	"unprognostic (6.85e-3)"	"unprognostic (3.24e-1)"	"unprognostic (1.07e-1)"			"potential prognostic favorable (6.45e-6)"		"unprognostic (4.58e-1)"	"unprognostic (1.89e-1)"	"unprognostic (8.29e-2)"	"unprognostic (4.34e-3)"	"unprognostic (9.24e-3)"	"potential prognostic favorable (9.43e-4)"	"unprognostic (7.11e-2)"	"unprognostic (3.92e-1)"	"unprognostic (1.34e-1)"	"unprognostic (8.27e-2)"		"unprognostic (1.20e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.92e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.86e-1)"	"unprognostic (9.52e-2)"
CD52	"CDW52, EDDM5, HE5"	ENSG00000169442	"CD52 molecule"	P31358	1	26317958-26320523	"Cancer-related genes, CD markers, FDA approved drug targets, Predicted membrane proteins"			"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	29	"epididymis: 35271.0"	"Cell type enhanced"	"Detected in many"		"B-cells: 1880.8;granulocytes: 476.9;Hofbauer cells: 965.0;Langerhans cells: 740.3;Macrophages: 545.3;monocytes: 1356.6;NK-cells: 479.6;T-cells: 1189.9"	"Cell type enriched"	"Detected in some"	20	"leukocyte: 85.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"Leukemia: 303.1;lymphoma: 667.3"	"Adipose visceral - T-cells, Breast - T-cells, Lung - Macrophages, Prostate - T-cells, Spleen - B-cells (Spleen), Thyroid gland - T-cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"										NA	NA			"Cluster 3: Non-specific - Nuclear processes"	"Cluster 50: Epididymis - Male reproductive secretion"	"Cluster 23: Choroid plexus - Mixed function"	"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 73: B-cells - B-cell function"					"unprognostic (1.36e-1)"	"potential prognostic favorable (4.16e-4)"	"unprognostic (4.91e-2)"	"unprognostic (4.84e-3)"	"unprognostic (1.57e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.04e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.74e-3)"	"unprognostic (2.55e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.77e-1)"	"unprognostic (7.12e-2)"	"unprognostic (2.55e-2)"	"unprognostic (3.85e-3)"	"unprognostic (1.03e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.43e-1)"	"unprognostic (8.21e-2)"	"unprognostic (2.11e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.55e-2)"	"unprognostic (4.57e-2)"	"potential prognostic favorable (9.61e-4)"	"unprognostic (3.11e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.41e-1)"
CD53	"MOX44, TSPAN25"	ENSG00000143119	"CD53 molecule"	P19397	1	110871188-110899922	"CD markers, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 436.0"	"Cell type enhanced"	"Detected in many"		"B-cells: 329.4;dendritic cells: 235.5;Hofbauer cells: 390.5;Kupffer cells: 363.7;Langerhans cells: 201.1;Macrophages: 287.4;monocytes: 537.9;NK-cells: 424.4;T-cells: 289.6"	"Group enriched"	"Detected in many"	36	"central nervous system macrophage: 423.9;leukocyte: 382.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	49	"Leukemia: 176.0;lymphoma: 278.2;Myeloma: 139.8"	"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Breast - Macrophages, Colon - Macrophages, Heart muscle - Macrophages, Liver - Kupffer cells, Minor Salivary Gland - Macrophages, Pancreas - Macrophages, Pituitary gland - Macrophages, Skeletal muscle - Macrophages, Stomach - Macrophages"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047216	Enhanced						NA	NA			"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 36: Lymphoid tissue - Cytokine signaling"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 55: Lymphoma - Immune response"	"Cluster 73: B-cells - B-cell function"	57			"HPA047216: AB_2679986"	"unprognostic (1.96e-1)"	"unprognostic (2.30e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.55e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.61e-2)"	"unprognostic (7.63e-2)"	"unprognostic (5.55e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.83e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.42e-2)"	"unprognostic (9.66e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.37e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.24e-1)"	"unprognostic (4.66e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.36e-1)"
CD55	"CR, CROM, DAF, TC"	ENSG00000196352	"CD55 molecule (Cromer blood group)"	P08174	1	207321519-207386804	"Blood group antigen proteins, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Complement pathway, Host-virus interaction, Immunity, Innate immunity"	"Blood group antigen, Host cell receptor for virus entry, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 1446.0;monocytes: 1765.3;Syncytiotrophoblasts: 871.0"	"Cell type enhanced"	"Detected in all"		"leukocyte: 199.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 653.3"	"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Lung - Alveolar cells type 1, Spleen - Neutrophils, Testis - Early spermatids, Testis - Late spermatids"					"Low region specificity"	"Detected in many"			"HPA002190, CAB010454, HPA024386"	Enhanced				"Secreted to blood"	"Complement pathway"	NA	No	32300000	180000000	"Cluster 35: Neutrophils - Protein binding"	"Cluster 7: Adipose tissue - Mixed function"	"Cluster 28: Oligodendrocytes - Mixed function"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 29: Monocytes - Innate immune response"				"CAB010454: AB_2075970, HPA002190: AB_1078472, HPA024386: AB_1846319"	"unprognostic (4.12e-1)"	"unprognostic (7.61e-2)"	"unprognostic (9.07e-2)"	"unprognostic (3.32e-1)"	"unprognostic (6.26e-2)"	"unprognostic (2.24e-2)"	"unprognostic (2.62e-2)"	"unprognostic (4.30e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.19e-2)"	"potential prognostic unfavorable (3.47e-6)"	"unprognostic (3.46e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.37e-1)"	"unprognostic (5.31e-3)"	"unprognostic (4.16e-1)"	"unprognostic (3.13e-2)"	"potential prognostic unfavorable (6.72e-5)"	"unprognostic (4.58e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.43e-2)"	"unprognostic (6.70e-2)"
CD58	LFA3	ENSG00000116815	"CD58 molecule"	P19256	1	116514534-116571039	"CD markers, Human disease related genes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 137.5;Langerhans cells: 243.1"	"Cell type enhanced"	"Detected in many"		"central nervous system macrophage: 123.4;endothelial cell: 93.1;leukocyte: 127.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"								"Low region specificity"	"Detected in all"										NA	NA		5800000	"Cluster 37: Monocytes & Neutrophils - Innate immune response"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 55: Lymphoma - Immune response"	"Cluster 14: Langerhans cells - Innate immune response"	1				"unprognostic (2.75e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.02e-1)"	"unprognostic (9.52e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.20e-2)"	"potential prognostic unfavorable (2.29e-6)"	"unprognostic (3.82e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.65e-3)"	"unprognostic (3.20e-1)"	"unprognostic (1.42e-1)"	"potential prognostic unfavorable (8.97e-7)"	"unprognostic (2.87e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.59e-3)"	"unprognostic (2.65e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.44e-1)"	"validated prognostic unfavorable (7.68e-5)"	"validated prognostic unfavorable (3.32e-4)"	"unprognostic (1.67e-1)"	"unprognostic (3.84e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.39e-1)"
CD59	"16.3A5, EJ16, EJ30, EL32, G344, MIC11, MIN1, MIN2, MIN3, MSK21, p18-20"	ENSG00000085063	"CD59 molecule (CD59 blood group)"	P13987	11	33703010-33736479	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes, Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Ductal cells: 1341.1;Melanocytes: 1613.1"	"Cell type enhanced"	"Detected in all"		"endothelial cell: 276.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Minor Salivary Gland - Minor salivary glandular cells"					"Low region specificity"	"Detected in all"			"CAB001448, HPA026494"	Supported		Uncertain	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	"No annotated function"	NA	NA		38000000	"Cluster 42: Non-specific - Vesicular transport"	"Cluster 60: Choroid plexus - Transmembrane transport"	"Cluster 44: Non-specific - Mixed function"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 45: Non-specific - Mixed function"	8	"Golgi apparatus, Vesicles"		"CAB001448: AB_563604, HPA026494: AB_1846321"	"unprognostic (1.58e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.83e-2)"	"unprognostic (4.96e-3)"	"unprognostic (6.20e-2)"	"unprognostic (8.60e-3)"	"unprognostic (5.49e-3)"	"unprognostic (2.50e-2)"	"potential prognostic unfavorable (9.32e-4)"	"unprognostic (1.11e-2)"	"potential prognostic favorable (1.47e-8)"	"unprognostic (1.86e-3)"	"unprognostic (3.68e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.74e-3)"	"unprognostic (5.73e-3)"	"unprognostic (3.97e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.70e-3)"	"unprognostic (2.67e-2)"	"unprognostic (7.11e-2)"	"unprognostic (3.60e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.49e-1)"	"potential prognostic unfavorable (6.25e-5)"	"unprognostic (1.71e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.18e-1)"
CD6	Tp120	ENSG00000013725	"CD6 molecule"	P30203	11	60971680-61020377	"CD markers, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Cell adhesion, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 13.2;lymphoid tissue: 42.2"	"Group enriched"	"Detected in some"	8	"NK-cells: 40.2;T-cells: 99.6"	"Cell type enriched"	"Detected in many"	29	"leukocyte: 129.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	33	"gdT-cell: 27.8;MAIT T-cell: 24.7;memory CD4 T-cell: 51.5;memory CD8 T-cell: 48.4;naive CD4 T-cell: 34.5;naive CD8 T-cell: 25.2;T-reg: 25.5"	"Lineage enriched"	"Detected in many"	50	"T-cells: 51.5"	"Group enriched"	"Detected in some"	10	"Leukemia: 10.8;lymphoma: 11.0"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Adrenal gland - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Kidney - T-cells, Liver - T-cells, Lung - T-cells, Minor Salivary Gland - T-cells, Pituitary gland - T-cells, Prostate - T-cells, Spleen - T-cells, Thyroid gland - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB002489, CAB016252"	Enhanced				"Secreted to blood"	Immunity	NA	NA	5270000	100000	"Cluster 11: T-cells - Unknown function"	"Cluster 36: Lymphoid tissue - Cytokine signaling"	"Cluster 41: Monoamines - Neurotransmitter signalling"	"Cluster 59: Leukemia - T-cell receptor"	"Cluster 78: NK-cells & T-cells - Immune system & Transcription"	7			"CAB002489: AB_563605, CAB016252: AB_631163"	"unprognostic (9.32e-2)"	"potential prognostic favorable (2.12e-4)"	"unprognostic (1.43e-2)"	"potential prognostic favorable (7.70e-5)"	"unprognostic (2.21e-1)"	"unprognostic (2.29e-1)"			"potential prognostic favorable (1.42e-5)"		"unprognostic (8.82e-2)"	"unprognostic (2.61e-1)"	"unprognostic (6.07e-3)"	"unprognostic (8.79e-3)"	"potential prognostic favorable (6.48e-4)"	"unprognostic (1.22e-2)"	"unprognostic (9.83e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.22e-1)"	"unprognostic (4.07e-3)"	"unprognostic (1.96e-2)"	"unprognostic (4.06e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.57e-2)"	"unprognostic (2.98e-1)"	"potential prognostic favorable (6.31e-4)"	"unprognostic (7.20e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.14e-1)"
CD63	"ME491, MLA1, TSPAN30"	ENSG00000135404	"CD63 molecule"	P08962	12	55725323-55729707	"CD markers, Plasma proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"pericyte: 302.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 1861.6"	"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Spleen - Macrophages"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010088, CAB026356, HPA073506"	Supported		Supported	Vesicles	"Intracellular and membrane"	Transport	NA	NA			"Cluster 22: Eosinophils - Transcription"	"Cluster 60: Choroid plexus - Transmembrane transport"	"Cluster 12: Non-specific - Vasculature"	"Cluster 9: Skin cancer - Melanin biosynthesis"	"Cluster 45: Non-specific - Mixed function"	34	Vesicles		"CAB026356: AB_629864, HPA010088: AB_1846323, HPA073506: "	"unprognostic (8.38e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.59e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.29e-2)"	"unprognostic (9.37e-3)"	"potential prognostic unfavorable (7.36e-4)"	"unprognostic (4.40e-3)"	"unprognostic (4.85e-2)"	"unprognostic (8.60e-3)"	"unprognostic (6.06e-2)"	"unprognostic (1.62e-1)"	"potential prognostic unfavorable (6.81e-6)"	"unprognostic (1.54e-3)"	"unprognostic (1.40e-1)"	"unprognostic (7.14e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.64e-1)"	"unprognostic (5.59e-2)"	"unprognostic (9.76e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.73e-1)"	"potential prognostic unfavorable (1.36e-4)"	"unprognostic (9.64e-2)"	"unprognostic (8.15e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.87e-3)"	"unprognostic (3.90e-2)"
CD68	"DKFZp686M18236, GP110, LAMP4, SCARD1"	ENSG00000129226	"CD68 molecule"	P34810	17	7579491-7582111	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 346.5;lymphoid tissue: 360.8"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 223.6;Kupffer cells: 258.2;Langerhans cells: 80.9;Macrophages: 190.0;Proximal enterocytes: 193.1"	"Cell type enriched"	"Detected in some"	5	"central nervous system macrophage: 88.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"classical monocyte: 3264.9;intermediate monocyte: 3664.2;non-classical monocyte: 3764.8"	"Group enriched"	"Detected in all"	11	"dendritic cells: 1382.0;monocytes: 3764.8"	"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Breast - Macrophages, Colon - Macrophages, Heart muscle - Macrophages, Lung - Macrophages, Pituitary gland - Macrophages, Prostate - Macrophages, Skeletal muscle - Macrophages, Skin - Macrophages, Spleen - Macrophages, Stomach - Macrophages, Testis - Macrophages, Thyroid gland - Macrophages"					"Low region specificity"	"Detected in all"			"CAB000051, CAB000066, HPA048982, CAB072861, CAB072862"	Enhanced		Supported	"Golgi apparatus,Vesicles"			NA	NA		11000000	"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 58: Macrophages - Innate immune response"	11	"Golgi apparatus, Vesicles"		"CAB000051: AB_2314148, CAB000066: AB_2074844, CAB072861: AB_2665705, CAB072862: AB_2665706, HPA048982: AB_2680587"	"unprognostic (9.25e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.00e-2)"	"unprognostic (8.87e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.53e-3)"	"unprognostic (2.68e-1)"	"unprognostic (5.75e-2)"	"unprognostic (9.00e-3)"	"unprognostic (1.58e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.69e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.09e-1)"	"unprognostic (8.14e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.50e-3)"	"unprognostic (2.51e-1)"	"unprognostic (2.14e-1)"
CD69	CLEC2C	ENSG00000110848	"CD69 molecule"	Q07108	12	9752486-9760901	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 167.0;lymphoid tissue: 92.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 934.4;granulocytes: 2458.1;NK-cells: 508.7;T-cells: 1192.8"	"Group enriched"	"Detected in some"	168	"central nervous system macrophage: 124.4;leukocyte: 405.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"NK-cells: 26.8;T-cells: 30.8"	"Group enriched"	"Detected in some"	6	"Leukemia: 45.9;lymphoma: 25.6"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Adrenal gland - T-cells, Breast - T-cells, Kidney - T-cells, Minor Salivary Gland - T-cells, Thyroid gland - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB002503, HPA050525"	Enhanced						NA	NA			"Cluster 24: Non-specific - Transcription"	"Cluster 77: Bone marrow - Cell proliferation"	"Cluster 8: Immune cells - Immune response"	"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 30: Granulocytes - Unknown function"	13			"CAB002503: AB_563625, HPA050525: AB_2681157"	"unprognostic (7.30e-2)"	"potential prognostic favorable (3.45e-4)"	"unprognostic (1.36e-2)"	"unprognostic (8.81e-3)"	"unprognostic (8.19e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.45e-2)"	"unprognostic (5.57e-2)"	"unprognostic (7.13e-3)"	"unprognostic (4.90e-3)"	"unprognostic (3.02e-1)"	"unprognostic (4.20e-2)"	"unprognostic (2.12e-1)"	"unprognostic (9.56e-3)"	"unprognostic (1.19e-2)"	"unprognostic (2.81e-3)"	"unprognostic (3.79e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.50e-2)"	"potential prognostic favorable (1.90e-4)"	"unprognostic (4.77e-3)"	"unprognostic (3.72e-2)"	"unprognostic (2.54e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.03e-1)"
CD7	"GP40, LEU-9, Tp40, TP41"	ENSG00000173762	"CD7 molecule"	P09564	17	82314868-82317608	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 28.1;lymphoid tissue: 52.4"	"Group enriched"	"Detected in many"	14	"NK-cells: 1153.0;T-cells: 557.6"	"Cell type enriched"	"Detected in some"	21	"leukocyte: 196.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 232.4"	"Group enriched"	"Detected in many"	22	"NK-cells: 232.4;T-cells: 71.8"	"Group enriched"	"Detected in some"	6	"Leukemia: 50.4;liver cancer: 16.7;Myeloma: 21.7"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Adrenal gland - T-cells, Breast - T-cells, Heart muscle - T-cells, Liver - NK-cells (Liver), Lung - NK-cells (Lung), Pancreas - T-cells, Prostate - T-cells, Thyroid gland - T-cells"	"Region enhanced"	"Detected in some"		"cerebral cortex: 3.2"	"Not detected"	"Not detected"			"CAB002594, HPA039079"	Enhanced						NA	NA			"Cluster 1: T-cells - Unknown function"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 44: Non-specific - Mixed function"	"Cluster 59: Leukemia - T-cell receptor"	"Cluster 19: NK-cells - Adaptive immune response"	17			"CAB002594: , HPA039079: AB_2676337"	"unprognostic (1.80e-3)"	"unprognostic (5.84e-3)"	"unprognostic (9.08e-2)"	"unprognostic (1.69e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.19e-3)"		"unprognostic (1.07e-3)"	"unprognostic (8.01e-2)"	"potential prognostic unfavorable (3.32e-4)"	"unprognostic (2.61e-1)"	"unprognostic (2.02e-3)"	"unprognostic (4.51e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.24e-1)"	"unprognostic (7.95e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.72e-2)"	"unprognostic (3.12e-1)"	"unprognostic (5.43e-2)"	"unprognostic (8.98e-2)"	"potential prognostic favorable (9.26e-6)"	"unprognostic (1.03e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.39e-1)"	"unprognostic (5.28e-3)"
CD70	"CD27L, CD27LG, TNFSF7"	ENSG00000125726	"CD70 molecule"	P32970	19	6583183-6604103	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 3.3"	"Cell type enhanced"	"Detected in some"		"B-cells: 46.4;Basal respiratory cells: 9.5;Fibroblasts: 7.9;Langerhans cells: 15.7;Plasma cells: 19.3;T-cells: 14.9"	"Cell type enriched"	"Detected in some"	8	"leukocyte: 11.6"	"Cancer enhanced"	"Detected in many"		"Kidney Renal Clear Cell Carcinoma (TCGA): 97.1"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"T-reg: 44.3"	"Group enriched"	"Detected in many"	35	"B-cells: 24.3;T-cells: 44.3"	"Cancer enhanced"	"Detected in many"		"Kidney cancer: 386.8"	"Thyroid gland - T-cells"	"Region enriched"	"Detected in single"	25	"cerebellum: 11.3"	"Low region specificity"	"Detected in many"			HPA046582			Uncertain	Nucleoplasm			NA	NA			"Cluster 16: Non-specific - Cell proliferation"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 25: Non-specific - Transcription"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 14: Langerhans cells - Innate immune response"	83	Nucleoplasm		"HPA046582: "	"unprognostic (1.40e-1)"	"unprognostic (1.92e-1)"	"unprognostic (4.64e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.02e-3)"	"unprognostic (1.22e-1)"	"unprognostic (9.36e-2)"	"unprognostic (6.66e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.81e-1)"			"unprognostic (9.92e-3)"	"unprognostic (1.79e-2)"	"unprognostic (2.69e-2)"	"unprognostic (4.14e-1)"	"unprognostic (2.85e-1)"		"unprognostic (7.29e-2)"	"potential prognostic unfavorable (3.56e-4)"		"unprognostic (1.26e-1)"	"unprognostic (1.21e-2)"	"unprognostic (6.05e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.71e-1)"	"unprognostic (3.29e-1)"
CD72	"CD72b, LYB2"	ENSG00000137101	"CD72 molecule"	P21854	9	35609982-35646810	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lymphoid tissue: 63.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 80.8;dendritic cells: 17.1;Hofbauer cells: 18.0;Kupffer cells: 19.2;Langerhans cells: 16.8;Macrophages: 18.6;monocytes: 26.2;NK-cells: 20.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	16	"memory B-cell: 233.6;naive B-cell: 413.2"	"Lineage enriched"	"Detected in all"	20	"B-cells: 413.2"	"Group enriched"	"Detected in some"	32	"Leukemia: 20.9;lymphoma: 39.1"	"Prostate - T-cells, Thyroid gland - T-cells"	"Region enriched"	"Detected in single"	7	"basal ganglia: 4.1"	"Low region specificity"	"Detected in some"			"CAB002505, HPA044658"	Enhanced		Uncertain	Nucleoplasm,Mitochondria			NA	NA			"Cluster 34: B-cells - Unknown function"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 12: Non-specific - Vasculature"	"Cluster 35: RS4;11 - Unknown function"	"Cluster 73: B-cells - B-cell function"	16	"Nucleoplasm, Mitochondria"		"CAB002505: AB_563629, HPA044658: AB_2679039"	"unprognostic (7.25e-2)"	"unprognostic (3.59e-1)"	"unprognostic (3.32e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.40e-3)"	"unprognostic (2.03e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.78e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.31e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.97e-1)"	"unprognostic (9.33e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.16e-2)"	"unprognostic (7.46e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.37e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.93e-1)"	"unprognostic (5.06e-2)"
CD74	"CLIP, DHLAG"	ENSG00000019582	"CD74 molecule"	P04233	5	150401637-150412969	"Cancer-related genes, CD markers, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Adaptive immunity, Immunity"	Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 5112.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 11727.2;dendritic cells: 8645.4;Hofbauer cells: 5396.5;Langerhans cells: 26767.6;Macrophages: 7008.6;Proximal enterocytes: 5477.7;Schwann cells: 10143.4"	"Cell type enriched"	"Detected in many"	5	"central nervous system macrophage: 1596.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 11129.6;intermediate monocyte: 16174.8;memory B-cell: 27121.2;myeloid DC: 23965.9;naive B-cell: 28192.5;non-classical monocyte: 8146.1;plasmacytoid DC: 17015.9"	"Group enriched"	"Detected in all"	6	"B-cells: 28192.5;dendritic cells: 23965.9;monocytes: 16174.8"	"Group enriched"	"Detected in many"	7	"Leukemia: 998.7;lymphoma: 3214.7;Myeloma: 1807.4;skin cancer: 961.7"	"Adipose visceral - T-cells, Testis - Macrophages, Thyroid gland - T-cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002506, HPA010592, CAB079994"	Enhanced		Supported	"Golgi apparatus"	"Secreted to blood"	Immunity	NA	NA		140000	"Cluster 2: Dendritic cells - Unknown function"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 21: Lymphoma - Adaptive immune response"	"Cluster 28: Dendritic cells - Antigen presentation"	19	"Golgi apparatus"		"CAB002506: AB_563630, CAB079994: , HPA010592: AB_1078482"	"unprognostic (1.93e-3)"	"potential prognostic favorable (9.48e-5)"	"unprognostic (7.99e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.10e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.17e-1)"	"unprognostic (4.14e-1)"	"unprognostic (3.94e-2)"	"unprognostic (3.54e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.12e-3)"	"unprognostic (9.15e-2)"	"unprognostic (9.54e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.36e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.47e-3)"
CD79A	"Ig-alpha, IGA, IGAlpha, MB-1, MB1"	ENSG00000105369	"CD79a molecule"	P11912	19	41877279-41881372	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 148.2;lymphoid tissue: 529.7"	"Group enriched"	"Detected in some"	29	"B-cells: 1202.8;Plasma cells: 778.7"	"Cell type enriched"	"Detected in single"	39	"leukocyte: 9.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	38	"memory B-cell: 1278.3;naive B-cell: 1462.8"	"Lineage enriched"	"Detected in all"	40	"B-cells: 1462.8"	"Cancer enriched"	"Detected in many"	4	"lymphoma: 867.0"	"Breast - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Skin - Plasma cells, Spleen - B-cells (Spleen), Stomach - Plasma cells, Thyroid gland - Plasma cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB000019, HPA056444"	Enhanced						NA	NA			"Cluster 14: Non-specific - Unknown function"	"Cluster 36: Lymphoid tissue - Cytokine signaling"	"Cluster 6: Non-specific - Immune response"	"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 73: B-cells - B-cell function"	166			"CAB000019: AB_2244527, HPA056444: "	"unprognostic (6.14e-2)"	"potential prognostic favorable (4.61e-6)"	"unprognostic (1.62e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.17e-1)"			"potential prognostic favorable (3.21e-5)"	"unprognostic (8.87e-2)"	"unprognostic (5.96e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.47e-3)"	"unprognostic (2.47e-2)"	"unprognostic (6.52e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.98e-2)"	"unprognostic (4.28e-1)"	"unprognostic (6.97e-2)"	"unprognostic (4.94e-3)"	"unprognostic (6.71e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.62e-3)"	"unprognostic (1.20e-1)"	"unprognostic (6.73e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.99e-1)"
CD79B	"B29, Ig-beta, IGB, Igbeta"	ENSG00000007312	"CD79b molecule"	P40259	17	63928738-63932336	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins"	"Adaptive immunity, Immunity"		"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 258.7"	"Cell type enriched"	"Detected in many"	4	"B-cells: 490.9"	"Group enriched"	"Detected in some"	5	"fibroblast: 8.8;leukocyte: 18.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in all"	4	"memory B-cell: 1119.4;naive B-cell: 1488.8"	"Lineage enriched"	"Detected in all"	5	"B-cells: 1488.8"	"Cancer enriched"	"Detected in some"	6	"lymphoma: 657.0"	"Pituitary gland - Somatotropes, Prostate - Endothelial cells, Spleen - B-cells (Spleen)"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA009178, CAB009751, HPA044107"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"			NA	NA			"Cluster 23: B-cells - Immunoglobulins"	"Cluster 70: Lymphoid tissue - Immune response"		"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 73: B-cells - B-cell function"	3	"Plasma membrane"	"Nucleoplasm, Cytosol"	"CAB009751: AB_2275844, HPA009178: AB_1078483, HPA044107: "	"unprognostic (1.46e-1)"	"unprognostic (1.55e-2)"	"potential prognostic favorable (2.92e-5)"	"potential prognostic favorable (3.09e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.67e-1)"	"potential prognostic unfavorable (4.18e-4)"	"unprognostic (1.78e-1)"	"potential prognostic favorable (4.85e-4)"	"unprognostic (1.39e-1)"	"potential prognostic favorable (2.74e-4)"	"unprognostic (1.70e-2)"	"potential prognostic unfavorable (3.33e-4)"	"unprognostic (1.82e-1)"	"unprognostic (2.64e-2)"	"potential prognostic favorable (2.91e-4)"	"unprognostic (1.02e-1)"	"unprognostic (7.09e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.06e-2)"	"unprognostic (5.15e-2)"	"unprognostic (5.97e-2)"	"unprognostic (4.42e-3)"	"unprognostic (1.85e-1)"	"unprognostic (7.89e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.47e-1)"
CD80	"B7-1, B7.1, CD28LG, CD28LG1"	ENSG00000121594	"CD80 molecule"	P33681	3	119524293-119559614	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lung: 2.9;lymphoid tissue: 6.6"	"Group enriched"	"Detected in some"	4	"B-cells: 9.1;Langerhans cells: 21.3;Macrophages: 7.2;monocytes: 19.3"	"Cell type enhanced"	"Detected in some"		"central nervous system macrophage: 4.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 1.4;T-reg: 1.3"	"Low lineage specificity"	"Detected in many"			"Cancer enriched"	"Detected in some"	5	"lymphoma: 19.6"	"Liver - Kupffer cells"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB025368, HPA050092"	Enhanced				"Intracellular and membrane"	Receptor	NA	NA			"Cluster 14: Non-specific - Unknown function"	"Cluster 36: Lymphoid tissue - Cytokine signaling"	"Cluster 8: Immune cells - Immune response"	"Cluster 55: Lymphoma - Immune response"	"Cluster 14: Langerhans cells - Innate immune response"	6			"CAB025368: , HPA050092: AB_2681012"		"unprognostic (2.18e-1)"	"unprognostic (7.63e-2)"			"unprognostic (4.98e-2)"		"unprognostic (1.46e-1)"	"unprognostic (9.23e-2)"			"unprognostic (1.86e-1)"			"unprognostic (1.93e-1)"	"unprognostic (2.59e-3)"	"unprognostic (2.58e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.04e-1)"			"unprognostic (1.83e-2)"	"potential prognostic unfavorable (9.01e-5)"			"unprognostic (1.87e-2)"		"unprognostic (3.67e-1)"	"unprognostic (1.25e-2)"		
CD81	"TAPA-1, TAPA1, TSPAN28"	ENSG00000110651	"CD81 molecule"	P60033	11	2376177-2397802	"CD markers, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Adaptive immunity, Host-virus interaction, Immunity"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 2015.8;Endometrial stromal cells: 1072.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory B-cell: 149.3;naive B-cell: 137.6"	"Lineage enriched"	"Detected in all"	4	"B-cells: 149.3"	"Low cancer specificity"	"Detected in all"			"Adrenal gland - Fibroblasts, Skin - Fibroblast_2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002507, HPA007234"	Supported		Approved	"Plasma membrane,Cytosol"			NA	NA		1400000	"Cluster 12: Non-specific - Mitochondrial translation"	"Cluster 62: Connective tissue - ECM organization"	"Cluster 19: Astrocytes - Mixed function"	"Cluster 44: Connective tissue cells - ECM organization"	"Cluster 3: Basal prostatic cells - Lipid metabolism"	49	"Plasma membrane"	Cytosol	"CAB002507: AB_563639, HPA007234: AB_1846333"	"unprognostic (2.98e-1)"	"unprognostic (8.15e-2)"	"unprognostic (1.47e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.74e-1)"	"potential prognostic unfavorable (3.91e-4)"	"unprognostic (1.41e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.09e-1)"	"potential prognostic favorable (4.91e-5)"	"unprognostic (2.80e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.62e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.15e-3)"	"unprognostic (1.89e-1)"	"unprognostic (5.10e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.37e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.62e-2)"
CD82	"IA4, KAI1, R2, ST6, TSPAN27"	ENSG00000085117	"CD82 molecule"	P27701	11	44564427-44620358	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"granulocytes: 203.0;Proximal enterocytes: 205.8"	"Cell type enhanced"	"Detected in many"		"oligodendrocyte: 61.3;oligodendrocyte precursor cell: 171.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 537.1"	"Group enriched"	"Detected in all"	6	"B-cells: 308.8;granulocytes: 537.1;T-cells: 172.7"	"Low cancer specificity"	"Detected in all"			"Liver - Hepatocytes, Spleen - Macrophages, Stomach - Mitotic cells (Stomach)"	"Region enhanced"	"Detected in all"		"white matter: 210.9"	"Low region specificity"	"Detected in all"			"CAB002508, HPA028900, HPA061418"	Supported		Uncertain	Vesicles			NA	NA		11000	"Cluster 20: Non-specific - DNA binding"	"Cluster 77: Bone marrow - Cell proliferation"	"Cluster 19: Astrocytes - Mixed function"	"Cluster 55: Lymphoma - Immune response"	"Cluster 30: Granulocytes - Unknown function"	9	Vesicles		"CAB002508: AB_563640, HPA028900: AB_10603558, HPA061418: AB_2684510"	"unprognostic (2.21e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.98e-1)"	"unprognostic (7.51e-2)"	"unprognostic (4.26e-2)"	"unprognostic (1.43e-1)"	"potential prognostic unfavorable (1.22e-6)"	"unprognostic (1.37e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.09e-2)"	"unprognostic (7.51e-2)"	"unprognostic (8.03e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.86e-2)"	"unprognostic (7.81e-3)"	"unprognostic (2.53e-1)"	"unprognostic (9.93e-2)"	"unprognostic (4.21e-2)"	"unprognostic (4.15e-2)"	"unprognostic (5.63e-2)"	"unprognostic (9.51e-2)"	"unprognostic (8.69e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.13e-2)"	"unprognostic (6.01e-2)"	"unprognostic (8.35e-2)"	"unprognostic (2.53e-1)"
CD83	"BL11, HB15"	ENSG00000112149	"CD83 molecule"	Q01151	6	14117256-14136918	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 207.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 665.5;granulocytes: 358.9;Langerhans cells: 1778.3;Macrophages: 631.3;monocytes: 995.6;Schwann cells: 428.5"	"Group enriched"	"Detected in all"	5	"central nervous system macrophage: 261.1;leukocyte: 73.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cancer enriched"	"Detected in all"	5	"lymphoma: 133.1"	"Adrenal gland - Adrenal cortex cells, Spleen - B-cells (Spleen), Stomach - Fibroblasts"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002509, HPA041454, HPA064421"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Plasma membrane"			NA	NA			"Cluster 14: Non-specific - Unknown function"	"Cluster 77: Bone marrow - Cell proliferation"	"Cluster 44: Non-specific - Mixed function"	"Cluster 55: Lymphoma - Immune response"	"Cluster 28: Dendritic cells - Antigen presentation"	12	"Nucleoplasm, Plasma membrane"	"Nucleoli, Golgi apparatus"	"CAB002509: AB_563641, HPA041454: AB_2677489, HPA064421: "	"unprognostic (1.03e-1)"	"unprognostic (1.61e-2)"	"unprognostic (4.92e-2)"	"unprognostic (2.91e-2)"	"unprognostic (3.91e-2)"	"unprognostic (8.31e-3)"	"unprognostic (3.70e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.47e-2)"	"unprognostic (3.43e-1)"	"potential prognostic favorable (6.59e-5)"	"unprognostic (5.49e-2)"	"potential prognostic favorable (6.34e-4)"	"unprognostic (3.38e-3)"	"unprognostic (5.33e-2)"	"unprognostic (3.09e-3)"	"unprognostic (1.15e-2)"	"unprognostic (7.46e-2)"	"unprognostic (4.68e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.86e-1)"	"unprognostic (5.48e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.82e-1)"	"unprognostic (6.48e-3)"	"unprognostic (1.72e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.49e-1)"	"unprognostic (8.07e-2)"
CD84	"hCD84, mCD84, SLAMF5"	ENSG00000066294	"CD84 molecule"	Q9UIB8	1	160541095-160579516	"CD markers, Predicted membrane proteins"	"Adaptive immunity, Autophagy, Cell adhesion, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 23.6"	"Cell type enhanced"	"Detected in many"		"granulocytes: 174.5;Hofbauer cells: 90.3;Kupffer cells: 136.0;Langerhans cells: 47.6;Macrophages: 109.6;T-cells: 53.0"	"Group enriched"	"Detected in some"	45	"central nervous system macrophage: 226.4;leukocyte: 62.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	61	"Leukemia: 11.4;lymphoma: 8.2"	"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Breast - Macrophages, Liver - Kupffer cells, Minor Salivary Gland - Macrophages, Skeletal muscle - Macrophages, Stomach - Macrophages"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063316, HPA068020, HPA070502"	Enhanced		Enhanced	"Vesicles,Plasma membrane"			NA	NA		19000000	"Cluster 42: Non-specific - Vesicular transport"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 49: HMC-1 - Innate immune response"	"Cluster 58: Macrophages - Innate immune response"	1	"Plasma membrane"	Vesicles	"HPA063316: , HPA068020: , HPA070502: AB_2686274"	"unprognostic (4.21e-2)"	"unprognostic (2.15e-2)"	"unprognostic (4.87e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.48e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.40e-2)"	"unprognostic (9.86e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.23e-1)"		"unprognostic (6.70e-2)"	"unprognostic (2.64e-3)"	"unprognostic (1.61e-2)"	"unprognostic (9.69e-2)"	"unprognostic (7.25e-2)"	"unprognostic (7.67e-2)"	"unprognostic (3.15e-1)"	"unprognostic (6.20e-2)"	"unprognostic (4.36e-2)"	"unprognostic (2.79e-1)"	"unprognostic (5.92e-2)"	"unprognostic (4.61e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.24e-1)"
CD86	"B7-2, B7.2, CD28LG2"	ENSG00000114013	"CD86 molecule"	P42081	3	122055362-122121139	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Host-virus interaction, Immunity"	"Host cell receptor for virus entry, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 33.5"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 151.9;Kupffer cells: 91.5;Langerhans cells: 191.7;Macrophages: 142.5;Microglial cells: 75.1;monocytes: 464.6"	"Cell type enriched"	"Detected in some"	8	"central nervous system macrophage: 472.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"classical monocyte: 80.1;intermediate monocyte: 79.2;memory B-cell: 41.1;myeloid DC: 79.0;naive B-cell: 28.7;non-classical monocyte: 85.6"	"Group enriched"	"Detected in many"	18	"B-cells: 41.1;dendritic cells: 79.0;monocytes: 85.6"	"Cancer enriched"	"Detected in some"	6	"lymphoma: 54.5"	"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Breast - Macrophages, Colon - Macrophages, Heart muscle - Macrophages, Kidney - Macrophages, Liver - Kupffer cells, Minor Salivary Gland - Macrophages, Pancreas - Macrophages, Pituitary gland - Macrophages, Prostate - Macrophages, Skeletal muscle - Macrophages, Spleen - Macrophages, Stomach - Macrophages, Thyroid gland - Macrophages"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB004319, HPA026802"	Approved		Supported	"Plasma membrane,Centriolar satellite"			NA	NA		94000	"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 21: Lymphoma - Adaptive immune response"	"Cluster 14: Langerhans cells - Innate immune response"	3	"Plasma membrane"	"Centriolar satellite"	"CAB004319: AB_627200, HPA026802: "	"unprognostic (1.96e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.93e-1)"	"unprognostic (6.14e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.50e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.98e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.75e-1)"	"unprognostic (8.71e-2)"	"unprognostic (3.25e-1)"	"unprognostic (8.71e-2)"	"unprognostic (1.02e-3)"	"unprognostic (3.57e-1)"	"unprognostic (7.46e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.03e-2)"	"unprognostic (7.84e-2)"	"unprognostic (2.94e-1)"
CD8A	CD8	ENSG00000153563	"CD8a molecule"	P01732	2	86784610-86808396	"CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"lymphoid tissue: 226.2"	"Cell type enriched"	"Detected in many"	4	"T-cells: 243.8"	"Cell type enriched"	"Detected in many"	9	"leukocyte: 170.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	14	"MAIT T-cell: 227.9;memory CD8 T-cell: 509.4;naive CD8 T-cell: 461.5"	"Lineage enriched"	"Detected in many"	19	"T-cells: 509.4"	"Group enriched"	"Detected in some"	9	"Leukemia: 4.0;lymphoma: 5.1"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Adrenal gland - T-cells, Breast - T-cells, Colon - T-cells, Kidney - T-cells, Liver - T-cells, Lung - T-cells, Minor Salivary Gland - T-cells, Pancreas - T-cells, Pituitary gland - T-cells, Prostate - T-cells, Skin - T-cells, Stomach - T-cells, Thyroid gland - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB000012, HPA037756, CAB075722"	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"	Immunity	NA	NA		220000	"Cluster 11: T-cells - Unknown function"	"Cluster 71: Thymus - Adaptive immune response"	"Cluster 8: Immune cells - Immune response"	"Cluster 59: Leukemia - T-cell receptor"	"Cluster 7: T-cells - T-cell receptor"	6	"Plasma membrane"		"CAB000012: AB_2075537, CAB075722: AB_2665709, HPA037756: AB_2675648"	"unprognostic (5.62e-2)"	"unprognostic (2.24e-3)"	"unprognostic (8.45e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.79e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.42e-3)"	"unprognostic (2.91e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.73e-3)"	"unprognostic (3.28e-3)"	"unprognostic (9.10e-3)"	"unprognostic (2.97e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.16e-1)"	"unprognostic (4.58e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.09e-3)"	"unprognostic (1.32e-1)"	"unprognostic (4.00e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.65e-1)"
CD8B	CD8B1	ENSG00000172116	"CD8b molecule"	P10966	2	86815339-86861924	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	14	"lymphoid tissue: 447.5"	"Cell type enriched"	"Detected in many"	11	"T-cells: 159.0"	"Cell type enriched"	"Detected in some"	14	"leukocyte: 126.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"memory CD8 T-cell: 602.5;naive CD8 T-cell: 1058.1"	"Lineage enriched"	"Detected in all"	25	"T-cells: 1058.1"	"Group enriched"	"Detected in some"	9	"Leukemia: 8.7;Myeloma: 33.2"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Adrenal gland - T-cells, Colon - T-cells, Kidney - T-cells, Liver - T-cells, Lung - T-cells, Minor Salivary Gland - T-cells, Pancreas - T-cells, Pituitary gland - Corticotropes, Prostate - T-cells, Skin - T-cells, Spleen - T-cells, Stomach - T-cells, Thyroid gland - T-cells"									"CAB004353, HPA029164"	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"	Immunity	NA	NA			"Cluster 43: Non-specific - Transcription & Translation"	"Cluster 71: Thymus - Adaptive immune response"	"Cluster 49: Hindbrain - Mixed function"	"Cluster 59: Leukemia - T-cell receptor"	"Cluster 19: NK-cells - Adaptive immune response"		"Plasma membrane"		"CAB004353: AB_627211, HPA029164: AB_2672936"	"unprognostic (5.53e-3)"	"unprognostic (1.52e-3)"	"unprognostic (6.39e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.76e-1)"	"potential prognostic unfavorable (2.85e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.03e-3)"		"unprognostic (4.71e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.27e-2)"	"unprognostic (4.54e-3)"	"unprognostic (9.97e-2)"	"unprognostic (1.79e-2)"	"unprognostic (5.63e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.21e-1)"	"unprognostic (7.60e-2)"	"unprognostic (7.58e-2)"	"unprognostic (4.21e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.27e-2)"	"unprognostic (6.30e-3)"	"unprognostic (1.21e-1)"	"unprognostic (2.80e-2)"	"unprognostic (6.73e-2)"	"unprognostic (2.73e-1)"
CD9	"BA2, MIC3, MRP-1, P24, TSPAN29"	ENSG00000010278	"CD9 molecule"	P21926	12	6199715-6238271	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Fertilization"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 2694.8;Ionocytes: 2140.8"	"Cell type enhanced"	"Detected in many"		"oligodendrocyte: 263.5;pericyte: 336.9;vascular associated smooth muscle cell: 199.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	26	"basophil: 1961.8;eosinophil: 1159.2"	"Lineage enriched"	"Detected in all"	32	"granulocytes: 1961.8"	"Low cancer specificity"	"Detected in all"			"Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB002490	Supported		Supported	"Plasma membrane"	"Intracellular and membrane"	"Cell adhesion"	NA	NA		2800000	"Cluster 41: Basophils - Unknown function"	"Cluster 75: Epithelium - Extracellular exosomes"	"Cluster 11: White matter - Signal transduction"	"Cluster 48: Adipocytes & Endothelial cells - Angiogenesis"	"Cluster 35: Respiratory epithelial cells - Unknown function"	20	"Plasma membrane"		"CAB002490: AB_563643"	"unprognostic (2.47e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.66e-2)"	"unprognostic (7.09e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.40e-1)"	"potential prognostic unfavorable (4.96e-4)"	"unprognostic (5.92e-2)"	"unprognostic (1.15e-1)"	"validated prognostic favorable (1.87e-6)"	"validated prognostic favorable (3.24e-5)"	"unprognostic (1.34e-1)"	"unprognostic (7.21e-2)"	"unprognostic (3.13e-2)"	"unprognostic (8.25e-2)"	"unprognostic (3.86e-2)"	"potential prognostic favorable (5.09e-4)"	"unprognostic (4.27e-1)"	"unprognostic (2.59e-2)"	"unprognostic (3.02e-2)"	"potential prognostic unfavorable (1.07e-4)"	"unprognostic (4.92e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.18e-1)"	"unprognostic (5.90e-3)"	"unprognostic (1.05e-1)"
CD93	"C1qR(P), C1QR1, C1qRP, CDw93, dJ737E23.1, ECSM3, MXRA4"	ENSG00000125810	"CD93 molecule"	Q9NPY3	20	23079360-23086324	"CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 133.0"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 312.1;Endothelial cells: 272.5;Kupffer cells: 141.1;Macrophages: 121.0;monocytes: 87.4"	"Group enriched"	"Detected in some"	21	"central nervous system macrophage: 10.9;endothelial cell: 34.4;leukocyte: 9.8;vascular associated smooth muscle cell: 15.1"	"Cancer enhanced"	"Detected in all"		"Kidney Renal Clear Cell Carcinoma (TCGA): 65.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	15	"classical monocyte: 25.8;intermediate monocyte: 16.8;myeloid DC: 9.1;neutrophil: 27.8;non-classical monocyte: 7.5"	"Group enriched"	"Detected in many"	41	"dendritic cells: 9.1;granulocytes: 27.8;monocytes: 25.8"	"Cancer enhanced"	"Detected in some"		"Leukemia: 17.2;lymphoma: 6.8"	"Adipose subcutaneous - Endothelial cells, Breast - Endothelial cells, Colon - Endothelial cells, Heart muscle - Endothelial cells, Kidney - Endothelial cells, Liver - Vascular Endothelial cells, Lung - Endothelial cells, Minor Salivary Gland - Endothelial cells, Pituitary gland - Endothelial cells, Prostate - Endothelial cells, Skeletal muscle - Endothelial cells, Stomach - Endothelial cells, Testis - Endothelial cells, Thyroid gland - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009300, HPA012368"	Enhanced		Approved	"Vesicles,Plasma membrane"			NA	NA		330000000	"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 7: Adipose tissue - Mixed function"	"Cluster 12: Non-specific - Vasculature"	"Cluster 48: Adipocytes & Endothelial cells - Angiogenesis"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	9	"Vesicles, Plasma membrane"		"HPA009300: AB_1846342, HPA012368: AB_1846341"	"unprognostic (7.45e-2)"	"unprognostic (2.24e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.54e-1)"	"unprognostic (8.87e-2)"	"unprognostic (4.81e-2)"	"potential prognostic favorable (3.00e-6)"	"unprognostic (1.42e-3)"	"unprognostic (5.89e-3)"	"unprognostic (8.97e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.47e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.64e-2)"	"unprognostic (2.62e-2)"	"unprognostic (6.68e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.47e-2)"	"unprognostic (8.62e-2)"	"unprognostic (7.62e-2)"	"unprognostic (1.30e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.68e-2)"	"unprognostic (4.21e-1)"
CD96	TACTILE	ENSG00000153283	"CD96 molecule"	P40200	3	111292719-111665750	"CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Craniosynostosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 60.2"	"Group enriched"	"Detected in many"	12	"NK-cells: 119.6;T-cells: 206.8"	"Cell type enriched"	"Detected in many"	25	"leukocyte: 573.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"gdT-cell: 74.0;MAIT T-cell: 117.3;memory CD4 T-cell: 67.1;memory CD8 T-cell: 85.2;naive CD4 T-cell: 68.8;naive CD8 T-cell: 81.9;NK-cell: 79.7;T-reg: 47.4"	"Group enriched"	"Detected in many"	5	"NK-cells: 79.7;T-cells: 117.3"	"Cancer enhanced"	"Detected in many"		"Leukemia: 31.3;skin cancer: 14.7"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Adrenal gland - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Kidney - T-cells, Liver - T-cells, Minor Salivary Gland - T-cells, Pancreas - T-cells, Pituitary gland - T-cells, Prostate - T-cells, Skin - T-cells, Thyroid gland - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA066754	Enhanced						NA	NA		47000	"Cluster 24: Non-specific - Transcription"	"Cluster 71: Thymus - Adaptive immune response"	"Cluster 6: Non-specific - Immune response"	"Cluster 59: Leukemia - T-cell receptor"	"Cluster 78: NK-cells & T-cells - Immune system & Transcription"				"HPA066754: AB_2685714"	"unprognostic (4.56e-2)"	"unprognostic (2.31e-3)"	"unprognostic (5.10e-3)"	"potential prognostic favorable (7.56e-4)"	"unprognostic (1.36e-1)"	"unprognostic (2.38e-1)"		"unprognostic (2.95e-1)"	"unprognostic (1.12e-2)"		"unprognostic (1.10e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.63e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.65e-1)"	"unprognostic (5.44e-2)"	"unprognostic (3.57e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.13e-1)"	"unprognostic (7.71e-2)"	"unprognostic (5.32e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.73e-1)"
CD99	MIC2	ENSG00000002586	"CD99 molecule (Xg blood group)"	P14209	X	2691187-2741309	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"ependymal cell: 6.5;leukocyte: 5.7;pericyte: 7.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Skin - Fibroblast_1, Skin - Fibroblast_2"					"Low region specificity"	"Detected in all"			"CAB000020, HPA035304"	Supported		Approved	"Golgi apparatus"			NA	NA		64000000	"Cluster 13: Non-specific - Mitochondria"	"Cluster 41: Smooth muscle tissue - ECM organization"	"Cluster 39: Astrocytes - Mixed function"	"Cluster 12: Bone cancer - Neuronal signaling"	"Cluster 53: Fibroblasts - ECM organization"	3	"Golgi apparatus"		"CAB000020: AB_2076419, HPA035304: AB_10672861"	"unprognostic (3.10e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.61e-2)"	"unprognostic (5.06e-2)"	"unprognostic (5.03e-2)"		"unprognostic (4.27e-2)"	"unprognostic (4.04e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.76e-3)"		"validated prognostic unfavorable (2.05e-4)"	"validated prognostic unfavorable (3.63e-4)"	"unprognostic (1.25e-1)"	"unprognostic (3.44e-2)"	"unprognostic (4.17e-1)"	"unprognostic (3.57e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.67e-1)"	"unprognostic (4.33e-2)"	"unprognostic (4.23e-2)"	"unprognostic (5.65e-3)"	"unprognostic (8.43e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.60e-1)"
CDCP1	"CD318, SIMA135"	ENSG00000163814	"CUB domain containing protein 1"	Q9H5V8	3	45082277-45146422	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 36.1"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 111.9;Basal respiratory cells: 87.9;Suprabasal keratinocytes: 73.2"	"Cell type enhanced"	"Detected in many"		"central nervous system macrophage: 31.6;choroid plexus epithelial cell: 41.8;deep-layer near-projecting: 64.2"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"choroid plexus: 26.9"	"Immune cell enhanced"	"Detected in some"		"myeloid DC: 2.3;NK-cell: 4.2"	"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Adipose subcutaneous - Macrophages, Heart muscle - Macrophages, Skin - Keratinocyte (other), Spleen - Macrophages, Stomach - Gastric mucous cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA010978, HPA010979, HPA011405, CAB025637"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Vesicles"	"Intracellular and membrane"	"No annotated function"	NA	NA			"Cluster 14: Non-specific - Unknown function"	"Cluster 75: Epithelium - Extracellular exosomes"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 45: Non-specific - Mixed function"	5	"Nucleoplasm, Vesicles"	"Nuclear bodies"	"CAB025637: , HPA010978: AB_1846403, HPA010979: AB_1846401, HPA011405: "	"unprognostic (1.26e-1)"	"unprognostic (3.79e-2)"	"unprognostic (4.37e-2)"	"unprognostic (4.21e-3)"	"unprognostic (6.03e-3)"	"unprognostic (9.82e-2)"	"unprognostic (9.81e-3)"	"unprognostic (2.46e-2)"	"unprognostic (5.93e-3)"	"unprognostic (2.62e-2)"	"validated prognostic unfavorable (6.19e-4)"	"validated prognostic unfavorable (3.32e-4)"	"unprognostic (1.09e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.41e-2)"	"potential prognostic unfavorable (3.27e-5)"	"unprognostic (1.76e-3)"	"unprognostic (1.64e-2)"	"unprognostic (6.45e-3)"	"unprognostic (6.19e-3)"	"unprognostic (3.65e-1)"	"potential prognostic unfavorable (1.83e-4)"	"unprognostic (2.02e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.72e-1)"	"unprognostic (6.66e-2)"	"unprognostic (7.81e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.89e-1)"
CDH1	"CD324, UVO, uvomorulin"	ENSG00000039068	"Cadherin 1"	P12830	16	68737292-68835537	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell adhesion"		"Cancer-related genes, Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 191.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 256.1;Distal enterocytes: 307.5;Glandular and luminal cells: 313.0"	"Group enriched"	"Detected in many"	8	"choroid plexus epithelial cell: 52.1;committed oligodendrocyte precursor: 41.5;fibroblast: 17.4;oligodendrocyte: 53.1"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"choroid plexus: 43.1"	"Group enriched"	"Detected in some"	13	"myeloid DC: 1.7;plasmacytoid DC: 4.7"	"Lineage enriched"	"Detected in single"	19	"dendritic cells: 4.7"	"Low cancer specificity"	"Detected in many"			"Adipose visceral - Mesothelial cells, Colon - Colon enterocytes, Liver - Hepatocytes, Lung - Alveolar cells type 2, Prostate - Prostate glandular cells, Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000087, HPA004812, CAB028364, CAB072855, CAB072856, CAB072857"	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Cell Junctions"			NA	NA		140000000	"Cluster 13: Non-specific - Mitochondria"	"Cluster 55: Kidney & Intestine - Metabolism"	"Cluster 36: Choroid plexus - Mixed function"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 37: Glandular & Luminal cells - Unknown function"	108	"Plasma membrane, Cell Junctions"	"Golgi apparatus"	"CAB000087: AB_2533003, CAB028364: AB_2076812, CAB072855: AB_2665698, CAB072856: AB_2665699, CAB072857: AB_2665700, HPA004812: AB_1078369"	"unprognostic (2.74e-1)"	"unprognostic (3.08e-2)"	"unprognostic (8.05e-3)"	"unprognostic (6.64e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.77e-1)"	"unprognostic (9.33e-2)"	"unprognostic (2.21e-1)"	"unprognostic (9.84e-2)"	"potential prognostic favorable (3.08e-8)"	"unprognostic (2.11e-3)"	"unprognostic (1.17e-2)"	"unprognostic (2.04e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.61e-2)"	"unprognostic (5.62e-2)"	"unprognostic (3.69e-3)"	"unprognostic (9.81e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.66e-2)"	"unprognostic (9.66e-3)"	"unprognostic (1.57e-1)"	"unprognostic (8.58e-3)"	"unprognostic (7.03e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.51e-2)"
CDH2	"CD325, CDHN, NCAD"	ENSG00000170558	"Cadherin 2"	P19022	18	27932879-28177946	"CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cardiomyopathy, Disease variant, Intellectual disability"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 189.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 206.5;Cardiomyocytes: 382.4;Cone photoreceptor cells: 132.5;Excitatory neurons: 300.3;Inhibitory neurons: 189.4;Oligodendrocyte precursor cells: 251.4"	"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"Glioblastoma Multiforme (TCGA): 82.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 1.7;neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.7"	"Low cancer specificity"	"Detected in many"			"Adrenal gland - Adrenal cortex cells, Colon - Enteric glia cells, Pituitary gland - Undifferentiated cells (Pituitary gland)"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000141, CAB018580, HPA058574, CAB078686, CAB080169"	Enhanced		Supported	"Plasma membrane,Cell Junctions"			NA	NA		160000000	"Cluster 35: Neutrophils - Protein binding"	"Cluster 30: Heart muscle - Heart development"	"Cluster 40: Astrocytes - Astrocyte-neuron interactions"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 34: Neurons - Neuronal signaling"	28	"Plasma membrane"	"Cell Junctions"	"CAB000141: , CAB018580: AB_626778, CAB078686: AB_2665849, CAB080169: , HPA058574: AB_2683760"	"unprognostic (2.90e-1)"	"unprognostic (1.34e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.66e-2)"	"unprognostic (7.64e-2)"		"potential prognostic favorable (7.16e-5)"	"unprognostic (2.92e-3)"	"unprognostic (5.18e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.64e-2)"	"unprognostic (7.69e-2)"	"unprognostic (2.48e-2)"	"unprognostic (7.27e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.90e-2)"	"unprognostic (3.81e-2)"	"unprognostic (7.90e-2)"		"unprognostic (1.71e-1)"	"unprognostic (1.08e-3)"	"unprognostic (5.44e-3)"	"unprognostic (9.80e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.22e-2)"
CDH5	"7B4, CD144"	ENSG00000179776	"Cadherin 5"	P33151	16	66366622-66404784	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 228.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 292.8;Endothelial cells: 190.1;Late spermatids: 84.9;Lymphatic endothelial cells: 152.3;Syncytiotrophoblasts: 119.6"	"Cell type enriched"	"Detected in some"	4	"endothelial cell: 186.4"	"Cancer enhanced"	"Detected in all"		"Kidney Renal Clear Cell Carcinoma (TCGA): 64.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"ovarian cancer: 12.0;pancreatic cancer: 9.6;Rhabdoid: 12.8"	"Adipose subcutaneous - Endothelial cells, Adipose visceral - Endothelial cells, Adrenal gland - Endothelial cells, Breast - Endothelial cells, Colon - Endothelial cells, Heart muscle - Endothelial cells, Kidney - Endothelial cells, Liver - Vascular Endothelial cells, Lung - Endothelial cells, Minor Salivary Gland - Endothelial cells, Pancreas - Endothelial cells, Prostate - Endothelial cells, Stomach - Endothelial cells, Thyroid gland - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB028366, HPA075875"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Plasma membrane"			NA	NA		1100000000		"Cluster 7: Adipose tissue - Mixed function"	"Cluster 47: Endothelial cells - Vasculature"	"Cluster 48: Adipocytes & Endothelial cells - Angiogenesis"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	18	"Plasma membrane"	"Nucleoplasm, Nuclear membrane"	"CAB028366: AB_2276033, HPA075875: "	"unprognostic (9.32e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.68e-2)"	"unprognostic (8.62e-2)"	"unprognostic (3.66e-1)"	"unprognostic (9.58e-2)"	"unprognostic (5.26e-2)"	"unprognostic (6.52e-3)"	"unprognostic (1.55e-1)"	"validated prognostic favorable (1.37e-7)"	"validated prognostic favorable (9.91e-4)"	"potential prognostic unfavorable (9.22e-5)"	"unprognostic (1.37e-1)"	"unprognostic (8.39e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.25e-2)"	"unprognostic (5.76e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.12e-1)"	"unprognostic (6.53e-3)"	"unprognostic (9.63e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.16e-2)"
CEACAM1	"BGP, BGP1, CD66a"	ENSG00000079385	"CEA cell adhesion molecule 1"	P13688	19	42507304-42561234	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 238.1"	"Group enriched"	"Detected in many"	5	"Distal enterocytes: 797.7;Paneth cells: 241.7"	"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"Colon Adenocarcinoma (TCGA): 122.5;Rectum Adenocarcinoma (TCGA): 128.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"eosinophil: 44.1;neutrophil: 26.9"	"Lineage enriched"	"Detected in many"	13	"granulocytes: 44.1"	"Low cancer specificity"	"Detected in many"			"Adipose visceral - Endothelial cells, Adrenal gland - Endothelial cells, Colon - Colon enterocytes, Heart muscle - Endothelial cells, Kidney - Endothelial cells, Skin - Eccrine sweat gland cells"									"CAB002146, HPA011041"	Enhanced				"Intracellular and membrane"	"No annotated function"	NA	NA		61000000	"Cluster 21: Neutrophils - Unknown function"	"Cluster 45: Intestine - Digestion"	"Cluster 15: Non-specific - Transcription"	"Cluster 9: Skin cancer - Melanin biosynthesis"	"Cluster 5: Enterocytes - Absorption"	6			"CAB002146: AB_563614, HPA011041: AB_1078481"	"unprognostic (1.35e-1)"	"unprognostic (8.56e-3)"	"unprognostic (7.91e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.37e-2)"	"unprognostic (6.50e-2)"		"unprognostic (1.47e-2)"	"unprognostic (1.06e-1)"	"potential prognostic favorable (6.68e-7)"	"unprognostic (3.29e-3)"	"unprognostic (1.63e-2)"	"unprognostic (7.77e-2)"	"unprognostic (1.13e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.90e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.31e-2)"	"unprognostic (1.58e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.74e-2)"	"unprognostic (3.37e-1)"
CEACAM3	"CD66d, CGM1"	ENSG00000170956	"CEA cell adhesion molecule 3"	P40198	19	41796587-41811554	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"bone marrow: 43.8"	"Cell type enriched"	"Detected in some"	7	"Paneth cells: 47.5"	"Cell type enriched"	"Detected in single"	15	"leukocyte: 1.6"	"Cancer enhanced"	"Detected in single"		"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA): 1.2"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.9"	"Immune cell enriched"	"Detected in many"	6	"neutrophil: 290.5"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 290.5"	"Not detected"	"Not detected"			"Adipose visceral - Neutrophils, Heart muscle - Neutrophils, Lung - NK-cells (Lung), Minor Salivary Gland - Neutrophils, Pituitary gland - Neutrophils, Stomach - Neutrophils, Thyroid gland - Neutrophils"									HPA011041	Approved						NA	NA			"Cluster 4: Neutrophils - Degranulation"	"Cluster 6: Bone marrow - Innate immune response"	"Cluster 12: Non-specific - Vasculature"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 74: Neutrophils - Degranulation"	4			"HPA011041: AB_1078481"				"potential prognostic favorable (9.44e-4)"																			"unprognostic (1.35e-1)"								
CEACAM5	"CD66e, CEA"	ENSG00000105388	"CEA cell adhesion molecule 5"	P06731	19	41708585-41730433	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell adhesion"		"Cancer-related genes, Oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"intestine: 949.3"	"Group enriched"	"Detected in some"	8	"Distal enterocytes: 1949.2;Intestinal goblet cells: 820.7;Paneth cells: 991.4"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Colon Adenocarcinoma (TCGA): 1966.2;Rectum Adenocarcinoma (TCGA): 2245.2"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"colorectal cancer: 196.8;Gallbladder cancer: 484.8"	"Colon - Colon enterocytes, Minor Salivary Gland - Minor salivary gland basal cells, Prostate - Urothelial cells, Skin - Eccrine sweat gland cells, Stomach - Gastric mucous cells, Thyroid gland - Parafollicular cells"									"CAB000021, CAB000022, HPA011041, HPA019758"	Enhanced		Supported	"Plasma membrane"			NA	NA		11000000		"Cluster 45: Intestine - Digestion"	"Cluster 48: Non-specific - Mixed function"	"Cluster 16: Thyroid cancer - Neuronal signaling"	"Cluster 5: Enterocytes - Absorption"	1	"Plasma membrane"		"CAB000021: , CAB000022: AB_2335697, HPA011041: AB_1078481, HPA019758: AB_1846326"	"unprognostic (1.28e-1)"	"unprognostic (1.24e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.59e-2)"	"unprognostic (8.80e-3)"			"unprognostic (4.29e-3)"					"potential prognostic unfavorable (2.31e-4)"	"unprognostic (2.01e-1)"	"unprognostic (4.91e-1)"	"unprognostic (8.67e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.11e-1)"		"unprognostic (4.32e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.37e-2)"	"unprognostic (3.76e-1)"	"unprognostic (8.05e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.82e-1)"	"unprognostic (4.32e-1)"	"unprognostic (1.44e-1)"		"unprognostic (1.31e-1)"
CEACAM6	"CD66c, NCA"	ENSG00000086548	"CEA cell adhesion molecule 6"	P40199	19	41750977-41772211	"Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell adhesion"		"Cancer-related genes, Oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 179.4;esophagus: 189.8;intestine: 213.5;lung: 277.7;salivary gland: 172.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 1478.7;Alveolar cells type 2: 210.1;Club cells: 252.8;Distal enterocytes: 438.9;Paneth cells: 364.4"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Lung Adenocarcinoma (TCGA): 1045.8;Rectum Adenocarcinoma (TCGA): 1052.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 386.8"	"Colon - Colon enterocytes, Prostate - Urothelial cells, Skin - Eccrine sweat gland cells, Spleen - Hematopoietic stem cells"									"CAB008370, HPA011041"	Enhanced						NA	NA		41000000		"Cluster 77: Bone marrow - Cell proliferation"	"Cluster 34: Non-specific - Mixed function"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 45: Non-specific - Mixed function"	25			"CAB008370: AB_592067, HPA011041: AB_1078481"	"unprognostic (1.08e-1)"	"unprognostic (1.24e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.11e-1)"	"unprognostic (7.57e-3)"			"unprognostic (1.17e-2)"				"unprognostic (3.50e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.73e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.28e-2)"	"unprognostic (7.58e-2)"	"unprognostic (3.99e-2)"	"unprognostic (3.06e-1)"	"unprognostic (5.32e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.44e-1)"	"unprognostic (5.33e-3)"	"unprognostic (3.08e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.68e-1)"	"unprognostic (3.65e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.93e-2)"
CEACAM8	"CD66b, CGM6"	ENSG00000124469	"CEA cell adhesion molecule 8"	P31997	19	42580243-42595055	"CD markers, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	36	"bone marrow: 214.4"	"Cell type enriched"	"Detected in single"	4	"Paneth cells: 3.9"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"neutrophil: 1.6;non-classical monocyte: 1.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 1.6;monocytes: 1.1"	"Not detected"	"Not detected"			"Liver - Erythroid cells, Lung - Neutrophil_1, Pituitary gland - Neutrophils, Spleen - Hematopoietic stem cells"									"CAB033676, CAB080307"	Enhanced				"Intracellular and membrane"	"Cell adhesion"	NA	NA		4700000	"Cluster 37: Monocytes & Neutrophils - Innate immune response"	"Cluster 6: Bone marrow - Innate immune response"	"Cluster 34: Non-specific - Mixed function"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 74: Neutrophils - Degranulation"	6			"CAB033676: AB_1125678, CAB080307: "						"unprognostic (1.38e-3)"											"unprognostic (5.34e-2)"									"unprognostic (1.22e-1)"					"unprognostic (9.43e-2)"
CLEC10A	"CD301, CLECSF13, CLECSF14, HML, HML2"	ENSG00000132514	"C-type lectin domain containing 10A"	Q8IUN9	17	7074537-7080307	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Endocytosis, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 28.5"	"Cell type enriched"	"Detected in some"	5	"Langerhans cells: 1016.5"	"Cell type enriched"	"Detected in single"	5	"leukocyte: 4.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in many"	12	"myeloid DC: 466.5"	"Lineage enriched"	"Detected in many"	12	"dendritic cells: 466.5"	"Not detected"	"Not detected"			"Adrenal gland - Macrophages, Skeletal muscle - Macrophages"					"Not detected"	"Not detected"			HPA021937	Approved						NA	NA			"Cluster 2: Dendritic cells - Unknown function"	"Cluster 25: Small intestine - Absorption"	"Cluster 12: Non-specific - Vasculature"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 28: Dendritic cells - Antigen presentation"	25			"HPA021937: AB_1846905"	"unprognostic (1.21e-2)"	"unprognostic (3.41e-3)"	"potential prognostic favorable (2.75e-5)"	"unprognostic (3.52e-3)"	"unprognostic (2.59e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.35e-3)"	"unprognostic (2.29e-1)"	"potential prognostic favorable (5.61e-6)"		"unprognostic (3.13e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.10e-2)"	"potential prognostic favorable (3.24e-6)"	"unprognostic (2.39e-1)"	"unprognostic (6.68e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.16e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.40e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.63e-1)"	"unprognostic (5.13e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.37e-1)"
CLEC12A	"CD371, CLL-1, DCAL-2, MICL"	ENSG00000172322	"C-type lectin domain family 12 member A"	Q5QGZ9	12	9951316-9995694	"CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 78.8;lymphoid tissue: 21.6"	"Cell type enhanced"	"Detected in some"		"granulocytes: 40.1;Hofbauer cells: 63.8;Kupffer cells: 96.9;Macrophages: 119.6;monocytes: 183.0"	"Cell type enriched"	"Detected in some"	24	"leukocyte: 91.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 203.3"	"Group enriched"	"Detected in many"	37	"dendritic cells: 72.7;granulocytes: 203.3;monocytes: 137.1"	"Cancer enriched"	"Detected in some"	16	"Leukemia: 21.6"	"Minor Salivary Gland - Macrophages, Spleen - Neutrophils, Stomach - Macrophages"	"Region enriched"	"Detected in single"	7	"basal ganglia: 6.2"	"Low region specificity"	"Detected in single"			HPA048515	Enhanced						NA	NA			"Cluster 29: Non-specific - Unknown function"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 10: Cerebellum - Nucleic acid binding"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 29: Monocytes - Innate immune response"	1			"HPA048515: AB_2680425"	"unprognostic (2.84e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.51e-1)"	"unprognostic (6.19e-3)"	"unprognostic (9.54e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.25e-1)"	"unprognostic (5.62e-2)"		"unprognostic (3.78e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.89e-1)"		"unprognostic (6.86e-2)"	"potential prognostic favorable (1.84e-4)"	"unprognostic (1.14e-1)"	"unprognostic (2.71e-1)"	"unprognostic (5.06e-1)"	"unprognostic (9.41e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.15e-2)"		"unprognostic (1.23e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.69e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.68e-2)"	
CLEC4A	"CD367, CLECSF6, DCIR, DDB27, hDCIR"	ENSG00000111729	"C-type lectin domain family 4 member A"	Q9UMR7	12	8123617-8138607	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Host-virus interaction, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 21.3;lymphoid tissue: 26.1"	"Group enriched"	"Detected in some"	4	"Hofbauer cells: 14.1;Kupffer cells: 28.8;Langerhans cells: 31.2;Macrophages: 35.2;monocytes: 12.6"	"Cell type enhanced"	"Detected in all"		"central nervous system macrophage: 21.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 227.9;classical monocyte: 333.0;intermediate monocyte: 198.7;myeloid DC: 328.2;neutrophil: 300.4;non-classical monocyte: 130.7"	"Group enriched"	"Detected in all"	13	"dendritic cells: 328.2;granulocytes: 300.4;monocytes: 333.0"	"Low cancer specificity"	"Detected in some"				"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA007842	Uncertain						NA	NA			"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 7: Non-specific - Ribosome"	"Cluster 59: Leukemia - T-cell receptor"	"Cluster 29: Monocytes - Innate immune response"	37			"HPA007842: AB_1078534"	"unprognostic (2.90e-2)"	"unprognostic (9.08e-2)"	"unprognostic (2.18e-1)"	"potential prognostic favorable (6.05e-4)"	"unprognostic (2.18e-1)"	"unprognostic (9.85e-3)"	"unprognostic (1.14e-1)"	"unprognostic (4.52e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.01e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.87e-1)"	"potential prognostic favorable (2.05e-4)"	"unprognostic (9.66e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.89e-1)"	"unprognostic (5.76e-1)"	"unprognostic (6.08e-2)"	"unprognostic (3.40e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.29e-1)"
CLEC4C	"BDCA2, CD303, CLECSF11, CLECSF7, DLEC, HECL"	ENSG00000198178	"C-type lectin domain family 4 member C"	Q8WTT0	12	7729383-7751605	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 5.3"	"Group enriched"	"Detected in some"	16	"dendritic cells: 194.6;Oocytes: 87.5"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"Testicular Germ Cell Tumor (TCGA): 1.2"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in many"	16	"plasmacytoid DC: 469.2"	"Lineage enriched"	"Detected in many"	16	"dendritic cells: 469.2"	"Not detected"	"Not detected"												HPA029432	Approved						NA	NA			"Cluster 8: Plasmacytoid DCs - Unknown function"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 48: Non-specific - Mixed function"	"Cluster 55: Lymphoma - Immune response"	"Cluster 28: Dendritic cells - Antigen presentation"	3			"HPA029432: AB_10601259"			"unprognostic (5.88e-3)"														"unprognostic (1.61e-1)"		"unprognostic (2.40e-1)"										"unprognostic (7.59e-2)"		
CLEC4D	"CD368, CLECSF8, Dectin-3, MCL, Mpcl"	ENSG00000166527	"C-type lectin domain family 4 member D"	Q8WXI8	12	8509475-8522366	"CD markers, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"bone marrow: 64.0"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 8.0;Kupffer cells: 12.0;Macrophages: 10.1;monocytes: 2.6"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	63	"Testicular Germ Cell Tumor (TCGA): 26.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	17	"classical monocyte: 57.4;neutrophil: 99.4"	"Group enriched"	"Detected in many"	32	"granulocytes: 99.4;monocytes: 57.4"	"Cancer enhanced"	"Detected in some"		"lymphoma: 3.2;testis cancer: 8.4"	"Adipose visceral - Neutrophils, Colon - Neutrophils, Heart muscle - Neutrophils, Liver - Neutrophils, Lung - Neutrophil_2, Spleen - Neutrophils, Thyroid gland - Neutrophils"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA004906	Approved						NA	NA			"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 6: Bone marrow - Innate immune response"		"Cluster 71: Lymphoma - Inflammatory response"	"Cluster 74: Neutrophils - Degranulation"	54			"HPA004906: AB_1078535"																	"unprognostic (2.07e-1)"		"unprognostic (2.71e-1)"										"unprognostic (1.81e-1)"		
CLEC4M	"CD209L, CD299, DC-SIGN2, DC-SIGNR, DCSIGNR, HP10347, LSIGN"	ENSG00000104938	"C-type lectin domain family 4 member M"	Q9H2X3	19	7763210-7769605	"CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Adaptive immunity, Endocytosis, Host-virus interaction, Immunity, Innate immunity"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"liver: 60.8;lymphoid tissue: 16.0"	"Cell type enhanced"	"Detected in some"		"Endothelial cells: 21.8;Fibroblasts: 41.6;Granulosa cells: 32.9;Kupffer cells: 19.0;Sertoli cells: 40.8"	"Cell type enhanced"	"Detected in some"		"cerebellar inhibitory: 1.3;lower rhombic lip: 1.4;thalamic excitatory: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"												"CAB033689, CAB033691, HPA042661"	Supported				"Intracellular and membrane"	Receptor	NA	NA		19000000		"Cluster 31: Liver - Plasma proteins"	"Cluster 45: Non-specific - Mixed function"	"Cluster 47: Leukemia - Hemostasis"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	4			"CAB033689: AB_831088, CAB033691: AB_2081354, HPA042661: AB_2678101"															"unprognostic (2.50e-2)"																
CLEC7A	"CD369, CLECSF12, DECTIN-1, hDectin-1, SCARE2"	ENSG00000172243	"C-type lectin domain containing 7A"	Q9BXN2	12	10116777-10130258	"CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"bone marrow: 82.8;lung: 30.0;lymphoid tissue: 43.2"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 185.8;Kupffer cells: 344.2;Langerhans cells: 334.7;Macrophages: 238.2;monocytes: 818.0;Schwann cells: 228.1"	"Cell type enriched"	"Detected in some"	6	"central nervous system macrophage: 297.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 251.5"	"Low lineage specificity"	"Detected in many"			"Cancer enriched"	"Detected in many"	11	"Myeloma: 62.2"	"Adipose subcutaneous - Macrophages, Adrenal gland - Macrophages, Colon - Macrophages, Kidney - Macrophages, Pancreas - Macrophages, Skeletal muscle - Macrophages, Skin - T-cells, Spleen - Neutrophils, Stomach - Macrophages, Testis - Macrophages"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"										NA	NA			"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 29: Monocytes - Innate immune response"	12				"unprognostic (5.09e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.31e-1)"	"unprognostic (9.82e-3)"	"unprognostic (2.23e-1)"	"unprognostic (6.25e-2)"	"unprognostic (7.12e-3)"	"unprognostic (5.26e-2)"	"unprognostic (3.83e-2)"	"unprognostic (3.03e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.37e-1)"	"unprognostic (6.84e-3)"	"unprognostic (2.40e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.53e-3)"	"unprognostic (4.66e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.04e-1)"	"unprognostic (4.53e-1)"	"unprognostic (3.23e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.37e-2)"	"unprognostic (3.24e-1)"	"unprognostic (8.24e-2)"	"unprognostic (1.93e-2)"	"unprognostic (8.26e-2)"	"unprognostic (4.28e-2)"
CLEC9A	"CD370, DNGR-1, HEEE9341, UNQ9341"	ENSG00000197992	"C-type lectin domain containing 9A"	Q6UXN8	12	10030678-10066031	"CD markers, Predicted membrane proteins"	Endocytosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.3;lymphoid tissue: 7.3"	"Cell type enriched"	"Detected in some"	13	"Schwann cells: 243.1"	"Cell type enriched"	"Detected in some"	35	"central nervous system macrophage: 137.6"	"Cancer enhanced"	"Detected in some"		"Testicular Germ Cell Tumor (TCGA): 4.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	96	"myeloid DC: 22.0;neutrophil: 7.9"	"Group enriched"	"Detected in many"	96	"dendritic cells: 22.0;granulocytes: 7.9"	"Group enriched"	"Detected in some"	6	"Leukemia: 3.6;Myeloma: 3.2"	"Testis - Early spermatids, Thyroid gland - T-cells"	"Not detected"	"Not detected"														NA	NA			"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 36: Lymphoid tissue - Cytokine signaling"	"Cluster 39: Astrocytes - Mixed function"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 28: Dendritic cells - Antigen presentation"							"unprognostic (5.34e-2)"				"unprognostic (1.38e-2)"	"unprognostic (1.49e-1)"			"unprognostic (1.50e-3)"	"unprognostic (9.52e-3)"																	"unprognostic (6.07e-2)"		
CR1	"CD35, KN"	ENSG00000203710	"Complement C3b/C4b receptor 1 (Knops blood group)"	P17927	1	207496147-207641765	"Blood group antigen proteins, CD markers, Plasma proteins, Predicted membrane proteins"	"Complement pathway, Host-virus interaction, Immunity, Innate immunity"	"Blood group antigen, Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 12.8;lymphoid tissue: 26.5"	"Cell type enhanced"	"Detected in some"		"B-cells: 40.6;Erythroid cells: 17.0;Hofbauer cells: 16.9;Kupffer cells: 96.2;Macrophages: 42.4;monocytes: 23.2"	"Cell type enhanced"	"Detected in some"		"fibroblast: 7.1;leukocyte: 12.1;oligodendrocyte: 8.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 53.8;eosinophil: 17.2;neutrophil: 15.6"	"Lineage enriched"	"Detected in many"	12	"granulocytes: 53.8"	"Group enriched"	"Detected in some"	9	"Leukemia: 3.6;lymphoma: 1.0"	"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Breast - Macrophages, Colon - Macrophages, Kidney - Podocytes, Lung - Neutrophil_2, Pituitary gland - Macrophages, Prostate - Macrophages, Thyroid gland - Macrophages"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB002491, CAB016271, HPA042455, HPA043579, HPA049348"	Enhanced		Supported	"Plasma membrane"			NA	NA		69000000	"Cluster 20: Non-specific - DNA binding"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 11: White matter - Signal transduction"	"Cluster 55: Lymphoma - Immune response"	"Cluster 74: Neutrophils - Degranulation"	1	"Plasma membrane"		"CAB002491: AB_563553, CAB016271: AB_627040, HPA042455: AB_2678006, HPA043579: AB_2678564, HPA049348: AB_2680723"	"unprognostic (3.19e-1)"		"unprognostic (6.73e-3)"			"unprognostic (2.40e-1)"		"potential prognostic unfavorable (3.09e-4)"				"unprognostic (6.59e-2)"				"unprognostic (1.20e-3)"	"unprognostic (6.21e-2)"	"unprognostic (3.54e-2)"	"unprognostic (3.00e-1)"			"unprognostic (4.72e-2)"	"unprognostic (3.66e-2)"			"unprognostic (1.23e-1)"		"unprognostic (5.13e-2)"	"unprognostic (2.49e-2)"		
CR2	"C3DR, CD21"	ENSG00000117322	"Complement C3d receptor 2"	P20023	1	207453024-207489895	"CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Complement pathway, Host-virus interaction, Immunity, Innate immunity"	"Host cell receptor for virus entry, Receptor"	"Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"lymphoid tissue: 171.2"	"Cell type enhanced"	"Detected in some"		"B-cells: 43.3;Oocytes: 20.6;Plasma cells: 9.7"	"Low cell type specificity"	"Detected in some"			"Cancer enhanced"	"Detected in many"		"Pancreatic Adenocarcinoma (TCGA): 11.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"memory B-cell: 17.6;naive B-cell: 20.5"	"Lineage enriched"	"Detected in many"	8	"B-cells: 20.5"	"Group enriched"	"Detected in some"	7	"Leukemia: 8.6;lymphoma: 17.5;Myeloma: 8.1"	"Minor Salivary Gland - Plasma cells, Spleen - B-cells (Spleen)"	"Not detected"	"Not detected"							"CAB002659, HPA052942, HPA060715"	Enhanced						NA	NA		150000000	"Cluster 18: Non-specific - Translation"	"Cluster 36: Lymphoid tissue - Cytokine signaling"		"Cluster 55: Lymphoma - Immune response"	"Cluster 73: B-cells - B-cell function"	2			"CAB002659: , HPA052942: AB_2681994, HPA060715: AB_2684349"	"unprognostic (4.15e-1)"	"potential prognostic favorable (6.18e-4)"	"unprognostic (4.34e-2)"		"unprognostic (1.62e-1)"	"unprognostic (1.96e-1)"						"potential prognostic unfavorable (1.38e-4)"				"potential prognostic favorable (5.82e-5)"	"unprognostic (5.14e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.48e-1)"			"unprognostic (1.07e-1)"	"unprognostic (2.36e-1)"		"unprognostic (1.34e-1)"	"unprognostic (1.42e-2)"		"unprognostic (1.35e-1)"	"unprognostic (7.37e-2)"	"unprognostic (1.05e-1)"	"unprognostic (9.93e-2)"
CRTAM	CD355	ENSG00000109943	"Cytotoxic and regulatory T cell molecule"	O95727	11	122838500-122872643	"CD markers, Predicted membrane proteins"	"Adaptive immunity, Cell adhesion, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"brain: 129.0"	"Cell type enhanced"	"Detected in some"		"Kupffer cells: 11.5;Macrophages: 10.4;monocytes: 15.2;NK-cells: 54.4;T-cells: 55.1"	"Cell type enhanced"	"Detected in some"		"cerebellar inhibitory: 56.6;upper rhombic lip: 146.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	9	"cerebellum: 79.0"	"Immune cell enhanced"	"Detected in many"		"NK-cell: 54.1"	"Group enriched"	"Detected in many"	4	"NK-cells: 54.1;T-cells: 33.3"	"Not detected"	"Not detected"			"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Adrenal gland - T-cells, Breast - T-cells, Colon - T-cells, Liver - T-cells, Prostate - T-cells, Spleen - T-cells"	"Region enriched"	"Detected in some"	44	"cerebellum: 102.6"	"Region enhanced"	"Detected in all"		"cerebellum: 41.5"								NA	NA		3000000	"Cluster 24: Non-specific - Transcription"	"Cluster 65: Cerebellum - Nervous system development"	"Cluster 35: Non-specific - DNA binding"	"Cluster 59: Leukemia - T-cell receptor"	"Cluster 78: NK-cells & T-cells - Immune system & Transcription"						"unprognostic (2.24e-2)"	"unprognostic (3.11e-1)"	"potential prognostic favorable (1.38e-4)"		"unprognostic (3.05e-1)"					"unprognostic (1.96e-2)"	"unprognostic (1.43e-1)"				"unprognostic (1.08e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.32e-1)"			"unprognostic (3.58e-2)"	"unprognostic (1.53e-2)"			"unprognostic (7.74e-2)"			"unprognostic (7.38e-2)"		
CSF1R	"C-FMS, CD115, CSFR, FMS"	ENSG00000182578	"Colony stimulating factor 1 receptor"	P07333	5	150053291-150113372	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Neurodegeneration, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 110.4;placenta: 99.9"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 115.8;Hofbauer cells: 327.3;Kupffer cells: 256.3;Langerhans cells: 98.3;Macrophages: 218.3;Microglial cells: 128.8;monocytes: 218.3"	"Cell type enriched"	"Detected in many"	17	"central nervous system macrophage: 840.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 444.5;non-classical monocyte: 650.1"	"Lineage enriched"	"Detected in many"	5	"monocytes: 650.1"	"Cancer enhanced"	"Detected in many"		"Leukemia: 13.3"	"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Colon - Macrophages, Kidney - Macrophages, Liver - Kupffer cells, Lung - Macrophages, Minor Salivary Gland - Macrophages, Pancreas - Macrophages, Prostate - Macrophages, Skeletal muscle - Macrophages, Skin - Langerhans cells, Spleen - Macrophages, Stomach - Macrophages, Testis - Macrophages, Thyroid gland - Macrophages"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008970, HPA012323"	Approved		Supported	"Vesicles,Plasma membrane"	"Intracellular and membrane"	Receptor	NA	NA		960000000	"Cluster 40: Monocytes - Innate immune response"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 58: Macrophages - Innate immune response"	19	"Vesicles, Plasma membrane"		"CAB008970: , HPA012323: AB_1848977"	"unprognostic (1.28e-1)"	"unprognostic (6.19e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.78e-2)"	"unprognostic (1.01e-1)"	"unprognostic (8.10e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.41e-2)"	"unprognostic (9.98e-2)"	"unprognostic (6.89e-2)"	"unprognostic (5.10e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.73e-3)"	"unprognostic (1.93e-2)"	"unprognostic (3.91e-2)"	"unprognostic (7.55e-2)"	"unprognostic (2.76e-2)"	"unprognostic (9.96e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.01e-2)"	"unprognostic (9.85e-2)"	"unprognostic (3.02e-2)"	"potential prognostic unfavorable (5.12e-4)"	"unprognostic (3.95e-3)"	"unprognostic (2.40e-1)"
CSF2RA	"alphaGMR, CD116, CSF2R"	ENSG00000198223	"Colony stimulating factor 2 receptor subunit alpha"	P15509	X	1268800-1310381	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins"		Receptor	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 61.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 243.7;Extravillous trophoblasts: 130.8;Langerhans cells: 703.6;Macrophages: 108.0;Schwann cells: 140.4;Syncytiotrophoblasts: 345.1"	"Cell type enriched"	"Detected in single"	8	"central nervous system macrophage: 4.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 319.8"	"Group enriched"	"Detected in all"	29	"dendritic cells: 170.1;granulocytes: 319.8;monocytes: 160.9"	"Cancer enriched"	"Detected in many"	7	"Adrenocortical cancer: 111.7"	"Adipose subcutaneous - Adipocytes (Subcutaneous), Adrenal gland - Macrophages, Minor Salivary Gland - Macrophages, Pancreas - Macrophages, Skeletal muscle - Macrophages, Spleen - Neutrophils, Thyroid gland - T-cells"	"Low region specificity"	"Detected in single"							CAB016148	Uncertain				"Secreted to blood"	Receptor	NA	NA		6300000	"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 58: Placenta - Pregnancy"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 34: Testis cancer - Unknown function"	"Cluster 28: Dendritic cells - Antigen presentation"	2			"CAB016148: AB_626868"	"unprognostic (2.91e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.85e-2)"	"potential prognostic favorable (1.75e-4)"	"unprognostic (4.20e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.82e-1)"		"potential prognostic favorable (8.00e-4)"	"unprognostic (8.58e-2)"	"unprognostic (4.83e-3)"	"unprognostic (3.35e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.77e-2)"		"unprognostic (7.06e-2)"	"unprognostic (9.07e-3)"	"unprognostic (3.80e-2)"	"unprognostic (5.23e-2)"	"unprognostic (7.11e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.31e-3)"	"unprognostic (6.19e-2)"	"unprognostic (1.07e-3)"	"potential prognostic favorable (3.57e-4)"	"unprognostic (9.22e-2)"	"unprognostic (5.63e-3)"	"unprognostic (1.03e-3)"	"unprognostic (9.14e-2)"	"unprognostic (3.42e-1)"
CSF2RB	"betaGMR, CD131, IL3RB, IL5RB"	ENSG00000100368	"Colony stimulating factor 2 receptor subunit beta"	P32927	22	36913628-36940439	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 53.9;lymphoid tissue: 63.7"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 115.7;Extravillous trophoblasts: 43.3;granulocytes: 68.5;Kupffer cells: 36.9;Langerhans cells: 74.0;Late spermatids: 40.9;Macrophages: 36.3;monocytes: 36.6;Plasma cells: 43.1"	"Group enriched"	"Detected in some"	6	"central nervous system macrophage: 15.3;leukocyte: 5.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"basophil: 239.1;neutrophil: 76.3"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 239.1"	"Group enriched"	"Detected in some"	47	"Leukemia: 43.7;lymphoma: 16.5;Myeloma: 15.2"	"Adrenal gland - Macrophages, Spleen - Neutrophils, Testis - Late spermatids"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA078677			Approved	"Golgi apparatus"			NA	NA			"Cluster 41: Basophils - Unknown function"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 12: Non-specific - Vasculature"	"Cluster 49: HMC-1 - Innate immune response"	"Cluster 74: Neutrophils - Degranulation"	17	"Golgi apparatus"		"HPA078677: AB_2732389"	"unprognostic (3.93e-2)"	"unprognostic (1.56e-2)"	"unprognostic (5.87e-2)"	"unprognostic (2.98e-2)"	"unprognostic (6.20e-2)"	"unprognostic (6.34e-2)"	"unprognostic (6.50e-2)"	"unprognostic (9.21e-2)"	"potential prognostic favorable (4.95e-4)"	"unprognostic (3.53e-2)"	"unprognostic (2.35e-2)"	"unprognostic (4.95e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.32e-1)"	"potential prognostic favorable (5.00e-4)"	"unprognostic (2.38e-1)"	"unprognostic (5.43e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.58e-2)"	"unprognostic (4.46e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.71e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.25e-1)"	"unprognostic (9.41e-2)"	"unprognostic (4.39e-1)"	"unprognostic (3.74e-2)"	"unprognostic (9.69e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.35e-1)"
CSF3R	"CD114, GCSFR"	ENSG00000119535	"Colony stimulating factor 3 receptor"	Q99062	1	36466043-36483278	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	Receptor	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 192.3;lung: 132.6;lymphoid tissue: 366.7"	"Group enriched"	"Detected in many"	6	"Cytotrophoblasts: 395.7;Syncytiotrophoblasts: 1355.6"	"Cell type enriched"	"Detected in some"	13	"central nervous system macrophage: 410.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	7	"neutrophil: 1924.2"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 1924.2"	"Cancer enriched"	"Detected in some"	25	"Leukemia: 32.2"	"Adipose subcutaneous - Macrophages, Adipose visceral - Neutrophils, Colon - Neutrophils, Heart muscle - Neutrophils, Liver - Neutrophils, Lung - Neutrophil_2, Skeletal muscle - Neutrophils, Spleen - Neutrophils, Thyroid gland - Neutrophils"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB017116, HPA048086"	Enhanced				"Intracellular and membrane"	Receptor	NA	NA		4100000	"Cluster 21: Neutrophils - Unknown function"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 12: Non-specific - Vasculature"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 74: Neutrophils - Degranulation"	7			"CAB017116: , HPA048086: AB_2680257"	"unprognostic (1.05e-1)"	"unprognostic (2.86e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.94e-1)"	"unprognostic (5.81e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.95e-2)"	"unprognostic (3.25e-1)"	"unprognostic (4.07e-2)"	"unprognostic (5.05e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.58e-2)"	"unprognostic (8.72e-2)"	"unprognostic (8.56e-3)"	"unprognostic (1.96e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.83e-2)"	"unprognostic (3.81e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.44e-2)"	"unprognostic (7.89e-2)"	"potential prognostic unfavorable (2.26e-4)"	"unprognostic (1.90e-1)"	"unprognostic (2.79e-1)"
CTLA4	"CD, CD152, CELIAC3, CTLA-4, GSE, IDDM12"	ENSG00000163599	"Cytotoxic T-lymphocyte associated protein 4"	P16410	2	203853888-203873965	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"		"Diabetes mellitus, Disease variant, FDA approved drug targets, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lymphoid tissue: 36.7"	"Group enriched"	"Detected in some"	7	"Schwann cells: 28.0;T-cells: 57.4"	"Cell type enhanced"	"Detected in some"		"central nervous system macrophage: 3.8;ependymal cell: 1.5;leukocyte: 3.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in some"	7	"T-reg: 42.6"	"Lineage enriched"	"Detected in single"	427	"T-cells: 42.6"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 8.2;skin cancer: 5.6"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Kidney - T-cells, Minor Salivary Gland - T-cells, Prostate - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"										NA	NA			"Cluster 9: T-regs - Cell cycle regulation"	"Cluster 36: Lymphoid tissue - Cytokine signaling"	"Cluster 39: Astrocytes - Mixed function"	"Cluster 9: Skin cancer - Melanin biosynthesis"	"Cluster 78: NK-cells & T-cells - Immune system & Transcription"	13				"unprognostic (2.09e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.29e-2)"	"unprognostic (4.53e-2)"	"unprognostic (7.26e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.92e-2)"		"potential prognostic favorable (1.13e-4)"		"potential prognostic unfavorable (2.59e-4)"	"unprognostic (3.43e-1)"			"unprognostic (4.87e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.10e-2)"			"unprognostic (3.80e-1)"	"unprognostic (9.07e-3)"		"unprognostic (1.64e-1)"	"unprognostic (1.31e-2)"	"potential prognostic favorable (8.73e-4)"	"unprognostic (1.12e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.70e-1)"
CXCR1	"CD181, CDw128a, CKR-1, CMKAR1, IL8RA"	ENSG00000163464	"C-X-C motif chemokine receptor 1"	P25024	2	218162841-218166962	"Cancer-related genes, CD markers, G-protein coupled receptors, Predicted membrane proteins"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 12.7;lymphoid tissue: 39.5"	"Group enriched"	"Detected in some"	5	"NK-cells: 9.8;Serous glandular cells: 5.2"	"Cell type enriched"	"Detected in single"	25	"leukocyte: 2.5"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in many"	14	"neutrophil: 1477.6"	"Lineage enriched"	"Detected in many"	62	"granulocytes: 1477.6"	"Not detected"	"Not detected"			"Adipose visceral - Neutrophils, Colon - Neutrophils, Heart muscle - Neutrophils, Liver - Neutrophils, Lung - Neutrophil_2, Minor Salivary Gland - Neutrophils, Pituitary gland - Neutrophils, Skeletal muscle - Neutrophils, Spleen - Neutrophils, Stomach - Neutrophils, Thyroid gland - Neutrophils"	"Not detected"	"Not detected"							HPA031991	Uncertain						NA	NA			"Cluster 35: Neutrophils - Protein binding"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 12: Non-specific - Vasculature"	"Cluster 49: HMC-1 - Innate immune response"	"Cluster 74: Neutrophils - Degranulation"	4			"HPA031991: AB_2674103"			"unprognostic (8.16e-2)"			"unprognostic (6.79e-2)"		"unprognostic (2.02e-1)"	"unprognostic (2.13e-1)"			"unprognostic (1.86e-1)"					"unprognostic (1.20e-1)"		"unprognostic (1.85e-1)"				"unprognostic (1.28e-1)"			"unprognostic (6.53e-2)"					
CXCR2	"CD182, CMKAR2, IL8RB"	ENSG00000180871	"C-X-C motif chemokine receptor 2"	P25025	2	218125289-218137251	"Cancer-related genes, CD markers, Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 26.4;lymphoid tissue: 42.2"	"Cell type enhanced"	"Detected in some"		"NK-cells: 30.8;Serous glandular cells: 19.4;Squamous epithelial cells: 13.6;Suprabasal keratinocytes: 16.5"	"Group enriched"	"Detected in some"	14	"central nervous system macrophage: 1.3;leukocyte: 4.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	52	"neutrophil: 3297.5"	"Lineage enriched"	"Detected in many"	109	"granulocytes: 3297.5"	"Cancer enriched"	"Detected in single"	9	"Leukemia: 6.9"	"Adipose visceral - Neutrophils, Colon - Neutrophils, Heart muscle - Neutrophils, Lung - Neutrophil_2, Prostate - Urothelial cells, Skeletal muscle - Neutrophils, Spleen - Neutrophils, Stomach - Neutrophils, Thyroid gland - Neutrophils"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB016268, HPA031999, HPA032017, CAB080545"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Microtubules,Mitotic spindle"			Yes	NA			"Cluster 35: Neutrophils - Protein binding"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 12: Non-specific - Vasculature"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 74: Neutrophils - Degranulation"	13	"Plasma membrane"	"Nucleoplasm, Microtubules, Mitotic spindle"	"CAB016268: AB_626893, CAB080545: , HPA031999: AB_2674105, HPA032017: AB_2674112"	"unprognostic (1.85e-2)"		"unprognostic (2.82e-3)"	"unprognostic (2.27e-2)"	"unprognostic (3.32e-2)"	"unprognostic (9.35e-3)"	"unprognostic (7.78e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.12e-1)"		"unprognostic (1.16e-2)"	"unprognostic (1.71e-1)"				"unprognostic (7.00e-3)"	"unprognostic (8.57e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.02e-1)"			"unprognostic (1.98e-1)"	"unprognostic (2.39e-2)"			"unprognostic (1.39e-1)"		"unprognostic (5.72e-2)"			
CXCR3	"CD183, CKR-L2, CMKAR3, GPR9, IP10-R, MigR"	ENSG00000186810	"C-X-C motif chemokine receptor 3"	P49682	X	71615916-71618511	"CD markers, G-protein coupled receptors, Predicted membrane proteins"	"Angiogenesis, Apoptosis, Chemotaxis"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 7.1;intestine: 6.2;lymphoid tissue: 15.9"	"Cell type enriched"	"Detected in some"	8	"dendritic cells: 379.4"	"Cell type enriched"	"Detected in single"	212	"leukocyte: 32.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 307.2"	"Group enriched"	"Detected in many"	5	"dendritic cells: 307.2;NK-cells: 199.6;T-cells: 124.7"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 3.3;lymphoma: 9.3;Myeloma: 3.7"	"Adipose subcutaneous - T-cells, Colon - T-cells, Liver - T-cells, Lung - T-cells, Minor Salivary Gland - T-cells, Pancreas - T-cells, Pituitary gland - T-cells, Prostate - T-cells, Thyroid gland - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045942	Enhanced						NA	NA			"Cluster 8: Plasmacytoid DCs - Unknown function"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 48: Non-specific - Mixed function"	"Cluster 55: Lymphoma - Immune response"	"Cluster 28: Dendritic cells - Antigen presentation"	4			"HPA045942: AB_2679507"	"unprognostic (3.09e-2)"	"unprognostic (1.42e-3)"	"unprognostic (4.52e-2)"	"unprognostic (2.91e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.93e-1)"			"potential prognostic favorable (7.61e-4)"		"unprognostic (1.13e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.06e-2)"	"unprognostic (1.73e-2)"	"unprognostic (7.54e-2)"	"unprognostic (3.90e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.35e-1)"	"unprognostic (6.43e-3)"	"unprognostic (2.50e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.69e-2)"	"unprognostic (9.23e-2)"	"potential prognostic favorable (7.53e-5)"	"unprognostic (5.04e-2)"	"unprognostic (4.51e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.92e-1)"
CXCR4	"CD184, D2S201E, fusin, HM89, HSY3RR, LESTR, NPY3R, NPYR, NPYY3R"	ENSG00000121966	"C-X-C motif chemokine receptor 4"	P61073	2	136114349-136119177	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"G-protein coupled receptor, Host cell receptor for virus entry, Receptor, Transducer"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 1229.2;lymphoid tissue: 543.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 1653.4;dendritic cells: 2147.0;monocytes: 2202.0;NK-cells: 1186.4;Schwann cells: 984.9;T-cells: 1749.3"	"Cell type enriched"	"Detected in some"	6	"leukocyte: 200.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Leukemia: 190.2;lymphoma: 270.2;Myeloma: 151.1"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Kidney - T-cells, Skin - T-cells, Testis - Macrophages, Thyroid gland - T-cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"										NA	NA			"Cluster 20: Non-specific - DNA binding"	"Cluster 77: Bone marrow - Cell proliferation"	"Cluster 12: Non-specific - Vasculature"	"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 78: NK-cells & T-cells - Immune system & Transcription"	15				"unprognostic (1.64e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.80e-1)"	"unprognostic (8.28e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.77e-1)"	"unprognostic (9.34e-3)"	"unprognostic (2.36e-3)"	"unprognostic (7.14e-3)"	"unprognostic (6.67e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.64e-2)"	"unprognostic (3.84e-2)"	"unprognostic (2.90e-2)"	"unprognostic (3.59e-1)"	"unprognostic (5.95e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.69e-3)"	"unprognostic (2.99e-1)"	"unprognostic (2.23e-1)"	"unprognostic (8.50e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.37e-2)"	"unprognostic (5.13e-3)"	"unprognostic (3.81e-1)"	"unprognostic (1.11e-3)"	"unprognostic (8.57e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.72e-1)"
CXCR5	"BLR1, CD185, MDR15"	ENSG00000160683	"C-X-C motif chemokine receptor 5"	P32302	11	118883892-118897787	"CD markers, G-protein coupled receptors, Predicted membrane proteins"	"B-cell activation"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 9.3;intestine: 9.9;lymphoid tissue: 30.6"	"Cell type enriched"	"Detected in some"	14	"B-cells: 82.8"	"Cell type enriched"	"Detected in single"	8	"leukocyte: 2.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"memory B-cell: 67.9;naive B-cell: 92.5"	"Lineage enriched"	"Detected in many"	8	"B-cells: 92.5"	"Cancer enriched"	"Detected in some"	12	"lymphoma: 36.0"	"Spleen - B-cells (Spleen)"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB026149, HPA042432"	Enhanced						NA	NA			"Cluster 14: Non-specific - Unknown function"	"Cluster 70: Lymphoid tissue - Immune response"		"Cluster 55: Lymphoma - Immune response"	"Cluster 73: B-cells - B-cell function"	3			"CAB026149: , HPA042432: AB_2677995"	"unprognostic (4.25e-3)"	"unprognostic (6.82e-2)"	"unprognostic (3.64e-3)"	"unprognostic (1.88e-1)"	"potential prognostic unfavorable (2.17e-4)"	"unprognostic (1.42e-1)"	"unprognostic (8.82e-2)"		"unprognostic (8.64e-2)"	"unprognostic (5.76e-2)"	"potential prognostic unfavorable (1.18e-6)"	"unprognostic (6.21e-2)"	"unprognostic (3.35e-1)"	"unprognostic (8.06e-2)"		"unprognostic (4.18e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.96e-1)"	"potential prognostic favorable (2.38e-4)"	"unprognostic (1.05e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.85e-1)"	"unprognostic (8.44e-3)"	"unprognostic (8.06e-2)"	"unprognostic (9.91e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.31e-1)"	"unprognostic (4.38e-2)"
CXCR6	"BONZO, CD186, STRL33, TYMSTR"	ENSG00000172215	"C-X-C motif chemokine receptor 6"	O00574	3	45940933-45948351	"CD markers, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 16.6"	"Group enriched"	"Detected in some"	7	"Extravillous trophoblasts: 87.5;T-cells: 64.1"	"Cell type enriched"	"Detected in some"	25	"leukocyte: 34.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 446.5"	"Lineage enriched"	"Detected in many"	5	"T-cells: 446.5"	"Cancer enhanced"	"Detected in some"		"Gallbladder cancer: 2.1"	"Kidney - T-cells, Lung - T-cells, Pancreas - T-cells, Pituitary gland - T-cells, Prostate - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"										NA	NA			"Cluster 1: T-cells - Unknown function"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 30: White matter - Myelination"	"Cluster 71: Lymphoma - Inflammatory response"	"Cluster 78: NK-cells & T-cells - Immune system & Transcription"					"unprognostic (1.01e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.09e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.08e-1)"		"unprognostic (1.96e-1)"	"potential prognostic favorable (2.66e-4)"		"unprognostic (2.30e-1)"	"unprognostic (8.87e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.54e-3)"	"unprognostic (2.84e-2)"	"potential prognostic favorable (8.10e-4)"	"unprognostic (1.29e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.70e-3)"	"unprognostic (2.13e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.23e-2)"	"unprognostic (4.44e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.15e-2)"	"unprognostic (5.05e-2)"	"unprognostic (4.37e-2)"	"unprognostic (5.65e-2)"
DDR1	"CAK, CD167, EDDR1, NEP, NTRK4, PTK3A, RTK6"	ENSG00000204580	"Discoidin domain receptor tyrosine kinase 1"	Q08345	6	30876421-30900156	"CD markers, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lactation, Pregnancy"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"astrocyte: 116.1;ependymal cell: 130.3;oligodendrocyte: 97.1;oligodendrocyte precursor cell: 99.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Adipocytes (Subcutaneous), Minor Salivary Gland - Minor salivary glandular cells, Stomach - Gastric mucous cells, Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010162, CAB025656, HPA074209"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	Receptor	NA	NA		24000000		"Cluster 34: Non-specific - Mixed function"	"Cluster 19: Astrocytes - Mixed function"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 35: Respiratory epithelial cells - Unknown function"	12	"Plasma membrane"	"Nucleoplasm, Cytosol"	"CAB010162: AB_2092090, CAB025656: , HPA074209: "	"unprognostic (1.77e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.26e-1)"	"potential prognostic unfavorable (8.28e-4)"	"unprognostic (2.87e-1)"	"unprognostic (3.71e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.92e-1)"	"potential prognostic favorable (3.80e-6)"	"unprognostic (6.51e-3)"	"unprognostic (1.57e-1)"	"unprognostic (4.83e-2)"	"unprognostic (5.38e-3)"	"unprognostic (2.42e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.65e-2)"	"unprognostic (8.30e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.47e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.57e-2)"	"unprognostic (5.69e-3)"	"unprognostic (3.57e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.59e-1)"	"unprognostic (3.20e-2)"	"unprognostic (4.63e-2)"
DDR2	"NTRKR3, TKT, TYRO10"	ENSG00000162733	"Discoidin domain receptor tyrosine kinase 2"	Q16832	1	162631373-162787405	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	Osteogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 84.7;Fibroblasts: 128.6;Leydig cells: 62.8;Mesothelial cells: 69.7;Peritubular cells: 85.6;Smooth muscle cells: 77.5"	"Cell type enhanced"	"Detected in all"		"choroid plexus epithelial cell: 472.9;fibroblast: 253.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Neuroblastoma: 44.3"	"Adrenal gland - Adrenal cortex cells, Lung - Fibroblast_1, Spleen - Fibroblast_1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070112			Approved	"Plasma membrane,Actin filaments"			Yes	No		530000		"Cluster 41: Smooth muscle tissue - ECM organization"	"Cluster 39: Astrocytes - Mixed function"	"Cluster 44: Connective tissue cells - ECM organization"	"Cluster 32: Smooth muscle cells - Muscle contraction"	37	"Plasma membrane, Actin filaments"		"HPA070112: AB_2686229"	"unprognostic (4.93e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.10e-2)"	"unprognostic (6.72e-3)"	"unprognostic (5.10e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.48e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.29e-3)"	"unprognostic (5.27e-2)"	"potential prognostic unfavorable (5.22e-7)"	"unprognostic (2.74e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.89e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.07e-1)"	"unprognostic (5.31e-3)"	"potential prognostic unfavorable (9.83e-6)"	"unprognostic (1.68e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.48e-2)"	"unprognostic (6.21e-2)"	"unprognostic (3.94e-3)"	"unprognostic (6.62e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.49e-1)"
DPP4	"ADCP2, CD26, DPPIV"	ENSG00000197635	"Dipeptidyl peptidase 4"	P27487	2	161992245-162074394	"CD markers, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Cell adhesion, Host-virus interaction"	"Aminopeptidase, Hydrolase, Protease, Receptor, Serine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 134.2;parathyroid gland: 151.0;placenta: 129.7;prostate: 103.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 135.0;Prostatic glandular cells: 195.7;Proximal enterocytes: 277.2;Serous glandular cells: 142.3;Syncytiotrophoblasts: 167.3"	"Cell type enhanced"	"Detected in many"		"deep-layer corticothalamic and 6b: 38.5;leukocyte: 104.6"	"Cancer enhanced"	"Detected in all"		"Prostate Adenocarcinoma (TCGA): 108.1"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 52.4"	"Lineage enriched"	"Detected in many"	10	"T-cells: 52.4"	"Cancer enhanced"	"Detected in many"		"Kidney cancer: 54.4"	"Adipose visceral - Mesothelial cells, Kidney - Proximal tubular cells, Liver - Hepatocytes, Minor Salivary Gland - Minor salivary glandular cells, Prostate - Prostate glandular cells, Skin - Fibroblast_2, Testis - Early spermatids"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB045970, HPA068778, HPA071236"	Enhanced				"Secreted to blood"	Receptor	NA	NA	643000000	160000000	"Cluster 1: T-cells - Unknown function"	"Cluster 55: Kidney & Intestine - Metabolism"	"Cluster 53: Neurons - Mixed function"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 22: Proximal enterocytes - Digestion"	142			"CAB045970: AB_11140529, HPA068778: , HPA071236: "	"unprognostic (1.45e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.26e-1)"	"unprognostic (8.68e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.95e-1)"	"validated prognostic favorable (2.36e-9)"	"validated prognostic favorable (2.32e-5)"	"unprognostic (2.15e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.32e-2)"	"unprognostic (8.15e-3)"	"unprognostic (1.45e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.80e-3)"	"potential prognostic unfavorable (9.06e-4)"	"unprognostic (2.10e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.98e-2)"	"unprognostic (3.70e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.58e-1)"
ENG	"CD105, END, HHT1, ORW, ORW1"	ENSG00000106991	Endoglin	P17813	9	127815013-127854658	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Angiogenesis, Cell adhesion"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 511.3"	"Group enriched"	"Detected in many"	4	"Adipocytes: 404.5;Endothelial cells: 476.2;Extravillous trophoblasts: 342.8;Leydig cells: 473.5;Peritubular cells: 1364.0;Syncytiotrophoblasts: 471.6"	"Cell type enhanced"	"Detected in many"		"endothelial cell: 451.0;fibroblast: 178.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 19.9;intermediate monocyte: 28.2;myeloid DC: 10.3;NK-cell: 7.6;non-classical monocyte: 22.2"	"Group enriched"	"Detected in many"	4	"dendritic cells: 10.3;monocytes: 28.2;NK-cells: 7.6"	"Low cancer specificity"	"Detected in all"			"Adipose visceral - Endothelial cells, Colon - Endothelial cells, Heart muscle - Endothelial cells, Minor Salivary Gland - Endothelial cells, Prostate - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000096, HPA011862, HPA067440, CAB072873"	Enhanced		Supported	"Plasma membrane"			NA	NA		160000000	"Cluster 40: Monocytes - Innate immune response"	"Cluster 7: Adipose tissue - Mixed function"	"Cluster 47: Endothelial cells - Vasculature"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	11	"Plasma membrane"		"CAB000096: AB_563482, CAB072873: AB_2665725, HPA011862: AB_1846217, HPA067440: AB_2685840"	"unprognostic (1.19e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.89e-3)"	"unprognostic (7.97e-3)"	"unprognostic (2.94e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.87e-2)"	"unprognostic (5.99e-3)"	"unprognostic (1.19e-1)"	"validated prognostic favorable (2.31e-7)"	"validated prognostic favorable (7.87e-5)"	"unprognostic (1.34e-1)"	"validated prognostic favorable (1.53e-5)"	"validated prognostic favorable (2.80e-4)"	"unprognostic (7.58e-2)"	"unprognostic (4.91e-2)"	"unprognostic (4.32e-3)"	"unprognostic (2.33e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.84e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.64e-1)"	"unprognostic (7.10e-2)"	"unprognostic (8.68e-2)"	"unprognostic (2.03e-1)"	"potential prognostic unfavorable (7.45e-4)"	"unprognostic (8.01e-2)"	"unprognostic (2.22e-1)"	"unprognostic (4.65e-2)"
ENPEP	"CD249, gp160"	ENSG00000138792	"Glutamyl aminopeptidase"	Q07075	4	110365733-110565285	"CD markers, Enzymes, Plasma proteins, Predicted membrane proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 159.0;kidney: 86.9"	"Cell type enriched"	"Detected in many"	4	"Proximal enterocytes: 598.5"	"Group enriched"	"Detected in many"	4	"ependymal cell: 264.6;pericyte: 81.0"	"Group enriched"	"Detected in many"	8	"Kidney Renal Clear Cell Carcinoma (TCGA): 93.2;Kidney Renal Papillary Cell Carcinoma (TCGA): 24.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Bone cancer: 5.3;Kidney cancer: 14.1"	"Adipose subcutaneous - Endothelial cells, Adrenal gland - Fibroblasts, Breast - Endothelial cells, Kidney - Proximal tubular cells, Liver - Hepatocytes, Pituitary gland - Fibroblasts, Prostate - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA005128	Enhanced						NA	NA		49000000		"Cluster 55: Kidney & Intestine - Metabolism"	"Cluster 23: Choroid plexus - Mixed function"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 22: Proximal enterocytes - Digestion"				"HPA005128: AB_1844795"	"unprognostic (2.56e-1)"	"unprognostic (2.35e-3)"	"unprognostic (3.39e-1)"		"unprognostic (7.02e-3)"	"unprognostic (3.76e-1)"	"unprognostic (3.44e-1)"	"unprognostic (3.94e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.43e-1)"	"potential prognostic favorable (5.27e-9)"	"unprognostic (4.07e-3)"	"potential prognostic favorable (6.81e-4)"	"unprognostic (2.14e-2)"	"potential prognostic favorable (4.67e-5)"	"unprognostic (1.08e-1)"	"unprognostic (3.26e-2)"	"unprognostic (8.87e-2)"	"potential prognostic unfavorable (2.87e-4)"	"unprognostic (2.09e-2)"	"unprognostic (1.96e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.67e-3)"		"unprognostic (8.38e-2)"	"unprognostic (5.73e-2)"		"potential prognostic unfavorable (2.70e-4)"	"unprognostic (6.37e-2)"	"unprognostic (3.24e-2)"	
ENPP1	"M6S1, NPPS, PC-1, PCA1, PDNP1"	ENSG00000197594	"Ectonucleotide pyrophosphatase/phosphodiesterase 1"	P22413	6	131808016-131895155	"CD markers, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins"	Biomineralization	Hydrolase	"Diabetes mellitus, Disease variant, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 42.0"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 102.2;Endometrial stromal cells: 78.6;Hepatocytes: 95.2;Peritubular cells: 70.1"	"Cell type enhanced"	"Detected in many"		"central nervous system macrophage: 83.2;cerebellar inhibitory: 46.9"	"Cancer enhanced"	"Detected in many"		"Breast Invasive Carcinoma (TCGA): 18.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Low cancer specificity"	"Detected in many"			"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Adrenal gland - Fibroblasts, Liver - Hepatocytes, Pituitary gland - Somatotropes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032904, HPA062066"	Enhanced				"Secreted - unknown location"	Enzyme	NA	NA		2800000	"Cluster 35: Neutrophils - Protein binding"	"Cluster 11: Liver - Plasma proteins"	"Cluster 41: Monoamines - Neurotransmitter signalling"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 50: Connective tissue cells - ECM organization"	8			"CAB032904: AB_2099635, HPA062066: AB_2684674"	"unprognostic (2.75e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.49e-1)"	"potential prognostic unfavorable (7.86e-4)"	"unprognostic (1.55e-1)"	"unprognostic (3.07e-2)"	"unprognostic (3.90e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.62e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.86e-1)"	"potential prognostic unfavorable (3.95e-4)"	"unprognostic (1.10e-1)"		"unprognostic (2.80e-1)"	"unprognostic (9.70e-2)"	"potential prognostic unfavorable (6.75e-4)"	"unprognostic (1.94e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.56e-2)"	"unprognostic (4.92e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.53e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.06e-2)"
ENPP3	"B10, CD203c, gp130RB13-6, PD-IBETA, PDNP3"	ENSG00000154269	"Ectonucleotide pyrophosphatase/phosphodiesterase 3"	O14638	6	131628442-131747418	"CD markers, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 31.0;intestine: 43.2"	"Group enriched"	"Detected in many"	6	"Basal prostatic cells: 243.7;Glandular and luminal cells: 368.2"	"Low cell type specificity"	"Detected in many"			"Cancer enriched"	"Detected in many"	11	"Kidney Renal Clear Cell Carcinoma (TCGA): 138.1"	"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in single"	86	"basophil: 30.6"	"Lineage enriched"	"Detected in single"	86	"granulocytes: 30.6"	"Cancer enhanced"	"Detected in some"		"Bone cancer: 4.1;Kidney cancer: 4.0;Leukemia: 6.2"	"Kidney - Proximal tubular cells, Liver - Hepatocytes, Lung - Mast cells, Skeletal muscle - Fibroblasts, Thyroid gland - Fibroblasts"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA043772	Enhanced				"Secreted - unknown location"	Enzyme	NA	NA		600000	"Cluster 46: Basophils - Proteolysis"	"Cluster 45: Intestine - Digestion"	"Cluster 2: Neurons - Nucleosome"	"Cluster 47: Leukemia - Hemostasis"	"Cluster 37: Glandular & Luminal cells - Unknown function"				"HPA043772: AB_10795616"		"unprognostic (2.21e-1)"	"unprognostic (6.86e-3)"	"unprognostic (2.91e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.47e-2)"		"unprognostic (2.27e-2)"			"potential prognostic favorable (1.57e-7)"	"unprognostic (4.73e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.65e-2)"	"unprognostic (4.73e-3)"	"unprognostic (3.79e-2)"			"unprognostic (8.41e-2)"			"unprognostic (4.65e-2)"	"unprognostic (4.76e-1)"	"unprognostic (8.40e-2)"	"unprognostic (6.39e-2)"				"unprognostic (1.93e-1)"	"unprognostic (3.07e-1)"
ENTPD1	"ATPDase, CD39, NTPDase-1, SPG64"	ENSG00000138185	"Ectonucleoside triphosphate diphosphohydrolase 1"	P49961	10	95711779-95877266	"CD markers, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		Hydrolase	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 70.3;Endothelial cells: 64.1;Kupffer cells: 69.0;Langerhans cells: 143.9;Macrophages: 61.0;Microglial cells: 207.6;Plasma cells: 79.9"	"Group enriched"	"Detected in all"	4	"central nervous system macrophage: 763.4;endothelial cell: 342.1;vascular associated smooth muscle cell: 240.7"	"Cancer enhanced"	"Detected in all"		"Thyroid Carcinoma (TCGA): 71.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 102.4"	"Group enriched"	"Detected in all"	4	"dendritic cells: 31.9;granulocytes: 102.4;monocytes: 41.0"	"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Smooth muscle cells, Thyroid gland - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002494, HPA014067, CAB079986"	Enhanced		Uncertain	Microtubules			NA	NA		330000	"Cluster 7: Non-specific - Innate immune response"	"Cluster 62: Connective tissue - ECM organization"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 55: Lymphoma - Immune response"	"Cluster 28: Dendritic cells - Antigen presentation"	3	Microtubules		"CAB002494: AB_563557, CAB079986: , HPA014067: AB_1848178"	"unprognostic (2.22e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.99e-2)"	"unprognostic (6.37e-3)"	"unprognostic (8.45e-2)"	"validated prognostic favorable (3.00e-6)"	"validated prognostic favorable (3.51e-4)"	"unprognostic (2.65e-2)"	"unprognostic (5.53e-2)"	"unprognostic (2.83e-1)"	"potential prognostic favorable (4.08e-4)"	"unprognostic (1.59e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.77e-2)"	"potential prognostic unfavorable (2.98e-4)"	"unprognostic (1.28e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.43e-1)"	"potential prognostic favorable (1.44e-4)"	"unprognostic (3.27e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.30e-1)"	"unprognostic (6.70e-3)"	"unprognostic (2.58e-1)"
EPCAM	"17-1A, 323/A3, Ber-Ep4, BerEp4, CD326, CO-17A, EGP-2, EGP34, EGP40, Ep-CAM, ESA, GA733-2, HEA125, KS1/4, KSA, Ly74, M4S1, MH99, MIC18, MK-1, MOC-31, MOC31, TACST-1, TACSTD1, TROP1"	ENSG00000119888	"Epithelial cell adhesion molecule"	P16422	2	47345158-47387601	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Tumor antigen"	"Cancer-related genes, Disease variant, FDA approved drug targets, Hereditary nonpolyposis colorectal cancer"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 780.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 2590.4;Intestinal goblet cells: 1370.3;Paneth cells: 2221.3;Proximal enterocytes: 2597.5;Undifferentiated cells: 1520.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"colorectal cancer: 762.9"	"Colon - Colon enterocytes, Liver - Cholangiocyte, Lung - Alveolar cells type 2, Skin - Eccrine sweat gland cells, Stomach - Gastric mucous cells, Testis - Spermatogonia, Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB003809, HPA026761, CAB030012, CAB055098, HPA067463"	Enhanced		Supported	"Plasma membrane"			NA	NA		10000		"Cluster 55: Kidney & Intestine - Metabolism"	"Cluster 56: Hypothalamus - Neuropeptide signaling"	"Cluster 57: Stomach & Colon cancer - Digestion"	"Cluster 5: Enterocytes - Absorption"	7	"Plasma membrane"		"CAB003809: AB_562285, CAB030012: AB_756075, CAB055098: AB_2335685, HPA026761: AB_1848198, HPA067463: AB_2685846"	"unprognostic (3.41e-2)"	"unprognostic (1.52e-2)"	"unprognostic (8.29e-3)"	"unprognostic (2.22e-1)"	"unprognostic (4.13e-1)"	"unprognostic (8.83e-3)"		"unprognostic (9.22e-3)"	"unprognostic (4.51e-2)"	"unprognostic (2.73e-1)"	"potential prognostic favorable (3.91e-4)"	"unprognostic (4.55e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.00e-2)"	"unprognostic (9.92e-2)"	"unprognostic (2.74e-2)"	"unprognostic (5.14e-2)"	"unprognostic (4.88e-3)"	"unprognostic (2.48e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.42e-2)"		"unprognostic (6.94e-3)"	"unprognostic (7.93e-2)"	"unprognostic (3.56e-2)"	"unprognostic (6.07e-2)"
ERBB2	"c-ERB-2, c-ERB2, CD340, HER-2, HER2, MLN-19, NEU, NGL, p185(erbB2)"	ENSG00000141736	"Erb-b2 receptor tyrosine kinase 2"	P04626	17	39687914-39730426	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Transcription, Transcription regulation"	"Activator, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 120.6"	"Group enriched"	"Detected in many"	4	"astrocyte: 27.0;bergmann glia: 16.9;choroid plexus epithelial cell: 15.4;ependymal cell: 55.2;fibroblast: 34.0;pericyte: 14.2;vascular associated smooth muscle cell: 20.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 5.0"	"Group enriched"	"Detected in many"	5	"granulocytes: 1.2;T-cells: 5.0"	"Group enriched"	"Detected in all"	5	"breast cancer: 705.7;Esophageal cancer: 445.4;Gastric cancer: 199.3"	"Adrenal gland - Fibroblasts, Lung - Alveolar cells type 1, Spleen - Fibroblast_1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000043, HPA001060, HPA001338, HPA001383, HPA007983, CAB020416, CAB062555"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"			NA	NA		640000	"Cluster 24: Non-specific - Transcription"	"Cluster 24: Parathyroid gland - Vesicular transport"	"Cluster 39: Astrocytes - Mixed function"	"Cluster 27: Breast cancer - Unknown function"	"Cluster 35: Respiratory epithelial cells - Unknown function"	194	"Plasma membrane"	"Nucleoplasm, Cytosol"	"CAB000043: AB_2335701, CAB020416: AB_442047, CAB062555: AB_2665610, HPA001060: AB_2666185, HPA001338: AB_2666279, HPA001383: AB_1078500, HPA007983: "	"unprognostic (6.10e-2)"	"unprognostic (5.53e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.28e-1)"	"unprognostic (5.11e-3)"	"unprognostic (2.48e-1)"	"unprognostic (7.78e-2)"	"potential prognostic unfavorable (7.20e-5)"	"unprognostic (2.40e-2)"	"unprognostic (1.18e-1)"	"potential prognostic favorable (1.76e-8)"	"unprognostic (1.16e-3)"	"unprognostic (5.15e-3)"	"unprognostic (8.44e-2)"	"unprognostic (5.43e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.94e-1)"	"potential prognostic unfavorable (6.98e-4)"	"unprognostic (5.27e-1)"	"potential prognostic unfavorable (6.95e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.07e-2)"	"unprognostic (8.31e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.76e-1)"
EVI2B	"CD361, D17S376, EVDB"	ENSG00000185862	"Ecotropic viral integration site 2B"	P34910	17	31303770-31314105	"CD markers, Predicted membrane proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 186.9;lymphoid tissue: 165.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 221.7;Hofbauer cells: 195.7;Kupffer cells: 407.8;Langerhans cells: 189.3;Macrophages: 248.3;monocytes: 485.2;Schwann cells: 145.7;T-cells: 146.6"	"Group enriched"	"Detected in some"	6	"central nervous system macrophage: 61.1;leukocyte: 58.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1371.1"	"Group enriched"	"Detected in all"	5	"granulocytes: 1371.1;monocytes: 383.9"	"Group enriched"	"Detected in many"	11	"Adrenocortical cancer: 21.0;Leukemia: 50.5;lymphoma: 45.6;Myeloma: 68.3"	"Adipose subcutaneous - Macrophages, Adrenal gland - Macrophages, Breast - Macrophages, Lung - Neutrophil_2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA007346, HPA053383"	Enhanced		Approved	"Plasma membrane"			NA	NA			"Cluster 35: Neutrophils - Protein binding"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 30: White matter - Myelination"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 74: Neutrophils - Degranulation"		"Plasma membrane"		"HPA007346: , HPA053383: "	"unprognostic (5.10e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.31e-1)"	"unprognostic (8.15e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.97e-1)"	"unprognostic (6.74e-2)"	"unprognostic (6.11e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.37e-2)"	"unprognostic (2.85e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.08e-1)"	"unprognostic (5.88e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.67e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.37e-1)"
F11R	"CD321, JAM-1, JAM-A, JAM1, JAMA, JCAM, PAM-1"	ENSG00000158769	"F11 receptor"	Q9Y624	1	160995211-161021343	"CD markers, Plasma proteins, Predicted membrane proteins"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 200.3"	"Cell type enhanced"	"Detected in many"		"endothelial cell: 54.7;ependymal cell: 30.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"eosinophil: 166.2;neutrophil: 114.1"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 166.2"	"Cancer enhanced"	"Detected in all"		"testis cancer: 214.6"	"Heart muscle - Endothelial cells, Skeletal muscle - Endothelial cells, Stomach - Gastric mucous cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004671, HPA043616, HPA061700"	Enhanced		Supported	"Cell Junctions,Microtubules"			NA	NA		1800000	"Cluster 21: Neutrophils - Unknown function"	"Cluster 75: Epithelium - Extracellular exosomes"	"Cluster 12: Non-specific - Vasculature"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 37: Glandular & Luminal cells - Unknown function"	30	Microtubules	"Cell Junctions"	"CAB004671: AB_425964, HPA043616: , HPA061700: AB_2684589"	"unprognostic (2.88e-1)"	"unprognostic (1.56e-3)"	"unprognostic (5.01e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.52e-2)"	"unprognostic (2.86e-1)"	"unprognostic (7.60e-2)"	"unprognostic (2.79e-3)"	"unprognostic (1.32e-1)"	"unprognostic (4.69e-2)"	"potential prognostic favorable (8.87e-6)"	"unprognostic (5.87e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.65e-2)"	"potential prognostic unfavorable (4.26e-4)"	"unprognostic (1.38e-1)"	"unprognostic (4.38e-2)"	"unprognostic (4.10e-3)"	"unprognostic (1.35e-2)"	"unprognostic (3.68e-1)"	"unprognostic (9.89e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.21e-1)"
F3	"CD142, TF"	ENSG00000117525	"Coagulation factor III, tissue factor"	P13726	1	94529173-94541759	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Blood coagulation, Hemostasis"		"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 673.7;Basal respiratory cells: 344.3;Club cells: 387.7;Exocrine glandular cells: 355.4;Ionocytes: 309.6;Peritubular cells: 505.4"	"Cell type enhanced"	"Detected in many"		"astrocyte: 248.5;fibroblast: 443.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"head and neck cancer: 655.6"	"Kidney - Podocytes, Liver - Cholangiocyte, Lung - Alveolar cells type 2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009438, HPA049292, HPA069132"	Uncertain		Approved	Vesicles	"Secreted to blood"	"Blood coagulation"	NA	NA	603000			"Cluster 64: Neuronal - Transcription"	"Cluster 40: Astrocytes - Astrocyte-neuron interactions"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 45: Non-specific - Mixed function"	12	Vesicles		"CAB009438: AB_668005, HPA049292: AB_2680701, HPA069132: AB_2686092"	"unprognostic (1.24e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.73e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.11e-2)"	"potential prognostic unfavorable (7.75e-5)"	"unprognostic (4.84e-3)"	"unprognostic (1.44e-3)"	"potential prognostic unfavorable (2.57e-4)"	"unprognostic (3.19e-2)"	"unprognostic (1.61e-2)"	"unprognostic (5.22e-2)"	"unprognostic (4.06e-2)"	"unprognostic (7.62e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.43e-1)"	"potential prognostic unfavorable (1.26e-5)"	"unprognostic (2.62e-2)"	"unprognostic (2.11e-1)"	"unprognostic (6.14e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.77e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.55e-1)"	"unprognostic (8.97e-2)"
FAS	"APO-1, APT1, CD95, FAS1, TNFRSF6"	ENSG00000026103	"Fas cell surface death receptor"	P25445	10	88953813-89029605	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Apoptosis	"Calmodulin-binding, Receptor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 66.0;Secretory cells: 76.4"	"Group enriched"	"Detected in many"	4	"astrocyte: 31.2;central nervous system macrophage: 20.9;endothelial cell: 20.1;ependymal cell: 26.1;fibroblast: 29.7;leukocyte: 33.9;pericyte: 33.9;vascular associated smooth muscle cell: 21.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 101.1"	"Group enriched"	"Detected in all"	5	"granulocytes: 101.1;T-cells: 90.6"	"Low cancer specificity"	"Detected in all"			"Heart muscle - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027444	Uncertain		Supported	"Nuclear bodies,Plasma membrane,Cytosol"	"Secreted to blood"	Receptor	NA	NA	11900000	350000	"Cluster 35: Neutrophils - Protein binding"	"Cluster 41: Smooth muscle tissue - ECM organization"	"Cluster 48: Non-specific - Mixed function"	"Cluster 12: Bone cancer - Neuronal signaling"	"Cluster 78: NK-cells & T-cells - Immune system & Transcription"	35	"Plasma membrane"	"Nuclear bodies, Cytosol"	"HPA027444: AB_10601378"	"unprognostic (4.87e-2)"	"unprognostic (4.15e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.12e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.05e-2)"	"potential prognostic unfavorable (6.97e-4)"	"unprognostic (1.90e-1)"	"unprognostic (2.22e-1)"	"potential prognostic favorable (1.96e-5)"	"unprognostic (1.11e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.03e-3)"	"unprognostic (4.06e-2)"	"unprognostic (1.60e-2)"	"unprognostic (6.50e-2)"	"unprognostic (4.36e-3)"	"unprognostic (6.94e-3)"	"unprognostic (6.86e-2)"	"potential prognostic unfavorable (1.39e-4)"	"unprognostic (1.20e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.98e-2)"	"unprognostic (5.49e-2)"	"unprognostic (3.10e-1)"
FASLG	"APT1LG1, CD178, FasL, TNFSF6"	ENSG00000117560	"Fas ligand"	P48023	1	172659103-172666876	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins, Transporters"	"Apoptosis, Transcription, Transcription regulation"	"Cytokine, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 5.6"	"Group enriched"	"Detected in some"	7	"NK-cells: 71.7;T-cells: 26.6"	"Cell type enriched"	"Detected in single"	90	"leukocyte: 39.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 58.2"	"Group enriched"	"Detected in many"	9	"NK-cells: 41.6;T-cells: 58.2"	"Cancer enriched"	"Detected in single"	4	"colorectal cancer: 1.3"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Adrenal gland - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Kidney - T-cells, Liver - NK-cells (Liver), Lung - NK-cells (Lung), Minor Salivary Gland - T-cells, Pituitary gland - T-cells, Prostate - T-cells, Spleen - T-cells, Thyroid gland - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA054959	Approved				"Secreted to blood"	Cytokine	NA	NA	73600		"Cluster 15: NK-cells - Unknown function"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 9: Non-specific - Receptor signaling"	"Cluster 32: Non-specific - Cell proliferation"	"Cluster 19: NK-cells - Adaptive immune response"	62			"HPA054959: AB_2682650"		"unprognostic (9.66e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.36e-3)"		"unprognostic (4.01e-2)"			"unprognostic (1.76e-3)"		"unprognostic (8.66e-2)"	"unprognostic (1.80e-1)"			"potential prognostic favorable (7.12e-4)"	"unprognostic (8.23e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.07e-2)"							"unprognostic (2.64e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.03e-1)"		
FCAMR	"CD351, FCA/MR, Fcalpha/muR, FKSG87"	ENSG00000162897	"Fc alpha and mu receptor"	Q8WWV6	1	206957965-206970625	"CD markers, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"kidney: 36.7;lymphoid tissue: 25.5"	"Group enriched"	"Detected in some"	14	"Distal tubular cells: 6.1;Proximal tubular cells: 24.0"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Kidney Renal Papillary Cell Carcinoma (TCGA): 20.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Kidney - Proximal tubular cells, Kidney - Proximal tubular cells, Testis - Early spermatids, Testis - Late spermatids"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA056505	Enhanced						NA	NA		3800000		"Cluster 52: Kidney - Transmembrane transport"		"Cluster 57: Stomach & Colon cancer - Digestion"	"Cluster 38: Proximal tubular cells - Transmembrane transport"				"HPA056505: AB_2732604"						"unprognostic (1.50e-1)"					"unprognostic (1.69e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.85e-1)"	"unprognostic (6.26e-3)"	"unprognostic (3.47e-3)"											"unprognostic (3.37e-1)"		"unprognostic (8.60e-2)"			
FCAR	"CD89, FcalphaR, FcalphaRI"	ENSG00000186431	"Fc alpha receptor"	P24071	19	54874235-54891420	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"		"IgA-binding protein, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 25.9;lung: 10.2;lymphoid tissue: 13.1"	"Group enriched"	"Detected in some"	5	"Kupffer cells: 13.9;Macrophages: 20.4;monocytes: 47.3"	"Group enriched"	"Detected in some"	4	"central nervous system macrophage: 5.4;leukocyte: 6.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"classical monocyte: 1.3;neutrophil: 4.1"	"Group enriched"	"Detected in many"	27	"granulocytes: 4.1;monocytes: 1.3"	"Not detected"	"Not detected"			"Adipose visceral - Neutrophils, Colon - Neutrophils, Heart muscle - Neutrophils, Liver - Neutrophils, Lung - Neutrophil_2, Minor Salivary Gland - Neutrophils, Pituitary gland - Neutrophils, Skeletal muscle - Neutrophils, Spleen - Neutrophils, Thyroid gland - Neutrophils"					"Not detected"	"Not detected"			HPA014050	Approved		Supported	"Plasma membrane"	"Intracellular and membrane"	Receptor	NA	NA			"Cluster 21: Neutrophils - Unknown function"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"		"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 29: Monocytes - Innate immune response"	1	"Plasma membrane"		"HPA014050: AB_1846338"			"unprognostic (1.77e-1)"					"unprognostic (2.25e-2)"															"unprognostic (2.14e-2)"								
FCER2	"CD23, CD23A, CLEC4J, FCE2, FcepsilonRII, FCErII"	ENSG00000104921	"Fc epsilon receptor II"	P06734	19	7688758-7702146	"Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"IgE-binding protein, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"lymphoid tissue: 41.0"	"Cell type enriched"	"Detected in some"	16	"B-cells: 141.6"	"Cell type enriched"	"Detected in single"	5	"leukocyte: 2.7"	"Cancer enhanced"	"Detected in many"		"Pancreatic Adenocarcinoma (TCGA): 4.5"	"Region enhanced"	"Detected in single"		"cerebral cortex: 2.8"	"Group enriched"	"Detected in many"	24	"memory B-cell: 201.7;naive B-cell: 497.3"	"Lineage enriched"	"Detected in many"	34	"B-cells: 497.3"	"Group enriched"	"Detected in some"	16	"Leukemia: 49.4;lymphoma: 34.1;Myeloma: 41.1"	"Spleen - B-cells (Spleen)"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"CAB002624, HPA008928, HPA067430"	Enhanced				"Secreted to blood"	Receptor	NA	NA		3300000	"Cluster 18: Non-specific - Translation"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 12: Non-specific - Vasculature"	"Cluster 55: Lymphoma - Immune response"	"Cluster 73: B-cells - B-cell function"	1			"CAB002624: , HPA008928: AB_1846285, HPA067430: "	"unprognostic (2.76e-1)"	"unprognostic (3.12e-3)"	"unprognostic (3.71e-3)"			"unprognostic (2.52e-1)"										"potential prognostic favorable (9.66e-4)"		"unprognostic (1.79e-1)"				"unprognostic (6.24e-2)"						"unprognostic (2.13e-1)"	"unprognostic (1.26e-1)"		
FCGR1A	"CD64, CD64A, FCG1, FcgammaRI, FcgammaRIa, FCGR1"	ENSG00000150337	"Fc gamma receptor Ia"	P12314	1	149782671-149791675	"CD markers, FDA approved drug targets, Predicted membrane proteins"	"Immunity, Innate immunity"	"IgG-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 98.2"	"Group enriched"	"Detected in some"	5	"Hofbauer cells: 236.8;Kupffer cells: 103.7;Late spermatids: 60.3;Macrophages: 79.6"	"Cell type enriched"	"Detected in single"	27	"central nervous system macrophage: 24.2"	"Cancer enhanced"	"Detected in all"		"Glioblastoma Multiforme (TCGA): 65.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 137.1;intermediate monocyte: 57.3;myeloid DC: 37.3;neutrophil: 98.7"	"Group enriched"	"Detected in many"	55	"dendritic cells: 37.3;granulocytes: 98.7;monocytes: 137.1"	"Cancer enriched"	"Detected in single"	27	"Leukemia: 25.7"	"Adipose visceral - Macrophages, Adrenal gland - Macrophages, Heart muscle - Macrophages, Kidney - Macrophages, Lung - Macrophages, Pituitary gland - Macrophages, Prostate - Macrophages, Stomach - Macrophages, Testis - Late spermatids, Thyroid gland - Macrophages"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026910			Uncertain	"Golgi apparatus,Vesicles,Plasma membrane"			NA	NA			"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 50: Epididymis - Male reproductive secretion"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 58: Macrophages - Innate immune response"	21	Vesicles	"Golgi apparatus, Plasma membrane"	"HPA026910: "	"unprognostic (5.28e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.68e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.74e-2)"	"unprognostic (3.24e-2)"	"unprognostic (8.62e-2)"	"unprognostic (3.13e-1)"	"unprognostic (5.95e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.51e-2)"	"unprognostic (5.11e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.07e-2)"	"unprognostic (2.05e-1)"	"unprognostic (9.91e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.21e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.69e-2)"	"unprognostic (6.35e-2)"	"unprognostic (3.73e-2)"	"unprognostic (7.51e-3)"	"unprognostic (5.60e-2)"	"unprognostic (1.35e-1)"
FCGR2A	"CD32, CD32A, CDw32, Fc-gamma-RIIa, FCG2, FcgammaRIIa, FCGR2, FCGR2A1, IGFR2"	ENSG00000143226	"Fc gamma receptor IIa"	P12318	1	161505430-161524013	"CD markers, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Immunity	"IgG-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 116.9;placenta: 130.3"	"Group enriched"	"Detected in many"	5	"Hofbauer cells: 201.0;Kupffer cells: 179.0;Langerhans cells: 422.4;Macrophages: 294.0;monocytes: 183.9"	"Group enriched"	"Detected in some"	31	"central nervous system macrophage: 82.9;leukocyte: 22.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"neutrophil: 2531.1"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 2531.1"	"Cancer enriched"	"Detected in some"	5	"Leukemia: 40.8"	"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Breast - Macrophages, Heart muscle - Macrophages, Kidney - Macrophages, Liver - Neutrophils, Lung - Neutrophil_2, Minor Salivary Gland - Macrophages, Pancreas - Macrophages, Pituitary gland - Macrophages, Prostate - Macrophages, Skeletal muscle - Macrophages, Skin - Macrophages, Spleen - Neutrophils, Testis - Macrophages, Thyroid gland - Macrophages"									"HPA010718, HPA010776, HPA014730"	Supported		Supported	"Golgi apparatus,Plasma membrane"			NA	NA		40000000	"Cluster 21: Neutrophils - Unknown function"	"Cluster 57: Lung - Lung function"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 47: Leukemia - Hemostasis"	"Cluster 58: Macrophages - Innate immune response"	4	"Plasma membrane"	"Golgi apparatus"	"HPA010718: AB_1078463, HPA010776: , HPA014730: AB_2669074"	"unprognostic (2.04e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.57e-2)"	"unprognostic (6.11e-2)"	"unprognostic (5.06e-3)"	"unprognostic (3.20e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.65e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.18e-3)"	"unprognostic (3.85e-3)"	"unprognostic (9.64e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.90e-2)"	"unprognostic (3.68e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.83e-3)"	"unprognostic (9.63e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.91e-1)"	"unprognostic (4.06e-1)"
FCGR2B	"CD32, CD32B, FCG2, FcgammaRIIb, FCGR2, FcGRIIB"	ENSG00000072694	"Fc gamma receptor IIb"	P31994	1	161663143-161678654	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins"	"Host-virus interaction"	"IgG-binding protein, Receptor"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	9	"placenta: 389.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 63.1;Endothelial cells: 81.2;Fibroblasts: 53.7;Kupffer cells: 52.9;Langerhans cells: 332.8;Macrophages: 125.2;Plasma cells: 61.7"	"Cell type enhanced"	"Detected in some"		"central nervous system macrophage: 8.4;leukocyte: 3.7;vascular associated smooth muscle cell: 1.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 328.6;memory B-cell: 203.6"	"Low lineage specificity"	"Detected in many"			"Cancer enhanced"	"Detected in some"		"Leukemia: 10.4;lymphoma: 25.1"	"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Breast - Macrophages, Liver - Sinusoid Endothelial cells, Minor Salivary Gland - Macrophages, Skeletal muscle - Macrophages, Spleen - B-cells (Spleen), Testis - Macrophages, Thyroid gland - Macrophages"									"CAB007796, HPA014730"	Enhanced						NA	NA			"Cluster 32: Basophils - Transcription"	"Cluster 58: Placenta - Pregnancy"	"Cluster 8: Immune cells - Immune response"	"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	8			"CAB007796: AB_562288, HPA014730: AB_2669074"	"unprognostic (4.29e-1)"	"unprognostic (8.73e-2)"	"unprognostic (2.89e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.19e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.43e-3)"	"unprognostic (9.25e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.71e-2)"	"unprognostic (2.52e-2)"	"unprognostic (9.35e-3)"	"unprognostic (1.47e-1)"	"unprognostic (6.11e-2)"	"unprognostic (7.35e-3)"	"unprognostic (9.11e-3)"	"unprognostic (1.22e-1)"	"unprognostic (5.90e-2)"	"unprognostic (3.96e-3)"	"unprognostic (2.74e-1)"	"unprognostic (6.03e-2)"	"unprognostic (2.48e-2)"	"unprognostic (4.38e-1)"	"unprognostic (3.28e-2)"	"unprognostic (9.93e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.77e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.55e-1)"
FCGR3A	"CD16, CD16a, FCG3, FcgammaRIIIa, FCGR3, FcGRIIIA"	ENSG00000203747	"Fc gamma receptor IIIa"	P08637	1	161541759-161550968	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	Immunity	"IgG-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 202.0;lymphoid tissue: 294.7"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 240.5;Kupffer cells: 656.2;Macrophages: 303.8;monocytes: 1050.2;NK-cells: 597.4"	"Group enriched"	"Detected in some"	73	"central nervous system macrophage: 8.0;leukocyte: 6.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"intermediate monocyte: 1806.3;non-classical monocyte: 4107.1"	"Lineage enriched"	"Detected in all"	6	"monocytes: 4107.1"	"Not detected"	"Not detected"			"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Breast - Macrophages, Colon - Macrophages, Heart muscle - Macrophages, Kidney - Macrophages, Liver - Kupffer cells, Lung - Macrophages, Pancreas - Macrophages, Pituitary gland - Macrophages, Prostate - Macrophages, Skeletal muscle - Macrophages, Skin - Macrophages, Spleen - Macrophages, Stomach - Macrophages, Thyroid gland - Macrophages"									"CAB032435, HPA055431"	Supported				"Secreted to blood"	Receptor	NA	NA			"Cluster 37: Monocytes & Neutrophils - Innate immune response"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 29: Monocytes - Innate immune response"	4			"CAB032435: AB_626925, HPA055431: AB_2682815"	"unprognostic (1.54e-1)"	"unprognostic (6.90e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.27e-2)"	"unprognostic (8.73e-2)"	"unprognostic (6.79e-2)"	"unprognostic (2.89e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.46e-1)"	"unprognostic (4.24e-3)"	"unprognostic (3.67e-2)"	"unprognostic (3.44e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.13e-3)"	"unprognostic (3.31e-2)"	"unprognostic (2.98e-1)"	"unprognostic (3.55e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.53e-1)"	"unprognostic (9.66e-2)"	"unprognostic (6.55e-2)"	"unprognostic (2.44e-2)"	"unprognostic (4.57e-2)"
FCGR3B	"CD16, CD16b, FCG3, FcgammaRIIIb, FCGR3, FcRIIIb"	ENSG00000162747	"Fc gamma receptor IIIb"	O75015	1	161623196-161631963	"CD markers, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"		"IgG-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.5;lymphoid tissue: 79.0"	"Cell type enriched"	"Detected in some"	7	"Serous glandular cells: 28.8"	"Group enriched"	"Detected in some"	23	"central nervous system macrophage: 2.1;leukocyte: 2.6"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"cerebral cortex: 11.0;pons: 4.2"	"Immune cell enriched"	"Detected in many"	356	"neutrophil: 6077.6"	"Lineage enriched"	"Detected in many"	356	"granulocytes: 6077.6"	"Not detected"	"Not detected"			"Adipose visceral - Neutrophils, Colon - Neutrophils, Heart muscle - Neutrophils, Minor Salivary Gland - Neutrophils, Pituitary gland - Neutrophils, Skeletal muscle - Neutrophils, Spleen - Neutrophils, Stomach - Neutrophils, Thyroid gland - Neutrophils"														"Secreted to blood"	Receptor	NA	NA			"Cluster 4: Neutrophils - Degranulation"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 12: Non-specific - Vasculature"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 74: Neutrophils - Degranulation"	16				"unprognostic (9.39e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.08e-1)"	"unprognostic (8.14e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.06e-3)"	"unprognostic (7.70e-2)"		"unprognostic (5.61e-2)"	"unprognostic (9.38e-3)"	"unprognostic (8.82e-2)"	"unprognostic (3.26e-2)"	"potential prognostic favorable (1.48e-4)"	"unprognostic (1.44e-1)"	"unprognostic (2.08e-1)"	"unprognostic (8.95e-2)"	"unprognostic (7.10e-2)"		"unprognostic (1.20e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.78e-2)"		"unprognostic (1.21e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.94e-1)"	"unprognostic (5.97e-2)"			"unprognostic (7.81e-2)"
FCRL1	"CD307a, FCRH1, IFGP1, IRTA5"	ENSG00000163534	"Fc receptor like 1"	Q96LA6	1	157794403-157820120	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"bone marrow: 8.0;intestine: 8.4;lymphoid tissue: 26.6"	"Cell type enriched"	"Detected in some"	32	"B-cells: 99.2"	"Cell type enriched"	"Detected in single"	38	"leukocyte: 24.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	49	"memory B-cell: 39.4;naive B-cell: 68.3"	"Lineage enriched"	"Detected in many"	62	"B-cells: 68.3"	"Cancer enriched"	"Detected in single"	36	"lymphoma: 9.1"	"Heart muscle - Neutrophils, Spleen - B-cells (Spleen)"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA013323	Enhanced						NA	NA		270000	"Cluster 14: Non-specific - Unknown function"	"Cluster 70: Lymphoid tissue - Immune response"		"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 73: B-cells - B-cell function"				"HPA013323: AB_1848480"			"unprognostic (1.35e-3)"																												
FCRL2	"CD307b, FCRH2, IRTA4, SPAP1"	ENSG00000132704	"Fc receptor like 2"	Q96LA5	1	157745733-157777132	"CD markers, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"intestine: 20.3;lymphoid tissue: 33.5"	"Group enriched"	"Detected in some"	41	"B-cells: 73.6;Plasma cells: 48.0"	"Cell type enriched"	"Detected in single"	36	"leukocyte: 9.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	34	"memory B-cell: 29.8;naive B-cell: 18.5"	"Lineage enriched"	"Detected in single"	42	"B-cells: 29.8"	"Group enriched"	"Detected in some"	71	"lymphoma: 13.7;Myeloma: 5.3"	"Breast - Plasma cells, Lung - B-cells (Lung), Minor Salivary Gland - Plasma cells, Pituitary gland - Plasma cells, Spleen - B-cells (Spleen)"																NA	NA			"Cluster 17: B-cells - Immunoglobulins"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 9: Non-specific - Receptor signaling"	"Cluster 55: Lymphoma - Immune response"	"Cluster 73: B-cells - B-cell function"	2						"potential prognostic favorable (4.10e-4)"			"unprognostic (1.15e-1)"										"potential prognostic favorable (6.25e-4)"	"unprognostic (2.57e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.81e-2)"			"unprognostic (2.45e-2)"	"unprognostic (3.25e-2)"			"unprognostic (2.67e-3)"			"unprognostic (2.75e-1)"		
FCRL3	"CD307c, FCRH3, IFGP3, IRTA3, SPAP2, SPAP2a, SPAP2b, SPAP2c, SPAP2d, SPAP2e"	ENSG00000160856	"Fc receptor like 3"	Q96P31	1	157674321-157700769	"CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	Fertilization	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"lymphoid tissue: 48.3"	"Cell type enhanced"	"Detected in some"		"B-cells: 45.6;Late spermatids: 10.6;NK-cells: 28.7;T-cells: 9.6"	"Cell type enriched"	"Detected in single"	63	"leukocyte: 33.2"	"Cancer enhanced"	"Detected in some"		"Testicular Germ Cell Tumor (TCGA): 2.3"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 35.4"	"Group enriched"	"Detected in many"	54	"B-cells: 35.4;NK-cells: 20.5;T-cells: 19.1"	"Cancer enriched"	"Detected in single"	81	"lymphoma: 17.7"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Heart muscle - T-cells, Kidney - T-cells, Liver - NK-cells (Liver), Lung - NK-cells (Lung), Spleen - B-cells (Spleen), Testis - Late spermatids"					"Low region specificity"	"Detected in many"			HPA048022	Enhanced						NA	NA			"Cluster 14: Non-specific - Unknown function"	"Cluster 70: Lymphoid tissue - Immune response"		"Cluster 55: Lymphoma - Immune response"	"Cluster 73: B-cells - B-cell function"	1			"HPA048022: AB_2732541"			"unprognostic (3.41e-3)"			"unprognostic (1.67e-1)"						"unprognostic (2.38e-1)"				"unprognostic (1.65e-3)"	"unprognostic (2.55e-1)"		"unprognostic (1.32e-1)"			"unprognostic (8.42e-2)"				"unprognostic (4.83e-2)"		"unprognostic (2.78e-1)"	"unprognostic (1.16e-1)"		
FCRL4	"CD307d, FCRH4, IGFP2, IRTA1"	ENSG00000163518	"Fc receptor like 4"	Q96PJ5	1	157573747-157598085	"Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"lymphoid tissue: 10.2"	"Cell type enhanced"	"Detected in single"		"B-cells: 1.8"	"Cell type enhanced"	"Detected in single"		"LAMP5-LHX6 and Chandelier: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	5	"lymphoma: 1.7"	"Spleen - B-cells (Spleen)"					"Not detected"	"Not detected"			HPA054030	Approved						NA	NA				"Cluster 36: Lymphoid tissue - Cytokine signaling"		"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 73: B-cells - B-cell function"	8			"HPA054030: "																															
FCRL5	"BXMAS1, CD307e, FCRH5, IRTA2"	ENSG00000143297	"Fc receptor like 5"	Q96RD9	1	157513377-157552515	"CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins"	Fertilization	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"lymphoid tissue: 35.4"	"Group enriched"	"Detected in some"	9	"B-cells: 83.7;Early spermatids: 68.8;Plasma cells: 249.7"	"Cell type enriched"	"Detected in single"	18	"leukocyte: 6.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	17	"memory B-cell: 13.0;naive B-cell: 14.2"	"Lineage enriched"	"Detected in single"	17	"B-cells: 14.2"	"Group enriched"	"Detected in some"	12	"lymphoma: 20.4;Myeloma: 7.2"	"Adipose subcutaneous - Plasma cells, Adipose visceral - Plasma cells, Adrenal gland - Plasma cells, Breast - Plasma cells, Colon - Plasma cells, Heart muscle - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Pancreas - Plasma cells, Pituitary gland - Plasma cells, Prostate - Plasma cells, Skeletal muscle - Plasma cells, Skin - Plasma cells, Testis - Early spermatids, Testis - Late spermatids, Thyroid gland - Plasma cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	Receptor	NA	NA	169000000	59000000	"Cluster 23: B-cells - Immunoglobulins"	"Cluster 36: Lymphoid tissue - Cytokine signaling"		"Cluster 55: Lymphoma - Immune response"	"Cluster 77: Plasma cells - Protein processing"	2					"potential prognostic favorable (4.47e-4)"	"unprognostic (5.25e-2)"	"unprognostic (6.86e-3)"	"unprognostic (5.14e-2)"	"unprognostic (1.37e-1)"			"potential prognostic favorable (4.64e-5)"						"unprognostic (2.59e-1)"	"unprognostic (1.80e-2)"	"unprognostic (2.44e-3)"	"unprognostic (9.65e-2)"	"unprognostic (2.17e-1)"			"unprognostic (2.55e-1)"	"unprognostic (1.94e-1)"			"unprognostic (2.46e-2)"		"unprognostic (6.90e-2)"	"unprognostic (3.86e-1)"		
FGFR1	"BFGFR, CD331, CEK, FLG, FLT2, H2, H3, H4, H5, KAL2, N-SAM"	ENSG00000077782	"Fibroblast growth factor receptor 1"	P11362	8	38400215-38468834	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters"	"Transcription, Transcription regulation"	"Heparin-binding, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Craniosynostosis, Disease variant, Dwarfism, FDA approved drug targets, Holoprosencephaly, Hypogonadotropic hypogonadism, Intellectual disability, Kallmann syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 188.4;Leydig cells: 193.1;Oligodendrocyte precursor cells: 156.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cancer enhanced"	"Detected in all"		"Rhabdoid: 200.8"	"Breast - Fibroblasts, Kidney - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009029, CAB033614, HPA056402"	Approved		Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle,Primary cilium,Centriolar satellite,Basal body,Cytosol"			Yes	NA		46000000	"Cluster 43: Non-specific - Transcription & Translation"	"Cluster 41: Smooth muscle tissue - ECM organization"	"Cluster 44: Non-specific - Mixed function"	"Cluster 5: Rhabdoid - Unknown function"	"Cluster 53: Fibroblasts - ECM organization"	92	"Microtubules, Cytokinetic bridge, Mitotic spindle"	"Primary cilium, Centriolar satellite, Basal body, Cytosol"	"CAB033614: AB_783377, HPA009029: , HPA056402: AB_2683118"	"unprognostic (1.44e-1)"	"unprognostic (7.85e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.70e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.00e-2)"	"unprognostic (4.48e-3)"	"unprognostic (5.05e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.19e-2)"	"unprognostic (5.23e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.08e-2)"	"unprognostic (3.39e-2)"	"unprognostic (5.52e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.24e-3)"	"unprognostic (8.84e-2)"	"unprognostic (9.56e-3)"	"unprognostic (8.24e-2)"
FGFR2	"BEK, CD332, CEK3, CFD1, ECT1, JWS, K-SAM, KGFR, TK14, TK25"	ENSG00000066468	"Fibroblast growth factor receptor 2"	P21802	10	121478332-121598458	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Apoptosis	"Heparin-binding, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Craniosynostosis, Disease variant, Ectodermal dysplasia, FDA approved drug targets, Intellectual disability, Lacrimo-auriculo-dento-digital syndrome, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 594.1"	"Group enriched"	"Detected in many"	5	"Astrocytes: 216.4;Cholangiocytes: 190.8;Oligodendrocytes: 523.6"	"Group enriched"	"Detected in many"	4	"bergmann glia: 1277.6;choroid plexus epithelial cell: 1305.0;oligodendrocyte: 929.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"basophil: 3.0;eosinophil: 2.0"	"Lineage enriched"	"Detected in single"	28	"granulocytes: 3.0"	"Cancer enhanced"	"Detected in many"		"Gastric cancer: 171.5"	"Lung - Alveolar cells type 2, Minor Salivary Gland - Minor salivary gland ductal cells, Pituitary gland - Undifferentiated cells (Pituitary gland), Skin - Keratinocyte (other), Testis - Spermatogonia, Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010886, HPA035305"	Uncertain		Approved	"Nucleoplasm,Vesicles,Cell Junctions"	"Secreted - unknown location"	Receptor	NA	NA		860000	"Cluster 46: Basophils - Proteolysis"	"Cluster 9: Oligodendrocytes - Myelination"	"Cluster 30: White matter - Myelination"	"Cluster 40: Non-specific - Unknown function"	"Cluster 51: Oligodendrocytes - Unknown function"	34	"Cell Junctions"	"Nucleoplasm, Vesicles"	"CAB010886: AB_259379, HPA035305: AB_10672862"	"unprognostic (1.73e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.18e-2)"	"unprognostic (6.89e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.04e-3)"	"unprognostic (2.90e-1)"	"unprognostic (1.11e-3)"	"potential prognostic favorable (3.24e-6)"	"unprognostic (6.37e-2)"	"unprognostic (8.26e-2)"	"unprognostic (6.57e-3)"	"unprognostic (7.91e-3)"	"unprognostic (3.60e-2)"	"unprognostic (1.82e-3)"	"potential prognostic favorable (2.43e-5)"	"unprognostic (3.77e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.53e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.99e-1)"
FGFR3	"ACH, CD333, CEK2, JTK4"	ENSG00000068078	"Fibroblast growth factor receptor 3"	P22607	4	1793293-1808872	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Apoptosis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Craniosynostosis, Deafness, Disease variant, Dwarfism, Ectodermal dysplasia, FDA approved drug targets, Lacrimo-auriculo-dento-digital syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 155.8;esophagus: 135.7;skin 1: 264.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 389.2;Basal keratinocytes: 98.3;Cholangiocytes: 70.6;Suprabasal keratinocytes: 96.2"	"Group enriched"	"Detected in many"	6	"astrocyte: 516.1;bergmann glia: 251.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Myeloma: 150.3"	"Minor Salivary Gland - Minor salivary gland basal cells, Pituitary gland - Corticotropes, Testis - Spermatogonia"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004231, HPA067204"	Enhanced		Supported	"Endoplasmic reticulum"	"Secreted - unknown location"	Receptor	NA	NA		1500000		"Cluster 80: Non-specific - Endocytosis"	"Cluster 19: Astrocytes - Mixed function"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 47: Astrocytes - Unknown function"	217	"Endoplasmic reticulum"		"CAB004231: AB_627596, HPA067204: AB_2685804"	"unprognostic (7.73e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.81e-2)"	"unprognostic (8.61e-2)"	"potential prognostic favorable (6.13e-6)"	"unprognostic (1.48e-1)"	"unprognostic (2.38e-3)"	"unprognostic (2.46e-2)"		"potential prognostic favorable (2.62e-4)"	"unprognostic (1.54e-3)"	"unprognostic (1.17e-1)"	"unprognostic (9.96e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.95e-3)"	"unprognostic (5.08e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.59e-1)"	"unprognostic (5.81e-2)"	"unprognostic (1.92e-1)"	"unprognostic (9.33e-3)"	"unprognostic (3.15e-2)"	"unprognostic (8.71e-2)"	"unprognostic (5.51e-2)"	"unprognostic (3.73e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.47e-2)"	"unprognostic (5.02e-2)"
FGFR4	"CD334, JTK2"	ENSG00000160867	"Fibroblast growth factor receptor 4"	P22455	5	177086905-177098144	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 80.5;lung: 63.4"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 61.1;Enteroendocrine cells: 17.0;Hepatocytes: 23.4;Proximal tubular cells: 17.0;Undifferentiated cells: 32.0"	"Cell type enriched"	"Detected in some"	7	"fibroblast: 21.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in all"		"liver cancer: 117.0"	"Liver - Hepatocytes, Lung - Fibroblast_1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB005196, HPA027273, HPA027369, HPA028251"	Approved				"Intracellular and membrane"	Receptor	NA	NA		4600000		"Cluster 47: Spleen - Immune response"	"Cluster 15: Non-specific - Transcription"	"Cluster 18: Liver cancer - Metabolism"	"Cluster 2: Skeletal myocytes - Muscle contraction"	28			"CAB005196: AB_631512, HPA027273: AB_10600212, HPA027369: AB_10599427, HPA028251: AB_10601221"	"unprognostic (8.24e-3)"	"unprognostic (6.16e-2)"	"unprognostic (3.94e-2)"	"unprognostic (2.00e-3)"	"unprognostic (9.33e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.22e-1)"		"unprognostic (3.24e-3)"	"unprognostic (8.63e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.60e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.42e-1)"	"unprognostic (4.41e-2)"	"unprognostic (4.76e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.12e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.54e-1)"		"unprognostic (4.13e-1)"
FLT3	"CD135, FLK2, STK1"	ENSG00000122025	"Fms related receptor tyrosine kinase 3"	P36888	13	28003274-28100592	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, RAS pathway related proteins"	"Host-virus interaction"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 5.2;brain: 9.1;lymphoid tissue: 6.3"	"Group enriched"	"Detected in some"	5	"dendritic cells: 60.0;Inhibitory neurons: 57.5;Kupffer cells: 30.9;Langerhans cells: 21.1;Macrophages: 19.1;Schwann cells: 51.1"	"Cell type enhanced"	"Detected in many"		"lower rhombic lip: 79.5;MGE interneuron: 94.6;upper rhombic lip: 84.5"	"Cancer enhanced"	"Detected in single"		"Breast Invasive Carcinoma (TCGA): 2.5"	"Region enhanced"	"Detected in many"		"cerebellum: 10.7"	"Group enriched"	"Detected in many"	13	"myeloid DC: 68.7;plasmacytoid DC: 26.3"	"Lineage enriched"	"Detected in many"	19	"dendritic cells: 68.7"	"Cancer enriched"	"Detected in single"	67	"Leukemia: 28.4"	"Prostate - Macrophages, Spleen - Neutrophils, Stomach - Macrophages, Testis - Late spermatids"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA047539			Approved	"Endoplasmic reticulum"			NA	NA		200000	"Cluster 2: Dendritic cells - Unknown function"	"Cluster 16: Non-specific - Transcription"	"Cluster 25: Non-specific - Transcription"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 28: Dendritic cells - Antigen presentation"	12	"Endoplasmic reticulum"		"HPA047539: AB_2680080"		"unprognostic (6.35e-3)"	"unprognostic (1.19e-2)"					"unprognostic (6.61e-2)"																							
FZD10	CD350	ENSG00000111432	"Frizzled class receptor 10"	Q9ULW2	12	130162459-130165740	"CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 16.3;skin 1: 9.1"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 8.1;Basal squamous epithelial cells: 15.1;Lymphatic endothelial cells: 6.4;Smooth muscle cells: 7.5;Squamous epithelial cells: 27.6;Suprabasal keratinocytes: 13.2"	"Group enriched"	"Detected in some"	4	"fibroblast: 10.2;pericyte: 23.2;vascular associated smooth muscle cell: 11.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"cervical cancer: 3.3;Esophageal cancer: 3.1"	"Adipose subcutaneous - Smooth muscle cells, Testis - Spermatogonia"	"Region enhanced"	"Detected in many"		"thalamus: 7.0"	"Low region specificity"	"Detected in many"			"HPA014484, HPA014485"	Uncertain		Approved	Nucleoplasm			NA	NA				"Cluster 27: Squamous epithelium - Keratinization"	"Cluster 19: Astrocytes - Mixed function"	"Cluster 7: Liver cancer - Metabolism"	"Cluster 12: Squamous epithelial cells - Keratinization"	6	Nucleoplasm		"HPA014484: AB_1849132, HPA014485: AB_1849134"	"unprognostic (2.61e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.25e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.34e-2)"	"unprognostic (5.60e-2)"			"unprognostic (4.85e-2)"							"unprognostic (1.50e-1)"	"unprognostic (9.55e-3)"	"unprognostic (6.71e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.74e-2)"	"unprognostic (7.92e-2)"			"unprognostic (8.70e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.96e-2)"		"unprognostic (1.89e-1)"	"unprognostic (3.94e-1)"		"unprognostic (1.46e-2)"
FZD4	"CD344, EVR1"	ENSG00000174804	"Frizzled class receptor 4"	Q9ULV1	11	86945679-86955395	"CD markers, Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 115.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 82.2;Basal prostatic cells: 29.7;Collecting duct cells: 27.2;Endothelial cells: 61.4;Fibroblasts: 32.6;Skeletal myocytes: 28.3;Smooth muscle cells: 27.3"	"Cell type enriched"	"Detected in many"	4	"endothelial cell: 83.6"	"Cancer enhanced"	"Detected in all"		"Kidney Renal Clear Cell Carcinoma (TCGA): 42.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Prostate - Endothelial cells, Spleen - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042328, HPA074833"	Approved		Supported	"Nucleoplasm,Plasma membrane,Primary cilium"			NA	NA				"Cluster 7: Adipose tissue - Mixed function"	"Cluster 32: Cerebral cortex - Mixed function"	"Cluster 48: Adipocytes & Endothelial cells - Angiogenesis"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	7	"Plasma membrane"	"Nucleoplasm, Primary cilium"	"HPA042328: AB_10962494, HPA074833: AB_2686716"	"unprognostic (5.42e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.24e-3)"	"unprognostic (7.78e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.76e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.11e-1)"	"unprognostic (9.00e-2)"	"validated prognostic favorable (1.58e-8)"	"validated prognostic favorable (2.01e-4)"	"potential prognostic favorable (5.49e-4)"	"unprognostic (2.17e-1)"	"unprognostic (1.96e-2)"	"unprognostic (7.14e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.56e-1)"	"unprognostic (6.91e-2)"	"unprognostic (2.83e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.97e-2)"	"unprognostic (9.58e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.98e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.56e-1)"
FZD9	"CD349, FZD3"	ENSG00000188763	"Frizzled class receptor 9"	O00144	7	73433778-73436120	"CD markers, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.2;skeletal muscle: 6.8;testis: 4.5"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 4.2;Late spermatids: 13.7;Muller glia cells: 5.4;Oligodendrocyte precursor cells: 14.1"	"Group enriched"	"Detected in many"	5	"fibroblast: 13.2;oligodendrocyte precursor cell: 19.5;pericyte: 10.2"	"Cancer enriched"	"Detected in many"	5	"Skin Cuteneous Melanoma (TCGA): 9.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Testis - Late spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"										NA	NA				"Cluster 54: Non-specific - Basic cellular processes"	"Cluster 38: Sub-cortical - Mixed function"	"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 11: Late spermatids - Unknown function"						"unprognostic (1.18e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.66e-1)"												"unprognostic (1.38e-1)"		"unprognostic (1.71e-1)"						"unprognostic (2.58e-1)"			"unprognostic (2.29e-1)"		"unprognostic (8.22e-2)"		"unprognostic (1.43e-2)"
GGT1	"CD224, D22S672, D22S732, GGT"	ENSG00000100031	"Gamma-glutamyltransferase 1"	P19440	22	24594811-24629005	"Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Glutathione biosynthesis, Lipid metabolism"	"Acyltransferase, Hydrolase, Protease, Transferase"	"Disease variant, Intellectual disability"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 173.5;liver: 113.1"	"Group enriched"	"Detected in some"	4	"Distal enterocytes: 23.8;Ductal cells: 57.7;Exocrine glandular cells: 30.0;Proximal enterocytes: 49.9"	"Group enriched"	"Detected in some"	5	"fibroblast: 2.3;pericyte: 5.9"	"Cancer enhanced"	"Detected in all"		"Kidney Renal Papillary Cell Carcinoma (TCGA): 231.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"Kidney cancer: 119.6"	"Kidney - Proximal tubular cells, Minor Salivary Gland - Minor salivary glandular cells, Prostate - Prostate glandular cells, Stomach - Chief cells, Testis - Sertoli cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045635, HPA047534, HPA065444"	Supported		Uncertain	Vesicles	"Intracellular and membrane"	Enzyme	NA	NA		4100000	"Cluster 28: Neutrophils - Unknown function"	"Cluster 52: Kidney - Transmembrane transport"	"Cluster 30: White matter - Myelination"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 45: Non-specific - Mixed function"	4	Vesicles		"HPA045635: AB_2679400, HPA047534: AB_2680079, HPA065444: AB_2685491"	"potential prognostic unfavorable (6.50e-8)"	"unprognostic (1.36e-3)"	"unprognostic (6.84e-3)"	"unprognostic (7.62e-2)"	"unprognostic (8.29e-2)"	"unprognostic (7.51e-3)"	"unprognostic (6.17e-3)"	"potential prognostic favorable (9.95e-4)"	"unprognostic (2.28e-3)"	"unprognostic (4.79e-1)"	"potential prognostic favorable (1.44e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.88e-3)"	"unprognostic (5.57e-3)"	"unprognostic (9.20e-3)"	"unprognostic (5.97e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.06e-2)"	"unprognostic (8.62e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.13e-1)"
GP1BA	"CD42b, GP1B, GPIbalpha"	ENSG00000185245	"Glycoprotein Ib platelet subunit alpha"	P07359	17	4932277-4935023	"CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Blood coagulation, Cell adhesion, Hemostasis"		"Bernard Soulier syndrome, Disease variant, von Willebrand disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 4.9;lymphoid tissue: 14.3"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 3.1;Horizontal cells: 1.9;Langerhans cells: 2.7;Melanocytes: 1.7;Peritubular cells: 2.0;Rod photoreceptor cells: 1.9"	"Low cell type specificity"	"Detected in some"			"Cancer enhanced"	"Detected in some"		"Testicular Germ Cell Tumor (TCGA): 4.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	13	"basophil: 7.0"	"Lineage enriched"	"Detected in single"	44	"granulocytes: 7.0"	"Low cancer specificity"	"Detected in many"				"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB002496, HPA013316"	Supported						NA	NA		1100000000	"Cluster 4: Neutrophils - Degranulation"	"Cluster 36: Lymphoid tissue - Cytokine signaling"	"Cluster 15: Non-specific - Transcription"	"Cluster 47: Leukemia - Hemostasis"	"Cluster 57: Platelets - Hemostasis"	10			"CAB002496: AB_563748, HPA013316: AB_1855459"			"unprognostic (4.33e-2)"			"unprognostic (1.31e-1)"				"unprognostic (2.68e-2)"		"unprognostic (4.72e-2)"	"unprognostic (5.93e-2)"									"potential prognostic favorable (5.96e-4)"				"unprognostic (6.28e-3)"		"unprognostic (4.20e-3)"	"unprognostic (4.10e-1)"		
GP1BB	"CD42c, GPIbbeta"	ENSG00000203618	"Glycoprotein Ib platelet subunit beta"	P13224	22	19723539-19724771	"CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins"	"Blood coagulation, Cell adhesion, Hemostasis"		"Bernard Soulier syndrome, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 131.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"Testicular Germ Cell Tumor (TCGA): 4.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 73.7;neutrophil: 74.7"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 74.7"	"Cancer enhanced"	"Detected in single"		"Leukemia: 3.0"		"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"										NA	NA		7000000	"Cluster 21: Neutrophils - Unknown function"	"Cluster 61: Brain - Neuronal signaling"	"Cluster 51: Neurons - Mixed function"	"Cluster 49: HMC-1 - Innate immune response"		5				"unprognostic (2.00e-1)"			"unprognostic (1.85e-2)"		"unprognostic (3.21e-2)"						"unprognostic (1.66e-1)"			"unprognostic (2.68e-1)"					"unprognostic (6.95e-2)"						"unprognostic (2.34e-1)"	"unprognostic (5.27e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.55e-1)"		"unprognostic (2.62e-1)"
GP5	CD42d	ENSG00000178732	"Glycoprotein V platelet"	P40197	3	194394821-194399266	"CD markers, Plasma proteins, Predicted membrane proteins"	"Blood coagulation, Cell adhesion, Hemostasis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"lymphoid tissue: 1.1"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	21	"ependymal cell: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	8	"Leukemia: 1.2"	"Kidney - Proximal tubular cells"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA072646			Approved	Cytosol			NA	NA		280000000		"Cluster 70: Lymphoid tissue - Immune response"		"Cluster 6: Leukemia - Signal transduction"	"Cluster 7: T-cells - T-cell receptor"	34	Cytosol		"HPA072646: "																															
GP9	"CD42a, GPIX"	ENSG00000169704	"Glycoprotein IX platelet"	P14770	3	129060779-129062406	"CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins"	"Blood coagulation, Cell adhesion, Hemostasis"		"Bernard Soulier syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 5.0;lung: 3.1;lymphoid tissue: 8.7"	"Group enriched"	"Detected in some"	8	"Early spermatids: 8.3;Late spermatids: 20.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"choroid plexus: 1.3"	"Group enriched"	"Detected in some"	7	"basophil: 29.4;neutrophil: 14.0"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 29.4"	"Cancer enriched"	"Detected in single"	97	"Leukemia: 9.6"	"Spleen - Platelets, Testis - Late spermatids"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA063182	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"			NA	NA		4300000	"Cluster 4: Neutrophils - Degranulation"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 23: Choroid plexus - Mixed function"	"Cluster 47: Leukemia - Hemostasis"	"Cluster 57: Platelets - Hemostasis"	57	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA063182: AB_2684956"																															
GYPA	"CD235a, GPA, MN, MNS"	ENSG00000170180	"Glycophorin A (MNS blood group)"	P02724	4	144109303-144140751	"Blood group antigen proteins, CD markers, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Blood group antigen, Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	39	"bone marrow: 154.0"	"Cell type enriched"	"Detected in some"	308	"Erythroid cells: 1200.4"	"Low cell type specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	18	"Leukemia: 32.6"	"Kidney - Proximal tubular cells, Liver - Erythroid cells, Lung - Neutrophil_1, Spleen - Erythrocytes"									"CAB002658, HPA014811"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"			NA	NA		9100000		"Cluster 6: Bone marrow - Innate immune response"	"Cluster 53: Neurons - Mixed function"	"Cluster 47: Leukemia - Hemostasis"	"Cluster 1: Erythroid cells - Oxygen transport"	27	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB002658: , HPA014811: AB_1849827"																															
GYPB	"CD235b, GPB, MNS, SS"	ENSG00000250361	"Glycophorin B (MNS blood group)"	P06028	4	143996104-144019380	"Blood group antigen proteins, CD markers, Predicted intracellular proteins, Predicted membrane proteins"		"Blood group antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"bone marrow: 62.2"	"Cell type enriched"	"Detected in some"	310	"Erythroid cells: 915.5"	"Cell type enhanced"	"Detected in many"		"upper-layer intratelencephalic: 10.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	149	"Leukemia: 17.3"	"Liver - Erythroid cells, Spleen - Erythrocytes"														"Intracellular and membrane"	Other	NA	NA				"Cluster 6: Bone marrow - Innate immune response"	"Cluster 53: Neurons - Mixed function"	"Cluster 47: Leukemia - Hemostasis"	"Cluster 1: Erythroid cells - Oxygen transport"	4																																		
GYPC	"CD236, CD236R, Ge, GPC, GYPD"	ENSG00000136732	"Glycophorin C (Gerbich blood group)"	P04921	2	126656133-126696667	"Blood group antigen proteins, CD markers, Predicted membrane proteins"		"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 434.8"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 1183.3;Hofbauer cells: 460.5;Lymphatic endothelial cells: 567.0"	"Cell type enhanced"	"Detected in many"		"central nervous system macrophage: 87.4;fibroblast: 71.2;leukocyte: 65.8;vascular associated smooth muscle cell: 43.7"	"Cancer enhanced"	"Detected in all"		"Skin Cuteneous Melanoma (TCGA): 387.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"Leukemia: 222.8;skin cancer: 319.3"	"Liver - Vascular Endothelial cells, Pituitary gland - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008965, CAB009445"	Enhanced		Supported	"Plasma membrane"			NA	NA		1400000	"Cluster 43: Non-specific - Transcription & Translation"	"Cluster 56: Non-specific - Unknown function"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 9: Skin cancer - Melanin biosynthesis"	"Cluster 1: Erythroid cells - Oxygen transport"	11	"Plasma membrane"		"CAB009445: AB_2116251, HPA008965: AB_1078455"	"unprognostic (8.65e-3)"	"unprognostic (1.11e-2)"	"unprognostic (7.03e-2)"	"unprognostic (9.19e-2)"	"unprognostic (5.64e-2)"	"unprognostic (7.49e-2)"	"unprognostic (9.16e-3)"	"unprognostic (2.81e-3)"	"unprognostic (3.00e-2)"	"unprognostic (2.40e-1)"	"potential prognostic favorable (2.09e-4)"	"unprognostic (7.37e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.35e-2)"	"unprognostic (5.42e-2)"	"unprognostic (4.80e-2)"	"unprognostic (9.28e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.07e-2)"	"unprognostic (4.32e-1)"	"unprognostic (2.61e-1)"	"unprognostic (6.10e-2)"	"unprognostic (8.84e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.53e-1)"
HAVCR1	"CD365, HAVCR, HAVCR-1, KIM1, TIM-1, TIM1, TIMD1"	ENSG00000113249	"Hepatitis A virus cellular receptor 1"	Q96D42	5	157026742-157069396	"CD markers, Predicted membrane proteins"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 4.5;kidney: 6.7"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 1.9;Inhibitory neurons: 1.3;Microglial cells: 5.4;Oligodendrocytes: 1.7;Proximal tubular cells: 2.6"	"Cell type enhanced"	"Detected in some"		"central nervous system macrophage: 9.9"	"Group enriched"	"Detected in many"	13	"Kidney Renal Clear Cell Carcinoma (TCGA): 56.0;Kidney Renal Papillary Cell Carcinoma (TCGA): 69.7"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 2.5"	"Low lineage specificity"	"Detected in single"			"Cancer enriched"	"Detected in many"	4	"Kidney cancer: 194.7"	"Testis - Early spermatids, Testis - Late spermatids"					"Low region specificity"	"Detected in all"			"HPA007173, CAB075697"	Uncertain		Uncertain	Vesicles			NA	NA			"Cluster 43: Non-specific - Transcription & Translation"	"Cluster 52: Kidney - Transmembrane transport"	"Cluster 48: Non-specific - Mixed function"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 38: Proximal tubular cells - Transmembrane transport"	2	Vesicles		"CAB075697: , HPA007173: AB_1080282"	"unprognostic (1.86e-1)"				"unprognostic (1.46e-1)"	"unprognostic (6.17e-3)"					"potential prognostic favorable (7.21e-5)"	"unprognostic (1.70e-1)"	"unprognostic (1.79e-1)"	"unprognostic (6.57e-3)"	"unprognostic (4.63e-3)"	"unprognostic (2.10e-3)"	"unprognostic (7.53e-2)"					"unprognostic (1.22e-3)"	"unprognostic (1.59e-2)"		"unprognostic (6.01e-3)"	"unprognostic (6.89e-2)"		"unprognostic (7.39e-3)"	"unprognostic (9.04e-2)"		"unprognostic (2.35e-2)"
HAVCR2	"CD366, FLJ14428, Tim-3, TIM3, TIMD3"	ENSG00000135077	"Hepatitis A virus cellular receptor 2"	Q8TDQ0	5	157085422-157142869	"CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity, Inflammatory response, Innate immunity"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"granulocytes: 53.6;Hofbauer cells: 144.9;Kupffer cells: 65.7;Langerhans cells: 77.2;Macrophages: 86.7;monocytes: 49.7;NK-cells: 134.1;Proximal tubular cells: 57.8;Schwann cells: 92.3"	"Cell type enriched"	"Detected in all"	4	"central nervous system macrophage: 280.0"	"Cancer enhanced"	"Detected in all"		"Kidney Renal Clear Cell Carcinoma (TCGA): 61.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 57.2;intermediate monocyte: 62.7;myeloid DC: 118.8;NK-cell: 76.0;non-classical monocyte: 45.9"	"Group enriched"	"Detected in all"	6	"dendritic cells: 118.8;monocytes: 62.7;NK-cells: 76.0"	"Cancer enhanced"	"Detected in some"		"lymphoma: 10.0"	"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Breast - Macrophages, Colon - Macrophages, Heart muscle - Macrophages, Kidney - Proximal tubular cells, Minor Salivary Gland - Macrophages, Pituitary gland - Macrophages, Prostate - Macrophages, Skeletal muscle - Macrophages, Stomach - Macrophages"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			CAB026003	Enhanced						NA	NA		17000000	"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 71: Lymphoma - Inflammatory response"	"Cluster 28: Dendritic cells - Antigen presentation"	7			"CAB026003: "	"unprognostic (4.39e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.65e-2)"	"unprognostic (7.31e-2)"	"potential prognostic favorable (2.67e-4)"	"unprognostic (3.51e-2)"	"unprognostic (8.67e-3)"	"unprognostic (5.30e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.56e-3)"	"unprognostic (1.13e-1)"	"unprognostic (7.09e-2)"	"unprognostic (4.97e-2)"	"unprognostic (3.32e-1)"	"unprognostic (8.70e-2)"	"unprognostic (8.27e-3)"	"unprognostic (1.69e-1)"	"unprognostic (9.67e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.83e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.29e-1)"
HMMR	"CD168, RHAMM"	ENSG00000072571	"Hyaluronan mediated motility receptor"	O75330	5	163460203-163491941	"CD markers, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 20.3;lymphoid tissue: 26.5;testis: 26.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 103.7;Erythroid cells: 123.5;Extravillous trophoblasts: 59.3;Late spermatids: 62.4;Spermatocytes: 94.5"	"Low cell type specificity"	"Detected in some"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.5"	"Low lineage specificity"	"Detected in single"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Mitotic cells (Adrenal gland), Colon - Mitotic cells (Colon), Lung - Mitotic cells (Lung), Minor Salivary Gland - Mitotic cells (Minor salivary gland), Skin - Mitotic cells (Skin), Spleen - Mitotic cells (Spleen), Stomach - Mitotic cells (Stomach), Testis - Early spermatids, Thyroid gland - Mitotic cells (Thyroid)"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB002433, HPA040025, HPA043926, HPA061524"	Enhanced		Enhanced	Microtubules,Centrosome,Cytosol			Yes	Yes			"Cluster 13: Non-specific - Mitochondria"	"Cluster 67: Lymphoid tissue & Bone marrow - Cell proliferation"	"Cluster 30: White matter - Myelination"	"Cluster 22: Non-specific - mRNA splicing & Cell cycle"	"Cluster 52: Non-specific - Cell proliferation"	25	Microtubules	"Centrosome, Cytosol"	"CAB002433: AB_564080, HPA040025: AB_2676805, HPA043926: , HPA061524: AB_2684551"	"unprognostic (3.14e-2)"	"unprognostic (3.10e-2)"	"unprognostic (6.94e-3)"	"unprognostic (6.23e-2)"	"unprognostic (1.54e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.62e-2)"	"unprognostic (2.21e-2)"	"potential prognostic unfavorable (1.83e-4)"	"validated prognostic unfavorable (6.62e-6)"	"validated prognostic unfavorable (1.22e-7)"	"potential prognostic unfavorable (3.18e-7)"	"validated prognostic unfavorable (4.04e-8)"	"validated prognostic unfavorable (2.90e-10)"	"validated prognostic unfavorable (8.47e-7)"	"validated prognostic unfavorable (3.79e-4)"	"unprognostic (6.08e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.10e-1)"	"validated prognostic unfavorable (6.82e-4)"	"validated prognostic unfavorable (9.43e-4)"	"unprognostic (3.38e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.52e-1)"		"unprognostic (4.72e-2)"
ICAM1	"BB2, CD54"	ENSG00000090339	"Intercellular adhesion molecule 1"	P05362	19	10271093-10286615	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 212.5;urinary bladder: 207.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 518.0;Alveolar cells type 2: 276.8;Endothelial cells: 318.0;Langerhans cells: 216.7;Macrophages: 230.4;monocytes: 345.6"	"Cell type enriched"	"Detected in some"	8	"endothelial cell: 105.4"	"Cancer enhanced"	"Detected in all"		"Lung Adenocarcinoma (TCGA): 244.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002126, CAB002142, HPA004877"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"			NA	NA		1200000000	"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 12: Non-specific - Vasculature"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	35	"Plasma membrane"	"Vesicles, Cytosol"	"CAB002142: AB_563596, HPA002126: AB_1078470, HPA004877: AB_1846317"	"unprognostic (8.42e-2)"	"unprognostic (4.57e-3)"	"unprognostic (7.39e-2)"	"unprognostic (2.30e-2)"	"unprognostic (3.86e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.61e-3)"	"unprognostic (4.21e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.67e-2)"	"potential prognostic unfavorable (2.83e-4)"	"unprognostic (2.22e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.95e-3)"	"unprognostic (3.28e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.50e-2)"	"unprognostic (4.08e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.04e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.65e-1)"	"potential prognostic favorable (2.21e-4)"	"unprognostic (9.78e-2)"	"unprognostic (1.21e-1)"	"unprognostic (8.87e-3)"	"unprognostic (1.17e-1)"	"unprognostic (6.59e-2)"
ICAM2	CD102	ENSG00000108622	"Intercellular adhesion molecule 2"	P13598	17	64002594-64020634	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 164.0"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 346.2;Endothelial cells: 215.8;Lymphatic endothelial cells: 85.3;monocytes: 149.0;NK-cells: 86.1;Plasma cells: 130.7"	"Cell type enriched"	"Detected in some"	4	"endothelial cell: 176.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"Leukemia: 72.4;lymphoma: 56.2;Myeloma: 73.0"	"Adipose subcutaneous - Endothelial cells, Adipose visceral - Endothelial cells, Adrenal gland - Endothelial cells, Breast - Endothelial cells, Colon - Endothelial cells, Heart muscle - Endothelial cells, Kidney - Endothelial cells, Lung - Endothelial cells, Minor Salivary Gland - Endothelial cells, Pituitary gland - Endothelial cells, Prostate - Endothelial cells, Skeletal muscle - Endothelial cells, Skin - Endothelial cells, Testis - Endothelial cells, Thyroid gland - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071155			Approved	"Plasma membrane,Cytosol"			NA	NA		390000000	"Cluster 5: Non-specific - Cell proliferation"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 47: Endothelial cells - Vasculature"	"Cluster 48: Adipocytes & Endothelial cells - Angiogenesis"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	32	"Plasma membrane"	Cytosol	"HPA071155: "	"unprognostic (2.15e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.60e-3)"	"unprognostic (4.22e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.40e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.16e-2)"	"validated prognostic favorable (2.90e-4)"	"validated prognostic favorable (8.15e-4)"	"unprognostic (1.68e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.67e-2)"	"unprognostic (4.29e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.93e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.11e-3)"	"unprognostic (1.35e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.79e-2)"	"unprognostic (7.51e-3)"	"unprognostic (5.65e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.11e-2)"
ICAM3	"CD50, CDW50, ICAM-R"	ENSG00000076662	"Intercellular adhesion molecule 3"	P32942	19	10333776-10339661	"CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Phagocytosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 175.2;lymphoid tissue: 76.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 144.5;Hepatocytes: 174.9;monocytes: 235.7;NK-cells: 242.4;Plasma cells: 174.7;T-cells: 176.5"	"Cell type enriched"	"Detected in some"	14	"leukocyte: 61.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1772.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 1772.8"	"Cancer enhanced"	"Detected in all"		"Leukemia: 103.0;Myeloma: 120.8"	"Adipose subcutaneous - T-cells, Adipose visceral - Neutrophils, Heart muscle - Neutrophils, Kidney - T-cells, Lung - Neutrophil_2, Minor Salivary Gland - Plasma cells, Pituitary gland - T-cells, Prostate - T-cells, Spleen - Neutrophils"					"Low region specificity"	"Detected in many"			"CAB002498, HPA049820"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Mitochondria"			NA	NA		190000000	"Cluster 21: Neutrophils - Unknown function"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 47: Endothelial cells - Vasculature"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 19: NK-cells - Adaptive immune response"	10	Mitochondria	"Nucleoplasm, Nuclear membrane"	"CAB002498: AB_563593, HPA049820: AB_2680897"	"unprognostic (1.64e-3)"	"unprognostic (3.12e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.32e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.72e-3)"	"unprognostic (3.61e-3)"	"potential prognostic favorable (2.35e-4)"	"unprognostic (2.82e-3)"	"unprognostic (1.71e-2)"	"unprognostic (2.16e-2)"	"unprognostic (9.28e-2)"	"unprognostic (3.97e-2)"	"unprognostic (3.61e-1)"	"unprognostic (8.03e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.20e-1)"	"unprognostic (6.67e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.84e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.27e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.15e-1)"	"unprognostic (5.94e-2)"
ICAM4	"CD242, LW"	ENSG00000105371	"Intercellular adhesion molecule 4 (Landsteiner-Wiener blood group)"	Q14773	19	10286955-10288522	"Blood group antigen proteins, CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Blood group antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 13.2;lung: 9.0"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 25.1;Alveolar cells type 2: 83.9;Endothelial cells: 21.3;Erythroid cells: 33.2;monocytes: 31.0"	"Cell type enhanced"	"Detected in single"		"leukocyte: 1.8"	"Cancer enhanced"	"Detected in many"		"Lung Adenocarcinoma (TCGA): 16.4"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"non-classical monocyte: 216.1"	"Lineage enriched"	"Detected in many"	7	"monocytes: 216.1"	"Cancer enriched"	"Detected in many"	5	"Leukemia: 35.5"		"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"								"Intracellular and membrane"	"Cell adhesion"	NA	NA			"Cluster 37: Monocytes & Neutrophils - Innate immune response"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 48: Non-specific - Mixed function"	"Cluster 47: Leukemia - Hemostasis"	"Cluster 1: Erythroid cells - Oxygen transport"					"unprognostic (1.12e-1)"		"unprognostic (1.69e-1)"	"unprognostic (1.33e-2)"		"unprognostic (2.16e-2)"			"unprognostic (2.24e-3)"	"unprognostic (3.98e-2)"	"potential prognostic unfavorable (2.09e-5)"		"unprognostic (3.11e-1)"	"potential prognostic unfavorable (2.96e-4)"	"unprognostic (8.13e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.85e-1)"	"unprognostic (3.46e-1)"	"unprognostic (7.91e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.54e-1)"	"unprognostic (7.85e-2)"				"unprognostic (9.83e-3)"	"unprognostic (2.26e-2)"	"unprognostic (3.74e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.60e-1)"
ICOS	"AILIM, CD278"	ENSG00000163600	"Inducible T cell costimulator"	Q9Y6W8	2	203936763-203961577	"CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"bone marrow: 16.3;lymphoid tissue: 19.6"	"Cell type enriched"	"Detected in some"	16	"T-cells: 96.3"	"Cell type enriched"	"Detected in single"	136	"leukocyte: 86.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 29.2"	"Lineage enriched"	"Detected in single"	54	"T-cells: 29.2"	"Cancer enhanced"	"Detected in some"		"Leukemia: 2.4;lymphoma: 2.6"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Adrenal gland - T-cells, Breast - T-cells, Colon - T-cells, Kidney - T-cells, Liver - T-cells, Minor Salivary Gland - T-cells, Pituitary gland - T-cells, Prostate - T-cells, Skin - T-cells, Testis - Spermatogonia, Thyroid gland - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB032575, HPA034865"	Approved		Approved	"Plasma membrane,Actin filaments"	"Intracellular and membrane"	"No annotated function"	NA	NA			"Cluster 31: T-cells - T-cell receptor"	"Cluster 67: Lymphoid tissue & Bone marrow - Cell proliferation"		"Cluster 59: Leukemia - T-cell receptor"	"Cluster 78: NK-cells & T-cells - Immune system & Transcription"	5	"Plasma membrane"	"Actin filaments"	"CAB032575: AB_2122593, HPA034865: "		"unprognostic (3.34e-2)"	"unprognostic (7.43e-2)"	"potential prognostic favorable (4.60e-4)"		"unprognostic (6.97e-2)"			"potential prognostic favorable (6.45e-4)"		"unprognostic (1.47e-1)"	"unprognostic (1.23e-1)"			"unprognostic (3.87e-2)"	"unprognostic (4.90e-3)"	"unprognostic (5.07e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.72e-1)"				"unprognostic (1.37e-2)"			"unprognostic (6.94e-3)"		"unprognostic (4.13e-2)"	"unprognostic (5.09e-2)"		
ICOSLG	"B7-H2, B7h, B7H2, B7RP-1, B7RP1, CD275, GL50, ICOS-L, ICOSL, KIAA0653"	ENSG00000160223	"Inducible T cell costimulator ligand"	O75144	21	44215382-44241446	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, B-cell activation, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 69.4;Langerhans cells: 34.3;Schwann cells: 48.5"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026037, HPA029179, CAB079997"	Approved		Approved	"Vesicles,Plasma membrane"			NA	NA		79000000	"Cluster 23: B-cells - Immunoglobulins"	"Cluster 33: Brain - Neuronal signaling"	"Cluster 11: White matter - Signal transduction"	"Cluster 6: Leukemia - Signal transduction"	"Cluster 28: Dendritic cells - Antigen presentation"	3	"Vesicles, Plasma membrane"		"CAB026037: , CAB079997: , HPA029179: AB_2732445"	"unprognostic (2.07e-1)"	"potential prognostic unfavorable (6.31e-4)"	"unprognostic (2.83e-3)"	"unprognostic (7.04e-3)"	"unprognostic (3.61e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.20e-2)"	"unprognostic (3.54e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.21e-1)"	"unprognostic (8.81e-2)"	"unprognostic (7.04e-3)"	"unprognostic (6.07e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.61e-2)"	"unprognostic (7.53e-2)"	"unprognostic (3.97e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.03e-2)"	"potential prognostic unfavorable (3.63e-4)"	"unprognostic (1.26e-2)"	"unprognostic (2.65e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.47e-1)"	"unprognostic (6.24e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.70e-1)"
IFITM1	"9-27, CD225, DSPA2a, IFI17"	ENSG00000185885	"Interferon induced transmembrane protein 1"	P13164	11	310041-315272	"CD markers, Plasma proteins, Predicted membrane proteins, Transporters"	"Antiviral defense, Immunity, Innate immunity, Osteogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 347.5;Endothelial cells: 319.6;Leydig cells: 223.1;Mesothelial cells: 297.5;NK-cells: 253.8;T-cells: 487.1"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"eosinophil: 1500.1;gdT-cell: 2915.2;MAIT T-cell: 2008.6;memory CD4 T-cell: 3131.5;memory CD8 T-cell: 3002.0;naive CD4 T-cell: 2949.8;naive CD8 T-cell: 3007.1;neutrophil: 2758.0;NK-cell: 4694.8;T-reg: 1950.8"	"Group enriched"	"Detected in all"	7	"granulocytes: 2758.0;NK-cells: 4694.8;T-cells: 3131.5"	"Low cancer specificity"	"Detected in all"			"Colon - Endothelial cells, Heart muscle - Endothelial cells, Skeletal muscle - Endothelial cells"									"HPA004810, CAB017615"	Enhanced		Approved	"Golgi apparatus,Plasma membrane"			NA	NA			"Cluster 24: Non-specific - Transcription"	"Cluster 53: Non-specific - Glycosylation"	"Cluster 47: Endothelial cells - Vasculature"	"Cluster 31: Non-specific - Antiviral immune response"	"Cluster 7: T-cells - T-cell receptor"	36	"Golgi apparatus, Plasma membrane"		"CAB017615: AB_2264496, HPA004810: AB_1851419"	"unprognostic (2.90e-1)"	"unprognostic (2.71e-3)"	"unprognostic (7.60e-2)"	"unprognostic (8.33e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.76e-2)"	"unprognostic (7.24e-2)"	"unprognostic (9.56e-2)"	"unprognostic (3.54e-1)"	"unprognostic (8.98e-2)"	"unprognostic (2.04e-3)"	"unprognostic (3.38e-1)"	"potential prognostic unfavorable (2.43e-5)"	"unprognostic (1.06e-1)"	"unprognostic (8.64e-3)"	"unprognostic (9.45e-2)"	"unprognostic (4.53e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.81e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.78e-3)"	"unprognostic (1.55e-3)"	"unprognostic (5.94e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.38e-1)"	"unprognostic (6.09e-2)"	"unprognostic (2.02e-1)"	"unprognostic (6.49e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.50e-1)"
IFNGR1	"CD119, IFNGR"	ENSG00000027697	"Interferon gamma receptor 1"	P15260	6	137197483-137219449	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 840.3;Ionocytes: 628.8;monocytes: 682.3"	"Cell type enhanced"	"Detected in all"		"central nervous system macrophage: 750.0;endothelial cell: 370.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Spleen - Macrophages"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025889, HPA029213, HPA063871, CAB080493, CAB080494, CAB080495"	Supported		Supported	"Plasma membrane"			NA	NA			"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 30: White matter - Myelination"	"Cluster 71: Lymphoma - Inflammatory response"	"Cluster 35: Respiratory epithelial cells - Unknown function"	24	"Plasma membrane"		"CAB025889: , CAB080493: , CAB080494: , CAB080495: , HPA029213: AB_10601023, HPA063871: AB_2685138"	"unprognostic (1.31e-1)"	"unprognostic (2.66e-1)"	"unprognostic (9.31e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.36e-2)"	"unprognostic (8.76e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.26e-1)"	"unprognostic (5.61e-2)"	"unprognostic (8.62e-3)"	"potential prognostic favorable (4.69e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.12e-2)"	"unprognostic (4.87e-3)"	"unprognostic (4.63e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.15e-1)"	"unprognostic (6.69e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.42e-1)"
IGF1R	"CD221, IGFIR, IGFR, JTK13, MGC18216"	ENSG00000140443	"Insulin like growth factor 1 receptor"	P08069	15	98648539-98964530	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Host-virus interaction"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 231.4;Inhibitory neurons: 186.7;Microglial cells: 234.4;Oligodendrocyte precursor cells: 223.1;Oligodendrocytes: 242.8"	"Cell type enhanced"	"Detected in all"		"endothelial cell: 1591.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.3"	"Group enriched"	"Detected in many"	6	"granulocytes: 4.3;T-cells: 1.4"	"Low cancer specificity"	"Detected in all"			"Liver - Vascular Endothelial cells, Minor Salivary Gland - Minor salivary glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004822, CAB010268, HPA045563"	Approved		Approved	"Nucleoli,Nucleoli rim,Plasma membrane,Primary cilium"			NA	NA		21000	"Cluster 35: Neutrophils - Protein binding"	"Cluster 64: Neuronal - Transcription"	"Cluster 42: Choroid plexus - Mitochondria"	"Cluster 58: Non-specific - Nuclear processes"	"Cluster 37: Glandular & Luminal cells - Unknown function"	126	"Nucleoli rim, Plasma membrane"	"Nucleoli, Primary cilium"	"CAB010268: AB_671792, HPA004822: , HPA045563: AB_2679368"	"unprognostic (1.45e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.15e-1)"	"potential prognostic unfavorable (7.78e-4)"	"unprognostic (2.57e-2)"	"potential prognostic unfavorable (4.03e-5)"	"unprognostic (1.43e-1)"	"unprognostic (9.27e-3)"	"unprognostic (4.46e-2)"	"unprognostic (3.08e-1)"	"validated prognostic favorable (3.89e-9)"	"validated prognostic favorable (2.90e-4)"	"unprognostic (1.95e-1)"		"unprognostic (4.72e-2)"	"unprognostic (5.61e-2)"	"potential prognostic unfavorable (3.73e-4)"	"unprognostic (1.75e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.66e-2)"	"unprognostic (3.49e-1)"	"unprognostic (8.00e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.20e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.04e-1)"	"unprognostic (6.77e-2)"	"unprognostic (4.48e-3)"
IGF2R	"CD222, CI-M6PR, CI-MPR, CIMPR, M6P-R, MPR1, MPR300, MPRI"	ENSG00000197081	"Insulin like growth factor 2 receptor"	P11717	6	159969082-160113507	"Cancer-related genes, CD markers, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 67.0"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 200.3;NK-cells: 202.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.4"	"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Adrenal cortex cells, Colon - Macrophages, Lung - Neutrophil_2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009661, HPA011332"	Supported		Supported	"Golgi apparatus,Vesicles"			NA	NA		190000000	"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 19: Non-specific - Basic cellular processes"	"Cluster 21: Non-specific - Metabolism"	"Cluster 28: Non-specific - Nuclear processes"	"Cluster 74: Neutrophils - Degranulation"	58	"Golgi apparatus"	Vesicles	"CAB009661: AB_2122795, HPA011332: AB_1846276"	"unprognostic (3.42e-2)"	"unprognostic (1.39e-3)"	"unprognostic (3.72e-1)"	"potential prognostic unfavorable (1.44e-4)"	"unprognostic (3.01e-2)"	"unprognostic (2.26e-1)"	"unprognostic (8.47e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.61e-3)"	"potential prognostic favorable (1.61e-6)"	"unprognostic (6.81e-2)"	"unprognostic (1.05e-1)"	"potential prognostic unfavorable (6.08e-4)"	"unprognostic (5.16e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.04e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.51e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.84e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.61e-1)"
IGLL1	"14.1, CD179B, IGL5, IGLL, IGVPB"	ENSG00000128322	"Immunoglobulin lambda like polypeptide 1"	P15814	22	23573125-23580302	"CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 69.3;testis: 24.5"	"Cell type enriched"	"Detected in some"	4	"Late spermatids: 162.7"	"Cell type enhanced"	"Detected in single"		"choroid plexus epithelial cell: 3.1"	"Cancer enhanced"	"Detected in single"		"Stomach Adenocarcinoma (TCGA): 3.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"memory B-cell: 12.0;naive B-cell: 14.9"	"Lineage enriched"	"Detected in many"	11	"B-cells: 14.9"	"Group enriched"	"Detected in some"	13	"Leukemia: 379.0;lymphoma: 146.4"	"Breast - Plasma cells, Minor Salivary Gland - Plasma cells, Spleen - Plasma cells, Testis - Early spermatids, Testis - Late spermatids"					"Not detected"	"Not detected"			"HPA051134, HPA071406"	Enhanced		Approved	"Endoplasmic reticulum"	"Secreted to blood"	"No annotated function"	NA	NA		35000000000	"Cluster 17: B-cells - Immunoglobulins"	"Cluster 6: Bone marrow - Innate immune response"		"Cluster 35: RS4;11 - Unknown function"	"Cluster 36: Late spermatids - Unknown function"	3	"Endoplasmic reticulum"		"HPA051134: AB_2681356, HPA071406: AB_2686393"																												"unprognostic (1.95e-2)"			
IGSF8	"CD316, CD81P3, EWI2, PGRL"	ENSG00000162729	"Immunoglobulin superfamily member 8"	Q969P0	1	160091340-160098943	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 153.6"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 247.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Skin - Keratinocyte (other), Testis - Sertoli cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011917, HPA075970"	Approved		Supported	Vesicles			NA	NA		3500000	"Cluster 43: Non-specific - Transcription & Translation"	"Cluster 9: Oligodendrocytes - Myelination"	"Cluster 53: Neurons - Mixed function"	"Cluster 9: Skin cancer - Melanin biosynthesis"	"Cluster 4: Extravillous trophoblasts - Unknown function"	14	Vesicles		"HPA011917: AB_1851536, HPA075970: "	"unprognostic (2.23e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.26e-3)"	"unprognostic (1.08e-3)"	"unprognostic (1.13e-3)"	"unprognostic (6.71e-3)"	"unprognostic (2.18e-1)"	"unprognostic (3.71e-1)"	"unprognostic (2.15e-1)"	"unprognostic (9.93e-2)"	"potential prognostic favorable (6.88e-4)"	"unprognostic (2.52e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.74e-1)"	"potential prognostic favorable (4.24e-4)"	"unprognostic (2.97e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.78e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.75e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.72e-2)"	"unprognostic (6.89e-2)"
IL10RA	"CD210, CD210a, CDW210A, HIL-10R, IL10R"	ENSG00000110324	"Interleukin 10 receptor subunit alpha"	Q13651	11	117986370-118003037	"CD markers, Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"		Receptor	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 57.1;lymphoid tissue: 71.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 86.1;Extravillous trophoblasts: 105.7;Hofbauer cells: 91.4;Kupffer cells: 163.9;Langerhans cells: 181.9;Macrophages: 131.9;monocytes: 262.6;NK-cells: 104.4;Plasma cells: 93.4;T-cells: 111.3"	"Group enriched"	"Detected in many"	32	"central nervous system macrophage: 125.7;leukocyte: 186.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in some"		"lymphoma: 28.7;Myeloma: 13.1"	"Adipose subcutaneous - Macrophages, Adrenal gland - Macrophages, Breast - Macrophages, Skeletal muscle - Macrophages, Skin - T-cells, Stomach - Macrophages, Testis - Macrophages"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065647, HPA069086"			Supported	"Plasma membrane,Primary cilium,Cytosol"			NA	NA			"Cluster 33: Non-specific - ATP binding"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 22: Non-specific - Mixed function"	"Cluster 55: Lymphoma - Immune response"	"Cluster 78: NK-cells & T-cells - Immune system & Transcription"	30	"Plasma membrane, Cytosol"	"Primary cilium"	"HPA065647: , HPA069086: "	"unprognostic (4.85e-2)"	"unprognostic (3.46e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.13e-1)"	"unprognostic (6.19e-2)"	"unprognostic (2.84e-2)"	"unprognostic (5.03e-3)"	"unprognostic (3.33e-1)"	"unprognostic (9.06e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.93e-3)"	"unprognostic (8.50e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.22e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.14e-2)"	"unprognostic (8.27e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.11e-1)"	"unprognostic (4.26e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.53e-1)"
IL10RB	"CDW210B, CRF2-4, CRFB4, D21S58, D21S66, IL-10R2"	ENSG00000243646	"Interleukin 10 receptor subunit beta"	Q08334	21	33266367-33311420	"CD markers, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Antiviral defense"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 47.6;Paneth cells: 43.6;Proximal enterocytes: 54.4;Syncytiotrophoblasts: 52.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Macrophages"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020670, HPA047550"	Approved		Approved	Cytosol			NA	NA		760000	"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 45: Intestine - Digestion"	"Cluster 6: Non-specific - Immune response"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 49: Non-specific - Transcription"	2	Cytosol		"CAB020670: , HPA047550: AB_2680086"	"unprognostic (1.31e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.64e-1)"	"unprognostic (3.52e-1)"	"unprognostic (4.93e-3)"	"unprognostic (1.04e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.45e-1)"	"unprognostic (5.13e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.34e-3)"	"unprognostic (5.82e-2)"	"unprognostic (6.70e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.49e-1)"	"unprognostic (5.19e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.64e-3)"	"unprognostic (4.02e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.88e-1)"	"unprognostic (8.82e-2)"	"unprognostic (2.33e-1)"
IL12RB1	"CD212, IL12RB"	ENSG00000096996	"Interleukin 12 receptor subunit beta 1"	P42701	19	18058995-18098944	"CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 23.7"	"Cell type enhanced"	"Detected in some"		"Kupffer cells: 12.2;monocytes: 36.4;NK-cells: 54.6;Plasma cells: 11.0;T-cells: 26.0"	"Group enriched"	"Detected in some"	4	"central nervous system macrophage: 10.3;leukocyte: 21.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	14	"Leukemia: 9.4;lymphoma: 19.8;Myeloma: 26.5"	"Adrenal gland - Macrophages, Breast - T-cells, Lung - T-cells, Prostate - T-cells, Skeletal muscle - Macrophages, Skin - T-cells, Thyroid gland - T-cells"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA074414			Approved	"Plasma membrane"	"Intracellular and membrane"	Receptor	NA	NA			"Cluster 33: Non-specific - ATP binding"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 11: White matter - Signal transduction"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 19: NK-cells - Adaptive immune response"		"Plasma membrane"		"HPA074414: AB_2686687"	"unprognostic (1.13e-1)"	"unprognostic (1.17e-1)"	"unprognostic (6.67e-2)"	"unprognostic (8.61e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.87e-1)"	"unprognostic (4.07e-2)"	"potential prognostic favorable (1.36e-4)"	"unprognostic (5.13e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.94e-1)"	"unprognostic (6.75e-2)"	"unprognostic (4.09e-2)"	"unprognostic (9.32e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.53e-2)"	"unprognostic (9.17e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.70e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.54e-2)"
IL13RA1	"CD213a1, IL-13Ra, NR4"	ENSG00000131724	"Interleukin 13 receptor subunit alpha 1"	P78552	X	118727133-118794535	"CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 181.7;Macrophages: 147.4"	"Group enriched"	"Detected in many"	8	"central nervous system macrophage: 384.0;endothelial cell: 135.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 10.9;eosinophil: 12.1;myeloid DC: 17.2;neutrophil: 29.0"	"Group enriched"	"Detected in many"	7	"dendritic cells: 17.2;granulocytes: 29.0;monocytes: 10.9"	"Low cancer specificity"	"Detected in all"			"Liver - Hepatocytes, Skeletal muscle - Endothelial cells, Spleen - Fibroblast_2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	Receptor	NA	NA		11000000	"Cluster 7: Non-specific - Innate immune response"	"Cluster 1: Liver & Kidney - Metabolism"	"Cluster 44: Non-specific - Mixed function"	"Cluster 24: Non-specific - Unknown function"	"Cluster 28: Dendritic cells - Antigen presentation"	8				"unprognostic (1.41e-1)"	"unprognostic (7.71e-3)"	"unprognostic (2.68e-2)"	"unprognostic (5.22e-3)"	"unprognostic (9.54e-3)"	"unprognostic (1.72e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.84e-2)"	"potential prognostic unfavorable (1.42e-5)"	"unprognostic (3.17e-3)"	"unprognostic (4.29e-2)"	"unprognostic (4.68e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.91e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.09e-3)"	"unprognostic (6.14e-2)"	"unprognostic (1.01e-3)"	"unprognostic (6.11e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.32e-1)"	"unprognostic (5.47e-2)"	"unprognostic (7.50e-2)"	"unprognostic (7.70e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.81e-3)"	"unprognostic (2.86e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.48e-1)"
IL13RA2	"CD213a2, CT19, IL-13R, IL13BP"	ENSG00000123496	"Interleukin 13 receptor subunit alpha 2"	Q14627	X	115003975-115019977	"Cancer-related genes, CD markers, Predicted membrane proteins"		Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 29.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 345.4;Late spermatids: 109.8;Spermatocytes: 65.6"	"Cell type enhanced"	"Detected in many"		"ependymal cell: 14.0"	"Cancer enhanced"	"Detected in many"		"Glioblastoma Multiforme (TCGA): 34.1"	"Region enhanced"	"Detected in many"		"hypothalamus: 24.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Brain cancer: 77.2;Sarcoma: 84.5;skin cancer: 80.6"	"Liver - Sinusoid Endothelial cells, Minor Salivary Gland - Minor salivary glandular cells, Testis - Early spermatids"	"Region enhanced"	"Detected in many"		"olfactory bulb: 7.0"	"Low region specificity"	"Detected in many"			"HPA045831, HPA067363"			Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions"			NA	NA				"Cluster 63: Testis - Spermatid development"	"Cluster 56: Hypothalamus - Neuropeptide signaling"	"Cluster 72: Neuronal - Signal transduction"	"Cluster 21: Early spermatids - Spermatogenesis"	12	"Plasma membrane, Cell Junctions"	"Nucleoplasm, Vesicles"	"HPA045831: , HPA067363: "	"unprognostic (1.50e-2)"		"unprognostic (2.05e-2)"			"unprognostic (1.13e-1)"	"unprognostic (4.44e-2)"	"unprognostic (2.65e-2)"	"unprognostic (8.77e-2)"		"unprognostic (9.88e-2)"	"unprognostic (1.16e-3)"		"unprognostic (5.72e-3)"	"unprognostic (3.61e-2)"	"unprognostic (3.18e-2)"	"unprognostic (5.32e-2)"	"unprognostic (8.12e-2)"	"unprognostic (2.86e-1)"	"unprognostic (4.84e-2)"		"unprognostic (1.54e-3)"	"unprognostic (5.97e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.71e-1)"	"unprognostic (7.36e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.32e-1)"		"unprognostic (9.87e-2)"
IL15RA	"CD215, IL-15RA"	ENSG00000134470	"Interleukin 15 receptor subunit alpha"	Q13261	10	5943639-5978187	"CD markers, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 35.8;Exocrine glandular cells: 36.4;Fibroblasts: 34.9"	"Group enriched"	"Detected in many"	4	"central nervous system macrophage: 24.9;endothelial cell: 37.7;fibroblast: 30.5;leukocyte: 26.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Kidney - Endothelial cells, Pituitary gland - Endothelial cells, Testis - Sertoli cells"	"Low region specificity"	"Detected in all"							"CAB026215, HPA036245"	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"	"Secreted to blood"	Receptor	NA	NA			"Cluster 42: Non-specific - Vesicular transport"	"Cluster 57: Lung - Lung function"	"Cluster 47: Endothelial cells - Vasculature"	"Cluster 31: Non-specific - Antiviral immune response"	"Cluster 53: Fibroblasts - ECM organization"	3	"Vesicles, Plasma membrane"	Cytosol	"CAB026215: , HPA036245: "	"unprognostic (2.77e-1)"	"unprognostic (4.63e-2)"	"unprognostic (2.69e-3)"	"unprognostic (9.21e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.27e-1)"	"potential prognostic unfavorable (1.75e-5)"	"unprognostic (4.15e-1)"	"potential prognostic unfavorable (8.57e-6)"	"validated prognostic unfavorable (7.22e-6)"	"validated prognostic unfavorable (1.91e-4)"	"unprognostic (5.30e-2)"	"unprognostic (7.50e-3)"	"unprognostic (3.62e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.53e-2)"	"potential prognostic unfavorable (1.80e-4)"	"unprognostic (8.30e-2)"	"unprognostic (2.61e-1)"	"unprognostic (7.75e-2)"	"unprognostic (3.28e-3)"	"unprognostic (2.79e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.54e-2)"
IL17RA	"CD217, CDw217, hIL-17R, IL-17RA, IL17R"	ENSG00000177663	"Interleukin 17 receptor A"	Q96F46	22	17084954-17115693	"CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Host-virus interaction, Immunity, Inflammatory response, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 34.7"	"Cell type enhanced"	"Detected in all"		"dendritic cells: 77.9;Kupffer cells: 83.4;Macrophages: 65.6;monocytes: 60.1"	"Cell type enhanced"	"Detected in all"		"central nervous system macrophage: 270.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 15.3"	"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Colon - Macrophages, Lung - Neutrophil_2, Skin - Macrophages, Spleen - Neutrophils"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			CAB024996	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	Receptor	NA	NA		59000	"Cluster 21: Neutrophils - Unknown function"	"Cluster 77: Bone marrow - Cell proliferation"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 74: Neutrophils - Degranulation"	36	"Nucleoplasm, Cytosol"		"CAB024996: "	"unprognostic (1.57e-1)"	"unprognostic (8.79e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.36e-2)"	"unprognostic (7.73e-2)"	"unprognostic (4.10e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.42e-3)"	"unprognostic (1.08e-3)"	"unprognostic (5.60e-2)"	"unprognostic (3.34e-1)"	"unprognostic (6.79e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.47e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.47e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.84e-3)"	"unprognostic (1.44e-1)"	"unprognostic (5.44e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.26e-2)"	"unprognostic (2.31e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.95e-2)"
IL18R1	"CD218a, IL-1Rrp, IL1RRP"	ENSG00000115604	"Interleukin 18 receptor 1"	Q13478	2	102311529-102398777	"CD markers, Enzymes, Plasma proteins, Predicted membrane proteins"	"Inflammatory response"	"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 23.5;lymphoid tissue: 18.1"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 37.8;dendritic cells: 55.4;granulocytes: 126.7;Langerhans cells: 32.8;NK-cells: 47.0;Schwann cells: 26.2;T-cells: 36.2"	"Group enriched"	"Detected in some"	6	"endothelial cell: 71.4;leukocyte: 89.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 45.8"	"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Liver - Neutrophils, Spleen - Neutrophils"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA007615	Approved		Approved	Mitochondria			Yes	No			"Cluster 15: NK-cells - Unknown function"	"Cluster 47: Spleen - Immune response"	"Cluster 47: Endothelial cells - Vasculature"	"Cluster 55: Lymphoma - Immune response"	"Cluster 74: Neutrophils - Degranulation"	1	Mitochondria		"HPA007615: AB_1851675"			"potential prognostic favorable (1.88e-4)"			"unprognostic (3.53e-1)"		"unprognostic (6.53e-3)"	"unprognostic (4.07e-2)"		"potential prognostic favorable (7.74e-7)"	"unprognostic (5.14e-2)"	"unprognostic (7.94e-3)"		"unprognostic (6.30e-2)"	"unprognostic (2.99e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.85e-3)"		"unprognostic (3.33e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.25e-2)"			"unprognostic (5.97e-3)"		"unprognostic (1.30e-1)"		"unprognostic (2.74e-2)"	
IL18RAP	"AcPL, CD218b"	ENSG00000115607	"Interleukin 18 receptor accessory protein"	O95256	2	102418689-102452565	"CD markers, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Inflammatory response"	"Hydrolase, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 106.6;lymphoid tissue: 45.6"	"Group enriched"	"Detected in some"	7	"NK-cells: 75.1;T-cells: 21.2"	"Cell type enriched"	"Detected in single"	135	"leukocyte: 86.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 120.7"	"Group enriched"	"Detected in many"	104	"granulocytes: 69.6;NK-cells: 120.7;T-cells: 67.5"	"Group enriched"	"Detected in some"	20	"Leukemia: 2.6;lymphoma: 1.6"	"Adipose visceral - Neutrophils, Heart muscle - Neutrophils, Lung - Neutrophil_2, Minor Salivary Gland - Neutrophils, Skeletal muscle - Neutrophils, Spleen - Neutrophils, Thyroid gland - Neutrophils"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB025270	Enhanced						NA	NA			"Cluster 24: Non-specific - Transcription"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 12: Non-specific - Vasculature"	"Cluster 71: Lymphoma - Inflammatory response"	"Cluster 74: Neutrophils - Degranulation"	1			"CAB025270: "			"unprognostic (8.95e-2)"	"unprognostic (7.15e-2)"		"unprognostic (4.93e-1)"		"unprognostic (3.04e-1)"		"unprognostic (4.01e-3)"	"unprognostic (3.12e-3)"	"unprognostic (7.88e-2)"			"unprognostic (3.28e-3)"		"unprognostic (9.31e-2)"		"unprognostic (3.77e-2)"				"unprognostic (2.31e-2)"			"unprognostic (9.19e-2)"			"unprognostic (1.10e-1)"		
IL1R1	"CD121A, D2S1473, IL1R, IL1RA"	ENSG00000115594	"Interleukin 1 receptor type 1"	P14778	2	102064544-102179874	"Cancer-related genes, CD markers, Enzymes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Inflammatory response"	"Hydrolase, Receptor"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 303.4;Glandular and luminal cells: 312.5;Langerhans cells: 221.8;Mesothelial cells: 245.0;Prostatic glandular cells: 291.9"	"Cell type enhanced"	"Detected in many"		"endothelial cell: 312.2;fibroblast: 120.4;pericyte: 102.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Low cancer specificity"	"Detected in many"			"Kidney - Endothelial cells, Pituitary gland - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001237, HPA005823, CAB007779, HPA029560"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"	"Secreted to blood"	Receptor	NA	NA		870000	"Cluster 35: Neutrophils - Protein binding"	"Cluster 62: Connective tissue - ECM organization"	"Cluster 12: Non-specific - Vasculature"	"Cluster 44: Connective tissue cells - ECM organization"	"Cluster 37: Glandular & Luminal cells - Unknown function"	13	"Nucleoplasm, Vesicles"	"Plasma membrane, Cytosol"	"CAB007779: AB_562073, HPA001237: , HPA005823: AB_2667445, HPA029560: AB_2673094"	"unprognostic (2.65e-2)"	"unprognostic (4.67e-3)"	"unprognostic (2.16e-2)"	"unprognostic (6.26e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.24e-2)"	"potential prognostic unfavorable (8.74e-4)"	"unprognostic (2.42e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.41e-2)"	"unprognostic (8.22e-3)"	"unprognostic (1.69e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.34e-3)"	"unprognostic (2.02e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.86e-2)"	"unprognostic (5.11e-2)"	"unprognostic (9.99e-2)"	"unprognostic (3.78e-2)"	"unprognostic (9.79e-3)"	"unprognostic (7.90e-2)"	"unprognostic (6.69e-2)"	"unprognostic (2.78e-1)"
IL1R2	"CD121b, IL1RB"	ENSG00000115590	"Interleukin 1 receptor type 2"	P27930	2	101991960-102028544	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 87.9"	"Cell type enriched"	"Detected in many"	5	"Langerhans cells: 1470.9"	"Cell type enriched"	"Detected in single"	20	"leukocyte: 7.4"	"Cancer enhanced"	"Detected in many"		"Head and Neck Squamous Cell Carcinoma (TCGA): 45.4"	"Region enhanced"	"Detected in many"		"cerebral cortex: 14.5"	"Immune cell enriched"	"Detected in some"	26	"neutrophil: 378.7"	"Lineage enriched"	"Detected in many"	26	"granulocytes: 378.7"	"Cancer enhanced"	"Detected in many"		"lymphoma: 66.7"	"Adipose visceral - Neutrophils, Lung - Neutrophil_2, Pituitary gland - Neutrophils, Prostate - Macrophages, Skeletal muscle - Neutrophils, Spleen - Neutrophils"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA027597, HPA027598"	Uncertain				"Secreted to blood"	Receptor	NA	NA	7130000	21000000	"Cluster 4: Neutrophils - Degranulation"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 12: Non-specific - Vasculature"	"Cluster 71: Lymphoma - Inflammatory response"	"Cluster 28: Dendritic cells - Antigen presentation"	20			"HPA027597: AB_10600768, HPA027598: AB_10601229"	"unprognostic (1.57e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.58e-2)"	"unprognostic (8.58e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.33e-3)"	"unprognostic (3.84e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.86e-1)"	"potential prognostic unfavorable (3.74e-4)"	"unprognostic (2.46e-2)"	"potential prognostic unfavorable (8.46e-4)"	"unprognostic (3.59e-2)"	"potential prognostic unfavorable (2.25e-5)"	"potential prognostic unfavorable (8.06e-5)"	"unprognostic (5.20e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.85e-3)"	"unprognostic (8.14e-2)"		"unprognostic (7.23e-2)"	"unprognostic (7.49e-2)"	"unprognostic (1.70e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.13e-1)"	"unprognostic (6.14e-3)"
IL21R	CD360	ENSG00000103522	"Interleukin 21 receptor"	Q9HBE5	16	27402174-27452042	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins"		Receptor	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 7.4;lymphoid tissue: 23.9"	"Cell type enhanced"	"Detected in some"		"B-cells: 12.1;Langerhans cells: 19.3;monocytes: 14.7;NK-cells: 29.2;T-cells: 24.5"	"Cell type enriched"	"Detected in some"	9	"leukocyte: 66.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cancer enhanced"	"Detected in some"		"lymphoma: 53.9;Myeloma: 24.7"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Spleen - T-cells, Testis - Early spermatids, Testis - Late spermatids, Thyroid gland - T-cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA042296	Uncertain		Approved	"Plasma membrane,Cytosol"			NA	NA			"Cluster 33: Non-specific - ATP binding"	"Cluster 36: Lymphoid tissue - Cytokine signaling"	"Cluster 41: Monoamines - Neurotransmitter signalling"	"Cluster 55: Lymphoma - Immune response"	"Cluster 78: NK-cells & T-cells - Immune system & Transcription"	1	"Plasma membrane, Cytosol"		"HPA042296: AB_10806236"	"unprognostic (4.61e-3)"	"unprognostic (1.30e-1)"	"unprognostic (8.04e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.06e-2)"	"unprognostic (5.04e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.79e-3)"		"unprognostic (3.58e-2)"	"unprognostic (1.88e-1)"			"unprognostic (4.81e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.27e-1)"	"unprognostic (4.59e-3)"	"unprognostic (1.51e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.52e-2)"		"unprognostic (5.36e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.07e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.40e-1)"
IL2RA	"CD25, IDDM10, IL2R"	ENSG00000134460	"Interleukin 2 receptor subunit alpha"	P01589	10	6010689-6062370	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins"	Immunity	Receptor	"Cancer-related genes, Diabetes mellitus, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 18.1;lymphoid tissue: 17.5;urinary bladder: 10.5"	"Cell type enhanced"	"Detected in some"		"B-cells: 12.1;granulocytes: 21.6;Kupffer cells: 7.5;Macrophages: 11.7;NK-cells: 12.2;T-cells: 25.2"	"Cell type enriched"	"Detected in some"	5	"leukocyte: 13.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	8	"basophil: 192.6;T-reg: 271.0"	"Group enriched"	"Detected in many"	15	"granulocytes: 192.6;T-cells: 271.0"	"Cancer enriched"	"Detected in some"	31	"lymphoma: 158.1"	"Heart muscle - Macrophages, Minor Salivary Gland - Macrophages, Pituitary gland - Macrophages, Stomach - Macrophages, Thyroid gland - Macrophages"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB002419, HPA054622"	Enhanced						NA	NA		270000	"Cluster 5: Non-specific - Cell proliferation"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 8: Immune cells - Immune response"	"Cluster 71: Lymphoma - Inflammatory response"	"Cluster 14: Langerhans cells - Innate immune response"	1			"CAB002419: AB_563538, HPA054622: AB_2682546"	"unprognostic (1.10e-1)"	"unprognostic (1.68e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.96e-2)"	"unprognostic (7.10e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.10e-2)"	"potential prognostic unfavorable (7.60e-4)"	"unprognostic (1.11e-2)"		"potential prognostic unfavorable (8.13e-5)"	"unprognostic (4.84e-2)"	"unprognostic (7.93e-3)"		"unprognostic (4.14e-1)"	"unprognostic (1.94e-1)"	"potential prognostic unfavorable (2.71e-4)"	"unprognostic (9.68e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.15e-2)"	"unprognostic (3.65e-1)"	"unprognostic (5.21e-2)"	"potential prognostic unfavorable (8.26e-4)"		"unprognostic (1.17e-1)"	"unprognostic (1.36e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.33e-2)"	"unprognostic (7.39e-2)"	"unprognostic (4.95e-3)"
IL2RB	"CD122, IL15RB"	ENSG00000100385	"Interleukin 2 receptor subunit beta"	P14784	22	37118666-37175118	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Host-virus interaction"	Receptor	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 34.4;lymphoid tissue: 48.0"	"Group enriched"	"Detected in many"	7	"Extravillous trophoblasts: 97.1;NK-cells: 299.6;T-cells: 95.9"	"Cell type enriched"	"Detected in single"	131	"leukocyte: 108.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"gdT-cell: 49.8;NK-cell: 184.0"	"Group enriched"	"Detected in many"	30	"NK-cells: 184.0;T-cells: 49.8"	"Cancer enriched"	"Detected in some"	8	"lymphoma: 69.8"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Adrenal gland - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Kidney - T-cells, Liver - NK-cells (Liver), Minor Salivary Gland - T-cells, Pancreas - T-cells, Pituitary gland - T-cells, Prostate - T-cells, Thyroid gland - T-cells"	"Region enriched"	"Detected in single"	7	"basal ganglia: 1.8"	"Low region specificity"	"Detected in many"			HPA062657	Enhanced						NA	NA			"Cluster 15: NK-cells - Unknown function"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 38: Sub-cortical - Mixed function"	"Cluster 59: Leukemia - T-cell receptor"	"Cluster 19: NK-cells - Adaptive immune response"	9			"HPA062657: AB_2684822"	"unprognostic (3.48e-2)"	"unprognostic (4.47e-3)"	"unprognostic (1.98e-3)"	"unprognostic (3.00e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.58e-3)"	"unprognostic (1.16e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.52e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.67e-2)"	"potential prognostic unfavorable (5.33e-4)"	"unprognostic (3.82e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.84e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.43e-1)"	"unprognostic (9.56e-2)"	"unprognostic (9.04e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.91e-2)"	"potential prognostic favorable (6.40e-4)"	"unprognostic (9.05e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.12e-2)"	"unprognostic (3.12e-1)"
IL2RG	"CD132, CIDX, IMD4, SCIDX1"	ENSG00000147168	"Interleukin 2 receptor subunit gamma"	P31785	X	71107404-71112108	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	Receptor	"Cancer-related genes, Disease variant, FDA approved drug targets, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 112.7;lymphoid tissue: 332.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 111.4;dendritic cells: 92.3;Distal enterocytes: 97.2;Langerhans cells: 150.0;NK-cells: 280.1;Plasma cells: 127.0;Proximal enterocytes: 79.5;T-cells: 192.5"	"Cell type enriched"	"Detected in single"	116	"leukocyte: 11.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"Leukemia: 207.1;lymphoma: 145.1;Myeloma: 354.9"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Adrenal gland - T-cells, Colon - T-cells, Kidney - T-cells, Liver - T-cells, Minor Salivary Gland - Plasma cells, Pancreas - T-cells, Pituitary gland - T-cells, Prostate - T-cells, Spleen - T-cells, Thyroid gland - T-cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA046641, CAB080341"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"			NA	NA		49000	"Cluster 1: T-cells - Unknown function"	"Cluster 36: Lymphoid tissue - Cytokine signaling"	"Cluster 42: Choroid plexus - Mitochondria"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 19: NK-cells - Adaptive immune response"	9	"Plasma membrane"	Nucleoplasm	"CAB080341: , HPA046641: AB_2679733"	"unprognostic (1.11e-2)"	"unprognostic (4.75e-3)"	"unprognostic (4.55e-3)"	"unprognostic (6.80e-2)"	"unprognostic (2.87e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.13e-3)"	"unprognostic (3.08e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.33e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.15e-1)"	"unprognostic (9.48e-2)"	"unprognostic (3.91e-1)"	"unprognostic (9.50e-2)"	"unprognostic (5.57e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.56e-2)"	"potential prognostic favorable (2.33e-4)"	"unprognostic (1.70e-1)"	"unprognostic (4.79e-2)"	"unprognostic (6.17e-2)"	"unprognostic (2.32e-2)"
IL3RA	CD123	ENSG00000185291	"Interleukin 3 receptor subunit alpha"	P26951	X	1336616-1382689	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 79.5;dendritic cells: 466.3;Endothelial cells: 81.2;Langerhans cells: 57.8;Oocytes: 139.0"	"Low cell type specificity"	"Detected in some"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"basophil: 2669.0"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 2669.0"	"Cancer enhanced"	"Detected in many"		"Leukemia: 20.7"	"Adipose subcutaneous - Endothelial cells, Adipose visceral - Endothelial cells, Adrenal gland - Endothelial cells, Breast - Endothelial cells, Colon - Endothelial cells, Heart muscle - Endothelial cells, Kidney - Endothelial cells, Liver - Vascular Endothelial cells, Minor Salivary Gland - Endothelial cells, Prostate - Endothelial cells, Skeletal muscle - Endothelial cells, Skin - Endothelial cells, Testis - Endothelial cells, Thyroid gland - Endothelial cells"									"HPA003539, CAB018374"	Uncertain						NA	NA			"Cluster 41: Basophils - Unknown function"	"Cluster 7: Adipose tissue - Mixed function"	"Cluster 6: Non-specific - Immune response"	"Cluster 21: Lymphoma - Adaptive immune response"	"Cluster 28: Dendritic cells - Antigen presentation"	18			"CAB018374: AB_2233620, HPA003539: AB_1078438"	"unprognostic (2.78e-2)"	"unprognostic (1.01e-3)"	"unprognostic (5.83e-2)"	"unprognostic (1.97e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.55e-1)"		"unprognostic (5.44e-3)"	"unprognostic (1.43e-1)"	"validated prognostic favorable (2.65e-4)"	"validated prognostic favorable (2.52e-4)"	"unprognostic (2.17e-3)"	"unprognostic (2.45e-1)"		"unprognostic (9.21e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.16e-3)"	"unprognostic (2.90e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.50e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.19e-2)"	"unprognostic (5.59e-2)"	"unprognostic (4.27e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.90e-3)"	"unprognostic (1.42e-1)"	"unprognostic (5.39e-2)"
IL4R	CD124	ENSG00000077238	"Interleukin 4 receptor"	P24394	16	27313668-27364778	"Cancer-related genes, CD markers, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	Immunity	Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 71.7;granulocytes: 115.8"	"Cell type enhanced"	"Detected in many"		"central nervous system macrophage: 90.5;endothelial cell: 197.2;vascular associated smooth muscle cell: 79.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"naive B-cell: 77.1"	"Group enriched"	"Detected in all"	5	"B-cells: 77.1;granulocytes: 31.1"	"Cancer enhanced"	"Detected in all"		"Gallbladder cancer: 139.2"	"Adrenal gland - Neutrophils, Kidney - Endothelial cells, Skeletal muscle - Endothelial cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB004451, HPA050124, HPA070380"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Centriolar satellite"	"Secreted to blood"	Receptor	NA	NA	38500	59000	"Cluster 34: B-cells - Unknown function"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 74: Neutrophils - Degranulation"	12	"Plasma membrane"	"Nucleoplasm, Centriolar satellite"	"CAB004451: AB_626889, HPA050124: AB_2681026, HPA070380: "	"unprognostic (1.22e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.80e-3)"	"unprognostic (2.44e-3)"	"unprognostic (2.15e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.53e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.76e-1)"	"unprognostic (7.42e-2)"	"potential prognostic favorable (2.13e-4)"	"unprognostic (7.35e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.99e-3)"	"potential prognostic unfavorable (3.26e-4)"	"unprognostic (4.67e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.50e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.20e-2)"
IL5RA	"CD125, CDw125, IL5R"	ENSG00000091181	"Interleukin 5 receptor subunit alpha"	Q01344	3	3066324-3126613	"CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 6.0;fallopian tube: 10.4"	"Group enriched"	"Detected in some"	5	"Ciliated cells: 31.3;granulocytes: 34.5;Plasma cells: 16.6"	"Cell type enriched"	"Detected in many"	4	"ependymal cell: 101.1"	"Cancer enhanced"	"Detected in some"		"Prostate Adenocarcinoma (TCGA): 3.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	190	"basophil: 179.4;eosinophil: 356.1"	"Lineage enriched"	"Detected in many"	253	"granulocytes: 356.1"	"Cancer enhanced"	"Detected in some"		"lymphoma: 2.7;Myeloma: 8.5"	"Adipose subcutaneous - Mast cells, Colon - Mast cells, Lung - Respiratory ciliated cells, Minor Salivary Gland - Plasma cells, Prostate - Prostate glandular cells, Skin - Mast cells, Spleen - Plasma cells, Testis - Early spermatids, Testis - Late spermatids"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Intracellular and membrane"	Receptor	NA	NA		7700000	"Cluster 22: Eosinophils - Transcription"	"Cluster 8: Ciliated cells - Cilium organization"	"Cluster 3: Choroid plexus - Cilium"	"Cluster 50: Lymphoma - Unknown function"	"Cluster 42: Ciliated cells - Cilium assembly"	9						"unprognostic (7.54e-2)"			"unprognostic (1.46e-1)"											"unprognostic (1.72e-3)"		"unprognostic (1.09e-1)"					"unprognostic (3.08e-2)"		"unprognostic (4.14e-2)"					"unprognostic (1.74e-2)"
IL6R	"CD126, gp80, IL-1Ra, IL-6R, IL6RA"	ENSG00000160712	"Interleukin 6 receptor"	P08887	1	154405193-154469450	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 56.9;skeletal muscle: 90.8"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 86.2;Langerhans cells: 91.5"	"Cell type enhanced"	"Detected in many"		"central nervous system macrophage: 194.2;endothelial cell: 88.4;fibroblast: 101.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 89.4"	"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"Myeloma: 83.8"	"Pituitary gland - Corticotropes, Spleen - Neutrophils"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted to blood"	Receptor	NA	NA	24800000	19000000	"Cluster 7: Non-specific - Innate immune response"	"Cluster 19: Non-specific - Basic cellular processes"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 29: Monocytes - Innate immune response"	7				"unprognostic (1.11e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.77e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.95e-2)"	"unprognostic (2.54e-1)"	"unprognostic (8.01e-2)"	"unprognostic (7.43e-3)"	"unprognostic (4.60e-2)"	"unprognostic (5.42e-2)"	"potential prognostic favorable (6.13e-6)"	"unprognostic (7.34e-3)"	"unprognostic (1.54e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.09e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.01e-2)"	"unprognostic (8.25e-2)"	"potential prognostic favorable (3.20e-4)"	"unprognostic (2.03e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.87e-1)"	"unprognostic (7.90e-2)"
IL6ST	"CD130, GP130, IL-6RB, sGP130"	ENSG00000134352	"Interleukin 6 cytokine family signal transducer"	P40189	5	55935095-55995022	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Host-virus interaction"	Receptor	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 689.8;Mesothelial cells: 413.6"	"Cell type enhanced"	"Detected in all"		"central nervous system macrophage: 924.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 22.8"	"Lineage enriched"	"Detected in many"	5	"T-cells: 22.8"	"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010558, CAB025784"	Approved		Supported	"Golgi apparatus,Plasma membrane"	"Secreted to blood"	Receptor	NA	NA		110000000	"Cluster 33: Non-specific - ATP binding"	"Cluster 11: Liver - Plasma proteins"	"Cluster 28: Oligodendrocytes - Mixed function"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 37: Glandular & Luminal cells - Unknown function"	22	"Plasma membrane"	"Golgi apparatus"	"CAB025784: , HPA010558: AB_1078439"	"unprognostic (3.34e-2)"	"unprognostic (9.54e-3)"	"unprognostic (6.35e-2)"	"unprognostic (4.58e-2)"	"unprognostic (3.44e-1)"	"unprognostic (5.93e-3)"	"unprognostic (1.49e-1)"	"potential prognostic unfavorable (3.79e-5)"	"unprognostic (1.62e-2)"	"unprognostic (1.27e-2)"	"potential prognostic favorable (3.47e-5)"	"unprognostic (6.75e-3)"	"unprognostic (1.20e-1)"	"unprognostic (7.66e-2)"	"unprognostic (2.13e-3)"	"unprognostic (4.31e-3)"	"unprognostic (2.61e-1)"	"unprognostic (5.52e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.74e-1)"	"unprognostic (5.83e-3)"	"unprognostic (1.16e-2)"	"unprognostic (4.67e-2)"	"unprognostic (7.33e-2)"	"unprognostic (6.47e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.75e-2)"	"unprognostic (5.11e-3)"	"unprognostic (4.99e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.40e-1)"
IL7R	"CD127, IL7RA, lnc-IL7R"	ENSG00000168685	"Interleukin 7 receptor"	P16871	5	35852695-35879603	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Cancer-related genes, Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 178.8"	"Cell type enriched"	"Detected in many"	6	"T-cells: 1368.7"	"Cell type enriched"	"Detected in some"	115	"leukocyte: 454.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"gdT-cell: 102.3;MAIT T-cell: 370.2;memory CD4 T-cell: 214.4;memory CD8 T-cell: 151.1;naive CD4 T-cell: 180.0;naive CD8 T-cell: 125.1;NK-cell: 113.4"	"Group enriched"	"Detected in all"	34	"NK-cells: 113.4;T-cells: 370.2"	"Low cancer specificity"	"Detected in many"			"Adipose subcutaneous - T-cells, Colon - T-cells, Prostate - T-cells, Skin - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB010215, HPA067550"			Supported	"Plasma membrane"	"Intracellular and membrane"	Receptor	NA	NA		360000	"Cluster 27: T-cells - Unknown function"	"Cluster 36: Lymphoid tissue - Cytokine signaling"	"Cluster 48: Non-specific - Mixed function"	"Cluster 6: Leukemia - Signal transduction"	"Cluster 78: NK-cells & T-cells - Immune system & Transcription"	12	"Plasma membrane"		"CAB010215: AB_673727, HPA067550: "	"unprognostic (2.81e-1)"	"unprognostic (5.36e-3)"	"unprognostic (4.45e-2)"	"unprognostic (6.91e-2)"	"unprognostic (9.97e-2)"	"unprognostic (3.73e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.18e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.20e-3)"	"unprognostic (6.89e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.79e-1)"	"unprognostic (8.32e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.94e-2)"	"unprognostic (3.92e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.03e-2)"	"unprognostic (8.41e-2)"	"unprognostic (5.78e-2)"
IL9R	CD129	ENSG00000124334	"Interleukin 9 receptor"	Q01113	X	155997696-156010817	"CD markers, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 3.3;urinary bladder: 4.1"	"Cell type enhanced"	"Detected in some"		"granulocytes: 1.7;T-cells: 2.3"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Bladder Urothelial Carcinoma (TCGA): 2.9"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 3.5"	"Group enriched"	"Detected in many"	23	"B-cells: 1.9;granulocytes: 3.5;T-cells: 1.4"	"Group enriched"	"Detected in some"	7	"Leukemia: 18.3;lymphoma: 14.4"	"Thyroid gland - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA063240, HPA064557"	Approved				"Intracellular and membrane"	Receptor	NA	NA			"Cluster 14: Non-specific - Unknown function"	"Cluster 36: Lymphoid tissue - Cytokine signaling"		"Cluster 59: Leukemia - T-cell receptor"	"Cluster 7: T-cells - T-cell receptor"	4			"HPA063240: AB_2732700, HPA064557: AB_2732716"	"unprognostic (1.04e-1)"		"unprognostic (5.01e-2)"	"unprognostic (6.34e-3)"		"unprognostic (2.49e-1)"											"unprognostic (8.56e-2)"		"unprognostic (2.74e-1)"							"unprognostic (7.09e-2)"					
INSR	CD220	ENSG00000171105	"Insulin receptor"	P06213	19	7112255-7294414	"CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Carbohydrate metabolism"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Diabetes mellitus, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"monocytes: 261.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"dendritic cells: 9.8;granulocytes: 5.9;monocytes: 12.6"	"Cancer enhanced"	"Detected in all"		"Myeloma: 24.6"	"Pituitary gland - Corticotropes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036302, HPA036303"	Uncertain		Approved	"Vesicles,Plasma membrane,Primary cilium transition zone,Centriolar satellite,Basal body"			NA	Yes		140000	"Cluster 10: Non-specific - Membrane trafficking"	"Cluster 68: Non-specific - Protein processing"	"Cluster 26: Oligodendrocytes - Mixed function"	"Cluster 6: Leukemia - Signal transduction"	"Cluster 55: Non-specific - Transcription"	103	"Vesicles, Plasma membrane"	"Primary cilium transition zone, Centriolar satellite, Basal body"	"HPA036302: AB_2675048, HPA036303: "	"unprognostic (1.21e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.41e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.46e-1)"	"unprognostic (4.55e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.14e-1)"	"validated prognostic favorable (5.63e-8)"	"validated prognostic favorable (5.67e-5)"	"unprognostic (2.44e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.91e-2)"	"unprognostic (9.70e-2)"	"potential prognostic favorable (2.02e-4)"	"unprognostic (2.30e-1)"	"unprognostic (3.88e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.40e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.29e-1)"
ITGA1	"CD49a, VLA1"	ENSG00000213949	"Integrin subunit alpha 1"	P56199	5	52787916-52959209	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Transporters"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 35.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 230.2;Endothelial cells: 109.9;Hepatocytes: 85.4;Lymphatic endothelial cells: 68.4;Smooth muscle cells: 140.3"	"Cell type enhanced"	"Detected in all"		"endothelial cell: 497.4;pericyte: 578.6;vascular associated smooth muscle cell: 396.9"	"Cancer enhanced"	"Detected in many"		"Kidney Renal Clear Cell Carcinoma (TCGA): 4.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in single"			"Adipose subcutaneous - Endothelial cells, Adipose visceral - Endothelial cells, Breast - Endothelial cells, Heart muscle - Endothelial cells, Minor Salivary Gland - Endothelial cells, Pancreas - Endothelial cells, Prostate - Smooth muscle cells, Skeletal muscle - Endothelial cells, Skin - Endothelial cells, Spleen - Endothelial cells, Testis - Endothelial cells, Thyroid gland - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042555	Uncertain		Approved	"Endoplasmic reticulum"			NA	NA		17000000		"Cluster 47: Spleen - Immune response"	"Cluster 47: Endothelial cells - Vasculature"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 48: Smooth muscle cells - Signal transduction"	6	"Endoplasmic reticulum"		"HPA042555: AB_10794281"			"unprognostic (2.92e-2)"			"unprognostic (1.55e-1)"		"unprognostic (9.04e-2)"			"potential prognostic favorable (1.59e-4)"	"unprognostic (1.10e-3)"		"unprognostic (3.46e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.42e-3)"		"unprognostic (2.13e-2)"		"unprognostic (1.30e-3)"	"unprognostic (6.03e-2)"	"unprognostic (9.55e-2)"	"unprognostic (2.68e-1)"		"unprognostic (1.45e-1)"		"unprognostic (4.49e-3)"		"unprognostic (5.91e-2)"	
ITGA2	CD49B	ENSG00000164171	"Integrin subunit alpha 2"	P17301	5	52989340-53094779	"Cancer-related genes, CD markers, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 144.3;Basal respiratory cells: 132.7;Ductal cells: 122.3;Exocrine glandular cells: 128.5;Mucus glandular cells: 128.1;Oligodendrocytes: 345.3;Salivary duct cells: 209.1"	"Cell type enhanced"	"Detected in many"		"ependymal cell: 200.0;oligodendrocyte: 479.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"				"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB017690, HPA060991, HPA063556"	Enhanced						NA	No		29000000		"Cluster 27: Squamous epithelium - Keratinization"	"Cluster 28: Oligodendrocytes - Mixed function"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 45: Non-specific - Mixed function"	18			"CAB017690: AB_1124939, HPA060991: AB_2684405, HPA063556: AB_2685040"	"unprognostic (3.05e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.02e-2)"	"unprognostic (9.55e-2)"	"unprognostic (4.04e-1)"	"unprognostic (2.64e-3)"	"unprognostic (5.49e-2)"	"unprognostic (7.06e-2)"	"potential prognostic favorable (6.41e-7)"	"unprognostic (1.56e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.10e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.27e-2)"	"unprognostic (9.70e-2)"	"unprognostic (7.90e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.85e-3)"	"potential prognostic unfavorable (5.52e-5)"	"unprognostic (1.08e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.69e-2)"	"unprognostic (4.63e-1)"	"unprognostic (9.70e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.44e-1)"
ITGA2B	"CD41, CD41B, GP2B, PPP1R93"	ENSG00000005961	"Integrin subunit alpha 2b"	P08514	17	44372180-44389649	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 16.4;epididymis: 10.4;lymphoid tissue: 10.9"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 38.7;Late spermatids: 26.7;Lymphatic endothelial cells: 8.9;Oligodendrocyte precursor cells: 9.0"	"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in some"		"Testicular Germ Cell Tumor (TCGA): 6.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	14	"basophil: 65.1"	"Lineage enriched"	"Detected in single"	75	"granulocytes: 65.1"	"Cancer enriched"	"Detected in some"	59	"Leukemia: 83.1"	"Spleen - Platelets, Testis - Late spermatids"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB018611, HPA031168, HPA031169, HPA031170, HPA031171"	Enhanced		Approved	"Plasma membrane"			NA	NA		120000000	"Cluster 41: Basophils - Unknown function"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 48: Non-specific - Mixed function"	"Cluster 47: Leukemia - Hemostasis"	"Cluster 57: Platelets - Hemostasis"	8	"Plasma membrane"		"CAB018611: AB_2265153, HPA031168: AB_10664706, HPA031169: AB_10669671, HPA031170: AB_10696214, HPA031171: AB_10669773"	"unprognostic (2.44e-2)"		"unprognostic (2.67e-1)"	"unprognostic (1.27e-2)"				"unprognostic (9.29e-3)"												"unprognostic (5.64e-2)"	"unprognostic (3.09e-1)"								"unprognostic (1.49e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.52e-1)"
ITGA3	"CD49c, GAP-B3, MSK18, VCA-2, VLA3a"	ENSG00000005884	"Integrin subunit alpha 3"	P26006	17	50055968-50090481	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes, Disease variant, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 279.9;Ductal cells: 113.7;Exocrine glandular cells: 95.6"	"Cell type enhanced"	"Detected in many"		"vascular associated smooth muscle cell: 121.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Kidney - Endothelial cells, Lung - Alveolar cells type 1, Spleen - Fibroblast_1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008572, CAB018594"	Enhanced		Supported	"Plasma membrane"			NA	NA		2700000		"Cluster 51: Thyroid gland - Unknown function"	"Cluster 1: Neurons - Mixed function"	"Cluster 72: Neuronal - Signal transduction"	"Cluster 45: Non-specific - Mixed function"	14	"Plasma membrane"		"CAB018594: AB_668044, HPA008572: AB_2668094"	"unprognostic (7.22e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.78e-2)"	"unprognostic (5.74e-3)"	"unprognostic (1.35e-1)"	"unprognostic (4.84e-3)"	"unprognostic (2.05e-3)"	"potential prognostic unfavorable (1.60e-4)"	"unprognostic (2.19e-1)"	"potential prognostic favorable (6.07e-4)"	"unprognostic (5.51e-2)"	"unprognostic (7.36e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.32e-3)"	"unprognostic (4.09e-2)"	"unprognostic (8.18e-3)"	"potential prognostic unfavorable (9.31e-5)"	"unprognostic (3.58e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.72e-1)"	"validated prognostic unfavorable (1.33e-4)"	"validated prognostic unfavorable (2.27e-5)"	"unprognostic (1.48e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.81e-2)"	"potential prognostic favorable (8.80e-4)"	"unprognostic (1.84e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.40e-2)"
ITGA4	CD49D	ENSG00000115232	"Integrin subunit alpha 4"	P13612	2	181457202-181538940	"Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 46.0;lymphoid tissue: 72.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 97.4;Erythroid cells: 158.8;Kupffer cells: 101.2;Macrophages: 101.4;monocytes: 212.7;NK-cells: 269.6;Oocytes: 172.8;Plasma cells: 117.2;T-cells: 156.6"	"Cell type enriched"	"Detected in many"	4	"leukocyte: 647.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"Leukemia: 112.7;Myeloma: 80.8"	"Adipose visceral - T-cells, Adrenal gland - Macrophages, Breast - T-cells, Thyroid gland - T-cells"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	7	"cerebellum: 18.6"	HPA074961			Approved	"Plasma membrane"	"Intracellular and membrane"	Receptor	NA	NA		140000	"Cluster 25: Non-specific - Unknown function"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 35: Non-specific - DNA binding"	"Cluster 47: Leukemia - Hemostasis"	"Cluster 78: NK-cells & T-cells - Immune system & Transcription"	9	"Plasma membrane"		"HPA074961: AB_2732273"	"unprognostic (2.03e-2)"	"unprognostic (2.69e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.59e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.37e-3)"	"unprognostic (9.56e-2)"	"potential prognostic favorable (7.59e-4)"	"unprognostic (5.42e-2)"	"unprognostic (3.01e-3)"	"unprognostic (3.03e-1)"	"unprognostic (4.21e-2)"	"potential prognostic favorable (9.06e-4)"	"unprognostic (5.85e-3)"	"unprognostic (2.06e-2)"	"unprognostic (7.26e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.30e-2)"	"unprognostic (3.18e-1)"	"unprognostic (7.23e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.77e-2)"	"unprognostic (3.33e-3)"	"unprognostic (4.44e-2)"	"unprognostic (3.18e-1)"
ITGA5	"CD49e, FNRA"	ENSG00000161638	"Integrin subunit alpha 5"	P08648	12	54395261-54419266	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 385.2;smooth muscle: 348.0;urinary bladder: 373.7"	"Cell type enriched"	"Detected in many"	4	"Extravillous trophoblasts: 444.6"	"Group enriched"	"Detected in many"	5	"central nervous system macrophage: 54.2;endothelial cell: 76.7;fibroblast: 27.5;leukocyte: 37.8;vascular associated smooth muscle cell: 24.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 89.4"	"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Adrenal cortex cells, Kidney - Endothelial cells, Liver - Vascular Endothelial cells, Prostate - Smooth muscle cells, Testis - Endothelial cells"	"Region enriched"	"Detected in many"	5	"basal ganglia: 10.4"	"Low region specificity"	"Detected in many"			"HPA002642, CAB009008"	Enhanced						NA	NA		23000000	"Cluster 21: Neutrophils - Unknown function"	"Cluster 41: Smooth muscle tissue - ECM organization"	"Cluster 12: Non-specific - Vasculature"	"Cluster 48: Adipocytes & Endothelial cells - Angiogenesis"	"Cluster 4: Extravillous trophoblasts - Unknown function"	32			"CAB009008: AB_647474, HPA002642: AB_1078469"	"unprognostic (3.86e-1)"	"unprognostic (7.37e-3)"	"unprognostic (2.32e-1)"	"potential prognostic unfavorable (4.44e-5)"	"unprognostic (1.79e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.40e-3)"	"unprognostic (5.39e-3)"	"potential prognostic unfavorable (1.78e-4)"	"unprognostic (7.83e-2)"	"unprognostic (7.16e-2)"	"unprognostic (3.37e-1)"	"potential prognostic unfavorable (6.56e-4)"	"potential prognostic unfavorable (5.01e-6)"	"unprognostic (1.33e-1)"	"unprognostic (2.03e-3)"	"potential prognostic unfavorable (1.36e-5)"	"unprognostic (7.09e-3)"	"unprognostic (8.52e-2)"	"unprognostic (7.14e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.42e-2)"	"potential prognostic unfavorable (9.34e-4)"	"unprognostic (4.97e-2)"	"unprognostic (4.54e-3)"	"unprognostic (3.17e-1)"
ITGA6	CD49f	ENSG00000091409	"Integrin subunit alpha 6"	P23229	2	172427354-172506459	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 324.3;Basal keratinocytes: 228.1"	"Cell type enriched"	"Detected in many"	4	"endothelial cell: 920.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 22.5"	"Group enriched"	"Detected in many"	28	"granulocytes: 22.5;NK-cells: 7.3;T-cells: 12.5"	"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Endothelial cells, Adipose visceral - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009009, HPA012696, HPA027582"	Supported						NA	NA		3600000	"Cluster 3: Non-specific - Nuclear processes"	"Cluster 45: Intestine - Digestion"	"Cluster 8: Immune cells - Immune response"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	16			"CAB009009: AB_2128038, HPA012696: AB_1851822, HPA027582: AB_10602606"	"unprognostic (8.51e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.93e-2)"	"unprognostic (5.40e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.03e-1)"	"potential prognostic unfavorable (8.11e-4)"	"unprognostic (9.86e-3)"	"unprognostic (4.86e-2)"	"validated prognostic favorable (3.55e-15)"	"validated prognostic favorable (8.53e-4)"	"unprognostic (1.36e-1)"	"unprognostic (2.65e-2)"	"unprognostic (5.70e-2)"	"potential prognostic unfavorable (1.44e-5)"	"unprognostic (6.88e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.35e-1)"	"unprognostic (8.13e-3)"	"unprognostic (2.98e-3)"	"unprognostic (1.92e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.32e-1)"	"unprognostic (9.85e-2)"	"unprognostic (5.02e-2)"	"unprognostic (3.52e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.05e-1)"
ITGAD	"ADB2, CD11d"	ENSG00000156886	"Integrin subunit alpha D"	Q13349	16	31393335-31426505	"CD markers, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"lymphoid tissue: 20.0"	"Cell type enhanced"	"Detected in some"		"Kupffer cells: 2.6;NK-cells: 1.3;T-cells: 1.5"	"Group enriched"	"Detected in some"	4	"central nervous system macrophage: 1.4;hippocampal dentate gyrus: 1.1;leukocyte: 3.8"	"Cancer enhanced"	"Detected in single"		"Kidney Renal Papillary Cell Carcinoma (TCGA): 1.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Adipose subcutaneous - T-cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA026786	Uncertain						NA	NA			"Cluster 15: NK-cells - Unknown function"	"Cluster 70: Lymphoid tissue - Immune response"		"Cluster 59: Leukemia - T-cell receptor"	"Cluster 19: NK-cells - Adaptive immune response"	25			"HPA026786: AB_10603773"			"unprognostic (1.52e-1)"									"unprognostic (4.68e-2)"	"unprognostic (1.06e-1)"		"unprognostic (1.17e-3)"																
ITGAE	"CD103, HUMINAE"	ENSG00000083457	"Integrin subunit alpha E"	P38570	17	3714628-3801188	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 6.4;intestine: 5.7;lung: 6.4"	"Low cell type specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"leukocyte: 73.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"memory CD8 T-cell: 3.7"	"Lineage enriched"	"Detected in single"	6	"T-cells: 3.7"	"Group enriched"	"Detected in some"	11	"Leukemia: 1.7;lymphoma: 2.5"	"Spleen - B-cells (Spleen), Testis - Early spermatids"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA036313, HPA052147"	Enhanced						NA	NA		36000	"Cluster 27: T-cells - Unknown function"	"Cluster 25: Small intestine - Absorption"	"Cluster 33: Neurons - Mixed function"	"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 7: T-cells - T-cell receptor"				"HPA036313: AB_10795355, HPA052147: "	"unprognostic (1.73e-1)"	"unprognostic (1.45e-2)"	"unprognostic (5.26e-1)"	"unprognostic (8.32e-3)"	"unprognostic (1.18e-2)"	"unprognostic (7.58e-2)"		"unprognostic (1.20e-2)"	"unprognostic (2.02e-3)"			"unprognostic (7.24e-3)"			"unprognostic (7.82e-3)"	"unprognostic (2.87e-2)"	"unprognostic (2.07e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.70e-1)"		"unprognostic (2.43e-1)"	"unprognostic (4.22e-2)"	"unprognostic (4.16e-2)"			"unprognostic (3.81e-2)"	"unprognostic (4.38e-3)"	"unprognostic (8.82e-2)"	"unprognostic (4.75e-2)"		"unprognostic (3.41e-1)"
ITGAL	"CD11A, LFA-1, LFA1A"	ENSG00000005844	"Integrin subunit alpha L"	P20701	16	30472658-30523567	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Host-virus interaction, Phagocytosis"	"Integrin, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 36.5;lymphoid tissue: 63.4"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 43.0;monocytes: 180.8;NK-cells: 191.9;T-cells: 88.6"	"Cell type enriched"	"Detected in many"	5	"leukocyte: 391.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"non-classical monocyte: 122.4"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	95	"Leukemia: 76.8;lymphoma: 43.9;Myeloma: 52.9"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Adrenal gland - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Kidney - T-cells, Liver - T-cells, Minor Salivary Gland - T-cells, Pancreas - T-cells, Pituitary gland - T-cells, Prostate - T-cells, Spleen - T-cells, Thyroid gland - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB025011	Enhanced						NA	NA		4600000	"Cluster 37: Monocytes & Neutrophils - Innate immune response"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 49: HMC-1 - Innate immune response"	"Cluster 19: NK-cells - Adaptive immune response"	7			"CAB025011: "	"unprognostic (1.70e-1)"	"unprognostic (1.30e-2)"	"potential prognostic favorable (4.34e-4)"	"unprognostic (2.50e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.82e-1)"	"unprognostic (6.44e-2)"	"unprognostic (4.83e-2)"	"potential prognostic favorable (8.09e-4)"	"unprognostic (4.51e-1)"	"unprognostic (8.80e-3)"	"unprognostic (2.59e-1)"	"unprognostic (6.15e-2)"	"unprognostic (2.47e-1)"	"unprognostic (7.68e-3)"	"unprognostic (1.87e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.85e-1)"	"unprognostic (6.30e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.93e-2)"	"unprognostic (2.82e-2)"	"unprognostic (5.35e-2)"	"unprognostic (3.56e-1)"	"unprognostic (4.25e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.64e-1)"
ITGAM	"CD11B, CR3A, MAC-1"	ENSG00000169896	"Integrin subunit alpha M"	P11215	16	31259967-31332892	"Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Immunity, Innate immunity"	"Integrin, Receptor"	"Cancer-related genes, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"bone marrow: 180.9"	"Cell type enhanced"	"Detected in many"		"granulocytes: 43.1;Hofbauer cells: 62.7;Kupffer cells: 121.7;Langerhans cells: 60.3;Macrophages: 85.5;Microglial cells: 39.4;NK-cells: 67.9"	"Cell type enriched"	"Detected in some"	4	"central nervous system macrophage: 246.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cancer enriched"	"Detected in some"	8	"Leukemia: 11.3"	"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Breast - Macrophages, Colon - Macrophages, Heart muscle - Macrophages, Lung - Neutrophil_2, Minor Salivary Gland - Macrophages, Skeletal muscle - Macrophages, Spleen - Neutrophils, Thyroid gland - Macrophages"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002274, CAB025091, CAB072870"	Enhanced						NA	NA		860000	"Cluster 41: Basophils - Unknown function"	"Cluster 77: Bone marrow - Cell proliferation"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 58: Macrophages - Innate immune response"	37			"CAB025091: , CAB072870: AB_2665722, HPA002274: AB_1078435"	"unprognostic (3.46e-2)"	"unprognostic (7.29e-3)"	"unprognostic (4.18e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.53e-1)"	"unprognostic (4.04e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.56e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.46e-1)"	"potential prognostic unfavorable (1.80e-4)"	"unprognostic (2.54e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.87e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.80e-1)"	"unprognostic (9.16e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.59e-1)"	"unprognostic (7.95e-3)"	"unprognostic (1.69e-3)"	"unprognostic (2.41e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.27e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.14e-1)"
ITGAV	"CD51, MSK8, VNRA, VTNR"	ENSG00000138448	"Integrin subunit alpha V"	P06756	2	186590010-186680901	"Cancer-related genes, CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 181.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cancer enhanced"	"Detected in all"		"testis cancer: 265.2"	"Adrenal gland - Adrenal cortex cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002499, HPA004856"	Supported		Approved	"Focal adhesion sites,Cytosol"			NA	NA		1400000	"Cluster 37: Monocytes & Neutrophils - Innate immune response"	"Cluster 7: Adipose tissue - Mixed function"	"Cluster 27: Non-specific - Mixed function"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 45: Non-specific - Mixed function"	21	"Focal adhesion sites, Cytosol"		"CAB002499: AB_563594, HPA004856: AB_1846316"	"unprognostic (6.72e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.21e-1)"	"potential prognostic unfavorable (9.83e-4)"	"unprognostic (4.26e-1)"	"unprognostic (4.39e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.07e-1)"	"unprognostic (9.40e-2)"	"potential prognostic favorable (4.05e-8)"	"unprognostic (1.08e-2)"	"unprognostic (2.13e-3)"	"potential prognostic unfavorable (3.68e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.44e-3)"	"potential prognostic unfavorable (7.00e-5)"	"unprognostic (1.90e-1)"	"unprognostic (6.01e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.94e-2)"	"unprognostic (3.17e-1)"	"unprognostic (3.36e-2)"	"unprognostic (6.85e-2)"	"potential prognostic unfavorable (6.45e-5)"	"unprognostic (1.29e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.20e-1)"
ITGAX	CD11C	ENSG00000140678	"Integrin subunit alpha X"	P20702	16	31355134-31382999	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 47.5;lung: 56.3;lymphoid tissue: 65.9"	"Cell type enhanced"	"Detected in some"		"granulocytes: 76.6;Hofbauer cells: 70.9;Langerhans cells: 141.8;Macrophages: 125.7;monocytes: 419.8;NK-cells: 63.4"	"Cell type enriched"	"Detected in some"	5	"central nervous system macrophage: 457.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 86.3"	"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in some"		"Leukemia: 7.5;lymphoma: 7.8"	"Adipose visceral - Neutrophils, Heart muscle - Neutrophils, Kidney - T-cells, Liver - Neutrophils, Skeletal muscle - Neutrophils, Spleen - Neutrophils, Thyroid gland - T-cells"	"Not detected"	"Not detected"							"CAB004458, HPA004723, CAB072871, CAB080214"	Enhanced		Supported	"Vesicles,Plasma membrane"			NA	NA		45000	"Cluster 37: Monocytes & Neutrophils - Innate immune response"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 12: Non-specific - Vasculature"	"Cluster 49: HMC-1 - Innate immune response"	"Cluster 29: Monocytes - Innate immune response"	2	"Vesicles, Plasma membrane"		"CAB004458: AB_626859, CAB072871: AB_2665723, CAB080214: , HPA004723: AB_1846231"	"unprognostic (1.92e-1)"	"unprognostic (5.48e-3)"	"unprognostic (1.24e-2)"	"unprognostic (3.52e-1)"	"unprognostic (8.23e-2)"	"unprognostic (5.35e-2)"	"unprognostic (9.77e-2)"	"unprognostic (9.55e-2)"	"unprognostic (8.97e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.02e-2)"	"unprognostic (3.16e-1)"	"unprognostic (3.37e-1)"	"unprognostic (4.36e-2)"	"unprognostic (8.16e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.31e-2)"	"unprognostic (4.74e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.64e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.77e-3)"	"unprognostic (2.49e-2)"	"unprognostic (3.41e-2)"	"unprognostic (5.05e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.62e-1)"
ITGB1	"CD29, FNRB, GPIIA, MDF2, MSK12"	ENSG00000150093	"Integrin subunit beta 1"	P05556	10	32887273-33005792	"Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Host-virus interaction, Myogenesis"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Ductal cells: 1089.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Colon - Smooth muscle cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003434, HPA059297, HPA069003"	Enhanced		Supported	"Endoplasmic reticulum,Plasma membrane,Focal adhesion sites"			NA	NA		180000000	"Cluster 16: Non-specific - Cell proliferation"	"Cluster 62: Connective tissue - ECM organization"	"Cluster 47: Endothelial cells - Vasculature"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 45: Non-specific - Mixed function"	92	"Plasma membrane, Focal adhesion sites"	"Endoplasmic reticulum"	"CAB003434: AB_303570, HPA059297: AB_2732634, HPA069003: AB_2732125"	"unprognostic (4.54e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.88e-1)"	"unprognostic (5.64e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.28e-2)"	"unprognostic (7.99e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.98e-3)"	"potential prognostic favorable (4.33e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.23e-3)"	"unprognostic (8.77e-2)"	"validated prognostic unfavorable (1.05e-5)"	"validated prognostic unfavorable (7.17e-4)"	"potential prognostic unfavorable (2.85e-4)"	"unprognostic (2.00e-2)"	"unprognostic (1.71e-2)"	"potential prognostic unfavorable (7.34e-4)"	"unprognostic (1.55e-3)"	"unprognostic (1.99e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.51e-1)"	"unprognostic (5.64e-2)"	"unprognostic (2.77e-1)"	"unprognostic (4.34e-3)"	"unprognostic (3.02e-1)"	"unprognostic (9.42e-2)"	"unprognostic (1.39e-1)"
ITGB2	"CD18, LFA-1, MAC-1, MFI7"	ENSG00000160255	"Integrin subunit beta 2"	P05107	21	44885953-44931989	"CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Phagocytosis"	"Integrin, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 359.1;lymphoid tissue: 167.7"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 750.2;Kupffer cells: 648.1;Langerhans cells: 317.3;Macrophages: 491.9;monocytes: 638.7;NK-cells: 687.0"	"Group enriched"	"Detected in some"	15	"central nervous system macrophage: 126.3;leukocyte: 200.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Bone cancer: 64.2;Leukemia: 194.5;lymphoma: 74.0"	"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Breast - Macrophages, Colon - Macrophages, Heart muscle - Macrophages, Kidney - Macrophages, Liver - Kupffer cells, Lung - Macrophages, Minor Salivary Gland - Macrophages, Pancreas - Macrophages, Pituitary gland - Macrophages, Prostate - Macrophages, Skeletal muscle - Macrophages, Spleen - Neutrophils, Stomach - Macrophages, Testis - Macrophages, Thyroid gland - Macrophages"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008877, HPA016894"	Enhanced		Supported	"Plasma membrane,Rods & Rings"			NA	NA		5000000	"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 29: Monocytes - Innate immune response"	34	"Plasma membrane"	"Rods & Rings"	"HPA008877: AB_1846256, HPA016894: AB_1846257"	"unprognostic (4.81e-2)"	"unprognostic (4.76e-2)"	"unprognostic (2.34e-2)"	"unprognostic (5.75e-2)"	"unprognostic (8.94e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.59e-3)"	"unprognostic (2.22e-1)"	"unprognostic (8.19e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.78e-3)"	"unprognostic (2.33e-1)"	"unprognostic (3.55e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.88e-2)"	"unprognostic (4.43e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.67e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.46e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.14e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.08e-2)"
ITGB3	"CD61, GP3A, GPIIIa"	ENSG00000259207	"Integrin subunit beta 3"	P05106	17	47253827-47313743	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 54.6"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 9.7;Pancreatic endocrine cells: 10.2;Proximal tubular cells: 19.4;Salivary duct cells: 14.8;Sertoli cells: 13.6"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in all"		"Skin Cuteneous Melanoma (TCGA): 42.7;Thyroid Carcinoma (TCGA): 54.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	17	"basophil: 5.6;neutrophil: 3.0"	"Lineage enriched"	"Detected in single"	22	"granulocytes: 5.6"	"Cancer enhanced"	"Detected in many"		"Kidney cancer: 99.0;skin cancer: 125.1"	"Liver - Vascular Endothelial cells, Prostate - Smooth muscle cells, Spleen - Platelets, Testis - Spermatogonia"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA027852	Approved		Supported	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	Receptor	NA	NA		54000000	"Cluster 35: Neutrophils - Protein binding"	"Cluster 51: Thyroid gland - Unknown function"	"Cluster 12: Non-specific - Vasculature"	"Cluster 69: Skin cancer - ECM organization"	"Cluster 57: Platelets - Hemostasis"	26	"Plasma membrane"	Nucleoplasm	"HPA027852: AB_10601760"	"unprognostic (3.07e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.97e-1)"	"potential prognostic unfavorable (1.29e-5)"	"unprognostic (2.03e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.19e-2)"	"unprognostic (6.47e-3)"	"potential prognostic unfavorable (6.40e-4)"	"unprognostic (1.20e-3)"	"unprognostic (2.55e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.08e-1)"	"unprognostic (8.90e-2)"	"unprognostic (1.38e-1)"	"potential prognostic unfavorable (1.51e-4)"	"unprognostic (6.12e-2)"	"potential prognostic unfavorable (8.56e-4)"	"unprognostic (3.74e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.33e-2)"	"unprognostic (8.62e-2)"	"unprognostic (8.26e-2)"	"unprognostic (5.73e-2)"	"unprognostic (6.30e-3)"	"unprognostic (3.24e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.83e-2)"
ITGB4	CD104	ENSG00000132470	"Integrin subunit beta 4"	P16144	17	75721328-75757818	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes, Disease variant, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 194.7;skin 1: 199.3"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 161.2;Gastric mucus-secreting cells: 164.5;Mucus glandular cells: 163.8;Salivary duct cells: 287.3;Schwann cells: 164.5"	"Group enriched"	"Detected in many"	5	"astrocyte: 182.1;bergmann glia: 78.1;ependymal cell: 126.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 4.6"	"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Schwann cells, Minor Salivary Gland - Minor salivary glandular cells, Prostate - Prostate basal glandular cells, Spleen - Endothelial cells"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 49.5"	"CAB002422, CAB005258, HPA036348, HPA036349"	Enhanced		Supported	"Plasma membrane,Cell Junctions"			NA	NA		23000000	"Cluster 30: Non-specific - DNA binding"	"Cluster 48: Stomach - Proteolysis"	"Cluster 39: Astrocytes - Mixed function"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 45: Non-specific - Mixed function"	14	"Plasma membrane, Cell Junctions"		"CAB002422: AB_563480, CAB005258: AB_2129021, HPA036348: AB_2675077, HPA036349: AB_2675078"	"unprognostic (3.96e-2)"	"unprognostic (3.58e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.28e-1)"	"unprognostic (9.55e-3)"	"unprognostic (2.98e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.44e-1)"	"potential prognostic unfavorable (6.61e-6)"	"unprognostic (1.89e-1)"	"unprognostic (3.45e-2)"	"unprognostic (4.45e-3)"	"unprognostic (6.51e-2)"	"potential prognostic unfavorable (1.75e-5)"	"unprognostic (2.89e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.34e-1)"	"unprognostic (8.15e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.67e-2)"	"unprognostic (8.89e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.47e-1)"
JAG1	"AGS, AHD, AWS, CD339, HJ1, JAGL1"	ENSG00000101384	"Jagged canonical Notch ligand 1"	P78504	20	10637684-10673999	"CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Notch signaling pathway"	"Developmental protein"	"Charcot-Marie-Tooth disease, Deafness, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 260.8;Smooth muscle cells: 167.8;Squamous epithelial cells: 335.8"	"Cell type enhanced"	"Detected in many"		"pericyte: 204.2;vascular associated smooth muscle cell: 624.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Kidney - Fibroblasts, Spleen - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010343, HPA021555"	Supported		Approved	"Golgi apparatus,Plasma membrane"			NA	NA		14000000	"Cluster 29: Non-specific - Unknown function"	"Cluster 75: Epithelium - Extracellular exosomes"	"Cluster 44: Non-specific - Mixed function"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 12: Squamous epithelial cells - Keratinization"	9	"Golgi apparatus, Plasma membrane"		"CAB010343: AB_649685, HPA021555: AB_1851969"	"unprognostic (1.69e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.28e-3)"	"unprognostic (2.45e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.74e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.00e-1)"	"validated prognostic favorable (1.07e-6)"	"validated prognostic favorable (6.60e-4)"	"unprognostic (6.19e-2)"	"unprognostic (4.18e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.46e-1)"	"potential prognostic unfavorable (2.92e-5)"	"unprognostic (2.33e-1)"	"unprognostic (5.25e-2)"	"unprognostic (7.50e-2)"	"potential prognostic favorable (2.39e-4)"	"unprognostic (2.13e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.29e-1)"
JAM2	"C21orf43, CD322, JAM-2, JAM-B, JAMB, VE-JAM"	ENSG00000154721	"Junctional adhesion molecule 2"	P57087	21	25639258-25717562	"CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 61.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 184.4;Astrocytes: 77.4;Endothelial cells: 131.1;Microglial cells: 78.7;Oligodendrocyte precursor cells: 72.2"	"Cell type enhanced"	"Detected in all"		"endothelial cell: 440.2"	"Cancer enriched"	"Detected in all"	8	"Glioblastoma Multiforme (TCGA): 54.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Neuroblastoma: 9.7;Rhabdoid: 8.5"	"Adipose subcutaneous - Endothelial cells, Adrenal gland - Adrenal cortex cells, Colon - Enteric glia cells, Liver - Vascular Endothelial cells, Skin - Endothelial cells, Testis - Sertoli cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028789, HPA077346"			Supported	"Nucleoplasm,Plasma membrane"			NA	NA		150000	"Cluster 24: Non-specific - Transcription"	"Cluster 34: Non-specific - Mixed function"	"Cluster 19: Astrocytes - Mixed function"	"Cluster 5: Rhabdoid - Unknown function"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	2	"Plasma membrane"	Nucleoplasm	"HPA028789: AB_2732443, HPA077346: AB_2732341"	"unprognostic (1.17e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.59e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.36e-1)"	"unprognostic (2.46e-2)"	"unprognostic (5.39e-2)"	"potential prognostic favorable (3.68e-6)"	"unprognostic (1.41e-3)"	"unprognostic (2.49e-3)"	"potential prognostic favorable (5.83e-4)"	"unprognostic (2.26e-3)"	"unprognostic (1.71e-2)"	"unprognostic (2.46e-3)"	"unprognostic (1.12e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.92e-2)"	"unprognostic (4.39e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.08e-2)"	"unprognostic (4.91e-2)"	"unprognostic (8.14e-2)"	"unprognostic (3.26e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.53e-2)"
KDR	"CD309, FLK1, VEGFR, VEGFR2"	ENSG00000128052	"Kinase insert domain receptor"	P35968	4	55078481-55125595	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation, Host-virus interaction"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Adipocytes: 138.5;Endothelial cells: 159.5;Lymphatic endothelial cells: 111.0;Mesothelial cells: 193.9;Muller glia cells: 172.6"	"Group enriched"	"Detected in many"	4	"endothelial cell: 114.8;fibroblast: 55.5"	"Cancer enhanced"	"Detected in many"		"Kidney Renal Clear Cell Carcinoma (TCGA): 27.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	6	"Rhabdoid: 54.8"	"Adipose subcutaneous - Endothelial cells, Adrenal gland - Endothelial cells, Breast - Endothelial cells, Colon - Endothelial cells, Heart muscle - Endothelial cells, Kidney - Endothelial cells, Liver - Sinusoid Endothelial cells, Minor Salivary Gland - Endothelial cells, Skeletal muscle - Endothelial cells, Stomach - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004028, HPA069304, HPA073577"	Enhanced		Approved	"Nuclear membrane,Vesicles,Cytosol,Connecting piece,Mid piece,Principal piece"	"Intracellular and membrane"	Receptor	NA	NA		10000000		"Cluster 7: Adipose tissue - Mixed function"	"Cluster 42: Choroid plexus - Mitochondria"	"Cluster 5: Rhabdoid - Unknown function"	"Cluster 54: Lymphatic endothelial cells - Lymph vessel development"	44	Vesicles	"Nuclear membrane, Cytosol, Connecting piece, Mid piece, Principal piece"	"CAB004028: AB_2212507, HPA069304: , HPA073577: "	"unprognostic (2.09e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.24e-1)"		"unprognostic (3.63e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.04e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.09e-1)"	"validated prognostic favorable (5.31e-10)"	"validated prognostic favorable (1.73e-5)"	"unprognostic (3.65e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.62e-3)"	"unprognostic (8.98e-2)"	"unprognostic (2.02e-3)"	"unprognostic (5.90e-2)"	"unprognostic (1.76e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.01e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.09e-3)"
KEL	"CD238, ECE3"	ENSG00000197993	"Kell metallo-endopeptidase (Kell blood group)"	P23276	7	142941114-142962363	"Blood group antigen proteins, Cancer-related genes, CD markers, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Blood group antigen, Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"bone marrow: 55.5;testis: 31.4"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 8.4;Erythroid cells: 62.1;Oligodendrocytes: 28.0;Sertoli cells: 21.8;Squamous epithelial cells: 16.7"	"Cell type enriched"	"Detected in many"	5	"oligodendrocyte: 54.7"	"Cancer enhanced"	"Detected in some"		"Testicular Germ Cell Tumor (TCGA): 4.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	19	"Leukemia: 10.4"	"Minor Salivary Gland - Minor salivary glandular cells, Testis - Sertoli cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA064442			Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"			NA	NA				"Cluster 77: Bone marrow - Cell proliferation"	"Cluster 6: Non-specific - Immune response"	"Cluster 47: Leukemia - Hemostasis"	"Cluster 1: Erythroid cells - Oxygen transport"	7	"Golgi apparatus, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA064442: "	"unprognostic (9.70e-2)"		"unprognostic (2.99e-2)"	"potential prognostic favorable (2.19e-4)"				"unprognostic (1.98e-2)"						"unprognostic (1.49e-2)"	"unprognostic (1.35e-2)"			"unprognostic (4.43e-2)"	"unprognostic (5.55e-2)"										"unprognostic (1.52e-1)"		
KIR2DL1	"47.11, CD158A, cl-42, nkat1, p58.1"	ENSG00000125498	"Killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 1"	P43626	19	54769793-54784322	"CD markers, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"lymphoid tissue: 2.0"	"Cell type enriched"	"Detected in some"	7	"NK-cells: 32.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Adipose visceral - T-cells, Lung - NK-cells (Lung)"																NA	NA				"Cluster 47: Spleen - Immune response"		"Cluster 70: DU4475 - Unknown function"	"Cluster 19: NK-cells - Adaptive immune response"	5																																		
KIR2DL3	"CD158B2, cl-6, nkat2, nkat2a, nkat2b, p58"	ENSG00000243772	"Killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 3"	P43628	19	54738513-54753052	"CD markers, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"lymphoid tissue: 1.5"	"Cell type enhanced"	"Detected in some"		"NK-cells: 16.3;Pancreatic endocrine cells: 5.1;T-cells: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.4"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Lung - NK-cells (Lung)"																NA	NA			"Cluster 15: NK-cells - Unknown function"	"Cluster 47: Spleen - Immune response"		"Cluster 70: DU4475 - Unknown function"	"Cluster 19: NK-cells - Adaptive immune response"	56						"unprognostic (6.44e-2)"																												
KIR2DL4	"103AS, 15.212, CD158D"	ENSG00000189013	"Killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 4"	Q99706	19	54803610-54814517	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	7	"lymphoid tissue: 3.9"	"Group enriched"	"Detected in some"	16	"NK-cells: 35.0;T-cells: 23.0"	"Cell type enriched"	"Detected in single"	15	"leukocyte: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	80	"NK-cell: 8.0"	"Lineage enriched"	"Detected in single"	80	"NK-cells: 8.0"	"Not detected"	"Not detected"																	"Intracellular and membrane"	Receptor	NA	NA			"Cluster 15: NK-cells - Unknown function"	"Cluster 47: Spleen - Immune response"		"Cluster 71: Lymphoma - Inflammatory response"	"Cluster 7: T-cells - T-cell receptor"	8						"unprognostic (2.68e-1)"																												
KIR3DL1	"AMB11, CD158E1, CD158e1/2, CD158e2, cl-11, cl-2, KIR, nkat3, NKB1, NKB1B"	ENSG00000167633	"Killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 1"	P43629	19	54816468-54830778	"CD markers, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"lymphoid tissue: 1.5"	"Cell type enriched"	"Detected in some"	9	"NK-cells: 21.3"	"Cell type enriched"	"Detected in single"	89	"leukocyte: 9.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	5	"gdT-cell: 1.8"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.8"	"Not detected"	"Not detected"			"Lung - NK-cells (Lung)"																NA	NA			"Cluster 15: NK-cells - Unknown function"	"Cluster 47: Spleen - Immune response"			"Cluster 19: NK-cells - Adaptive immune response"	5																																		
KIR3DL2	"CD158K, cl-5, nkat4, nkat4a, nkat4b"	ENSG00000240403	"Killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 2"	P43630	19	54850443-54867207	"CD markers, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"lymphoid tissue: 1.9"	"Group enriched"	"Detected in some"	7	"NK-cells: 37.3;T-cells: 11.3"	"Cell type enriched"	"Detected in single"	22	"leukocyte: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Adipose visceral - T-cells, Lung - NK-cells (Lung), Minor Salivary Gland - Minor salivary glandular cells, Thyroid gland - T-cells"																NA	NA				"Cluster 47: Spleen - Immune response"			"Cluster 19: NK-cells - Adaptive immune response"	1						"unprognostic (1.79e-2)"																												
KIT	"C-Kit, CD117, PBT, SCFR"	ENSG00000157404	"KIT proto-oncogene, receptor tyrosine kinase"	P10721	4	54657267-54740783	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 82.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 984.7;Melanocytes: 386.5"	"Cell type enhanced"	"Detected in many"		"cerebellar inhibitory: 699.5;CGE interneuron: 325.6;midbrain-derived inhibitory: 571.8"	"Cancer enhanced"	"Detected in many"		"Kidney Chromophobe (TCGA): 143.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 16.1;eosinophil: 9.6;NK-cell: 11.1"	"Group enriched"	"Detected in many"	7	"granulocytes: 16.1;NK-cells: 11.1"	"Cancer enhanced"	"Detected in many"		"Leukemia: 28.3"	"Adipose subcutaneous - Mast cells, Lung - Mast cells, Minor Salivary Gland - Minor salivary glandular cells, Testis - Spermatogonia, Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003288, HPA004471, CAB068253, CAB072867, HPA073252"	Enhanced	Supported	Supported	"Plasma membrane"			NA	NA		46000000	"Cluster 32: Basophils - Transcription"	"Cluster 73: Breast - Lactation"	"Cluster 35: Non-specific - DNA binding"	"Cluster 49: HMC-1 - Innate immune response"	"Cluster 30: Granulocytes - Unknown function"	42	"Plasma membrane"		"CAB003288: AB_2335702, CAB068253: AB_2665717, CAB072867: AB_2665718, HPA004471: AB_1078431, HPA073252: AB_2686589"	"unprognostic (7.25e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.57e-1)"	"unprognostic (2.82e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.60e-1)"	"validated prognostic favorable (7.36e-5)"	"validated prognostic favorable (6.08e-5)"	"unprognostic (2.94e-1)"		"unprognostic (7.19e-3)"	"unprognostic (2.19e-3)"	"unprognostic (1.04e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.38e-1)"			"unprognostic (2.74e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.24e-2)"	"potential prognostic favorable (3.33e-4)"	"unprognostic (1.39e-2)"	"unprognostic (8.07e-2)"	"unprognostic (2.38e-3)"	"unprognostic (7.41e-2)"	"unprognostic (1.10e-2)"	"unprognostic (3.71e-1)"
KLRB1	"CD161, CLEC5B, hNKR-P1A, NKR, NKR-P1, NKR-P1A"	ENSG00000111796	"Killer cell lectin like receptor B1"	Q12918	12	9594551-9607916	"CD markers, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 46.6;lymphoid tissue: 35.4"	"Group enriched"	"Detected in many"	7	"NK-cells: 1483.6;T-cells: 754.4"	"Cell type enriched"	"Detected in many"	25	"leukocyte: 124.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"MAIT T-cell: 2180.9"	"Group enriched"	"Detected in all"	140	"NK-cells: 758.3;T-cells: 2180.9"	"Cancer enhanced"	"Detected in single"		"Brain cancer: 1.1"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Adrenal gland - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Kidney - T-cells, Liver - NK-cells (Liver), Lung - NK-cells (Lung), Minor Salivary Gland - T-cells, Pancreas - T-cells, Pituitary gland - T-cells, Prostate - T-cells, Spleen - NK-cells (Spleen), Thyroid gland - T-cells"					"Not detected"	"Not detected"			HPA039113	Approved		Uncertain	Nucleoplasm,Cytosol			NA	NA			"Cluster 1: T-cells - Unknown function"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 14: Neurons - Synaptic function"	"Cluster 72: Neuronal - Signal transduction"	"Cluster 19: NK-cells - Adaptive immune response"	35	Nucleoplasm	Cytosol	"HPA039113: AB_10674979"	"unprognostic (1.82e-2)"	"potential prognostic favorable (8.92e-5)"	"unprognostic (1.34e-1)"	"potential prognostic favorable (2.67e-4)"	"unprognostic (1.54e-1)"	"unprognostic (4.37e-2)"		"unprognostic (4.89e-2)"	"potential prognostic favorable (4.39e-4)"	"unprognostic (1.88e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.85e-2)"	"unprognostic (2.20e-1)"	"potential prognostic favorable (3.47e-4)"	"unprognostic (6.44e-2)"	"unprognostic (1.26e-3)"	"unprognostic (2.08e-2)"	"unprognostic (3.78e-1)"	"unprognostic (2.21e-1)"	"unprognostic (7.04e-3)"	"unprognostic (3.43e-1)"	"unprognostic (2.54e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.59e-1)"		"unprognostic (2.00e-1)"	"unprognostic (5.19e-1)"	"unprognostic (1.30e-3)"	"unprognostic (8.69e-2)"
KLRC1	"CD159a, NKG2, NKG2-A, NKG2-B"	ENSG00000134545	"Killer cell lectin like receptor C1"	P26715	12	10442264-10454685	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Host-virus interaction, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 6.5"	"Group enriched"	"Detected in some"	23	"NK-cells: 225.5;T-cells: 104.2"	"Cell type enriched"	"Detected in some"	60	"leukocyte: 107.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"gdT-cell: 229.7;NK-cell: 368.5"	"Group enriched"	"Detected in many"	47	"NK-cells: 368.5;T-cells: 229.7"	"Low cancer specificity"	"Detected in many"			"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Liver - NK-cells (Liver), Pancreas - T-cells, Prostate - T-cells, Spleen - NK-cells (Spleen)"									HPA058052			Approved	"Plasma membrane"			NA	NA			"Cluster 15: NK-cells - Unknown function"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 11: White matter - Signal transduction"	"Cluster 71: Lymphoma - Inflammatory response"	"Cluster 19: NK-cells - Adaptive immune response"	44	"Plasma membrane"		"HPA058052: AB_2683589"	"unprognostic (4.00e-2)"		"unprognostic (2.80e-1)"	"unprognostic (5.81e-2)"		"unprognostic (5.44e-3)"	"unprognostic (7.23e-2)"	"unprognostic (3.31e-3)"	"unprognostic (5.21e-3)"		"unprognostic (3.31e-3)"	"unprognostic (1.84e-1)"				"unprognostic (1.03e-1)"	"unprognostic (4.05e-1)"	"unprognostic (6.17e-3)"	"unprognostic (3.03e-1)"			"unprognostic (1.47e-1)"	"unprognostic (2.38e-1)"			"unprognostic (5.03e-2)"		"unprognostic (1.04e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.88e-1)"
KLRC2	"CD159c, NKG2-C, NKG2C"	ENSG00000205809	"Killer cell lectin like receptor C2"	P26717	12	10426854-10442300	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.4;lymphoid tissue: 5.3"	"Group enriched"	"Detected in some"	12	"NK-cells: 76.6;Oligodendrocyte precursor cells: 30.7;T-cells: 59.7"	"Group enriched"	"Detected in some"	5	"leukocyte: 49.4;oligodendrocyte precursor cell: 56.1"	"Cancer enriched"	"Detected in many"	10	"Glioblastoma Multiforme (TCGA): 18.6"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"gdT-cell: 24.7;NK-cell: 84.6"	"Group enriched"	"Detected in many"	103	"NK-cells: 84.6;T-cells: 24.7"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 16.2"	"Adipose visceral - T-cells, Minor Salivary Gland - T-cells, Prostate - T-cells, Thyroid gland - T-cells"									HPA058052			Approved	"Plasma membrane"			NA	NA			"Cluster 15: NK-cells - Unknown function"	"Cluster 33: Brain - Neuronal signaling"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 16: Thyroid cancer - Neuronal signaling"	"Cluster 19: NK-cells - Adaptive immune response"	3	"Plasma membrane"		"HPA058052: AB_2683589"	"unprognostic (1.42e-1)"		"unprognostic (1.81e-1)"	"unprognostic (2.27e-3)"	"unprognostic (7.21e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.63e-1)"	"potential prognostic favorable (6.25e-4)"								"unprognostic (1.25e-1)"	"unprognostic (1.22e-1)"		"unprognostic (9.02e-2)"			"unprognostic (9.67e-3)"	"unprognostic (5.52e-3)"		"unprognostic (4.02e-1)"	"potential prognostic favorable (8.59e-5)"		"unprognostic (1.13e-1)"	"unprognostic (2.34e-2)"		
KLRD1	CD94	ENSG00000134539	"Killer cell lectin like receptor D1"	Q13241	12	10226058-10329608	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Host-virus interaction, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 16.6"	"Cell type enriched"	"Detected in many"	4	"NK-cells: 1385.8"	"Cell type enhanced"	"Detected in all"		"leukocyte: 344.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"gdT-cell: 513.3;memory CD8 T-cell: 218.1;naive CD8 T-cell: 219.5;NK-cell: 737.5"	"Group enriched"	"Detected in many"	66	"NK-cells: 737.5;T-cells: 513.3"	"Low cancer specificity"	"Detected in many"			"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Adrenal gland - T-cells, Heart muscle - T-cells, Liver - NK-cells (Liver), Lung - NK-cells (Lung), Minor Salivary Gland - T-cells, Pituitary gland - Somatotropes, Prostate - T-cells, Spleen - NK-cells (Spleen), Stomach - T-cells, Thyroid gland - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA069688	Uncertain						NA	NA			"Cluster 15: NK-cells - Unknown function"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 9: Non-specific - Receptor signaling"	"Cluster 12: Bone cancer - Neuronal signaling"	"Cluster 19: NK-cells - Adaptive immune response"	6			"HPA069688: AB_2686170"	"unprognostic (7.07e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.37e-1)"	"unprognostic (7.12e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.44e-1)"			"unprognostic (3.61e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.82e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.19e-2)"			"unprognostic (1.01e-1)"	"unprognostic (1.97e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.51e-2)"		"unprognostic (6.30e-2)"	"unprognostic (2.87e-3)"	"unprognostic (3.24e-1)"	"unprognostic (8.45e-2)"	"unprognostic (9.80e-3)"	"unprognostic (1.96e-1)"	"unprognostic (3.34e-1)"	"unprognostic (3.06e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.06e-2)"
KLRK1	"CD314, D12S2489E, KLR, NKG2-D, NKG2D"	ENSG00000213809	"Killer cell lectin like receptor K1"	P26718	12	10372353-10391874	"Cancer-related genes, CD markers, Predicted membrane proteins, Transporters"	"Adaptive immunity, Differentiation, Immunity, Innate immunity"	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 21.8;lymphoid tissue: 41.8"	"Group enriched"	"Detected in some"	5	"NK-cells: 26.0;T-cells: 41.7"	"Cell type enriched"	"Detected in some"	11	"leukocyte: 279.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	40	"gdT-cell: 287.0;MAIT T-cell: 111.2;memory CD8 T-cell: 260.3;naive CD8 T-cell: 258.6;NK-cell: 335.6"	"Group enriched"	"Detected in all"	49	"NK-cells: 335.6;T-cells: 287.0"	"Group enriched"	"Detected in some"	15	"Leukemia: 9.9;lymphoma: 31.2"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Adrenal gland - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Kidney - T-cells, Liver - NK-cells (Liver), Minor Salivary Gland - T-cells, Pancreas - T-cells, Pituitary gland - T-cells, Prostate - T-cells, Skin - T-cells, Thyroid gland - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB021896, HPA068877"	Enhanced		Supported	"Plasma membrane"			NA	NA		79000	"Cluster 1: T-cells - Unknown function"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 13: Oligodendrocytes - Mixed function"	"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 7: T-cells - T-cell receptor"	5	"Plasma membrane"		"CAB021896: , HPA068877: AB_2686052"	"unprognostic (4.38e-2)"	"potential prognostic favorable (2.53e-4)"	"unprognostic (6.76e-3)"	"unprognostic (2.28e-3)"	"unprognostic (8.77e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.87e-3)"	"unprognostic (4.21e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.39e-2)"	"unprognostic (3.41e-1)"	"potential prognostic unfavorable (9.13e-4)"	"unprognostic (5.88e-3)"	"unprognostic (1.87e-3)"	"unprognostic (2.92e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.23e-2)"	"unprognostic (2.57e-2)"	"unprognostic (4.22e-2)"	"unprognostic (9.51e-3)"	"unprognostic (9.90e-2)"	"unprognostic (3.06e-3)"	"unprognostic (3.34e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.94e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.90e-2)"	"unprognostic (5.00e-3)"	"unprognostic (1.50e-1)"
L1CAM	"CAML1, CD171, HSAS, HSAS1, MASA, MIC5, NCAM-L1, S10, SPG1"	ENSG00000198910	"L1 cell adhesion molecule"	P32004	X	153861514-153886173	"CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Differentiation, Neurogenesis"	"Developmental protein"	"Disease variant, Hereditary spastic paraplegia, Hirschsprung disease, Intellectual disability, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 137.1;intestine: 46.9"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 72.0;Horizontal cells: 39.7;Melanocytes: 58.4;Schwann cells: 199.6;Sertoli cells: 38.1"	"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in many"		"Skin Cuteneous Melanoma (TCGA): 114.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Adrenocortical cancer: 288.6"	"Adipose subcutaneous - Smooth muscle cells, Adipose visceral - Smooth muscle cells, Colon - Enteric glia cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010896	Enhanced		Approved	"Nucleoplasm,Plasma membrane"			NA	NA		86000000		"Cluster 65: Cerebellum - Nervous system development"	"Cluster 1: Neurons - Mixed function"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 26: Schwann cells & Melanocytes - Mixed function"	5	"Nucleoplasm, Plasma membrane"		"CAB010896: AB_609903"	"unprognostic (5.60e-2)"	"unprognostic (3.02e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.88e-1)"	"unprognostic (5.01e-2)"	"unprognostic (3.49e-2)"	"unprognostic (3.43e-2)"	"unprognostic (8.82e-3)"	"unprognostic (3.16e-2)"	"validated prognostic unfavorable (7.43e-6)"	"validated prognostic unfavorable (1.01e-4)"	"unprognostic (1.68e-3)"		"unprognostic (1.34e-1)"	"potential prognostic unfavorable (5.33e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.16e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.87e-1)"	"unprognostic (6.44e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.60e-3)"	"unprognostic (8.42e-2)"	"unprognostic (9.50e-2)"	"unprognostic (7.11e-3)"	"unprognostic (1.03e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.62e-1)"		"unprognostic (3.16e-3)"
LAG3	CD223	ENSG00000089692	"Lymphocyte activating 3"	P18627	12	6772512-6778455	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 13.3;lymphoid tissue: 23.0;ovary: 18.0"	"Cell type enhanced"	"Detected in many"		"Leydig cells: 38.5;Ovarian stromal cells: 28.1;Peritubular cells: 64.9;T-cells: 53.2"	"Cell type enriched"	"Detected in single"	39	"leukocyte: 37.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	8	"choroid plexus: 8.5"	"Immune cell enhanced"	"Detected in many"		"gdT-cell: 12.6;MAIT T-cell: 10.0;memory CD8 T-cell: 11.0"	"Lineage enriched"	"Detected in single"	49	"T-cells: 12.6"	"Cancer enhanced"	"Detected in some"		"lymphoma: 8.0"	"Breast - T-cells, Minor Salivary Gland - T-cells, Pituitary gland - T-cells, Thyroid gland - T-cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002301, HPA013967"	Enhanced				"Intracellular and membrane"	Immunity	NA	NA		12000	"Cluster 1: T-cells - Unknown function"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 36: Choroid plexus - Mixed function"	"Cluster 21: Lymphoma - Adaptive immune response"	"Cluster 78: NK-cells & T-cells - Immune system & Transcription"	1			"CAB002301: AB_564101, HPA013967: AB_1846277"	"unprognostic (9.77e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.50e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.28e-3)"			"unprognostic (5.36e-3)"		"unprognostic (2.80e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.16e-3)"	"unprognostic (3.19e-1)"	"unprognostic (3.96e-3)"	"unprognostic (6.29e-2)"	"unprognostic (7.84e-2)"	"unprognostic (1.90e-3)"	"unprognostic (3.94e-1)"	"unprognostic (4.63e-2)"	"potential prognostic favorable (3.09e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.68e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.43e-1)"	"unprognostic (5.45e-3)"	"unprognostic (3.94e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.39e-1)"
LAIR1	"CD305, LAIR-1"	ENSG00000167613	"Leukocyte associated immunoglobulin like receptor 1"	Q6GTX8	19	54351384-54370558	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 27.3;lymphoid tissue: 45.2"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 144.7;granulocytes: 80.6;Hofbauer cells: 188.9;Kupffer cells: 90.9;Macrophages: 126.2;monocytes: 115.3;NK-cells: 62.9"	"Group enriched"	"Detected in some"	33	"central nervous system macrophage: 108.8;leukocyte: 39.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"Leukemia: 4.3;Myeloma: 2.3"	"Adipose subcutaneous - Macrophages, Adrenal gland - Macrophages, Colon - Macrophages, Heart muscle - Macrophages, Kidney - Macrophages, Lung - Macrophages, Minor Salivary Gland - Macrophages, Pituitary gland - Macrophages, Prostate - Macrophages, Skeletal muscle - Macrophages, Stomach - Macrophages, Thyroid gland - Macrophages"	"Low region specificity"	"Detected in all"							HPA011155	Enhanced		Supported	"Plasma membrane"			NA	NA		240000	"Cluster 29: Non-specific - Unknown function"	"Cluster 47: Spleen - Immune response"	"Cluster 6: Non-specific - Immune response"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 58: Macrophages - Innate immune response"	6	"Plasma membrane"		"HPA011155: AB_1852685"	"unprognostic (1.88e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.82e-1)"	"unprognostic (4.84e-3)"		"unprognostic (6.56e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.84e-1)"		"unprognostic (1.31e-1)"	"unprognostic (1.24e-2)"	"unprognostic (9.98e-2)"	"unprognostic (2.97e-2)"		"unprognostic (1.16e-1)"	"unprognostic (8.67e-3)"	"unprognostic (3.81e-1)"		"unprognostic (8.78e-2)"		"unprognostic (3.53e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.66e-3)"			"unprognostic (4.00e-2)"	"potential prognostic favorable (8.76e-4)"	"unprognostic (1.39e-2)"	"unprognostic (1.05e-2)"		"unprognostic (2.08e-2)"
LAIR2	"CD306, LAIR-2"	ENSG00000167618	"Leukocyte associated immunoglobulin like receptor 2"	Q6ISS4	19	54497879-54510687	"CD markers, Predicted intracellular proteins, Predicted secreted proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 1.6;pituitary gland: 2.5"	"Cell type enriched"	"Detected in some"	7	"Extravillous trophoblasts: 882.9"	"Cell type enhanced"	"Detected in some"		"central nervous system macrophage: 1.6;leukocyte: 5.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	9	"gdT-cell: 14.0;memory CD4 T-cell: 13.8;memory CD8 T-cell: 19.6;naive CD8 T-cell: 13.3;T-reg: 49.6"	"Lineage enriched"	"Detected in many"	40	"T-cells: 49.6"	"Cancer enhanced"	"Detected in single"		"Rhabdoid: 1.4"	"Thyroid gland - T-cells"														"Secreted to blood"	Receptor	NA	NA			"Cluster 9: T-regs - Cell cycle regulation"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"		"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 4: Extravillous trophoblasts - Unknown function"	5						"unprognostic (1.15e-1)"	"unprognostic (6.90e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.64e-1)"										"unprognostic (8.77e-3)"	"unprognostic (1.82e-1)"					"unprognostic (1.81e-1)"	"unprognostic (1.57e-1)"					"unprognostic (2.30e-3)"			
LAMP1	CD107a	ENSG00000185896	"Lysosomal associated membrane protein 1"	P11279	13	113297239-113323672	"CD markers, Plasma proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 730.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Breast - Fibroblasts, Lung - Macrophages, Testis - Spermatocytes, Testis - Spermatogonia, Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004260, HPA014750"	Supported						NA	NA		270000000	"Cluster 45: Eosinophils - Unknown function"	"Cluster 73: Breast - Lactation"	"Cluster 30: White matter - Myelination"	"Cluster 19: Non-specific - Unknown function"	"Cluster 58: Macrophages - Innate immune response"	248			"CAB004260: AB_626851, HPA014750: AB_1846219"	"unprognostic (9.63e-2)"	"unprognostic (6.69e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.31e-2)"	"unprognostic (6.14e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.00e-2)"	"unprognostic (7.88e-2)"	"potential prognostic favorable (1.48e-5)"	"unprognostic (8.87e-2)"	"unprognostic (7.15e-2)"	"unprognostic (5.71e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.93e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.72e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.16e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.44e-2)"	"unprognostic (8.72e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.12e-1)"
LAMP2	CD107b	ENSG00000005893	"Lysosomal associated membrane protein 2"	P13473	X	120426148-120469365	"CD markers, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Autophagy		"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 472.1;Syncytiotrophoblasts: 485.3"	"Cell type enhanced"	"Detected in all"		"oligodendrocyte: 659.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 564.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 564.0"	"Low cancer specificity"	"Detected in all"			"Adrenal gland - Adrenal cortex cells, Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005272, HPA029100"	Supported		Supported	Vesicles			NA	NA		270000000	"Cluster 7: Non-specific - Innate immune response"	"Cluster 9: Oligodendrocytes - Myelination"	"Cluster 11: White matter - Signal transduction"	"Cluster 36: Non-specific - mRNA processing"	"Cluster 58: Macrophages - Innate immune response"	27	Vesicles		"CAB005272: AB_647855, HPA029100: AB_10795022"	"unprognostic (2.90e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.07e-3)"	"unprognostic (1.31e-3)"	"unprognostic (4.73e-2)"	"potential prognostic unfavorable (2.14e-4)"	"unprognostic (3.30e-2)"	"potential prognostic unfavorable (8.29e-4)"	"potential prognostic favorable (1.14e-5)"	"unprognostic (1.56e-2)"	"unprognostic (6.74e-2)"	"unprognostic (4.02e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.82e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.91e-1)"	"unprognostic (4.65e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.42e-1)"	"unprognostic (6.14e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.74e-2)"
LAMP3	"CD208, DC-LAMP, DCLAMP, LAMP, TSC403"	ENSG00000078081	"Lysosomal associated membrane protein 3"	Q9UQV4	3	183122215-183163839	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Host-virus interaction, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"lung: 212.8"	"Cell type enriched"	"Detected in many"	5	"Alveolar cells type 2: 454.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 5.6"	"Group enriched"	"Detected in many"	9	"granulocytes: 5.6;T-cells: 4.8"	"Low cancer specificity"	"Detected in many"			"Lung - Alveolar cells type 2, Minor Salivary Gland - Mitotic cells (Minor salivary gland), Testis - Early spermatids"									"CAB025133, HPA051467"	Enhanced		Enhanced	Vesicles			NA	NA		40000	"Cluster 3: Non-specific - Nuclear processes"	"Cluster 57: Lung - Lung function"	"Cluster 15: Non-specific - Transcription"	"Cluster 55: Lymphoma - Immune response"	"Cluster 72: Alveolar cells - Lung function"	32	Vesicles		"CAB025133: , HPA051467: AB_2681495"	"potential prognostic favorable (2.30e-4)"	"unprognostic (5.01e-3)"	"unprognostic (3.76e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.70e-2)"		"unprognostic (9.56e-3)"	"unprognostic (2.98e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.27e-3)"	"unprognostic (6.68e-2)"	"unprognostic (2.32e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.27e-1)"	"unprognostic (5.86e-3)"	"unprognostic (5.75e-2)"	"unprognostic (1.71e-3)"	"potential prognostic unfavorable (5.75e-4)"	"unprognostic (1.30e-1)"	"unprognostic (3.35e-1)"	"unprognostic (3.52e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.37e-2)"	"unprognostic (2.49e-2)"
LEPR	"CD295, OBR"	ENSG00000116678	"Leptin receptor"	P48357	1	65420652-65641559	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins"		Receptor	"Cancer-related genes, FDA approved drug targets, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"liver: 126.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 97.7;Endothelial cells: 85.6;Fibroblasts: 91.9;Hepatocytes: 137.3;Microglial cells: 123.5"	"Group enriched"	"Detected in all"	4	"choroid plexus epithelial cell: 132.0;endothelial cell: 493.1;fibroblast: 492.0"	"Cancer enriched"	"Detected in many"	5	"Liver Hepatocellular Carcinoma (TCGA): 39.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 5.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 5.0"	"Low cancer specificity"	"Detected in all"			"Prostate - Endothelial cells, Thyroid gland - Fibroblasts"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA030899	Approved	Supported	Approved	"Vesicles,Plasma membrane,Primary cilium,Basal body,Cytosol"	"Intracellular and membrane"	Receptor	NA	NA		7700000	"Cluster 33: Non-specific - ATP binding"	"Cluster 83: Liver - Metabolism"	"Cluster 36: Choroid plexus - Mixed function"	"Cluster 47: Leukemia - Hemostasis"	"Cluster 53: Fibroblasts - ECM organization"	7	Vesicles	"Plasma membrane, Primary cilium, Basal body, Cytosol"	"HPA030899: AB_10610003"	"unprognostic (4.19e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.50e-3)"	"unprognostic (1.17e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.06e-2)"	"potential prognostic favorable (5.17e-7)"	"unprognostic (3.92e-3)"	"unprognostic (1.75e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.85e-2)"	"unprognostic (4.63e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.66e-1)"		"unprognostic (7.42e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.10e-2)"	"unprognostic (4.15e-2)"
LIFR	CD118	ENSG00000113594	"LIF receptor subunit alpha"	P42702	5	38474668-38608354	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 337.3;Astrocytes: 357.3;Endothelial cells: 362.2;Oligodendrocytes: 256.5"	"Cell type enhanced"	"Detected in all"		"astrocyte: 876.6;bergmann glia: 904.8;endothelial cell: 639.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Adrenal gland - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	Receptor	NA	NA		160000		"Cluster 7: Adipose tissue - Mixed function"	"Cluster 19: Astrocytes - Mixed function"	"Cluster 18: Liver cancer - Metabolism"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	6				"unprognostic (4.87e-2)"	"unprognostic (1.14e-2)"	"unprognostic (3.63e-2)"	"unprognostic (2.53e-1)"		"unprognostic (1.23e-1)"	"unprognostic (2.53e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.36e-1)"	"validated prognostic favorable (4.76e-9)"	"validated prognostic favorable (2.39e-4)"	"potential prognostic favorable (2.11e-7)"	"unprognostic (9.21e-2)"	"potential prognostic favorable (4.23e-4)"	"potential prognostic favorable (8.96e-4)"	"unprognostic (4.50e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.73e-3)"	"unprognostic (2.19e-1)"	"unprognostic (3.32e-2)"	"potential prognostic favorable (7.14e-4)"	"unprognostic (5.43e-3)"	"unprognostic (6.68e-2)"		"unprognostic (3.24e-2)"		"unprognostic (5.66e-3)"	"unprognostic (3.53e-1)"	"unprognostic (1.77e-2)"	"unprognostic (6.85e-2)"
LILRA1	"CD85i, LIR-6, LIR6"	ENSG00000104974	"Leukocyte immunoglobulin like receptor A1"	O75019	19	54593582-54602381	"CD markers, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"lymphoid tissue: 11.6"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 19.2;Kupffer cells: 49.4;Macrophages: 29.8;monocytes: 144.4"	"Group enriched"	"Detected in some"	54	"central nervous system macrophage: 20.6;leukocyte: 9.5"	"Cancer enhanced"	"Detected in some"		"Glioblastoma Multiforme (TCGA): 1.3"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 126.7;non-classical monocyte: 169.8"	"Lineage enriched"	"Detected in many"	5	"monocytes: 169.8"	"Not detected"	"Not detected"			"Adrenal gland - Macrophages, Liver - Kupffer cells, Lung - Neutrophil_2, Pituitary gland - Macrophages, Prostate - Macrophages, Spleen - Macrophages, Stomach - Macrophages"																NA	NA		56000000	"Cluster 37: Monocytes & Neutrophils - Innate immune response"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 29: Monocytes - Innate immune response"							"unprognostic (5.03e-2)"				"unprognostic (2.50e-1)"	"unprognostic (3.23e-2)"			"potential prognostic favorable (6.40e-4)"																				
LILRA2	"CD85h, ILT1, LIR-7, LIR7"	ENSG00000239998	"Leukocyte immunoglobulin like receptor A2"	Q8N149	19	54572920-54590287	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 15.2;lymphoid tissue: 55.9"	"Group enriched"	"Detected in some"	8	"Hofbauer cells: 51.9;Kupffer cells: 73.3;Macrophages: 38.9;monocytes: 101.0"	"Cell type enriched"	"Detected in some"	5	"central nervous system macrophage: 43.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 31.8"	"Group enriched"	"Detected in many"	6	"granulocytes: 31.8;monocytes: 11.7"	"Cancer enriched"	"Detected in single"	7	"Leukemia: 2.6"	"Adipose subcutaneous - Macrophages, Adrenal gland - Macrophages, Breast - Macrophages, Colon - Macrophages, Kidney - Macrophages, Liver - Kupffer cells, Lung - Neutrophil_2, Minor Salivary Gland - Macrophages, Pancreas - Macrophages, Prostate - Macrophages, Stomach - Macrophages, Thyroid gland - Macrophages"														"Secreted to blood"	Receptor	NA	NA		85000000	"Cluster 37: Monocytes & Neutrophils - Innate immune response"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 6: Non-specific - Immune response"	"Cluster 35: RS4;11 - Unknown function"	"Cluster 29: Monocytes - Innate immune response"							"unprognostic (2.32e-1)"			"unprognostic (5.71e-2)"	"unprognostic (8.99e-2)"	"unprognostic (3.28e-1)"					"unprognostic (3.40e-3)"		"unprognostic (1.09e-2)"	"unprognostic (2.90e-3)"	"unprognostic (9.16e-2)"				"unprognostic (1.74e-1)"		"unprognostic (1.48e-1)"			"unprognostic (2.87e-1)"					
LILRA4	"CD85g, ILT7"	ENSG00000239961	"Leukocyte immunoglobulin like receptor A4"	P59901	19	54333185-54339162	"CD markers, Predicted membrane proteins"	"Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 4.4;lymphoid tissue: 10.6"	"Cell type enriched"	"Detected in some"	30	"dendritic cells: 597.3"	"Cell type enriched"	"Detected in single"	91	"central nervous system macrophage: 9.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in some"	21	"plasmacytoid DC: 176.0"	"Lineage enriched"	"Detected in many"	21	"dendritic cells: 176.0"	"Not detected"	"Not detected"			"Minor Salivary Gland - Macrophages, Spleen - B-cells (Spleen)"									HPA049418	Approved						NA	NA		8100000	"Cluster 44: Plasmacytoid DCs - Plasma membrane proteins"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 30: White matter - Myelination"	"Cluster 55: Lymphoma - Immune response"	"Cluster 28: Dendritic cells - Antigen presentation"	1			"HPA049418: AB_2680756"			"unprognostic (8.19e-2)"					"unprognostic (4.09e-2)"															"unprognostic (5.33e-2)"								
LILRA5	"CD85, CD85f, ILT11, LILRB7, LIR9"	ENSG00000187116	"Leukocyte immunoglobulin like receptor A5"	A6NI73	19	54307070-54313166	"CD markers, Predicted membrane proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 42.4;lymphoid tissue: 74.5"	"Cell type enriched"	"Detected in some"	8	"monocytes: 824.8"	"Cell type enriched"	"Detected in single"	119	"leukocyte: 11.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"classical monocyte: 128.6;intermediate monocyte: 252.9;neutrophil: 137.5;non-classical monocyte: 312.7"	"Group enriched"	"Detected in many"	6	"granulocytes: 137.5;monocytes: 312.7"	"Not detected"	"Not detected"			"Adipose subcutaneous - Macrophages, Adrenal gland - Neutrophils, Breast - Macrophages, Heart muscle - Neutrophils, Liver - Neutrophils, Lung - Neutrophil_2, Skeletal muscle - Neutrophils, Spleen - Neutrophils, Thyroid gland - Neutrophils"														"Secreted to blood"	Receptor	NA	NA		700000	"Cluster 40: Monocytes - Innate immune response"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 12: Non-specific - Vasculature"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 29: Monocytes - Innate immune response"							"unprognostic (1.11e-1)"			"unprognostic (3.22e-2)"		"potential prognostic unfavorable (9.55e-4)"			"unprognostic (3.03e-2)"	"unprognostic (1.02e-1)"			"unprognostic (2.59e-2)"	"unprognostic (3.22e-1)"	"unprognostic (6.25e-2)"	"unprognostic (6.64e-2)"	"unprognostic (5.63e-2)"		"unprognostic (8.45e-3)"	"unprognostic (1.47e-1)"	"unprognostic (9.43e-2)"			"unprognostic (1.79e-1)"		"unprognostic (3.69e-2)"			
LILRB2	"CD85d, ILT4, LIR-2, LIR2, MIR-10, MIR10"	ENSG00000131042	"Leukocyte immunoglobulin like receptor B2"	Q8N423	19	54273812-54281184	"CD markers, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 34.7;lung: 14.5;lymphoid tissue: 50.0"	"Cell type enriched"	"Detected in some"	4	"monocytes: 926.9"	"Group enriched"	"Detected in some"	144	"central nervous system macrophage: 17.8;leukocyte: 50.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"classical monocyte: 61.3;intermediate monocyte: 131.4;neutrophil: 63.2;non-classical monocyte: 152.2"	"Group enriched"	"Detected in many"	6	"granulocytes: 63.2;monocytes: 152.2"	"Not detected"	"Not detected"			"Adipose subcutaneous - Macrophages, Breast - Macrophages, Kidney - Macrophages, Lung - Neutrophil_2, Minor Salivary Gland - Macrophages, Pituitary gland - Macrophages, Stomach - Macrophages"																NA	NA		140000000	"Cluster 37: Monocytes & Neutrophils - Innate immune response"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 12: Non-specific - Vasculature"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 29: Monocytes - Innate immune response"	6						"unprognostic (5.92e-3)"			"unprognostic (8.63e-2)"		"unprognostic (9.88e-2)"			"unprognostic (3.71e-3)"	"unprognostic (1.88e-1)"			"unprognostic (3.95e-2)"		"unprognostic (3.12e-2)"		"unprognostic (3.52e-1)"		"unprognostic (4.52e-2)"		"unprognostic (9.29e-2)"			"unprognostic (8.20e-2)"		"unprognostic (1.99e-1)"			
LILRB3	"CD85a, HL9, ILT5, LIR-3, LIR3, PIR-B, PIRB"	ENSG00000204577	"Leukocyte immunoglobulin like receptor B3"	O75022	19	54216278-54223506	"CD markers, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 26.2;lymphoid tissue: 48.7"	"Group enriched"	"Detected in many"	4	"Hofbauer cells: 87.3;Kupffer cells: 93.5;Macrophages: 79.5;monocytes: 166.3"	"Cell type enriched"	"Detected in some"	5	"leukocyte: 26.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 43.2"	"Group enriched"	"Detected in many"	4	"granulocytes: 43.2;monocytes: 15.3"	"Not detected"	"Not detected"			"Adipose subcutaneous - Macrophages, Breast - Macrophages, Liver - Neutrophils, Lung - Neutrophil_2, Pituitary gland - Macrophages, Skin - Macrophages, Spleen - Neutrophils, Thyroid gland - Neutrophils"									HPA026985			Approved	"Plasma membrane,Cytosol"			NA	NA		10000000	"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 47: Spleen - Immune response"	"Cluster 12: Non-specific - Vasculature"	"Cluster 55: Lymphoma - Immune response"	"Cluster 74: Neutrophils - Degranulation"		"Plasma membrane"	Cytosol	"HPA026985: "			"unprognostic (3.18e-3)"			"unprognostic (5.14e-3)"					"potential prognostic unfavorable (1.31e-5)"				"unprognostic (1.01e-1)"	"unprognostic (2.63e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.00e-3)"	"unprognostic (1.20e-1)"		"unprognostic (5.06e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.63e-2)"			"unprognostic (1.78e-1)"		"unprognostic (1.18e-2)"			
LILRB4	"CD85k, HM18, ILT3, LIR-5, LIR5"	ENSG00000186818	"Leukocyte immunoglobulin like receptor B4"	Q8NHJ6	19	54643889-54670359	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.7;lung: 13.3;lymphoid tissue: 18.4"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 185.8;Hofbauer cells: 137.3;Kupffer cells: 104.7;Macrophages: 86.8;Plasma cells: 42.4"	"Cell type enriched"	"Detected in some"	20	"central nervous system macrophage: 157.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 37.8"	"Group enriched"	"Detected in many"	43	"dendritic cells: 37.8;monocytes: 11.0"	"Cancer enriched"	"Detected in some"	5	"Myeloma: 28.0"	"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Breast - Macrophages, Colon - Macrophages, Heart muscle - Macrophages, Kidney - Macrophages, Liver - Kupffer cells, Minor Salivary Gland - Macrophages, Pancreas - Macrophages, Skeletal muscle - Macrophages, Stomach - Macrophages, Testis - Macrophages, Thyroid gland - Macrophages"									HPA052807	Approved						NA	NA		190000	"Cluster 10: Non-specific - Membrane trafficking"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 58: Macrophages - Innate immune response"	3			"HPA052807: AB_2681958"	"unprognostic (1.88e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.42e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.72e-1)"	"unprognostic (6.04e-2)"		"unprognostic (1.62e-1)"	"unprognostic (9.71e-2)"	"unprognostic (2.73e-1)"	"unprognostic (4.98e-2)"	"unprognostic (6.09e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.80e-2)"		"unprognostic (4.24e-1)"	"unprognostic (2.20e-2)"	"unprognostic (4.14e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.15e-1)"
LILRB5	"CD85c, LIR-8, LIR8"	ENSG00000105609	"Leukocyte immunoglobulin like receptor B5"	O75023	19	54249421-54257301	"CD markers, Plasma proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 17.3;lymphoid tissue: 47.9"	"Group enriched"	"Detected in some"	9	"Hofbauer cells: 53.7;Kupffer cells: 122.3;Macrophages: 67.0"	"Cell type enriched"	"Detected in some"	8	"central nervous system macrophage: 10.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Breast - Macrophages, Heart muscle - Macrophages, Kidney - Macrophages, Liver - Kupffer cells, Minor Salivary Gland - Macrophages, Skeletal muscle - Macrophages, Testis - Macrophages, Thyroid gland - Macrophages"									HPA012069	Approved						NA	NA		55000000		"Cluster 47: Spleen - Immune response"	"Cluster 6: Non-specific - Immune response"	"Cluster 56: Non-specific - Sensory perception"	"Cluster 58: Macrophages - Innate immune response"				"HPA012069: AB_1852873"	"unprognostic (3.53e-2)"		"unprognostic (1.16e-2)"			"unprognostic (3.43e-2)"					"potential prognostic favorable (3.29e-4)"	"unprognostic (3.29e-2)"			"unprognostic (2.56e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.67e-1)"		"unprognostic (2.24e-1)"				"potential prognostic unfavorable (3.15e-4)"			"unprognostic (4.68e-2)"	"unprognostic (7.85e-2)"		"unprognostic (8.23e-2)"		
LRP1	"A2MR, APOER, APR, CD91, IGFBP-3R, IGFBP3R1, LRP, LRP1A"	ENSG00000123384	"LDL receptor related protein 1"	Q07954	12	57128483-57213361	"Candidate cardiovascular disease genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Endocytosis, Host-virus interaction"	"Developmental protein, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 105.5"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 328.0;Leydig cells: 229.9"	"Cell type enhanced"	"Detected in all"		"fibroblast: 578.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	18	"classical monocyte: 4.3;intermediate monocyte: 2.2;myeloid DC: 1.6;non-classical monocyte: 2.5"	"Group enriched"	"Detected in many"	21	"dendritic cells: 1.6;monocytes: 4.3"	"Low cancer specificity"	"Detected in all"			"Adrenal gland - Fibroblasts, Kidney - Fibroblasts, Liver - Hepatocytes, Lung - Fibroblast_2, Prostate - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004182, CAB018621, HPA022903"	Supported		Supported	"Nucleoli,Plasma membrane,Cytosol"	"Intracellular and membrane"	Receptor	NA	NA		230000000	"Cluster 26: Monocytes - Plasma membrane proteins"	"Cluster 62: Connective tissue - ECM organization"	"Cluster 44: Non-specific - Mixed function"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 53: Fibroblasts - ECM organization"	31	"Plasma membrane"	"Nucleoli, Cytosol"	"CAB018621: AB_627893, HPA004182: AB_2667163, HPA022903: AB_10602426"	"unprognostic (3.21e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.61e-2)"	"unprognostic (6.96e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.13e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.05e-1)"	"potential prognostic favorable (4.04e-4)"	"unprognostic (1.95e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.94e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.41e-2)"	"unprognostic (4.01e-1)"	"unprognostic (4.34e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.78e-2)"	"unprognostic (3.18e-1)"	"unprognostic (3.51e-1)"	"unprognostic (2.25e-3)"	"unprognostic (1.33e-1)"	"unprognostic (4.14e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.48e-1)"
LY75	"CD205, CLEC13B, DEC-205"	ENSG00000054219	"Lymphocyte antigen 75"	O60449	2	159803355-159904756	"CD markers, Predicted membrane proteins"	Endocytosis	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 76.3"	"Cell type enhanced"	"Detected in many"		"Ciliated cells: 20.7;Distal enterocytes: 19.7;Proximal enterocytes: 31.2"	"Group enriched"	"Detected in many"	11	"central nervous system macrophage: 81.4;endothelial cell: 42.3;leukocyte: 73.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"lymphoma: 19.6;Myeloma: 18.0"	"Skeletal muscle - Endothelial cells"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB001450, HPA049108, HPA054073"	Enhanced		Approved	"Golgi apparatus"			NA	NA		1200000	"Cluster 24: Non-specific - Transcription"	"Cluster 71: Thymus - Adaptive immune response"	"Cluster 49: Hindbrain - Mixed function"	"Cluster 55: Lymphoma - Immune response"	"Cluster 14: Langerhans cells - Innate immune response"	1	"Golgi apparatus"		"CAB001450: AB_563525, HPA049108: AB_2680635, HPA054073: AB_2682370"	"unprognostic (5.74e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.83e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.25e-1)"		"unprognostic (2.42e-1)"	"unprognostic (1.47e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.26e-2)"	"unprognostic (8.26e-2)"	"potential prognostic unfavorable (3.37e-4)"	"unprognostic (1.41e-1)"	"unprognostic (2.35e-1)"	"unprognostic (5.82e-3)"	"unprognostic (6.95e-2)"		"unprognostic (1.80e-1)"	"unprognostic (3.00e-1)"	"unprognostic (3.40e-1)"	"unprognostic (5.90e-2)"
LY9	"CD229, hly9, mLY9, SLAMF3"	ENSG00000122224	"Lymphocyte antigen 9"	Q9HBG7	1	160796074-160828261	"CD markers, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Cell adhesion, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 11.3;intestine: 11.7;lymphoid tissue: 30.3"	"Cell type enhanced"	"Detected in some"		"B-cells: 242.6;dendritic cells: 61.9;Langerhans cells: 37.4;Plasma cells: 84.4;T-cells: 44.6"	"Cell type enriched"	"Detected in single"	149	"leukocyte: 105.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"gdT-cell: 113.2;MAIT T-cell: 113.7;memory B-cell: 56.2;memory CD4 T-cell: 97.8;memory CD8 T-cell: 109.8;naive B-cell: 53.0;naive CD4 T-cell: 110.0;naive CD8 T-cell: 112.6;plasmacytoid DC: 73.0;T-reg: 80.5"	"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in some"		"lymphoma: 15.9;Myeloma: 38.0"	"Adipose visceral - T-cells, Adrenal gland - T-cells, Colon - T-cells, Heart muscle - T-cells, Liver - T-cells, Minor Salivary Gland - Plasma cells, Pancreas - T-cells, Skin - T-cells, Spleen - B-cells (Spleen), Thyroid gland - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA050917	Approved		Approved	"Plasma membrane,Centriolar satellite"	"Secreted - unknown location"	Immunity	NA	NA		22000	"Cluster 11: T-cells - Unknown function"	"Cluster 36: Lymphoid tissue - Cytokine signaling"		"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 73: B-cells - B-cell function"	1	"Plasma membrane"	"Centriolar satellite"	"HPA050917: AB_2681272"	"unprognostic (8.79e-2)"	"unprognostic (2.67e-3)"	"unprognostic (1.12e-1)"	"potential prognostic favorable (4.94e-4)"	"unprognostic (5.62e-2)"	"unprognostic (2.44e-1)"			"potential prognostic favorable (1.37e-4)"		"unprognostic (1.07e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.28e-1)"		"unprognostic (3.03e-3)"	"potential prognostic favorable (1.86e-4)"	"unprognostic (1.42e-2)"	"unprognostic (1.66e-1)"	"unprognostic (5.74e-2)"			"unprognostic (2.82e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.86e-1)"		"unprognostic (1.11e-3)"	"potential prognostic favorable (3.48e-4)"	"unprognostic (4.69e-2)"	"unprognostic (5.81e-2)"	"unprognostic (2.47e-2)"	
MCAM	"CD146, HEMCAM, MelCAM, METCAM, MUC18"	ENSG00000076706	"Melanoma cell adhesion molecule"	P43121	11	119308529-119321521	"CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 116.4;Endothelial cells: 105.5;Muller glia cells: 82.4;Sertoli cells: 193.1;Smooth muscle cells: 416.8"	"Cell type enriched"	"Detected in many"	5	"vascular associated smooth muscle cell: 849.7"	"Cancer enhanced"	"Detected in all"		"Skin Cuteneous Melanoma (TCGA): 309.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in all"		"skin cancer: 283.7"	"Colon - Smooth muscle cells, Liver - Vascular Endothelial cells, Prostate - Smooth muscle cells, Testis - Endothelial cells, Thyroid gland - Smooth muscle cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002147, HPA008848"	Enhanced		Supported	"Plasma membrane"			NA	NA		1000000000		"Cluster 62: Connective tissue - ECM organization"	"Cluster 6: Non-specific - Immune response"	"Cluster 69: Skin cancer - ECM organization"	"Cluster 48: Smooth muscle cells - Signal transduction"	26	"Plasma membrane"		"CAB002147: AB_563499, HPA008848: AB_1078445"	"unprognostic (5.46e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.08e-3)"	"unprognostic (4.26e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.81e-3)"	"potential prognostic favorable (7.26e-4)"	"unprognostic (2.45e-1)"	"unprognostic (6.80e-3)"	"unprognostic (9.00e-2)"	"unprognostic (7.24e-2)"	"potential prognostic unfavorable (4.77e-5)"	"unprognostic (3.52e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.11e-1)"
MELTF	"CD228, FLJ38863, MAP97, MFI2, MGC4856, MTf, MTF1"	ENSG00000163975	Melanotransferrin	P08582	3	196980590-197029835	"CD markers, Plasma proteins, Predicted intracellular proteins"	"Ion transport, Iron transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 34.1;salivary gland: 69.2"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 28.1;granulocytes: 43.4;Mesothelial cells: 33.3;Serous glandular cells: 27.2"	"Cell type enhanced"	"Detected in many"		"choroid plexus epithelial cell: 38.4;pericyte: 93.3"	"Cancer enhanced"	"Detected in all"		"Skin Cuteneous Melanoma (TCGA): 129.7"	"Region enhanced"	"Detected in all"		"choroid plexus: 63.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in all"		"skin cancer: 190.5"	"Skeletal muscle - Fibroblasts, Skin - Eccrine sweat gland cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA004880	Approved				"Intracellular and membrane"	Transport	NA	NA		140000000		"Cluster 52: Kidney - Transmembrane transport"	"Cluster 23: Choroid plexus - Mixed function"	"Cluster 69: Skin cancer - ECM organization"	"Cluster 45: Non-specific - Mixed function"	28			"HPA004880: AB_1853844"	"unprognostic (2.06e-2)"	"unprognostic (7.92e-3)"		"unprognostic (3.18e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.05e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.81e-2)"	"potential prognostic unfavorable (7.74e-4)"	"potential prognostic unfavorable (1.88e-10)"	"unprognostic (7.00e-3)"	"unprognostic (7.12e-2)"	"unprognostic (6.82e-2)"		"potential prognostic unfavorable (1.67e-5)"	"unprognostic (2.32e-2)"	"unprognostic (5.08e-2)"	"unprognostic (3.17e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.12e-3)"	"potential prognostic unfavorable (1.61e-4)"	"unprognostic (1.91e-1)"	"unprognostic (8.60e-3)"	"unprognostic (3.20e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.08e-2)"	"unprognostic (2.61e-1)"
MME	"CALLA, CD10, NEP"	ENSG00000196549	"Membrane metalloendopeptidase"	P08473	3	155024124-155183704	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Charcot-Marie-Tooth disease, Disease variant, FDA approved drug targets, Neurodegeneration, Neuropathy, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 324.3;kidney: 292.0"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 76.6;Cytotrophoblasts: 78.8;Endometrial stromal cells: 269.5;Prostatic glandular cells: 119.5;Proximal enterocytes: 322.6;Syncytiotrophoblasts: 127.2"	"Group enriched"	"Detected in many"	7	"lower rhombic lip: 200.6;medium spiny neuron: 247.5"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"basal ganglia: 37.9"	"Immune cell enriched"	"Detected in some"	123	"neutrophil: 139.9"	"Lineage enriched"	"Detected in many"	123	"granulocytes: 139.9"	"Low cancer specificity"	"Detected in many"			"Adipose visceral - Adipocytes (Visceral), Heart muscle - Fibroblasts, Kidney - Podocytes, Liver - Hepatocytes, Prostate - Prostate glandular cells"	"Region enhanced"	"Detected in many"		"basal ganglia: 28.1"	"Region enhanced"	"Detected in all"		"basal ganglia: 43.8"	"CAB000013, HPA052583, HPA056072"	Enhanced		Approved	"Plasma membrane,Centrosome,Basal body,Cytosol"			NA	NA		380000	"Cluster 35: Neutrophils - Protein binding"	"Cluster 55: Kidney & Intestine - Metabolism"	"Cluster 49: Hindbrain - Mixed function"	"Cluster 44: Connective tissue cells - ECM organization"	"Cluster 74: Neutrophils - Degranulation"	8	"Plasma membrane, Centrosome, Basal body"	Cytosol	"CAB000013: AB_563478, HPA052583: AB_2681872, HPA056072: AB_2683027"	"unprognostic (2.30e-1)"	"unprognostic (2.49e-1)"	"unprognostic (5.64e-2)"	"unprognostic (5.09e-3)"	"unprognostic (8.46e-2)"	"unprognostic (2.60e-2)"		"unprognostic (3.20e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.31e-2)"	"potential prognostic favorable (3.40e-4)"	"unprognostic (2.64e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.31e-1)"	"potential prognostic unfavorable (2.61e-4)"	"unprognostic (1.59e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.93e-2)"	"unprognostic (6.95e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.37e-3)"	"unprognostic (3.65e-2)"
MPL	"CD110, THPOR, TPOR"	ENSG00000117400	"MPL proto-oncogene, thrombopoietin receptor"	P40238	1	43337818-43354466	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"Erythroid cells: 2.2;Ovarian stromal cells: 3.1;Rod photoreceptor cells: 2.0"	"Cell type enhanced"	"Detected in some"		"ependymal cell: 3.1;upper-layer intratelencephalic: 4.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.4"	"Cancer enriched"	"Detected in single"	9	"Leukemia: 5.9"	"Testis - Early spermatids"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.5"	"Low region specificity"	"Detected in many"			HPA007619			Supported	"Nuclear membrane,Plasma membrane"			NA	NA			"Cluster 35: Neutrophils - Protein binding"	"Cluster 40: Non-specific - Transcription"	"Cluster 11: White matter - Signal transduction"	"Cluster 47: Leukemia - Hemostasis"	"Cluster 57: Platelets - Hemostasis"	3	"Plasma membrane"	"Nuclear membrane"	"HPA007619: AB_1854080"			"unprognostic (1.08e-2)"			"unprognostic (6.27e-2)"							"potential prognostic favorable (1.69e-4)"													"unprognostic (1.46e-1)"					"unprognostic (9.80e-3)"
MRC1	"bA541I19.1, CD206, CLEC13D, CLEC13DL, MRC1L1"	ENSG00000260314	"Mannose receptor C-type 1"	P22897	10	17809348-17911164	"CD markers, FDA approved drug targets, Plasma proteins, Predicted membrane proteins"	"Endocytosis, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 118.5"	"Group enriched"	"Detected in many"	4	"Breast glandular cells: 124.7;Hofbauer cells: 157.9;Kupffer cells: 348.2;Langerhans cells: 206.5;Lymphatic endothelial cells: 244.1;Macrophages: 414.9"	"Cell type enriched"	"Detected in many"	17	"central nervous system macrophage: 199.8"	"Cancer enhanced"	"Detected in many"		"Lung Adenocarcinoma (TCGA): 24.3"	"Region enhanced"	"Detected in all"		"choroid plexus: 20.4"	"Immune cell enriched"	"Detected in single"	16	"myeloid DC: 4.8"	"Lineage enriched"	"Detected in single"	16	"dendritic cells: 4.8"	"Cancer enriched"	"Detected in some"	7	"Rhabdoid: 8.4"	"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Breast - Macrophages, Colon - Macrophages, Heart muscle - Macrophages, Kidney - Macrophages, Lung - Macrophages, Minor Salivary Gland - Macrophages, Pancreas - Macrophages, Pituitary gland - Macrophages, Prostate - Macrophages, Skeletal muscle - Macrophages, Skin - Macrophages, Stomach - Macrophages, Thyroid gland - Macrophages"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004114, HPA045134, CAB068203"	Enhanced						NA	NA		140000000	"Cluster 2: Dendritic cells - Unknown function"	"Cluster 57: Lung - Lung function"	"Cluster 23: Choroid plexus - Mixed function"	"Cluster 5: Rhabdoid - Unknown function"	"Cluster 58: Macrophages - Innate immune response"	1			"CAB068203: AB_2665652, HPA004114: AB_1846270, HPA045134: AB_2679228"	"unprognostic (8.75e-2)"	"unprognostic (8.57e-2)"	"unprognostic (5.99e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.96e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.65e-2)"		"unprognostic (3.16e-1)"	"unprognostic (7.44e-2)"	"potential prognostic favorable (3.42e-4)"	"unprognostic (1.24e-1)"	"unprognostic (8.90e-2)"	"unprognostic (2.10e-2)"	"unprognostic (8.99e-2)"	"potential prognostic favorable (4.36e-4)"	"unprognostic (4.42e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.90e-1)"	"unprognostic (7.74e-3)"		"unprognostic (8.51e-2)"		"unprognostic (3.03e-1)"	"unprognostic (9.27e-3)"	"unprognostic (1.01e-1)"	"unprognostic (5.62e-3)"	"unprognostic (2.72e-2)"	"unprognostic (3.94e-2)"	"unprognostic (3.98e-2)"	
MRC2	"CD280, CLEC13E, ENDO180, KIAA0709"	ENSG00000011028	"Mannose receptor C type 2"	Q9UBG0	17	62627670-62693597	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	Endocytosis	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 62.5;Fibroblasts: 122.9;Late spermatids: 90.3;Leydig cells: 71.9;Peritubular cells: 94.8"	"Cell type enhanced"	"Detected in many"		"central nervous system macrophage: 192.1;fibroblast: 249.1;pericyte: 222.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Adrenocortical cancer: 132.9"	"Adipose subcutaneous - Adipose progenitor cells, Adipose visceral - Adipose progenitor cells, Adrenal gland - Fibroblasts, Heart muscle - Fibroblasts, Kidney - Fibroblasts, Liver - Hepatic stellate cells, Prostate - Fibroblasts, Skeletal muscle - Fibroblasts, Spleen - Fibroblast_1, Stomach - Fibroblasts, Thyroid gland - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041991	Enhanced						NA	NA		34000000		"Cluster 41: Smooth muscle tissue - ECM organization"	"Cluster 8: Immune cells - Immune response"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 53: Fibroblasts - ECM organization"	6			"HPA041991: AB_10794166"	"unprognostic (2.87e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.23e-1)"	"unprognostic (4.46e-2)"	"unprognostic (3.30e-2)"	"unprognostic (4.06e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.08e-3)"	"unprognostic (7.00e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.47e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.56e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.03e-2)"	"unprognostic (5.42e-1)"	"potential prognostic unfavorable (8.76e-4)"	"unprognostic (2.85e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.24e-2)"	"unprognostic (2.24e-1)"	"unprognostic (4.86e-3)"	"unprognostic (2.95e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.90e-1)"	"unprognostic (7.36e-2)"	"unprognostic (3.21e-1)"
MS4A1	"B1, Bp35, CD20, FMC7"	ENSG00000156738	"Membrane spanning 4-domains A1"	P11836	11	60455846-60470752	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"B-cell activation"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 655.0"	"Cell type enriched"	"Detected in some"	55	"B-cells: 969.4"	"Cell type enriched"	"Detected in single"	99	"leukocyte: 50.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	96	"memory B-cell: 627.9;naive B-cell: 630.0"	"Lineage enriched"	"Detected in many"	96	"B-cells: 630.0"	"Cancer enriched"	"Detected in some"	6	"lymphoma: 397.8"	"Breast - T-cells, Lung - B-cells (Lung), Spleen - B-cells (Spleen), Thyroid gland - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000015, HPA014341, HPA014391"	Enhanced		Supported	"Plasma membrane"			NA	NA			"Cluster 23: B-cells - Immunoglobulins"	"Cluster 36: Lymphoid tissue - Cytokine signaling"		"Cluster 55: Lymphoma - Immune response"	"Cluster 73: B-cells - B-cell function"	34	"Plasma membrane"		"CAB000015: AB_2282030, HPA014341: AB_1846265, HPA014391: AB_1846264"	"unprognostic (1.71e-1)"	"validated prognostic favorable (3.10e-4)"	"validated prognostic favorable (2.75e-5)"	"potential prognostic favorable (4.40e-5)"	"unprognostic (1.25e-1)"	"unprognostic (9.81e-2)"			"potential prognostic favorable (9.96e-7)"		"unprognostic (6.54e-3)"	"unprognostic (9.61e-2)"			"unprognostic (1.54e-2)"	"potential prognostic favorable (1.29e-4)"	"unprognostic (3.75e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.31e-1)"		"unprognostic (6.53e-2)"	"unprognostic (8.62e-2)"	"unprognostic (3.32e-1)"	"unprognostic (3.46e-2)"	"unprognostic (4.36e-2)"	"unprognostic (3.36e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.93e-1)"	"unprognostic (6.81e-2)"	"unprognostic (6.82e-2)"	
MSR1	"CD204, SCARA1, SR-A, SR-AI, SR-AII, SR-AIII"	ENSG00000038945	"Macrophage scavenger receptor 1"	P21757	8	16107878-16567490	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Endocytosis	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"lung: 116.4"	"Group enriched"	"Detected in many"	6	"Hofbauer cells: 122.6;Kupffer cells: 261.4;Langerhans cells: 97.4;Macrophages: 191.1;monocytes: 231.3"	"Group enriched"	"Detected in many"	7	"central nervous system macrophage: 282.4;upper rhombic lip: 274.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 16.8"	"Lineage enriched"	"Detected in many"	5	"monocytes: 16.8"	"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Breast - Macrophages, Heart muscle - Macrophages, Kidney - Macrophages, Liver - Kupffer cells, Pancreas - Macrophages, Pituitary gland - Macrophages, Prostate - Macrophages, Skeletal muscle - Macrophages, Skin - Macrophages, Spleen - Macrophages, Testis - Macrophages, Thyroid gland - Macrophages"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA000272, CAB032491"	Enhanced						NA	NA		46000	"Cluster 40: Monocytes - Innate immune response"	"Cluster 57: Lung - Lung function"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 58: Macrophages - Innate immune response"	9			"CAB032491: AB_672722, HPA000272: AB_1846269"	"unprognostic (1.63e-1)"	"unprognostic (1.66e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.06e-3)"	"unprognostic (4.04e-2)"	"unprognostic (5.69e-2)"	"unprognostic (4.12e-2)"	"unprognostic (4.10e-2)"	"unprognostic (8.65e-2)"	"unprognostic (5.99e-2)"	"unprognostic (2.57e-2)"	"unprognostic (3.03e-1)"	"unprognostic (3.56e-2)"	"unprognostic (5.68e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.11e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.86e-2)"	"potential prognostic unfavorable (8.07e-4)"	"unprognostic (8.31e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.45e-1)"
MST1R	"CD136, CDw136, PTK8, RON, SEA"	ENSG00000164078	"Macrophage stimulating 1 receptor"	Q04912	3	49887002-49903873	"CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Innate immunity"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 18.8;skin 1: 31.1;stomach 1: 26.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 25.7;Distal enterocytes: 32.8;Gastric mucus-secreting cells: 92.0;Intestinal goblet cells: 25.9;Proximal enterocytes: 21.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Gallbladder cancer: 49.5"	"Adipose visceral - Mesothelial cells, Minor Salivary Gland - Minor salivary gland basal cells, Prostate - Urothelial cells, Skin - Keratinocyte (other), Stomach - Gastric mucous cells, Testis - Late spermatids"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA007657, HPA008180, CAB008972"	Enhanced		Approved	Cytosol			NA	NA				"Cluster 45: Intestine - Digestion"		"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 46: Gastric mucus-secreting cells - Digestion"	12	Cytosol		"CAB008972: , HPA007657: AB_1079292, HPA008180: AB_1079291"	"unprognostic (3.03e-1)"	"unprognostic (2.38e-2)"	"unprognostic (7.02e-3)"	"unprognostic (1.29e-2)"	"unprognostic (2.41e-1)"	"unprognostic (8.94e-3)"			"unprognostic (2.46e-1)"			"unprognostic (2.14e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.12e-3)"	"unprognostic (2.30e-2)"	"unprognostic (5.05e-3)"	"potential prognostic unfavorable (3.86e-5)"	"unprognostic (3.71e-2)"	"unprognostic (1.15e-3)"	"unprognostic (3.64e-1)"	"unprognostic (5.34e-1)"	"unprognostic (2.13e-3)"	"unprognostic (2.41e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.79e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.61e-1)"	"potential prognostic favorable (6.59e-4)"	"unprognostic (2.23e-2)"
MUC1	"ADMCKD, ADMCKD1, Ca15-3, CD227, EMA, KL-6, MCD, MCKD, MCKD1, PEM, PUM"	ENSG00000185499	"Mucin 1, cell surface associated"	P15941	1	155185824-155192916	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"			"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 419.1;stomach 1: 862.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 963.7;Alveolar cells type 2: 1456.7;Exocrine glandular cells: 951.7;Gastric mucus-secreting cells: 572.5;Ionocytes: 447.7"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.2"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.2"	"Cancer enhanced"	"Detected in all"		"breast cancer: 211.1;pancreatic cancer: 218.2"	"Adipose visceral - Mesothelial cells, Breast - Breast glandular cells, Colon - Mitotic cells (Colon), Lung - Alveolar cells type 2, Minor Salivary Gland - Minor salivary glandular cells, Skin - Sebaceous gland cells, Stomach - Gastric mucous cells, Testis - Early spermatids, Testis - Late spermatids"					"Low region specificity"	"Detected in many"			"CAB000036, CAB001986, HPA004179, HPA007235, HPA008855, CAB080102, CAB080103"	Enhanced		Supported	"Plasma membrane"	"Secreted in other tissues"	"No annotated function"	NA	NA		4300000	"Cluster 5: Non-specific - Cell proliferation"	"Cluster 48: Stomach - Proteolysis"	"Cluster 44: Non-specific - Mixed function"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 45: Non-specific - Mixed function"	29	"Plasma membrane"		"CAB000036: AB_2148557, CAB001986: , CAB080102: , CAB080103: , HPA004179: AB_1846282, HPA007235: AB_1846281, HPA008855: AB_1846283"	"unprognostic (6.27e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.99e-1)"	"unprognostic (9.53e-3)"	"unprognostic (5.63e-2)"	"unprognostic (9.41e-2)"	"unprognostic (9.23e-2)"	"potential prognostic favorable (8.45e-4)"	"potential prognostic unfavorable (6.35e-4)"	"unprognostic (2.30e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.90e-3)"	"unprognostic (2.60e-2)"	"unprognostic (3.67e-1)"	"unprognostic (2.24e-1)"	"unprognostic (5.09e-3)"	"unprognostic (9.30e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.04e-1)"	"potential prognostic unfavorable (4.90e-4)"	"unprognostic (1.65e-1)"	"unprognostic (4.41e-1)"	"unprognostic (5.51e-3)"	"unprognostic (3.73e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.59e-2)"	"unprognostic (9.12e-2)"
NCAM1	"CD56, NCAM"	ENSG00000149294	"Neural cell adhesion molecule 1"	P13591	11	112961247-113278436	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 193.9;heart muscle: 140.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 503.5;Excitatory neurons: 445.6;Inhibitory neurons: 421.9;Oligodendrocyte precursor cells: 881.1;Oligodendrocytes: 943.3;Schwann cells: 249.7"	"Low cell type specificity"	"Detected in all"			"Cancer enriched"	"Detected in all"	10	"Glioblastoma Multiforme (TCGA): 129.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	15	"NK-cell: 53.9"	"Lineage enriched"	"Detected in many"	15	"NK-cells: 53.9"	"Cancer enhanced"	"Detected in many"		"Neuroblastoma: 126.4"	"Adipose subcutaneous - Smooth muscle cells, Kidney - Fibroblasts, Liver - Hepatic stellate cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000142, CAB018071, HPA039835"	Enhanced		Enhanced	"Plasma membrane,Cytosol"	"Secreted in other tissues"	Receptor	NA	NA		1300000000	"Cluster 15: NK-cells - Unknown function"	"Cluster 30: Heart muscle - Heart development"	"Cluster 28: Oligodendrocytes - Mixed function"	"Cluster 17: Neuroblastoma - Neuronal signaling"	"Cluster 69: Neurons - Neuronal signaling"	5	"Plasma membrane"	Cytosol	"CAB000142: , CAB018071: AB_627129, HPA039835: AB_2676705"	"unprognostic (9.56e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.54e-1)"	"unprognostic (7.30e-2)"	"unprognostic (3.55e-2)"	"unprognostic (8.34e-2)"	"unprognostic (2.63e-1)"	"potential prognostic favorable (1.51e-4)"	"unprognostic (5.08e-3)"	"unprognostic (3.00e-1)"	"unprognostic (9.30e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.21e-1)"	"unprognostic (7.41e-2)"		"unprognostic (3.92e-3)"	"unprognostic (2.09e-2)"	"unprognostic (7.56e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.93e-2)"	"unprognostic (8.16e-2)"	"potential prognostic favorable (1.08e-4)"	"unprognostic (7.84e-2)"	"unprognostic (7.01e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.64e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.22e-2)"	"unprognostic (3.74e-2)"
NCR1	"CD335, LY94, NK-p46, NKP46"	ENSG00000189430	"Natural cytotoxicity triggering receptor 1"	O76036	19	54906148-54916140	"CD markers, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	4	"lymphoid tissue: 3.4"	"Cell type enriched"	"Detected in some"	11	"NK-cells: 84.4"	"Cell type enriched"	"Detected in single"	37	"leukocyte: 32.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	8	"cerebral cortex: 2.4"	"Immune cell enriched"	"Detected in single"	4	"NK-cell: 1.1"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 1.1"	"Not detected"	"Not detected"			"Liver - NK-cells (Liver), Lung - NK-cells (Lung), Spleen - NK-cells (Spleen), Thyroid gland - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"										NA	NA			"Cluster 15: NK-cells - Unknown function"	"Cluster 47: Spleen - Immune response"	"Cluster 12: Non-specific - Vasculature"	"Cluster 71: Lymphoma - Inflammatory response"	"Cluster 19: NK-cells - Adaptive immune response"	1						"unprognostic (1.40e-1)"																												
NCR2	"CD336, LY95, NK-p44"	ENSG00000096264	"Natural cytotoxicity triggering receptor 2"	O95944	6	41335608-41350889	"CD markers, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	17	"NK-cell: 1.7;plasmacytoid DC: 4.9"	"Group enriched"	"Detected in many"	17	"dendritic cells: 4.9;NK-cells: 1.7"	"Group enriched"	"Detected in some"	23	"Leukemia: 1.3;lymphoma: 3.3"						"Not detected"	"Not detected"			HPA067249	Uncertain						NA	NA			"Cluster 8: Plasmacytoid DCs - Unknown function"		"Cluster 45: Non-specific - Mixed function"	"Cluster 59: Leukemia - T-cell receptor"	"Cluster 19: NK-cells - Adaptive immune response"	2			"HPA067249: AB_2685811"																															
NCR3	"1C7, CD337, LY117, NKp30"	ENSG00000204475	"Natural cytotoxicity triggering receptor 3"	O14931	6	31588895-31593006	"CD markers, Predicted membrane proteins"	Immunity	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 4.0;intestine: 5.5;lymphoid tissue: 15.8"	"Group enriched"	"Detected in some"	12	"B-cells: 45.5;NK-cells: 141.4;T-cells: 49.8"	"Cell type enriched"	"Detected in single"	121	"leukocyte: 22.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 275.0"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	21	"Leukemia: 2.2;lymphoma: 2.0"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Colon - T-cells, Heart muscle - T-cells, Lung - NK-cells (Lung), Thyroid gland - T-cells"					"Low region specificity"	"Detected in many"										NA	NA			"Cluster 24: Non-specific - Transcription"	"Cluster 70: Lymphoid tissue - Immune response"		"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 19: NK-cells - Adaptive immune response"	5						"unprognostic (2.62e-3)"																												
NECTIN1	"CD111, CLPED1, ED4, HIgR, HVEC, Nectin-1, OFC7, PRR, PRR1, PVRL1, PVRR1, SK-12"	ENSG00000110400	"Nectin cell adhesion molecule 1"	Q15223	11	119623408-119729200	"CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 125.1;skin 1: 130.9"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 89.1;Basal squamous epithelial cells: 60.5;Squamous epithelial cells: 109.7;Suprabasal keratinocytes: 153.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.6"	"Low lineage specificity"	"Detected in single"			"Cancer enhanced"	"Detected in all"		"Gallbladder cancer: 131.1"	"Breast - Breast myoepithelial cells, Minor Salivary Gland - Minor salivary gland basal cells, Pituitary gland - Gonadotropes, Spleen - Fibroblast_1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016135, HPA026846"	Approved				"Secreted in other tissues"	Receptor	NA	NA		92000000	"Cluster 8: Plasmacytoid DCs - Unknown function"	"Cluster 27: Squamous epithelium - Keratinization"	"Cluster 11: White matter - Signal transduction"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 12: Squamous epithelial cells - Keratinization"	10			"CAB016135: AB_626865, HPA026846: AB_1846226"	"unprognostic (3.83e-1)"	"unprognostic (2.91e-1)"		"unprognostic (2.65e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.78e-3)"	"unprognostic (5.28e-2)"	"potential prognostic favorable (3.83e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.10e-3)"		"unprognostic (2.25e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.05e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.51e-3)"	"unprognostic (9.80e-2)"	"unprognostic (2.87e-2)"	"unprognostic (3.74e-1)"	"unprognostic (5.82e-3)"	"unprognostic (9.13e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.45e-3)"
NECTIN2	"CD112, HVEB, Nectin-2, PRR2, PVRL2, PVRR2"	ENSG00000130202	"Nectin cell adhesion molecule 2"	Q92692	19	44846175-44889223	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 251.8"	"Cell type enhanced"	"Detected in many"		"endothelial cell: 130.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 10.4"	"Lineage enhanced"	"Detected in many"		"granulocytes: 10.4"	"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Endothelial cells, Colon - Endothelial cells, Skeletal muscle - Endothelial cells, Testis - Sertoli cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012374, HPA012759, CAB026138"	Enhanced		Approved	"Vesicles,Plasma membrane,Mitotic spindle"			Yes	Yes		8000000	"Cluster 19: Eosinophils - Unknown function"	"Cluster 68: Non-specific - Protein processing"	"Cluster 42: Choroid plexus - Mitochondria"	"Cluster 66: Non-specific - Mitochondria"	"Cluster 45: Non-specific - Mixed function"	26	Vesicles	"Plasma membrane, Mitotic spindle"	"CAB026138: , HPA012374: , HPA012759: AB_1846227"	"unprognostic (1.21e-2)"	"unprognostic (1.20e-2)"		"unprognostic (1.38e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.68e-2)"		"unprognostic (3.38e-3)"	"unprognostic (1.79e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.72e-1)"	"unprognostic (8.19e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.39e-1)"
NECTIN3	"CD113, CDw113, DKFZP566B0846, nectin-3, PPR3, PVRL3, PVRR3"	ENSG00000177707	"Nectin cell adhesion molecule 3"	Q9NQS3	3	111070071-111275563	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 53.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 191.3;Excitatory neurons: 214.0;Late spermatids: 228.2;Oligodendrocyte precursor cells: 154.2;Syncytiotrophoblasts: 158.8"	"Cell type enhanced"	"Detected in many"		"hippocampal CA4: 355.0;upper-layer intratelencephalic: 345.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Liver - Hepatocytes, Spleen - Fibroblast_1, Testis - Early spermatids, Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009869, HPA011038"	Approved		Uncertain	"Cell Junctions,Cytosol"			NA	NA		21000000		"Cluster 46: Testis - Spermatogenesis"	"Cluster 39: Astrocytes - Mixed function"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 34: Neurons - Neuronal signaling"	24	"Cell Junctions, Cytosol"		"CAB009869: AB_2284699, HPA011038: AB_1079719"	"unprognostic (6.40e-2)"	"unprognostic (2.89e-1)"		"unprognostic (1.98e-3)"	"unprognostic (1.57e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.36e-2)"	"unprognostic (2.91e-1)"	"unprognostic (8.18e-3)"	"potential prognostic favorable (2.94e-8)"	"unprognostic (4.02e-3)"	"unprognostic (1.10e-1)"	"unprognostic (5.57e-2)"		"unprognostic (1.96e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.64e-2)"	"unprognostic (1.08e-2)"	"unprognostic (7.66e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.51e-1)"	"unprognostic (9.33e-2)"
NGFR	"CD271, p75NTR, TNFRSF16"	ENSG00000064300	"Nerve growth factor receptor"	P08138	17	49495293-49515008	"Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters"	"Apoptosis, Biological rhythms, Differentiation, Neurogenesis"	"Developmental protein, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 47.5;Leydig cells: 91.1;Muller glia cells: 142.8;Schwann cells: 28.4;Sertoli cells: 29.9"	"Group enriched"	"Detected in some"	4	"fibroblast: 9.4;oligodendrocyte: 11.4"	"Cancer enhanced"	"Detected in all"		"Skin Cuteneous Melanoma (TCGA): 64.8"	"Region enhanced"	"Detected in all"		"cerebral cortex: 187.1"	"Immune cell enriched"	"Detected in single"	8	"plasmacytoid DC: 1.2"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 1.2"	"Cancer enhanced"	"Detected in many"		"Sarcoma: 69.2;skin cancer: 133.4"	"Adrenal gland - Fibroblasts, Lung - Fibroblast_2, Pituitary gland - Fibroblasts, Skeletal muscle - Fibroblasts, Spleen - Fibroblast_1"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 13.5"	"CAB000143, CAB001995, HPA004765"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"			NA	NA		4500000	"Cluster 8: Plasmacytoid DCs - Unknown function"	"Cluster 30: Heart muscle - Heart development"	"Cluster 6: Non-specific - Immune response"	"Cluster 69: Skin cancer - ECM organization"	"Cluster 10: Muller glia cells - Visual perception"	35	"Nucleoplasm, Plasma membrane"		"CAB000143: , CAB001995: , HPA004765: AB_1079233"	"unprognostic (4.27e-1)"	"unprognostic (5.70e-3)"	"unprognostic (1.33e-1)"	"unprognostic (6.45e-3)"	"unprognostic (2.03e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.21e-2)"	"unprognostic (9.19e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.26e-3)"	"potential prognostic favorable (3.07e-6)"	"unprognostic (2.19e-2)"	"unprognostic (1.16e-1)"	"potential prognostic favorable (6.12e-4)"	"unprognostic (4.25e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.37e-2)"	"unprognostic (4.98e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.79e-2)"	"unprognostic (3.41e-2)"	"unprognostic (5.25e-3)"	"unprognostic (3.29e-2)"
NRP1	"CD304, NRP, VEGF165R"	ENSG00000099250	"Neuropilin 1"	O14786	10	33177492-33336262	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Angiogenesis, Differentiation, Host-virus interaction, Neurogenesis"	"Developmental protein, Heparin-binding, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 336.4;Endothelial cells: 161.7;Hofbauer cells: 118.8"	"Cell type enhanced"	"Detected in all"		"hippocampal CA4: 1340.3;hippocampal dentate gyrus: 669.1"	"Cancer enhanced"	"Detected in all"		"Kidney Renal Clear Cell Carcinoma (TCGA): 170.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	16	"plasmacytoid DC: 39.4"	"Lineage enriched"	"Detected in many"	16	"dendritic cells: 39.4"	"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Endothelial cells, Adipose visceral - Endothelial cells, Adrenal gland - Fibroblasts, Breast - Endothelial cells, Prostate - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004511, HPA030278"	Approved		Uncertain	Mitochondria	"Secreted in other tissues"	Receptor	NA	NA		560000000	"Cluster 8: Plasmacytoid DCs - Unknown function"	"Cluster 7: Adipose tissue - Mixed function"	"Cluster 29: Forebrain - Mixed function"	"Cluster 72: Neuronal - Signal transduction"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	31	Mitochondria		"CAB004511: AB_2282634, HPA030278: AB_10601976"	"unprognostic (1.03e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.50e-1)"	"potential prognostic unfavorable (2.16e-6)"	"unprognostic (2.32e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.37e-3)"	"unprognostic (2.91e-1)"	"unprognostic (2.74e-2)"	"unprognostic (3.99e-2)"	"validated prognostic favorable (4.67e-7)"	"validated prognostic favorable (4.70e-4)"	"unprognostic (1.42e-1)"	"unprognostic (8.80e-3)"	"unprognostic (3.60e-1)"	"unprognostic (1.66e-1)"	"potential prognostic unfavorable (1.36e-4)"	"unprognostic (2.31e-2)"	"unprognostic (3.57e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.15e-1)"	"potential prognostic unfavorable (1.01e-4)"	"unprognostic (8.75e-2)"	"unprognostic (9.60e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.83e-2)"	"potential prognostic unfavorable (3.33e-5)"	"unprognostic (9.02e-2)"	"unprognostic (2.75e-2)"	"unprognostic (3.49e-1)"
NT5E	"CALJA, CD73, eN, eNT, NT5"	ENSG00000135318	"5'-nucleotidase ecto"	P21589	6	85449584-85495791	"CD markers, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 108.6;retina: 91.5"	"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 62.3;Lymphatic endothelial cells: 88.9;Oligodendrocyte precursor cells: 57.5;Paneth cells: 56.8;Rod photoreceptor cells: 78.5"	"Group enriched"	"Detected in many"	4	"astrocyte: 61.5;committed oligodendrocyte precursor: 49.2;fibroblast: 112.0;oligodendrocyte precursor cell: 93.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 33.1;naive CD8 T-cell: 30.8"	"Group enriched"	"Detected in many"	41	"B-cells: 33.1;T-cells: 30.8"	"Cancer enhanced"	"Detected in all"		"Adrenocortical cancer: 320.3"	"Adipose subcutaneous - Adipose progenitor cells, Adipose visceral - Adipose progenitor cells, Breast - Fibroblasts, Heart muscle - Fibroblasts, Lung - Fibroblast_2, Skeletal muscle - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017357	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	Enzyme	NA	NA		2000000	"Cluster 34: B-cells - Unknown function"	"Cluster 41: Smooth muscle tissue - ECM organization"	"Cluster 44: Non-specific - Mixed function"	"Cluster 72: Neuronal - Signal transduction"	"Cluster 45: Non-specific - Mixed function"	7	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA017357: AB_1846330"	"unprognostic (7.12e-3)"	"unprognostic (1.13e-1)"	"unprognostic (9.12e-2)"	"unprognostic (3.44e-3)"	"unprognostic (6.64e-2)"	"unprognostic (2.23e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.75e-3)"	"unprognostic (8.83e-2)"	"potential prognostic favorable (2.14e-5)"	"unprognostic (2.03e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.67e-3)"	"unprognostic (1.03e-2)"	"unprognostic (2.46e-3)"	"unprognostic (2.28e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.74e-2)"	"potential prognostic unfavorable (1.51e-7)"	"unprognostic (2.37e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.66e-1)"	"potential prognostic unfavorable (2.06e-5)"	"unprognostic (3.77e-2)"	"potential prognostic unfavorable (5.50e-5)"	"unprognostic (2.43e-2)"	"unprognostic (3.23e-1)"	"unprognostic (8.28e-2)"
PDCD1	"CD279, hSLE1, PD-1, PD1, SLEB2"	ENSG00000188389	"Programmed cell death 1"	Q15116	2	241849884-241858894	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Adaptive immunity, Apoptosis, Immunity"		"FDA approved drug targets, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 6.5;lymphoid tissue: 15.7"	"Cell type enriched"	"Detected in some"	4	"T-cells: 34.1"	"Cell type enriched"	"Detected in single"	35	"leukocyte: 25.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"midbrain: 3.1"	"Group enriched"	"Detected in many"	5	"gdT-cell: 4.4;MAIT T-cell: 4.8;memory CD4 T-cell: 8.7;memory CD8 T-cell: 12.4;T-reg: 4.3"	"Lineage enriched"	"Detected in single"	55	"T-cells: 12.4"	"Cancer enhanced"	"Detected in some"		"breast cancer: 1.2;lymphoma: 1.6"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Adrenal gland - T-cells, Colon - T-cells, Liver - T-cells, Prostate - T-cells, Skin - T-cells, Thyroid gland - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035981, CAB038418, CAB076386"	Enhanced						NA	NA			"Cluster 9: T-regs - Cell cycle regulation"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 19: Astrocytes - Mixed function"	"Cluster 70: DU4475 - Unknown function"	"Cluster 78: NK-cells & T-cells - Immune system & Transcription"	10			"CAB038418: AB_1160824, CAB076386: AB_881954, HPA035981: AB_10669664"	"unprognostic (4.27e-2)"	"unprognostic (1.50e-2)"	"unprognostic (6.30e-3)"	"unprognostic (2.35e-3)"	"unprognostic (2.57e-2)"	"unprognostic (1.79e-1)"			"potential prognostic favorable (4.39e-4)"		"unprognostic (1.92e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.88e-3)"	"unprognostic (3.45e-1)"	"unprognostic (7.17e-3)"	"unprognostic (3.98e-1)"		"unprognostic (1.65e-1)"				"unprognostic (5.85e-2)"				"unprognostic (9.20e-2)"	"unprognostic (4.57e-3)"	"unprognostic (6.28e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.13e-2)"
PDCD1LG2	"B7-DC, bA574F11.2, Btdc, CD273, PD-L2, PDL2"	ENSG00000197646	"Programmed cell death 1 ligand 2"	Q9BQ51	9	5510531-5571282	"Cancer-related genes, CD markers, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 14.8"	"Cell type enhanced"	"Detected in some"		"Extravillous trophoblasts: 21.7;Fibroblasts: 7.3;granulocytes: 11.8;Langerhans cells: 13.9;Leydig cells: 6.8;Microglial cells: 11.6"	"Cell type enhanced"	"Detected in all"		"central nervous system macrophage: 36.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Breast - Fibroblasts, Kidney - Endothelial cells, Minor Salivary Gland - Fibroblasts, Prostate - Fibroblasts, Skeletal muscle - Fibroblasts"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA013411	Approved		Uncertain	Cytosol	"Secreted - unknown location"	Receptor	NA	NA		16000000	"Cluster 42: Non-specific - Vesicular transport"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 30: White matter - Myelination"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 14: Langerhans cells - Innate immune response"	21	Cytosol		"HPA013411: AB_1855102"	"unprognostic (1.99e-1)"	"unprognostic (9.52e-2)"	"unprognostic (3.44e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.96e-1)"	"unprognostic (8.40e-2)"	"unprognostic (8.52e-2)"		"potential prognostic favorable (3.72e-4)"	"unprognostic (1.11e-1)"			"unprognostic (1.48e-3)"	"unprognostic (1.68e-1)"	"unprognostic (8.98e-2)"	"unprognostic (9.24e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.11e-2)"	"unprognostic (6.39e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.61e-1)"		"unprognostic (8.62e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.38e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.37e-1)"	
PDGFRA	"CD140a, GAS9, PDGFR2"	ENSG00000134853	"Platelet derived growth factor receptor alpha"	P16234	4	54229280-54298245	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Chemotaxis, Host-virus interaction"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 193.9"	"Group enriched"	"Detected in many"	9	"Endometrial stromal cells: 368.4;Fibroblasts: 258.5;Leydig cells: 422.2;Oligodendrocyte precursor cells: 468.8;Ovarian stromal cells: 204.8;Peritubular cells: 377.5"	"Group enriched"	"Detected in some"	13	"fibroblast: 133.8;oligodendrocyte precursor cell: 320.9"	"Cancer enhanced"	"Detected in all"		"Glioblastoma Multiforme (TCGA): 101.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Rhabdoid: 78.7;thyroid cancer: 38.5"	"Adrenal gland - Fibroblasts, Breast - Fibroblasts, Heart muscle - Fibroblasts, Kidney - Fibroblasts, Minor Salivary Gland - Macrophages, Pituitary gland - Fibroblasts, Prostate - Fibroblasts, Spleen - Fibroblast_2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004947, CAB018143"	Supported		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cell Junctions,Primary cilium"	"Intracellular and membrane"	Receptor	NA	NA		290000		"Cluster 62: Connective tissue - ECM organization"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 44: Connective tissue cells - ECM organization"	"Cluster 53: Fibroblasts - ECM organization"	36	"Nucleoplasm, Plasma membrane"	"Nuclear bodies, Cell Junctions, Primary cilium"	"CAB018143: AB_2162351, HPA004947: AB_2732399"	"unprognostic (1.39e-1)"	"unprognostic (2.75e-1)"	"unprognostic (4.29e-1)"	"unprognostic (3.15e-2)"	"unprognostic (5.76e-2)"	"unprognostic (9.07e-2)"	"unprognostic (3.95e-1)"	"unprognostic (8.34e-3)"	"potential prognostic favorable (6.22e-5)"	"unprognostic (2.31e-1)"	"unprognostic (3.55e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.09e-3)"	"unprognostic (7.37e-2)"	"unprognostic (4.97e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.17e-2)"	"unprognostic (3.70e-3)"	"unprognostic (9.86e-2)"	"unprognostic (6.95e-2)"	"unprognostic (8.35e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.53e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.22e-2)"
PDGFRB	"CD140b, JTK12, PDGFR, PDGFR1"	ENSG00000113721	"Platelet derived growth factor receptor beta"	P09619	5	150113839-150155872	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters"	Chemotaxis	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 138.3;Leydig cells: 158.6;Peritubular cells: 202.3;Sertoli cells: 514.0;Smooth muscle cells: 264.7"	"Cell type enhanced"	"Detected in many"		"pericyte: 1272.1;vascular associated smooth muscle cell: 573.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 1.6"	"Low lineage specificity"	"Detected in single"			"Cancer enhanced"	"Detected in many"		"Adrenocortical cancer: 36.3;testis cancer: 35.2"	"Adipose subcutaneous - Adipose progenitor cells, Adipose visceral - Adipose progenitor cells, Adrenal gland - Fibroblasts, Kidney - Fibroblasts, Pituitary gland - Fibroblasts, Prostate - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003842, CAB018144, HPA028499"	Enhanced		Supported	"Golgi apparatus,Vesicles"			NA	NA		24000000	"Cluster 33: Non-specific - ATP binding"	"Cluster 7: Adipose tissue - Mixed function"	"Cluster 23: Choroid plexus - Mixed function"	"Cluster 44: Connective tissue cells - ECM organization"	"Cluster 48: Smooth muscle cells - Signal transduction"	59	Vesicles	"Golgi apparatus"	"CAB003842: AB_562328, CAB018144: AB_2162497, HPA028499: AB_10602018"	"unprognostic (2.32e-2)"	"unprognostic (5.35e-2)"	"unprognostic (7.84e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.22e-2)"	"unprognostic (9.09e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.21e-3)"	"potential prognostic unfavorable (5.35e-5)"	"unprognostic (1.18e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.43e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.85e-3)"	"unprognostic (1.34e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.00e-2)"	"unprognostic (6.30e-3)"	"unprognostic (7.20e-3)"	"unprognostic (2.45e-2)"	"unprognostic (9.92e-2)"	"unprognostic (6.78e-2)"
PECAM1	CD31	ENSG00000261371	"Platelet and endothelial cell adhesion molecule 1"	P16284	17	64319415-64413776	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Phagocytosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 439.6"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 681.6;Endothelial cells: 592.8;Lymphatic endothelial cells: 217.7;monocytes: 309.0;Plasma cells: 138.0"	"Cell type enhanced"	"Detected in many"		"central nervous system macrophage: 140.9;endothelial cell: 446.3;leukocyte: 107.9"	"Cancer enhanced"	"Detected in all"		"Kidney Renal Clear Cell Carcinoma (TCGA): 166.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"non-classical monocyte: 706.3"	"Low lineage specificity"	"Detected in all"			"Cancer enriched"	"Detected in many"	5	"Leukemia: 41.9"	"Adipose subcutaneous - Endothelial cells, Adipose visceral - Endothelial cells, Adrenal gland - Endothelial cells, Breast - Endothelial cells, Colon - Endothelial cells, Heart muscle - Endothelial cells, Kidney - Endothelial cells, Liver - Vascular Endothelial cells, Lung - Endothelial cells, Minor Salivary Gland - Endothelial cells, Pancreas - Endothelial cells, Pituitary gland - Endothelial cells, Prostate - Endothelial cells, Skeletal muscle - Endothelial cells, Skin - Endothelial cells, Stomach - Endothelial cells, Testis - Endothelial cells, Thyroid gland - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004690, HPA004871"	Enhanced		Approved	"Nucleoli,Plasma membrane"			NA	NA		66000000	"Cluster 37: Monocytes & Neutrophils - Innate immune response"	"Cluster 58: Placenta - Pregnancy"	"Cluster 47: Endothelial cells - Vasculature"	"Cluster 48: Adipocytes & Endothelial cells - Angiogenesis"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	66	"Nucleoli, Plasma membrane"		"HPA004690: AB_1078462, HPA004871: "	"unprognostic (1.07e-1)"	"unprognostic (3.74e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.38e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.42e-2)"		"unprognostic (2.23e-2)"	"unprognostic (1.01e-1)"	"validated prognostic favorable (1.17e-10)"	"validated prognostic favorable (6.17e-5)"	"potential prognostic unfavorable (7.07e-4)"	"unprognostic (2.02e-1)"	"unprognostic (8.94e-2)"	"unprognostic (1.09e-3)"	"unprognostic (6.36e-2)"	"unprognostic (5.17e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.52e-2)"		"unprognostic (2.20e-1)"		"unprognostic (1.32e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.35e-3)"	"unprognostic (8.33e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.84e-1)"
PI16	"CD364, dJ90K10.5, MGC45378, MSMBBP"	ENSG00000164530	"Peptidase inhibitor 16"	Q6UXB8	6	36948263-36964837	"CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		"Protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 135.5;heart muscle: 123.5;vagina: 123.4"	"Group enriched"	"Detected in many"	6	"Fibroblasts: 179.7;Leydig cells: 199.8;Oligodendrocytes: 62.7;Peritubular cells: 141.8"	"Cell type enhanced"	"Detected in many"		"ependymal cell: 28.7;fibroblast: 33.8;oligodendrocyte: 82.0"	"Cancer enhanced"	"Detected in many"		"Glioblastoma Multiforme (TCGA): 23.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 66.3"	"Lineage enriched"	"Detected in many"	5	"T-cells: 66.3"	"Cancer enriched"	"Detected in some"	12	"Kidney cancer: 17.7"	"Adipose subcutaneous - Adipose progenitor cells, Colon - Fibroblasts, Heart muscle - Fibroblasts, Minor Salivary Gland - Fibroblasts, Pancreas - Fibroblasts, Prostate - Fibroblasts, Skin - Fibroblast_1, Stomach - Fibroblasts, Thyroid gland - Fibroblasts"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	6	"spinal cord: 45.1"	HPA076574	Approved				"Secreted to blood"	"Enzyme inhibitor"	NA	NA		1900000000	"Cluster 9: T-regs - Cell cycle regulation"	"Cluster 41: Smooth muscle tissue - ECM organization"	"Cluster 13: Oligodendrocytes - Mixed function"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 53: Fibroblasts - ECM organization"	5			"HPA076574: AB_2732314"	"unprognostic (6.63e-2)"	"unprognostic (6.11e-2)"	"potential prognostic favorable (3.77e-4)"	"unprognostic (7.74e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.86e-1)"								"unprognostic (2.28e-1)"		"unprognostic (1.45e-2)"	"unprognostic (8.02e-2)"		"unprognostic (2.72e-2)"	"unprognostic (8.33e-2)"	"unprognostic (1.79e-2)"	"unprognostic (5.16e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.17e-1)"	"unprognostic (9.99e-2)"	
PLAUR	"CD87, UPAR, URKR"	ENSG00000011422	"Plasminogen activator, urokinase receptor"	Q03405	19	43646095-43670547	"Cancer-related genes, CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"bone marrow: 680.7"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 806.7;Langerhans cells: 2298.1;Macrophages: 885.5;monocytes: 3085.0"	"Cell type enhanced"	"Detected in all"		"central nervous system macrophage: 39.5;leukocyte: 49.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1177.3"	"Group enriched"	"Detected in all"	4	"granulocytes: 1177.3;monocytes: 553.8"	"Low cancer specificity"	"Detected in all"			"Thyroid gland - Neutrophils"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA050843, CAB073533"	Uncertain		Supported	"Plasma membrane"	"Intracellular and membrane"	Receptor	NA	NA		13000000	"Cluster 7: Non-specific - Innate immune response"	"Cluster 77: Bone marrow - Cell proliferation"	"Cluster 12: Non-specific - Vasculature"	"Cluster 72: Neuronal - Signal transduction"	"Cluster 29: Monocytes - Innate immune response"	5	"Plasma membrane"		"CAB073533: , HPA050843: AB_2681255"	"unprognostic (1.01e-1)"	"unprognostic (8.30e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.73e-3)"	"unprognostic (1.43e-1)"	"unprognostic (9.42e-2)"	"unprognostic (1.67e-3)"	"unprognostic (7.01e-3)"	"unprognostic (9.80e-3)"	"unprognostic (1.78e-1)"	"potential prognostic unfavorable (1.24e-6)"	"unprognostic (2.64e-2)"	"unprognostic (2.51e-1)"	"potential prognostic unfavorable (4.24e-5)"	"unprognostic (1.64e-1)"	"potential prognostic unfavorable (4.67e-4)"	"unprognostic (3.24e-3)"	"unprognostic (2.28e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.28e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.37e-3)"	"unprognostic (9.71e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.75e-3)"	"unprognostic (1.52e-2)"	"unprognostic (8.71e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.52e-2)"	"unprognostic (6.37e-2)"
PLXNC1	"CD232, VESPR"	ENSG00000136040	"Plexin C1"	O60486	12	94148577-94307675	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 54.8;Macrophages: 64.7;Melanocytes: 166.6;monocytes: 119.2"	"Cell type enhanced"	"Detected in all"		"fibroblast: 346.8"	"Cancer enhanced"	"Detected in all"		"Skin Cuteneous Melanoma (TCGA): 51.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 16.5"	"Group enriched"	"Detected in all"	4	"granulocytes: 16.5;monocytes: 8.7"	"Cancer enhanced"	"Detected in many"		"Myeloma: 34.9;skin cancer: 21.8"	"Skin - Melanocytes, Spleen - Neutrophils, Testis - Sertoli cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066899			Approved	Mitochondria			NA	NA		74000	"Cluster 7: Non-specific - Innate immune response"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 56: Hypothalamus - Neuropeptide signaling"	"Cluster 9: Skin cancer - Melanin biosynthesis"	"Cluster 74: Neutrophils - Degranulation"	2	Mitochondria		"HPA066899: AB_2685743"	"unprognostic (1.80e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.21e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.92e-3)"	"unprognostic (1.35e-1)"	"unprognostic (5.36e-2)"	"unprognostic (7.63e-3)"	"unprognostic (8.56e-2)"	"unprognostic (2.21e-2)"	"unprognostic (7.10e-3)"	"unprognostic (6.25e-2)"	"unprognostic (2.10e-2)"	"unprognostic (8.12e-3)"	"potential prognostic unfavorable (9.44e-5)"	"unprognostic (2.57e-3)"	"unprognostic (3.39e-1)"	"unprognostic (2.67e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.20e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.55e-2)"
PRNP	"AltPrP, CD230, CJD, GSS, PRIP, PRP"	ENSG00000171867	"Prion protein"	P04156	20	4686350-4701590	"CD markers, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell cycle, Growth arrest"	Prion	"Amyloidosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 494.3"	"Cell type enhanced"	"Detected in all"		"monocytes: 457.0;Schwann cells: 409.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	9	"basophil: 879.6"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 879.6"	"Low cancer specificity"	"Detected in all"			"Breast - Breast myoepithelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042754, HPA043398"	Enhanced		Approved	"Nuclear membrane,Vesicles,Cytosol"			NA	Yes		5200000	"Cluster 41: Basophils - Unknown function"	"Cluster 60: Choroid plexus - Transmembrane transport"	"Cluster 23: Choroid plexus - Mixed function"	"Cluster 69: Skin cancer - ECM organization"	"Cluster 26: Schwann cells & Melanocytes - Mixed function"	73	"Nuclear membrane, Cytosol"	Vesicles	"HPA042754: AB_10964203, HPA043398: AB_2678461"	"unprognostic (6.95e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.13e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.49e-3)"	"unprognostic (2.00e-3)"	"unprognostic (5.66e-3)"	"unprognostic (4.30e-2)"	"potential prognostic favorable (3.02e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.44e-1)"	"potential prognostic unfavorable (4.78e-6)"	"unprognostic (1.11e-3)"	"unprognostic (1.30e-1)"	"unprognostic (6.04e-2)"	"unprognostic (1.84e-2)"	"potential prognostic unfavorable (2.81e-4)"	"unprognostic (5.09e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.37e-2)"
PROCR	"CCD41, CD201, EPCR"	ENSG00000101000	"Protein C receptor"	Q9UNN8	20	35172072-35216240	"Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Blood coagulation, Hemostasis"	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 122.7"	"Cell type enriched"	"Detected in many"	4	"Mesothelial cells: 659.6"	"Cell type enhanced"	"Detected in all"		"central nervous system macrophage: 51.7;endothelial cell: 66.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 14.8"	"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Minor Salivary Gland - Endothelial cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA039461	Enhanced						NA	NA		530000000	"Cluster 33: Non-specific - ATP binding"	"Cluster 7: Adipose tissue - Mixed function"	"Cluster 6: Non-specific - Immune response"	"Cluster 48: Adipocytes & Endothelial cells - Angiogenesis"	"Cluster 53: Fibroblasts - ECM organization"	1			"HPA039461: AB_10673359"	"unprognostic (2.04e-1)"	"unprognostic (3.22e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.30e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.87e-3)"	"unprognostic (6.11e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.68e-3)"	"unprognostic (8.57e-3)"	"unprognostic (1.14e-1)"	"unprognostic (7.52e-2)"	"unprognostic (2.54e-2)"	"unprognostic (8.08e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.43e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.74e-2)"	"unprognostic (3.85e-2)"	"unprognostic (8.42e-2)"	"unprognostic (4.53e-3)"	"unprognostic (7.66e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.73e-2)"
PROM1	"AC133, CD133, CORD12, MCDR2, PROML1, RP41, STGD4"	ENSG00000007062	"Prominin 1"	O43490	4	15963076-16084378	"CD markers, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Cone-rod dystrophy, Disease variant, Retinitis pigmentosa, Stargardt disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"retina: 264.6"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 300.7;Mucus glandular cells: 169.5;Rod photoreceptor cells: 329.2"	"Group enriched"	"Detected in many"	4	"endothelial cell: 166.7;ependymal cell: 43.0;oligodendrocyte precursor cell: 58.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Uterine cancer: 32.2"	"Lung - Respiratory ciliated cells, Minor Salivary Gland - Minor salivary glandular cells, Skin - Eccrine sweat gland cells, Testis - Early spermatids, Testis - Late spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004922, CAB011525, HPA031053, CAB080375, CAB080376"	Enhanced		Approved	"Plasma membrane"			NA	NA		53000		"Cluster 76: Retina - Visual perception"	"Cluster 47: Endothelial cells - Vasculature"	"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 66: Photoreceptor cells - Visual perception"	7	"Plasma membrane"		"CAB011525: AB_470302, CAB080375: , CAB080376: , HPA004922: AB_1846238, HPA031053: AB_2673713"	"unprognostic (3.11e-2)"	"unprognostic (9.79e-2)"	"unprognostic (4.24e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.17e-3)"	"unprognostic (1.69e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.10e-2)"	"unprognostic (3.42e-3)"	"potential prognostic favorable (2.33e-5)"	"unprognostic (1.10e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.14e-3)"	"unprognostic (2.83e-2)"	"unprognostic (3.33e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.59e-1)"	"unprognostic (9.12e-2)"	"unprognostic (2.75e-1)"
PSG1	"CD66f, PBG1, PSBG1, PSGGA"	ENSG00000231924	"Pregnancy specific beta-1-glycoprotein 1"	P11464	19	42866464-42879822	"CD markers, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	397	"placenta: 252.6"	"Cell type enriched"	"Detected in some"	92	"Syncytiotrophoblasts: 200.2"	"Low cell type specificity"	"Detected in some"			"Cancer enhanced"	"Detected in some"		"Thyroid Carcinoma (TCGA): 2.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"thyroid cancer: 173.3"										HPA046327	Supported				"Secreted in female reproductive system"	"No annotated function"	NA	NA		43000000		"Cluster 58: Placenta - Pregnancy"	"Cluster 10: Cerebellum - Nucleic acid binding"	"Cluster 72: Neuronal - Signal transduction"	"Cluster 27: Syncytiotrophoblasts - Pregnancy"	1			"HPA046327: AB_2679624"	"unprognostic (6.77e-2)"																													"unprognostic (2.78e-2)"	
PTGDR2	"CD294, CRTH2, DP2, GPR44"	ENSG00000183134	"Prostaglandin D2 receptor 2"	Q9Y5Y4	11	60850933-60855950	"CD markers, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 8.0;skeletal muscle: 7.1;stomach 1: 9.0"	"Cell type enhanced"	"Detected in some"		"Fibroblasts: 2.7;granulocytes: 3.3;Intestinal goblet cells: 2.3;Langerhans cells: 2.7;Microglial cells: 1.8;monocytes: 7.6;Muller glia cells: 2.3;Smooth muscle cells: 3.5"	"Cell type enriched"	"Detected in some"	6	"pericyte: 135.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"basophil: 178.8;eosinophil: 234.5"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 234.5"	"Cancer enriched"	"Detected in single"	6	"Leukemia: 3.4"	"Liver - Hepatocytes, Pancreas - Alpha cells, Pancreas - Beta cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA014259	Uncertain						NA	NA			"Cluster 36: Eosinophils - Protein ubiquitination"	"Cluster 23: Non-specific - Cellular respiration"	"Cluster 47: Endothelial cells - Vasculature"	"Cluster 59: Leukemia - T-cell receptor"	"Cluster 48: Smooth muscle cells - Signal transduction"				"HPA014259: AB_1849304"						"unprognostic (6.76e-2)"		"unprognostic (5.34e-3)"						"unprognostic (1.05e-1)"								"unprognostic (6.57e-3)"				"unprognostic (4.03e-2)"					
PTGFRN	"CD315, CD9P-1, EWI-F, FLJ11001, FPRP, KIAA1436, SMAP-6"	ENSG00000134247	"Prostaglandin F2 receptor inhibitor"	Q9P2B2	1	116909916-116990353	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 57.6;Cardiomyocytes: 70.0"	"Cell type enhanced"	"Detected in many"		"oligodendrocyte precursor cell: 60.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Adipose subcutaneous - Adipose progenitor cells, Breast - Breast myoepithelial cells, Colon - Smooth muscle cells, Lung - Fibroblast_2, Skeletal muscle - Fibroblasts, Thyroid gland - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017074	Approved						NA	NA		410000		"Cluster 41: Smooth muscle tissue - ECM organization"	"Cluster 23: Choroid plexus - Mixed function"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 45: Non-specific - Mixed function"	24			"HPA017074: AB_1855888"	"unprognostic (3.85e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.49e-2)"	"unprognostic (1.49e-3)"	"unprognostic (3.07e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.11e-1)"	"potential prognostic unfavorable (7.75e-4)"	"unprognostic (7.28e-2)"	"unprognostic (6.30e-3)"	"unprognostic (8.44e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.25e-1)"	"unprognostic (2.34e-3)"	"unprognostic (1.69e-2)"	"unprognostic (3.03e-3)"	"unprognostic (6.88e-2)"	"unprognostic (4.76e-2)"	"unprognostic (8.73e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.78e-3)"	"unprognostic (3.82e-1)"	"unprognostic (1.76e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.72e-1)"	"unprognostic (5.53e-2)"	"unprognostic (2.76e-1)"
PTPRC	"CD45, GP180, LCA, T200"	ENSG00000081237	"Protein tyrosine phosphatase receptor type C"	P08575	1	198638457-198757476	"Cancer-related genes, CD markers, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Hydrolase, Protein phosphatase"	"Cancer-related genes, Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 286.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 499.8;Macrophages: 517.0;monocytes: 1920.1;NK-cells: 1334.0;T-cells: 1095.2"	"Group enriched"	"Detected in many"	14	"central nervous system macrophage: 1145.9;leukocyte: 3019.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Leukemia: 84.8;lymphoma: 127.0"	"Adipose visceral - T-cells, Adrenal gland - Macrophages, Breast - T-cells, Kidney - T-cells, Lung - NK-cells (Lung), Skin - T-cells, Thyroid gland - T-cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000052, HPA000440, CAB002800, CAB056154, CAB068221, CAB080251"	Enhanced		Uncertain	Nucleoplasm,Vesicles	"Intracellular and membrane"	Enzyme	NA	NA		17000000	"Cluster 28: Neutrophils - Unknown function"	"Cluster 36: Lymphoid tissue - Cytokine signaling"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 78: NK-cells & T-cells - Immune system & Transcription"	15	"Nucleoplasm, Vesicles"		"CAB000052: AB_2314143, CAB002800: AB_2237910, CAB056154: AB_2665572, CAB068221: AB_2665571, CAB080251: , HPA000440: AB_611377"	"unprognostic (3.82e-2)"	"unprognostic (6.75e-2)"	"unprognostic (3.07e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.30e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.11e-2)"	"potential prognostic favorable (5.92e-5)"	"unprognostic (1.53e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.83e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.12e-2)"	"unprognostic (3.72e-2)"	"potential prognostic unfavorable (9.56e-4)"	"unprognostic (4.00e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.66e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.35e-1)"
PTPRJ	"CD148, DEP1, HPTPeta"	ENSG00000149177	"Protein tyrosine phosphatase receptor type J"	Q12913	11	47980425-48170839	"CD markers, Enzymes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	Angiogenesis	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 160.4;Microglial cells: 180.7;monocytes: 104.5;Oligodendrocyte precursor cells: 225.0;Oligodendrocytes: 156.1"	"Cell type enhanced"	"Detected in all"		"central nervous system macrophage: 1249.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 9.5"	"Group enriched"	"Detected in many"	4	"granulocytes: 9.5;monocytes: 4.8"	"Low cancer specificity"	"Detected in all"			"Adipose visceral - Macrophages, Adrenal gland - Macrophages, Lung - Neutrophil_2, Prostate - Prostate glandular cells, Testis - Spermatogonia"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006026	Approved		Approved	"Nucleoplasm,Nucleoli,Nuclear bodies,Cell Junctions"	"Secreted to blood"	Enzyme	NA	NA		400000000	"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 12: Non-specific - Vasculature"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 69: Neurons - Neuronal signaling"	21	"Nucleoplasm, Cell Junctions"	"Nucleoli, Nuclear bodies"	"HPA006026: AB_1078446"	"unprognostic (2.18e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.25e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.44e-3)"	"unprognostic (8.84e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.61e-1)"	"potential prognostic favorable (2.50e-4)"	"unprognostic (1.91e-2)"	"unprognostic (2.12e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.64e-2)"	"unprognostic (3.10e-1)"	"unprognostic (3.31e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.22e-2)"	"unprognostic (4.98e-2)"	"unprognostic (3.13e-1)"
PVR	"CD155, HVED, Necl-5, NECL5, PVS, Tage4"	ENSG00000073008	"PVR cell adhesion molecule"	P15151	19	44643798-44666162	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 51.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 4.4;intermediate monocyte: 4.4;myeloid DC: 3.6;neutrophil: 1.4;non-classical monocyte: 5.1"	"Group enriched"	"Detected in many"	4	"dendritic cells: 3.6;granulocytes: 1.4;monocytes: 5.1"	"Low cancer specificity"	"Detected in all"			"Adrenal gland - Adrenal cortex cells, Spleen - Fibroblast_1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012568, HPA064739"	Approved		Supported	"Nucleoplasm,Vesicles,Plasma membrane"	"Secreted - unknown location"	Receptor	NA	NA		450000000	"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 43: Non-specific - Mitochondrial translation"	"Cluster 56: Hypothalamus - Neuropeptide signaling"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 45: Non-specific - Mixed function"	58	"Nucleoplasm, Vesicles, Plasma membrane"		"HPA012568: AB_1846248, HPA064739: "	"unprognostic (2.97e-2)"	"unprognostic (2.42e-3)"	"unprognostic (1.30e-1)"	"potential prognostic unfavorable (1.01e-4)"	"unprognostic (6.93e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.77e-3)"	"unprognostic (4.32e-1)"	"unprognostic (4.41e-2)"	"unprognostic (9.65e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.44e-2)"	"potential prognostic unfavorable (5.78e-6)"	"unprognostic (1.01e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.75e-3)"	"unprognostic (2.53e-3)"	"unprognostic (7.85e-2)"	"unprognostic (1.38e-2)"	"unprognostic (5.42e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.76e-2)"	"unprognostic (3.53e-3)"	"unprognostic (1.74e-1)"
RHAG	"CD241, RH50A, SLC42A1"	ENSG00000112077	"Rh associated glycoprotein"	Q02094	6	49605175-49636839	"CD markers, Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ammonia transport, Transport"		"Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	55	"bone marrow: 117.8"	"Cell type enriched"	"Detected in some"	16	"Erythroid cells: 366.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	6	"Leukemia: 107.7"	"Liver - Erythroid cells, Lung - Neutrophil_1, Spleen - Erythrocytes"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA046051, HPA055331"	Approved		Approved	"Endoplasmic reticulum"			NA	NA				"Cluster 6: Bone marrow - Innate immune response"		"Cluster 47: Leukemia - Hemostasis"	"Cluster 1: Erythroid cells - Oxygen transport"	5	"Endoplasmic reticulum"		"HPA046051: , HPA055331: AB_2682785"																															
RHCE	"CD240CE, RH"	ENSG00000188672	"Rh blood group CcEe antigens"	P18577	1	25362249-25430192	"Blood group antigen proteins, CD markers, Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"bone marrow: 47.8"	"Cell type enriched"	"Detected in some"	33	"Erythroid cells: 254.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	5	"Leukemia: 5.4"	"Minor Salivary Gland - Minor salivary glandular cells, Spleen - Erythrocytes"									"HPA060951, HPA077385"	Supported		Uncertain	"Nucleoplasm,Plasma membrane"			NA	NA			"Cluster 41: Basophils - Unknown function"	"Cluster 6: Bone marrow - Innate immune response"	"Cluster 13: Oligodendrocytes - Mixed function"	"Cluster 47: Leukemia - Hemostasis"	"Cluster 1: Erythroid cells - Oxygen transport"		"Nucleoplasm, Plasma membrane"		"HPA060951: , HPA077385: "		"unprognostic (4.87e-2)"	"unprognostic (4.98e-1)"				"unprognostic (2.49e-3)"	"unprognostic (2.05e-1)"						"unprognostic (8.61e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.86e-2)"	"unprognostic (1.61e-1)"			"unprognostic (6.98e-2)"	"unprognostic (1.42e-3)"			"unprognostic (3.32e-2)"			"unprognostic (9.64e-2)"		"unprognostic (1.09e-2)"		"unprognostic (2.35e-1)"
RHD	"CD240D, DIIIc, RH, Rh30a, Rh4, RhII, RhPI"	ENSG00000187010	"Rh blood group D antigen"	Q02161	1	25272393-25330445	"Blood group antigen proteins, CD markers, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"		"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"bone marrow: 15.5"	"Cell type enriched"	"Detected in some"	15	"Erythroid cells: 104.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 6.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.0"	"Cancer enriched"	"Detected in single"	4	"Leukemia: 3.0"	"Minor Salivary Gland - Minor salivary glandular cells"									"HPA060951, HPA077385"	Supported		Uncertain	"Nucleoplasm,Plasma membrane"			NA	NA			"Cluster 35: Neutrophils - Protein binding"	"Cluster 6: Bone marrow - Innate immune response"	"Cluster 48: Non-specific - Mixed function"	"Cluster 47: Leukemia - Hemostasis"	"Cluster 1: Erythroid cells - Oxygen transport"	1	"Nucleoplasm, Plasma membrane"		"HPA060951: , HPA077385: "			"unprognostic (7.23e-2)"			"unprognostic (6.75e-2)"																				"unprognostic (3.51e-2)"		"unprognostic (7.54e-2)"			"unprognostic (7.03e-3)"
S1PR1	"CD363, D1S3362, edg-1, EDG1"	ENSG00000170989	"Sphingosine-1-phosphate receptor 1"	P21453	1	101236865-101243713	"Cancer-related genes, CD markers, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Angiogenesis, Chemotaxis"	"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 257.8;Endothelial cells: 150.8;Lymphatic endothelial cells: 76.8;NK-cells: 57.4"	"Group enriched"	"Detected in some"	6	"astrocyte: 43.8;bergmann glia: 82.6;endothelial cell: 85.0;leukocyte: 21.3"	"Cancer enhanced"	"Detected in all"		"Kidney Renal Clear Cell Carcinoma (TCGA): 58.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 1252.2"	"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Adipose subcutaneous - Endothelial cells, Adipose visceral - Endothelial cells, Breast - Endothelial cells, Colon - Endothelial cells, Heart muscle - Endothelial cells, Kidney - Endothelial cells, Lung - Endothelial cells, Minor Salivary Gland - Endothelial cells, Pancreas - Endothelial cells, Pituitary gland - Endothelial cells, Prostate - Endothelial cells, Skeletal muscle - Endothelial cells, Skin - Endothelial cells, Stomach - Endothelial cells, Testis - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010104, HPA075568"	Supported		Supported	Vesicles			No	NA			"Cluster 5: Non-specific - Cell proliferation"	"Cluster 7: Adipose tissue - Mixed function"	"Cluster 19: Astrocytes - Mixed function"	"Cluster 48: Adipocytes & Endothelial cells - Angiogenesis"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	56	Vesicles		"CAB010104: AB_2238920, HPA075568: AB_2686758"	"unprognostic (1.40e-1)"	"unprognostic (2.82e-1)"	"unprognostic (7.69e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.32e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.97e-1)"	"unprognostic (4.16e-3)"	"unprognostic (1.27e-3)"	"unprognostic (1.87e-1)"	"validated prognostic favorable (1.94e-9)"	"validated prognostic favorable (6.68e-4)"	"unprognostic (1.38e-2)"	"unprognostic (4.46e-3)"	"unprognostic (1.04e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.68e-2)"	"unprognostic (9.71e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.40e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.56e-2)"	"unprognostic (4.92e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.28e-1)"
SDC1	"CD138, SDC, SYND1, syndecan"	ENSG00000115884	"Syndecan 1"	P18827	2	20200797-20225433	"Cancer-related genes, CD markers, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 477.8;liver: 472.9;skin 1: 433.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 232.8;Cholangiocytes: 259.5;Hepatocytes: 515.2;Squamous epithelial cells: 275.0;Suprabasal keratinocytes: 456.1;Syncytiotrophoblasts: 421.4"	"Cell type enhanced"	"Detected in some"		"ependymal cell: 3.8;thalamic excitatory: 2.1"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"midbrain: 36.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in all"		"Gallbladder cancer: 564.7"	"Colon - Colon enterocytes, Lung - Alveolar cells type 2, Spleen - Plasma cells, Stomach - Gastric mucous cells, Testis - Spermatogonia"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002424, HPA006185, HPA067477"	Enhanced		Approved	"Focal adhesion sites"	"Secreted to blood"	"No annotated function"	NA	NA	63100000	4200000	"Cluster 17: B-cells - Immunoglobulins"	"Cluster 37: Liver & Intestine - Lipid metabolism"	"Cluster 41: Monoamines - Neurotransmitter signalling"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 12: Squamous epithelial cells - Keratinization"	18	"Focal adhesion sites"		"CAB002424: AB_442050, HPA006185: AB_1857705, HPA067477: "	"unprognostic (3.16e-1)"	"potential prognostic unfavorable (7.54e-5)"	"unprognostic (5.32e-2)"	"unprognostic (2.43e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.50e-2)"	"unprognostic (3.01e-3)"	"unprognostic (1.03e-1)"	"unprognostic (3.24e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.70e-2)"	"potential prognostic unfavorable (9.01e-4)"	"unprognostic (1.07e-1)"	"unprognostic (8.20e-2)"	"unprognostic (5.48e-2)"	"unprognostic (6.85e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.18e-2)"	"unprognostic (5.42e-2)"	"potential prognostic unfavorable (4.54e-4)"	"unprognostic (4.34e-1)"	"unprognostic (3.20e-1)"	"unprognostic (9.15e-2)"	"unprognostic (8.17e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.01e-1)"
SDC2	"CD362, fibroglycan, HSPG, HSPG1, SYND2"	ENSG00000169439	"Syndecan 2"	P34741	8	96493813-96611790	"CD markers, Predicted membrane proteins"	"Differentiation, Neurogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 445.9;thyroid gland: 411.6"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 181.0;Granulosa cells: 211.1;Hepatocytes: 227.8;Langerhans cells: 157.5;Ovarian stromal cells: 200.2"	"Cell type enhanced"	"Detected in all"		"bergmann glia: 209.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	7	"neutrophil: 13.7"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 13.7"	"Low cancer specificity"	"Detected in many"			"Colon - Fibroblasts, Liver - Hepatocytes, Minor Salivary Gland - Fibroblasts, Skeletal muscle - Fibroblasts, Spleen - Fibroblast_1, Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025123, HPA068532, HPA074427"	Uncertain		Enhanced	"Plasma membrane"			NA	NA			"Cluster 21: Neutrophils - Unknown function"	"Cluster 1: Liver & Kidney - Metabolism"	"Cluster 21: Non-specific - Metabolism"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 53: Fibroblasts - ECM organization"	54	"Plasma membrane"		"CAB025123: , HPA068532: , HPA074427: "	"unprognostic (6.47e-3)"	"unprognostic (2.22e-1)"	"unprognostic (2.37e-3)"	"unprognostic (1.43e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.02e-3)"	"potential prognostic unfavorable (8.09e-4)"	"unprognostic (3.09e-2)"	"unprognostic (5.69e-3)"	"potential prognostic favorable (1.36e-6)"	"unprognostic (2.12e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.25e-3)"	"unprognostic (1.52e-1)"	"unprognostic (7.45e-2)"	"unprognostic (1.43e-2)"	"unprognostic (6.05e-3)"	"unprognostic (8.86e-2)"	"unprognostic (2.07e-2)"	"unprognostic (9.98e-2)"	"unprognostic (5.76e-2)"	"unprognostic (7.68e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.14e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.42e-2)"	"unprognostic (7.57e-2)"
SELE	"CD62E, ELAM, ELAM1, ESEL"	ENSG00000007908	"Selectin E"	P16581	1	169722640-169764705	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"urinary bladder: 54.0"	"Cell type enriched"	"Detected in many"	13	"Endothelial cells: 637.0"	"Cell type enriched"	"Detected in some"	27	"endothelial cell: 45.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"				"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB002143	Enhanced						NA	NA		120000000		"Cluster 62: Connective tissue - ECM organization"	"Cluster 12: Non-specific - Vasculature"	"Cluster 27: Breast cancer - Unknown function"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	3			"CAB002143: AB_563608"	"unprognostic (1.21e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.74e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.20e-2)"		"unprognostic (1.07e-2)"	"unprognostic (5.84e-2)"	"unprognostic (4.77e-2)"	"potential prognostic favorable (2.54e-4)"	"unprognostic (2.41e-3)"			"potential prognostic favorable (1.02e-4)"	"unprognostic (2.23e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.64e-1)"			"unprognostic (1.35e-1)"	"unprognostic (4.40e-1)"	"unprognostic (2.00e-2)"	"unprognostic (8.03e-2)"	"unprognostic (9.39e-3)"	"unprognostic (4.51e-1)"	"unprognostic (1.02e-2)"		"unprognostic (1.67e-2)"	
SELL	"CD62L, hLHRc, LAM-1, LAM1, Leu-8, LNHR, LSEL, Lyam-1, LYAM1, PLNHR"	ENSG00000188404	"Selectin L"	P14151	1	169690665-169711702	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 148.8;lymphoid tissue: 225.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 216.9;dendritic cells: 367.1;Kupffer cells: 81.4;Macrophages: 66.8;NK-cells: 87.5;T-cells: 103.0"	"Cell type enriched"	"Detected in some"	5	"leukocyte: 58.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Leukemia: 34.0;lymphoma: 29.2;Myeloma: 15.1"	"Adipose visceral - Neutrophils, Heart muscle - Neutrophils, Liver - Neutrophils, Lung - Neutrophil_2, Skeletal muscle - Neutrophils, Spleen - Neutrophils"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB002144, HPA051972"	Enhanced		Uncertain	Cytosol			NA	NA		2800000000	"Cluster 35: Neutrophils - Protein binding"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 28: Oligodendrocytes - Mixed function"	"Cluster 55: Lymphoma - Immune response"	"Cluster 74: Neutrophils - Degranulation"	1	Cytosol		"CAB002144: AB_563862, HPA051972: AB_2797242"	"unprognostic (7.76e-2)"	"potential prognostic favorable (7.41e-4)"	"unprognostic (1.73e-2)"	"potential prognostic favorable (9.69e-4)"	"unprognostic (3.55e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.89e-3)"	"unprognostic (1.75e-3)"	"unprognostic (1.57e-3)"	"unprognostic (4.17e-2)"	"unprognostic (4.09e-2)"	"unprognostic (2.29e-1)"	"potential prognostic unfavorable (5.33e-4)"	"potential prognostic favorable (5.49e-4)"	"unprognostic (1.47e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.86e-2)"	"unprognostic (6.18e-2)"	"unprognostic (8.00e-2)"	"unprognostic (3.70e-3)"	"unprognostic (4.41e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.78e-2)"	"unprognostic (7.24e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.97e-2)"	"unprognostic (2.05e-2)"	"unprognostic (7.77e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.85e-1)"
SELP	"CD62, CD62P, GMP140, GRMP, PADGEM, PSEL"	ENSG00000174175	"Selectin P"	P16109	1	169588849-169630193	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 24.6;Endothelial cells: 48.0;Smooth muscle cells: 9.4"	"Cell type enhanced"	"Detected in many"		"endothelial cell: 5.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"choroid plexus: 8.2"	"Immune cell enhanced"	"Detected in some"		"basophil: 8.2;T-reg: 8.8"	"Group enriched"	"Detected in many"	7	"granulocytes: 8.2;T-cells: 8.8"	"Cancer enriched"	"Detected in single"	5	"Leukemia: 2.9"	"Breast - Endothelial cells, Colon - Endothelial cells, Minor Salivary Gland - Endothelial cells, Prostate - Endothelial cells, Skin - Endothelial cells, Spleen - Platelets"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB002145, HPA002655, HPA005990"	Enhanced						NA	NA		300000000	"Cluster 35: Neutrophils - Protein binding"	"Cluster 62: Connective tissue - ECM organization"	"Cluster 23: Choroid plexus - Mixed function"	"Cluster 47: Leukemia - Hemostasis"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	2			"CAB002145: AB_563984, HPA002655: AB_1078480, HPA005990: AB_1078479"	"unprognostic (1.84e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.42e-3)"	"unprognostic (3.20e-1)"	"unprognostic (1.21e-1)"			"potential prognostic favorable (2.91e-4)"	"unprognostic (2.72e-1)"	"validated prognostic favorable (9.05e-7)"	"validated prognostic favorable (7.30e-5)"	"unprognostic (3.45e-2)"		"potential prognostic favorable (1.11e-4)"	"unprognostic (4.47e-3)"	"unprognostic (3.29e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.30e-1)"			"unprognostic (9.44e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.58e-2)"		"unprognostic (6.80e-2)"	"unprognostic (3.87e-2)"
SELPLG	"CD162, PSGL-1"	ENSG00000110876	"Selectin P ligand"	Q14242	12	108621895-108633894	"Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 84.5"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 291.1;Kupffer cells: 82.9;Macrophages: 64.0;monocytes: 224.8;NK-cells: 163.3;T-cells: 70.8"	"Group enriched"	"Detected in some"	57	"central nervous system macrophage: 162.9;leukocyte: 71.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"Leukemia: 73.4;Myeloma: 231.6"	"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Colon - Macrophages, Heart muscle - Macrophages, Kidney - Macrophages, Liver - Kupffer cells, Minor Salivary Gland - Macrophages, Pancreas - Macrophages, Skeletal muscle - Macrophages, Spleen - Neutrophils, Stomach - Macrophages, Thyroid gland - Macrophages"	"Low region specificity"	"Detected in all"							"CAB002431, HPA011256, HPA069062"	Enhanced		Approved	Vesicles			NA	NA		17000000	"Cluster 35: Neutrophils - Protein binding"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 19: NK-cells - Adaptive immune response"	3	Vesicles		"CAB002431: AB_563509, HPA011256: , HPA069062: "	"unprognostic (3.56e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.64e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.06e-1)"	"potential prognostic favorable (9.12e-4)"	"unprognostic (1.03e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.80e-1)"	"unprognostic (8.40e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.26e-2)"	"unprognostic (4.22e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.51e-2)"	"unprognostic (3.24e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.74e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.61e-2)"	"unprognostic (3.85e-2)"	"unprognostic (8.63e-3)"	"unprognostic (2.34e-2)"	"unprognostic (3.75e-2)"	"unprognostic (5.63e-3)"	"unprognostic (6.18e-2)"
SEMA4D	"C9orf164, CD100, coll-4, FLJ39737, SEMAJ"	ENSG00000187764	"Semaphorin 4D"	Q92854	9	89360787-89498130	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 325.4"	"Cell type enhanced"	"Detected in many"		"monocytes: 78.3;NK-cells: 104.8;Oligodendrocytes: 289.0;T-cells: 97.0"	"Group enriched"	"Detected in all"	4	"central nervous system macrophage: 286.4;committed oligodendrocyte precursor: 512.8;leukocyte: 361.0;oligodendrocyte: 549.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"Leukemia: 47.6"	"Adipose subcutaneous - T-cells, Colon - T-cells, Skin - Keratinocyte (granular), Testis - Spermatogonia"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015662, HPA023277"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Primary cilium transition zone,Centrosome,Basal body"			NA	NA		6000000	"Cluster 21: Neutrophils - Unknown function"	"Cluster 9: Oligodendrocytes - Myelination"	"Cluster 30: White matter - Myelination"	"Cluster 59: Leukemia - T-cell receptor"	"Cluster 7: T-cells - T-cell receptor"	7	"Vesicles, Plasma membrane, Basal body"	"Nucleoplasm, Primary cilium transition zone, Centrosome"	"HPA015662: AB_1856671, HPA023277: AB_1856672"	"unprognostic (3.04e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.62e-2)"	"unprognostic (2.60e-1)"	"unprognostic (7.72e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.51e-2)"	"potential prognostic favorable (7.28e-5)"	"unprognostic (1.15e-2)"	"unprognostic (6.21e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.53e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.13e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.82e-1)"	"unprognostic (5.16e-2)"	"unprognostic (4.96e-2)"	"unprognostic (2.94e-2)"	"unprognostic (6.56e-2)"	"unprognostic (6.53e-2)"	"unprognostic (4.42e-3)"	"unprognostic (2.93e-2)"	"unprognostic (6.61e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.68e-1)"	"unprognostic (4.19e-2)"
SEMA7A	"CD108, H-Sema-L, SEMAL"	ENSG00000138623	"Semaphorin 7A (John Milton Hagen blood group)"	O75326	15	74409289-74433958	"Blood group antigen proteins, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Differentiation, Inflammatory response, Neurogenesis"	"Developmental protein"	"Disease variant, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 63.7;lymphoid tissue: 58.7"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 47.6;dendritic cells: 120.4;Extravillous trophoblasts: 64.0;Rod photoreceptor cells: 51.5;Syncytiotrophoblasts: 173.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"basophil: 1.8;eosinophil: 3.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.1"	"Low cancer specificity"	"Detected in all"			"Pituitary gland - Gonadotropes, Prostate - Endothelial cells, Skin - Keratinocyte (granular), Testis - Sertoli cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008210, HPA042273"	Uncertain		Uncertain	Vesicles			NA	NA		24000000	"Cluster 22: Eosinophils - Transcription"	"Cluster 9: Oligodendrocytes - Myelination"	"Cluster 30: White matter - Myelination"	"Cluster 55: Lymphoma - Immune response"	"Cluster 27: Syncytiotrophoblasts - Pregnancy"	3	Vesicles		"HPA008210: , HPA042273: AB_10806234"	"unprognostic (2.98e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.84e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.68e-2)"	"unprognostic (4.06e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.56e-3)"	"unprognostic (1.69e-1)"		"unprognostic (3.61e-2)"	"unprognostic (2.03e-3)"	"unprognostic (1.11e-2)"	"potential prognostic unfavorable (3.67e-4)"	"unprognostic (2.80e-3)"	"unprognostic (2.24e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.59e-2)"	"unprognostic (3.62e-3)"	"unprognostic (4.70e-3)"		"unprognostic (3.00e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.48e-1)"	"unprognostic (6.24e-2)"	"unprognostic (1.81e-2)"	"unprognostic (5.82e-2)"	"unprognostic (5.34e-2)"
SIGLEC1	"CD169, dJ1009E24.1, FLJ00051, FLJ00055, FLJ00073, FLJ32150, sialoadhesin, SIGLEC-1, SN"	ENSG00000088827	"Sialic acid binding Ig like lectin 1"	Q9BZZ2	20	3686970-3712600	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Endocytosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"Hofbauer cells: 76.4;Kupffer cells: 63.6;Macrophages: 44.5"	"Cell type enhanced"	"Detected in some"		"central nervous system macrophage: 22.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"classical monocyte: 1.5"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Breast - Macrophages, Colon - Macrophages, Heart muscle - Macrophages, Kidney - Macrophages, Liver - Kupffer cells, Lung - Macrophages, Minor Salivary Gland - Macrophages, Pancreas - Macrophages, Prostate - Macrophages, Skeletal muscle - Macrophages, Testis - Macrophages, Thyroid gland - Macrophages"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA053457	Supported				"Intracellular and membrane"	"Cell adhesion"	NA	NA		150000	"Cluster 26: Monocytes - Plasma membrane proteins"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 58: Macrophages - Innate immune response"				"HPA053457: AB_2682158"	"unprognostic (2.60e-2)"	"unprognostic (8.60e-2)"	"unprognostic (5.67e-2)"	"unprognostic (3.13e-2)"	"unprognostic (6.83e-3)"	"unprognostic (9.62e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.36e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.82e-2)"	"unprognostic (7.82e-2)"	"unprognostic (3.62e-2)"	"unprognostic (9.58e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.14e-3)"		"unprognostic (1.11e-1)"	"unprognostic (9.14e-2)"	"unprognostic (8.84e-2)"	"unprognostic (1.22e-1)"	"potential prognostic unfavorable (1.24e-4)"	"unprognostic (1.27e-1)"	"unprognostic (4.74e-3)"
SIGLEC5	"CD170, CD33L2, OB-BP2, SIGLEC-5"	ENSG00000268500	"Sialic acid binding Ig like lectin 5"	O15389	19	51610960-51630401	"CD markers, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"bone marrow: 28.9;lymphoid tissue: 12.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	12	"Bladder Urothelial Carcinoma (TCGA): 26.7"	"Region enhanced"	"Detected in many"		"cerebral cortex: 9.5"	"Group enriched"	"Detected in many"	4	"neutrophil: 284.6;non-classical monocyte: 96.2"	"Group enriched"	"Detected in many"	6	"granulocytes: 284.6;monocytes: 96.2"	"Group enriched"	"Detected in some"	7	"Leukemia: 6.0;lymphoma: 1.6"										HPA009085	Approved						NA	NA			"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 12: Non-specific - Vasculature"	"Cluster 49: HMC-1 - Innate immune response"		7			"HPA009085: AB_1079965"	"unprognostic (1.65e-1)"			"unprognostic (1.70e-1)"		"unprognostic (1.13e-1)"							"unprognostic (2.39e-1)"													"unprognostic (5.98e-2)"			"unprognostic (1.73e-1)"		"unprognostic (1.94e-2)"
SIGLEC6	"CD327, CD33L, CD33L1, OB-BP1, SIGLEC-6"	ENSG00000105492	"Sialic acid binding Ig like lectin 6"	O43699	19	51517819-51531856	"CD markers, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	24	"placenta: 103.1"	"Group enriched"	"Detected in some"	12	"Cytotrophoblasts: 172.9;granulocytes: 226.4;Syncytiotrophoblasts: 322.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"Bladder Urothelial Carcinoma (TCGA): 2.8;Thyroid Carcinoma (TCGA): 7.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 7.2;plasmacytoid DC: 11.0"	"Group enriched"	"Detected in many"	9	"B-cells: 7.2;dendritic cells: 11.0;granulocytes: 4.9"	"Group enriched"	"Detected in some"	5	"Bladder cancer: 7.8;colorectal cancer: 11.8;Leukemia: 25.0"	"Adipose subcutaneous - Mast cells, Adipose visceral - Mast cells, Colon - Mast cells, Lung - Mast cells, Minor Salivary Gland - Mast cells, Skin - Mast cells"					"Low region specificity"	"Detected in some"			"HPA008945, HPA009084, HPA018198"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted to blood"	"Cell adhesion"	NA	NA		100000	"Cluster 23: B-cells - Immunoglobulins"	"Cluster 58: Placenta - Pregnancy"	"Cluster 48: Non-specific - Mixed function"	"Cluster 49: HMC-1 - Innate immune response"	"Cluster 24: Cytotrophoblasts - Mitochondria"	2	"Plasma membrane, Cytosol"		"HPA008945: , HPA009084: AB_1079967, HPA018198: AB_1856868"	"unprognostic (6.51e-2)"		"unprognostic (5.75e-2)"			"unprognostic (1.42e-1)"										"potential prognostic favorable (1.21e-4)"	"unprognostic (4.50e-2)"		"unprognostic (1.16e-1)"			"unprognostic (1.54e-1)"	"unprognostic (1.51e-1)"			"unprognostic (1.69e-2)"		"unprognostic (1.32e-2)"		"unprognostic (4.26e-2)"	
SIGLEC7	"CD328, p75/AIRM1, QA79, SIGLEC-7, SIGLEC19P, SIGLECP2"	ENSG00000168995	"Sialic acid binding Ig like lectin 7"	Q9Y286	19	51142299-51153526	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 18.7"	"Group enriched"	"Detected in some"	5	"Hofbauer cells: 36.2;Kupffer cells: 60.6;Macrophages: 29.8;NK-cells: 38.5"	"Group enriched"	"Detected in some"	18	"central nervous system macrophage: 5.2;leukocyte: 7.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 242.7"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	16	"Leukemia: 3.5;Myeloma: 4.5"	"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Breast - Macrophages, Colon - Macrophages, Heart muscle - Macrophages, Lung - Macrophages, Minor Salivary Gland - Macrophages, Pancreas - Macrophages, Pituitary gland - Macrophages, Prostate - Macrophages, Skeletal muscle - Macrophages, Spleen - Macrophages, Stomach - Macrophages, Thyroid gland - Macrophages"									"HPA075513, CAB080396"	Enhanced		Approved	"Vesicles,Plasma membrane"	"Intracellular and membrane"	"Cell adhesion"	NA	NA		22000000	"Cluster 25: Non-specific - Unknown function"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 29: Monocytes - Innate immune response"	1	"Plasma membrane"	Vesicles	"CAB080396: , HPA075513: "	"unprognostic (2.87e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.70e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.53e-1)"	"unprognostic (9.60e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.33e-2)"	"unprognostic (4.38e-2)"	"potential prognostic unfavorable (8.95e-4)"	"unprognostic (4.36e-2)"	"unprognostic (8.85e-2)"	"unprognostic (3.48e-2)"	"unprognostic (4.22e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.22e-2)"		"unprognostic (9.99e-2)"	"unprognostic (9.29e-2)"	"unprognostic (3.53e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.14e-3)"	"unprognostic (2.92e-1)"	"unprognostic (2.18e-1)"
SIGLEC8	"MGC59785, SAF2, SIGLEC-8, SIGLEC8L"	ENSG00000105366	"Sialic acid binding Ig like lectin 8"	Q9NYZ4	19	51450847-51458456	"CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.3;lymphoid tissue: 6.7"	"Group enriched"	"Detected in some"	21	"granulocytes: 32.7;Kupffer cells: 12.8;Macrophages: 10.3;Microglial cells: 10.7"	"Cell type enriched"	"Detected in some"	55	"central nervous system macrophage: 66.2"	"Cancer enhanced"	"Detected in many"		"Glioblastoma Multiforme (TCGA): 12.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	38	"eosinophil: 290.9"	"Lineage enriched"	"Detected in single"	706	"granulocytes: 290.9"	"Cancer enriched"	"Detected in single"	7	"Leukemia: 2.4"	"Adipose subcutaneous - Mast cells, Adrenal gland - Macrophages, Colon - Mast cells, Pancreas - Macrophages, Pituitary gland - Macrophages, Skin - Mast cells, Spleen - Macrophages"									HPA012556	Uncertain		Uncertain	Cytosol			NA	NA			"Cluster 22: Eosinophils - Transcription"	"Cluster 9: Oligodendrocytes - Myelination"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 49: HMC-1 - Innate immune response"	"Cluster 30: Granulocytes - Unknown function"	1	Cytosol		"HPA012556: AB_1856869"		"unprognostic (7.62e-2)"	"unprognostic (9.23e-2)"			"unprognostic (2.35e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.50e-3)"		"unprognostic (3.35e-1)"	"potential prognostic favorable (9.39e-4)"	"unprognostic (4.97e-3)"	"unprognostic (2.25e-3)"			"unprognostic (2.31e-3)"	"unprognostic (4.63e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.72e-1)"			"unprognostic (2.92e-1)"	"unprognostic (2.52e-1)"			"unprognostic (1.90e-3)"		"unprognostic (1.97e-2)"	"unprognostic (2.11e-1)"		
SIRPA	"BIT, CD172a, MFR, MYD-1, P84, PTPNS1, SHPS-1, SHPS1, SIRP, SIRP-ALPHA-1, SIRPalpha, SIRPalpha2"	ENSG00000198053	"Signal regulatory protein alpha"	P78324	20	1894167-1940592	"CD markers, Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 165.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 131.0;Excitatory neurons: 84.5;Hofbauer cells: 100.3;Macrophages: 87.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 24.1;eosinophil: 48.7;myeloid DC: 13.9;neutrophil: 50.9"	"Group enriched"	"Detected in many"	150	"dendritic cells: 13.9;granulocytes: 50.9;monocytes: 24.1"	"Cancer enhanced"	"Detected in many"		"Kidney cancer: 121.9"	"Adipose subcutaneous - Macrophages, Spleen - Neutrophils, Testis - Spermatogonia"									"CAB002776, CAB015122, HPA054437, HPA058511"	Enhanced						NA	NA		70000000	"Cluster 21: Neutrophils - Unknown function"	"Cluster 22: Brain - Synaptic signal transduction"	"Cluster 40: Astrocytes - Astrocyte-neuron interactions"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 58: Macrophages - Innate immune response"	27			"CAB002776: , CAB015122: AB_677430, HPA054437: AB_2682488, HPA058511: AB_2683738"	"unprognostic (3.03e-1)"	"unprognostic (2.49e-1)"	"unprognostic (5.66e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.20e-2)"	"unprognostic (7.66e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.78e-2)"	"unprognostic (3.22e-1)"	"unprognostic (4.90e-2)"	"potential prognostic unfavorable (9.92e-5)"	"unprognostic (1.51e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.34e-2)"	"potential prognostic unfavorable (8.92e-4)"	"unprognostic (6.37e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.44e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.57e-1)"	"unprognostic (9.68e-3)"	"unprognostic (1.65e-1)"	"unprognostic (8.18e-2)"
SIRPB1	"CD172b, SIRP-BETA-1"	ENSG00000101307	"Signal regulatory protein beta 1"	"O00241, Q5TFQ8"	20	1561385-1620061	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 51.7;lung: 18.8;lymphoid tissue: 27.8"	"Group enriched"	"Detected in some"	8	"dendritic cells: 35.5;Hofbauer cells: 29.3;Kupffer cells: 44.1;Macrophages: 30.4;monocytes: 57.9"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1606.1"	"Group enriched"	"Detected in all"	6	"granulocytes: 1606.1;monocytes: 503.9"	"Cancer enhanced"	"Detected in many"		"Leukemia: 18.6;thyroid cancer: 23.3"	"Adipose subcutaneous - Macrophages, Liver - Neutrophils, Lung - Neutrophil_2, Spleen - Neutrophils"									HPA047463	Uncertain		Uncertain	Vesicles,Centrosome			NA	NA		28000000	"Cluster 7: Non-specific - Innate immune response"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 34: Non-specific - Mixed function"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 74: Neutrophils - Degranulation"	4	Vesicles	Centrosome	"HPA047463: AB_2680057"	"unprognostic (3.94e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.34e-1)"	"unprognostic (6.16e-3)"	"unprognostic (1.43e-1)"	"unprognostic (4.91e-3)"	"unprognostic (4.11e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.18e-1)"		"unprognostic (2.69e-1)"	"unprognostic (3.07e-2)"	"unprognostic (4.84e-2)"		"unprognostic (3.27e-1)"	"unprognostic (9.23e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.84e-1)"		"unprognostic (2.30e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.14e-2)"	"unprognostic (3.26e-3)"	"unprognostic (9.74e-3)"	"unprognostic (8.80e-2)"
SIRPG	"bA77C3.1, CD172g, SIRP-B2, SIRPB2, SIRPgamma"	ENSG00000089012	"Signal regulatory protein gamma"	Q9P1W8	20	1629152-1657779	"CD markers, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"lymphoid tissue: 38.0"	"Group enriched"	"Detected in some"	4	"Early spermatids: 67.6;T-cells: 38.5"	"Group enriched"	"Detected in some"	19	"leukocyte: 24.2;pericyte: 7.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 370.4"	"Lineage enriched"	"Detected in many"	6	"T-cells: 370.4"	"Cancer enhanced"	"Detected in some"		"Leukemia: 2.5;thyroid cancer: 4.2"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Adrenal gland - T-cells, Colon - T-cells, Kidney - T-cells, Liver - T-cells, Lung - T-cells, Minor Salivary Gland - T-cells, Pancreas - T-cells, Pituitary gland - T-cells, Prostate - T-cells, Spleen - T-cells, Stomach - T-cells, Testis - Early spermatids, Testis - Late spermatids"																NA	NA			"Cluster 39: T-cells - T-cell receptor"	"Cluster 71: Thymus - Adaptive immune response"		"Cluster 59: Leukemia - T-cell receptor"	"Cluster 7: T-cells - T-cell receptor"	2				"unprognostic (3.44e-2)"	"unprognostic (5.18e-3)"	"unprognostic (8.88e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.20e-1)"			"potential prognostic favorable (2.62e-4)"		"unprognostic (1.30e-1)"	"unprognostic (3.56e-1)"	"unprognostic (1.19e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.89e-3)"	"unprognostic (3.71e-2)"	"unprognostic (4.28e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.95e-2)"		"unprognostic (5.75e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.93e-2)"	"unprognostic (1.55e-2)"	"unprognostic (9.48e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.50e-2)"	"unprognostic (8.75e-2)"	"unprognostic (2.33e-1)"
SLAMF1	"CD150, SLAM"	ENSG00000117090	"Signaling lymphocytic activation molecule family member 1"	Q13291	1	160608106-160647044	"CD markers, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Cell adhesion, Host-virus interaction, Immunity, Innate immunity, Phagocytosis"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"lymphoid tissue: 61.9"	"Group enriched"	"Detected in some"	4	"B-cells: 25.3;Plasma cells: 74.3;T-cells: 40.5"	"Cell type enriched"	"Detected in single"	120	"leukocyte: 89.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 51.2;T-reg: 49.0"	"Group enriched"	"Detected in many"	16	"B-cells: 17.9;T-cells: 51.2"	"Cancer enhanced"	"Detected in some"		"Leukemia: 14.5;lymphoma: 35.8"	"Adipose subcutaneous - T-cells, Liver - T-cells, Minor Salivary Gland - Plasma cells, Prostate - T-cells, Skin - T-cells, Spleen - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002438, HPA069319"	Enhanced				"Secreted to blood"	Receptor	NA	NA		190000	"Cluster 16: Non-specific - Cell proliferation"	"Cluster 71: Thymus - Adaptive immune response"		"Cluster 55: Lymphoma - Immune response"	"Cluster 77: Plasma cells - Protein processing"	7			"CAB002438: AB_564011, HPA069319: AB_2732129"	"unprognostic (6.04e-2)"	"unprognostic (1.08e-2)"	"unprognostic (8.02e-2)"	"potential prognostic favorable (7.93e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.72e-2)"			"potential prognostic favorable (3.16e-5)"		"unprognostic (7.44e-2)"	"unprognostic (1.69e-1)"			"unprognostic (6.33e-3)"	"potential prognostic favorable (6.60e-6)"	"unprognostic (2.40e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.94e-1)"			"unprognostic (1.07e-1)"	"unprognostic (4.14e-1)"		"unprognostic (1.16e-2)"	"unprognostic (4.50e-2)"	"unprognostic (9.16e-2)"	"unprognostic (3.13e-1)"	"unprognostic (4.50e-2)"		
SLAMF6	"CD352, KALI, KALIb, Ly108, NTB-A, NTBA, SF2000"	ENSG00000162739	"SLAM family member 6"	Q96DU3	1	160485030-160523262	"CD markers, Predicted membrane proteins"	"Adaptive immunity, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 60.2"	"Group enriched"	"Detected in some"	5	"B-cells: 21.7;Late spermatids: 22.9;NK-cells: 39.2;Plasma cells: 16.0;T-cells: 34.4"	"Cell type enriched"	"Detected in some"	98	"leukocyte: 147.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Leukemia: 10.0;lymphoma: 35.7"	"Adrenal gland - T-cells, Breast - Plasma cells, Colon - T-cells, Liver - T-cells, Lung - T-cells, Pituitary gland - T-cells, Prostate - T-cells, Spleen - B-cells (Spleen), Stomach - T-cells, Testis - Late spermatids"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA051363, HPA051903"	Uncertain		Approved	"Plasma membrane,Cytosol"			NA	NA			"Cluster 24: Non-specific - Transcription"	"Cluster 36: Lymphoid tissue - Cytokine signaling"	"Cluster 48: Non-specific - Mixed function"	"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 19: NK-cells - Adaptive immune response"	6	"Plasma membrane, Cytosol"		"HPA051363: AB_2681454, HPA051903: AB_2681658"	"unprognostic (1.18e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.85e-2)"	"unprognostic (8.99e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.39e-1)"		"unprognostic (1.50e-1)"	"potential prognostic favorable (1.25e-4)"		"unprognostic (2.92e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.48e-3)"	"unprognostic (4.20e-3)"	"unprognostic (5.08e-3)"	"unprognostic (6.66e-3)"	"unprognostic (5.50e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.44e-2)"		"unprognostic (1.03e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.03e-2)"	"unprognostic (5.11e-2)"	"unprognostic (2.12e-2)"	"unprognostic (4.03e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.33e-1)"
SLAMF7	"19A, CD319, CRACC, CS1"	ENSG00000026751	"SLAM family member 7"	Q9NQ25	1	160739057-160754821	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity, Innate immunity"	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 31.5;lymphoid tissue: 60.3;stomach 1: 33.2"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 79.8;monocytes: 69.2;NK-cells: 63.0;Plasma cells: 252.7;Schwann cells: 65.1"	"Cell type enriched"	"Detected in single"	239	"leukocyte: 94.0"	"Cancer enhanced"	"Detected in all"		"Testicular Germ Cell Tumor (TCGA): 43.5"	"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cancer enriched"	"Detected in many"	5	"Myeloma: 188.3"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Heart muscle - T-cells, Liver - T-cells, Lung - T-cells, Minor Salivary Gland - Plasma cells, Pituitary gland - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB015445, HPA055945, HPA061654"	Enhanced		Approved	Vesicles			NA	NA		570000	"Cluster 8: Plasmacytoid DCs - Unknown function"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 8: Immune cells - Immune response"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 77: Plasma cells - Protein processing"		Vesicles		"CAB015445: AB_1121905, HPA055945: AB_2682980, HPA061654: AB_2684576"	"unprognostic (9.26e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.60e-1)"	"unprognostic (9.09e-3)"	"unprognostic (3.40e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.35e-2)"	"unprognostic (7.07e-2)"	"unprognostic (2.84e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.78e-1)"	"potential prognostic favorable (8.21e-4)"	"unprognostic (4.02e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.27e-2)"	"unprognostic (3.85e-1)"	"unprognostic (3.75e-3)"	"unprognostic (3.29e-1)"	"unprognostic (5.58e-3)"	"unprognostic (3.98e-1)"	"unprognostic (3.98e-2)"	"unprognostic (7.90e-2)"	"unprognostic (2.00e-1)"
SLAMF8	"BLAME, CD353, SBBI42"	ENSG00000158714	"SLAM family member 8"	Q9P0V8	1	159826811-159837492	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 32.1"	"Group enriched"	"Detected in some"	6	"Hofbauer cells: 34.5;Kupffer cells: 19.9;Langerhans cells: 69.2;Macrophages: 39.8;Schwann cells: 42.7"	"Cell type enhanced"	"Detected in some"		"ependymal cell: 2.0;leukocyte: 2.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 14.3"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"Leukemia: 1.4;lymphoma: 2.9"	"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Heart muscle - Macrophages, Lung - Macrophages, Minor Salivary Gland - Macrophages, Skeletal muscle - Fibroblasts, Stomach - Macrophages"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA067601	Enhanced						NA	NA			"Cluster 33: Non-specific - ATP binding"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 12: Non-specific - Vasculature"	"Cluster 71: Lymphoma - Inflammatory response"	"Cluster 28: Dendritic cells - Antigen presentation"	9			"HPA067601: AB_2685870"	"unprognostic (1.64e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.57e-1)"	"unprognostic (9.21e-3)"	"unprognostic (2.11e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.16e-2)"	"unprognostic (7.38e-2)"	"potential prognostic favorable (7.44e-4)"	"unprognostic (1.90e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.26e-1)"
SLC3A2	"4F2, 4F2HC, 4T2HC, CD98, CD98HC, MDU1, NACAE"	ENSG00000168003	"Solute carrier family 3 member 2"	P08195	11	62856004-62888880	"Cancer-related genes, CD markers, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"	"Host cell receptor for virus entry, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 944.3"	"Cell type enhanced"	"Detected in all"		"endothelial cell: 215.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Breast - Breast glandular cells, Kidney - Proximal tubular cells, Testis - Sertoli cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010455, HPA017980"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"			NA	NA		120000000	"Cluster 44: Plasmacytoid DCs - Plasma membrane proteins"	"Cluster 34: Non-specific - Mixed function"	"Cluster 19: Astrocytes - Mixed function"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 27: Syncytiotrophoblasts - Pregnancy"	49	"Nucleoplasm, Plasma membrane"		"CAB010455: AB_638288, HPA017980: AB_2669723"	"unprognostic (2.19e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.51e-1)"	"unprognostic (8.33e-2)"	"unprognostic (3.01e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.49e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.14e-3)"	"unprognostic (5.59e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.45e-2)"	"unprognostic (4.98e-2)"	"potential prognostic unfavorable (7.08e-5)"	"unprognostic (1.61e-2)"	"unprognostic (4.15e-1)"	"unprognostic (2.73e-1)"	"unprognostic (7.89e-2)"	"unprognostic (6.26e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.71e-1)"	"unprognostic (6.16e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.74e-2)"
SLC44A1	"CD92, CDW92, CHTL1, CTL1"	ENSG00000070214	"Solute carrier family 44 member 1"	Q8WWI5	9	105244622-105439171	"CD markers, Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Antiport, Transport"		Neurodegeneration	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 232.8"	"Cell type enriched"	"Detected in all"	8	"Oligodendrocytes: 2274.9"	"Group enriched"	"Detected in all"	7	"committed oligodendrocyte precursor: 2570.1;oligodendrocyte: 4379.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 8.5"	"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Liver - Hepatocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064714, HPA074007"	Enhanced		Supported	Nucleoplasm,Mitochondria			NA	NA		54000	"Cluster 14: Non-specific - Unknown function"	"Cluster 9: Oligodendrocytes - Myelination"	"Cluster 30: White matter - Myelination"	"Cluster 44: Connective tissue cells - ECM organization"	"Cluster 51: Oligodendrocytes - Unknown function"	1	Mitochondria	Nucleoplasm	"HPA064714: AB_2685334, HPA074007: "	"unprognostic (2.83e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.50e-1)"	"unprognostic (9.56e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.30e-1)"	"validated prognostic favorable (3.88e-10)"	"validated prognostic favorable (1.84e-4)"	"unprognostic (7.81e-3)"	"unprognostic (2.88e-2)"	"unprognostic (1.59e-3)"	"unprognostic (2.75e-3)"	"unprognostic (6.35e-3)"	"unprognostic (1.01e-1)"	"unprognostic (9.57e-2)"	"unprognostic (5.63e-3)"	"potential prognostic unfavorable (6.05e-4)"	"potential prognostic unfavorable (9.71e-4)"	"unprognostic (2.46e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.48e-1)"
SLC4A1	"AE1, CD233, DI, EPB3, FR, RTA1A, SW, WD, WR"	ENSG00000004939	"Solute carrier family 4 member 1 (Diego blood group)"	P02730	17	44248390-44268141	"Blood group antigen proteins, CD markers, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Anion exchange, Ion transport, Transport"	"Blood group antigen"	"Disease variant, Elliptocytosis, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"bone marrow: 397.2"	"Cell type enriched"	"Detected in some"	290	"Erythroid cells: 891.7"	"Cell type enhanced"	"Detected in single"		"central nervous system macrophage: 1.8"	"Cancer enriched"	"Detected in many"	56	"Kidney Chromophobe (TCGA): 363.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	62	"Leukemia: 15.2"	"Kidney - Intercalated cells, Liver - Erythroid cells, Pituitary gland - Neutrophils, Spleen - Erythrocytes"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA015584, CAB034438, HPA063911"	Enhanced						NA	NA		43000000		"Cluster 6: Bone marrow - Innate immune response"	"Cluster 48: Non-specific - Mixed function"	"Cluster 47: Leukemia - Hemostasis"	"Cluster 1: Erythroid cells - Oxygen transport"	14			"CAB034438: AB_2123479, HPA015584: AB_1844824, HPA063911: AB_2685151"	"unprognostic (1.32e-1)"			"unprognostic (2.52e-1)"		"unprognostic (2.13e-1)"				"unprognostic (2.49e-2)"	"unprognostic (1.46e-1)"		"unprognostic (8.00e-2)"													"unprognostic (2.46e-2)"	"unprognostic (2.60e-3)"		"unprognostic (1.76e-1)"		"unprognostic (1.98e-2)"
SPN	"CD43, GPL115, LEU-22, LSN"	ENSG00000197471	Sialophorin	P16150	16	29662979-29670876	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"bone marrow: 70.9;lung: 27.3;lymphoid tissue: 49.7"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 218.9;Erythroid cells: 123.5;monocytes: 499.5;NK-cells: 248.7;T-cells: 98.0"	"Cell type enhanced"	"Detected in single"		"leukocyte: 1.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"non-classical monocyte: 218.5"	"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"Leukemia: 185.3;Myeloma: 49.9"	"Pituitary gland - T-cells, Prostate - T-cells, Skin - Langerhans cells, Spleen - T-cells, Stomach - T-cells, Thyroid gland - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB002666, HPA055244"	Enhanced		Approved	"Plasma membrane"			NA	NA		130000	"Cluster 33: Non-specific - ATP binding"	"Cluster 77: Bone marrow - Cell proliferation"	"Cluster 6: Non-specific - Immune response"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 19: NK-cells - Adaptive immune response"	31	"Plasma membrane"		"CAB002666: , HPA055244: AB_2682756"	"unprognostic (1.56e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.64e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.08e-1)"	"potential prognostic favorable (9.85e-4)"	"unprognostic (5.44e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.84e-2)"	"unprognostic (2.42e-2)"	"unprognostic (3.57e-3)"	"unprognostic (3.70e-2)"	"unprognostic (6.73e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.78e-1)"	"unprognostic (7.40e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.46e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.34e-3)"	"unprognostic (1.97e-2)"	"unprognostic (2.70e-2)"	"unprognostic (8.47e-2)"	"unprognostic (4.74e-2)"
TEK	"CD202b, TIE-2, TIE2, VMCM, VMCM1"	ENSG00000120156	"TEK receptor tyrosine kinase"	Q02763	9	27109141-27230174	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Angiogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Glaucoma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 44.7"	"Group enriched"	"Detected in some"	6	"Adipocytes: 67.0;Endothelial cells: 74.2;Lymphatic endothelial cells: 34.9;Microglial cells: 36.7;Oligodendrocyte precursor cells: 129.2"	"Group enriched"	"Detected in all"	8	"endothelial cell: 417.7;oligodendrocyte precursor cell: 143.8"	"Cancer enhanced"	"Detected in all"		"Kidney Renal Clear Cell Carcinoma (TCGA): 13.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"Rhabdoid: 17.5;testis cancer: 16.9"	"Adipose subcutaneous - Endothelial cells, Adipose visceral - Endothelial cells, Adrenal gland - Endothelial cells, Breast - Endothelial cells, Colon - Endothelial cells, Heart muscle - Endothelial cells, Kidney - Endothelial cells, Liver - Sinusoid Endothelial cells, Lung - Endothelial cells, Minor Salivary Gland - Endothelial cells, Pituitary gland - Endothelial cells, Prostate - Endothelial cells, Skeletal muscle - Endothelial cells, Stomach - Endothelial cells, Testis - Endothelial cells, Thyroid gland - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010359, HPA073265"	Approved		Supported	"Plasma membrane,Centrosome,Basal body"	"Secreted to blood"	Receptor	NA	NA	7750000	8000000		"Cluster 7: Adipose tissue - Mixed function"	"Cluster 47: Endothelial cells - Vasculature"	"Cluster 48: Adipocytes & Endothelial cells - Angiogenesis"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	14	"Plasma membrane"	"Centrosome, Basal body"	"CAB010359: AB_2203226, HPA073265: AB_2686592"	"unprognostic (2.08e-1)"	"unprognostic (3.02e-1)"	"unprognostic (7.64e-3)"	"unprognostic (4.21e-2)"	"unprognostic (3.16e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.56e-1)"	"unprognostic (8.83e-3)"	"unprognostic (4.71e-3)"	"unprognostic (3.04e-1)"	"validated prognostic favorable (3.45e-13)"	"validated prognostic favorable (5.48e-5)"	"unprognostic (4.39e-3)"	"validated prognostic favorable (1.01e-4)"	"validated prognostic favorable (8.49e-4)"	"unprognostic (2.27e-2)"	"unprognostic (3.43e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.82e-1)"		"unprognostic (7.71e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.74e-2)"	"unprognostic (3.60e-3)"	"unprognostic (3.71e-2)"	"unprognostic (5.25e-2)"	"unprognostic (6.63e-2)"
TFRC	"CD71, p90, TFR1"	ENSG00000072274	"Transferrin receptor"	P02786	3	196012511-196082153	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Endocytosis, Host-virus interaction"	"Host cell receptor for virus entry, Receptor, Transducer"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 451.2;monocytes: 612.3;Syncytiotrophoblasts: 467.6"	"Cell type enriched"	"Detected in all"	6	"endothelial cell: 425.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 9.2"	"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Adrenal cortex cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000153, HPA028598"	Enhanced		Supported	Endosomes,Lysosomes	"Secreted to blood"	Receptor	NA	NA	1310000000	73000000	"Cluster 13: Non-specific - Mitochondria"	"Cluster 56: Non-specific - Unknown function"	"Cluster 52: Neurons & Synapses - Synaptic function"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 58: Macrophages - Innate immune response"	138	"Endosomes, Lysosomes"		"CAB000153: AB_2533029, HPA028598: AB_10601599"	"unprognostic (1.60e-2)"	"unprognostic (3.39e-2)"	"unprognostic (5.13e-2)"	"potential prognostic unfavorable (1.85e-4)"	"unprognostic (2.38e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.70e-2)"	"potential prognostic unfavorable (1.03e-4)"	"unprognostic (5.60e-2)"	"potential prognostic unfavorable (5.77e-4)"	"unprognostic (3.95e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.88e-2)"	"validated prognostic unfavorable (9.59e-6)"	"validated prognostic unfavorable (4.51e-6)"	"unprognostic (2.55e-2)"	"unprognostic (8.36e-3)"	"unprognostic (1.66e-2)"	"potential prognostic favorable (9.13e-4)"	"unprognostic (1.15e-2)"	"unprognostic (9.70e-3)"	"unprognostic (9.81e-3)"	"unprognostic (6.19e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.80e-2)"	"unprognostic (9.43e-3)"	"unprognostic (3.05e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.02e-3)"	"unprognostic (7.72e-2)"
THBD	"BDCA-3, CD141, THRM"	ENSG00000178726	Thrombomodulin	P07204	20	23045633-23049672	"Candidate cardiovascular disease genes, CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins"	"Blood coagulation, Hemostasis"	Receptor	"Disease variant, Hemolytic uremic syndrome, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 252.8;Endothelial cells: 251.1;Lymphatic endothelial cells: 205.8;Macrophages: 163.4;Peritubular cells: 254.5;Schwann cells: 206.1;Skeletal myocytes: 143.4;Squamous epithelial cells: 241.5"	"Group enriched"	"Detected in some"	6	"endothelial cell: 27.8;vascular associated smooth muscle cell: 11.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 24.6"	"Group enriched"	"Detected in many"	7	"dendritic cells: 10.9;granulocytes: 24.6;monocytes: 9.0"	"Cancer enhanced"	"Detected in many"		"Gallbladder cancer: 97.2"	"Breast - Endothelial cells, Heart muscle - Endothelial cells, Prostate - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002425, HPA002982"	Supported		Approved	Nucleoplasm,Cytosol			NA	NA		1100000	"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 7: Adipose tissue - Mixed function"	"Cluster 12: Non-specific - Vasculature"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	20	"Nucleoplasm, Cytosol"		"CAB002425: AB_563497, HPA002982: AB_1078444"	"unprognostic (1.19e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.74e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.74e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.78e-2)"	"potential prognostic favorable (3.82e-4)"	"unprognostic (3.66e-2)"	"unprognostic (7.57e-2)"	"unprognostic (4.68e-3)"	"unprognostic (1.30e-3)"	"unprognostic (2.30e-1)"	"unprognostic (6.41e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.12e-3)"	"unprognostic (4.25e-1)"
THY1	CD90	ENSG00000154096	"Thy-1 cell surface antigen"	P04216	11	119415476-119424985	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 276.2;smooth muscle: 292.8"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 146.7;Excitatory neurons: 112.0;Fibroblasts: 177.7;Horizontal cells: 114.6;Inhibitory neurons: 99.7;Leydig cells: 97.9;Muller glia cells: 96.9;Proximal tubular cells: 161.2;Smooth muscle cells: 128.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Brain cancer: 459.1;thyroid cancer: 259.2"	"Adipose subcutaneous - Adipose progenitor cells, Adipose visceral - Adipose progenitor cells, Liver - Hepatic stellate cells, Lung - Fibroblast_2, Pituitary gland - Lactotropes, Skin - Fibroblast_1, Spleen - Fibroblast_1, Stomach - Fibroblasts, Thyroid gland - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003733, CAB068243, CAB068244"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"			NA	NA		6800000		"Cluster 61: Brain - Neuronal signaling"	"Cluster 51: Neurons - Mixed function"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 53: Fibroblasts - ECM organization"	5	Nucleoplasm	"Plasma membrane"	"CAB068243: AB_2665687, CAB068244: AB_2665688, HPA003733: AB_1846340"	"unprognostic (3.70e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.72e-3)"	"unprognostic (2.48e-3)"	"unprognostic (1.17e-1)"	"potential prognostic unfavorable (4.42e-4)"	"unprognostic (3.26e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.97e-2)"	"unprognostic (3.35e-3)"	"unprognostic (3.80e-3)"	"unprognostic (1.89e-2)"	"unprognostic (2.59e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.35e-3)"	"unprognostic (3.42e-2)"	"unprognostic (5.31e-2)"	"unprognostic (4.47e-2)"	"unprognostic (3.22e-1)"	"unprognostic (2.01e-1)"	"unprognostic (6.41e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.28e-2)"	"unprognostic (4.67e-2)"	"unprognostic (3.89e-2)"
TLR1	"CD281, KIAA0012, rsc786"	ENSG00000174125	"Toll like receptor 1"	Q15399	4	38790677-38856817	"CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 34.0;lymphoid tissue: 26.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 17.3;Hofbauer cells: 19.2;Kupffer cells: 31.8;Langerhans cells: 19.4;Macrophages: 35.6;Microglial cells: 27.7;monocytes: 28.6"	"Cell type enriched"	"Detected in many"	9	"central nervous system macrophage: 250.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 128.9"	"Group enriched"	"Detected in all"	6	"granulocytes: 128.9;monocytes: 43.0"	"Cancer enhanced"	"Detected in many"		"lymphoma: 9.1"	"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Lung - Neutrophil_2, Thyroid gland - Macrophages"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"										NA	NA			"Cluster 37: Monocytes & Neutrophils - Innate immune response"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 55: Lymphoma - Immune response"	"Cluster 74: Neutrophils - Degranulation"	3				"unprognostic (5.78e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.86e-1)"	"potential prognostic favorable (9.37e-4)"	"unprognostic (7.09e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.93e-2)"	"unprognostic (7.51e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.59e-3)"	"unprognostic (8.62e-2)"	"unprognostic (4.82e-1)"	"unprognostic (5.12e-2)"	"unprognostic (3.47e-1)"	"unprognostic (8.39e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.95e-2)"	"unprognostic (9.27e-2)"	"unprognostic (5.17e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.52e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.63e-2)"	"unprognostic (4.17e-3)"	"unprognostic (3.69e-1)"	"unprognostic (1.04e-1)"
TLR10	CD290	ENSG00000174123	"Toll like receptor 10"	Q9BXR5	4	38772238-38782990	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 46.6"	"Cell type enhanced"	"Detected in some"		"B-cells: 58.6;dendritic cells: 13.0;Macrophages: 6.5;Microglial cells: 16.1"	"Cell type enriched"	"Detected in some"	7	"central nervous system macrophage: 104.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory B-cell: 39.1;naive B-cell: 24.1"	"Lineage enriched"	"Detected in many"	5	"B-cells: 39.1"	"Cancer enriched"	"Detected in some"	4	"lymphoma: 27.2"	"Adipose visceral - Neutrophils, Prostate - T-cells, Spleen - B-cells (Spleen)"					"Low region specificity"	"Detected in many"			HPA001940			Approved	"Endoplasmic reticulum,Plasma membrane"			NA	NA			"Cluster 23: B-cells - Immunoglobulins"	"Cluster 36: Lymphoid tissue - Cytokine signaling"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 55: Lymphoma - Immune response"	"Cluster 73: B-cells - B-cell function"	4	"Plasma membrane"	"Endoplasmic reticulum"	"HPA001940: "		"potential prognostic favorable (2.61e-4)"	"unprognostic (6.87e-2)"			"unprognostic (2.77e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.29e-3)"				"unprognostic (1.75e-1)"			"unprognostic (2.44e-2)"	"potential prognostic favorable (1.04e-4)"	"unprognostic (1.75e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.29e-1)"			"unprognostic (1.24e-1)"	"unprognostic (1.20e-2)"			"unprognostic (3.12e-2)"		"unprognostic (2.25e-1)"	"unprognostic (4.53e-2)"		
TLR2	"CD282, TIL4"	ENSG00000137462	"Toll like receptor 2"	O60603	4	153684070-153706260	"CD markers, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity"	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 69.1;lymphoid tissue: 50.3"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 106.9;Macrophages: 117.2;monocytes: 342.1;Mucus glandular cells: 67.3"	"Cell type enriched"	"Detected in some"	5	"central nervous system macrophage: 299.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 200.3;intermediate monocyte: 179.4;myeloid DC: 121.5;neutrophil: 460.9;non-classical monocyte: 122.1"	"Group enriched"	"Detected in all"	48	"dendritic cells: 121.5;granulocytes: 460.9;monocytes: 200.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 11.0;Leukemia: 10.6"	"Adipose subcutaneous - Macrophages, Adrenal gland - Macrophages, Kidney - Macrophages, Liver - Neutrophils, Lung - Neutrophil_2, Minor Salivary Gland - Minor salivary glandular cells, Spleen - Neutrophils, Stomach - Macrophages"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA078321			Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"			NA	NA			"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 29: Monocytes - Innate immune response"	13	"Plasma membrane"	"Nucleoplasm, Vesicles, Cytosol"	"HPA078321: "	"unprognostic (1.11e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.84e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.22e-1)"	"unprognostic (6.40e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.77e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.05e-2)"	"unprognostic (3.58e-3)"	"potential prognostic favorable (5.70e-4)"	"unprognostic (6.79e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.61e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.39e-1)"	"unprognostic (4.22e-1)"	"unprognostic (4.37e-3)"	"unprognostic (3.10e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.14e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.27e-2)"	"unprognostic (7.73e-2)"	"unprognostic (9.89e-2)"	"unprognostic (4.35e-1)"
TLR3	CD283	ENSG00000164342	"Toll like receptor 3"	O15455	4	186068911-186088073	"CD markers, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity"	"Receptor, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 76.2;Schwann cells: 36.0"	"Cell type enhanced"	"Detected in some"		"central nervous system macrophage: 37.6;fibroblast: 9.6"	"Cancer enriched"	"Detected in all"	5	"Kidney Renal Clear Cell Carcinoma (TCGA): 44.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 2.9;memory CD8 T-cell: 3.1"	"Low lineage specificity"	"Detected in single"			"Cancer enhanced"	"Detected in many"		"Kidney cancer: 12.1"	"Adrenal gland - Adrenal cortex cells, Testis - Early spermatids, Testis - Late spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB025658	Enhanced						NA	NA			"Cluster 1: T-cells - Unknown function"	"Cluster 45: Intestine - Digestion"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 21: Early spermatids - Spermatogenesis"	12			"CAB025658: "	"unprognostic (1.49e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.31e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.96e-1)"	"validated prognostic favorable (1.98e-11)"	"validated prognostic favorable (1.77e-4)"	"unprognostic (3.90e-2)"	"unprognostic (1.28e-2)"	"unprognostic (7.67e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.24e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.02e-1)"	"potential prognostic unfavorable (6.16e-4)"	"unprognostic (4.29e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.44e-1)"	"unprognostic (6.02e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.91e-2)"
TLR4	"ARMD10, CD284, hToll, TLR-4"	ENSG00000136869	"Toll like receptor 4"	O00206	9	117704175-117724735	"CD markers, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity"	Receptor	"Age-related macular degeneration, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 48.3;Hofbauer cells: 72.9;Kupffer cells: 156.6;Macrophages: 80.4;monocytes: 178.0"	"Cell type enhanced"	"Detected in single"		"central nervous system macrophage: 1.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 86.8"	"Group enriched"	"Detected in many"	33	"dendritic cells: 22.4;granulocytes: 86.8;monocytes: 65.9"	"Cancer enhanced"	"Detected in many"		"Brain cancer: 11.7"	"Heart muscle - Endothelial cells, Kidney - Endothelial cells, Lung - Neutrophil_2, Minor Salivary Gland - Macrophages"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB004025, HPA049174"	Approved		Approved	"Golgi apparatus,Plasma membrane"	"Intracellular and membrane"	Receptor	NA	NA			"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 39: Astrocytes - Mixed function"	"Cluster 72: Neuronal - Signal transduction"	"Cluster 74: Neutrophils - Degranulation"	25	"Golgi apparatus, Plasma membrane"		"CAB004025: , HPA049174: AB_2680662"	"unprognostic (1.71e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.44e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.87e-1)"	"unprognostic (2.10e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.14e-1)"	"potential prognostic favorable (1.51e-6)"	"unprognostic (1.28e-2)"	"unprognostic (9.68e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.14e-3)"	"unprognostic (2.99e-3)"	"unprognostic (5.26e-2)"	"unprognostic (4.44e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.26e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.94e-1)"	"unprognostic (8.41e-2)"	"unprognostic (8.50e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.27e-3)"	"unprognostic (4.00e-3)"	"unprognostic (5.86e-2)"
TLR6	CD286	ENSG00000174130	"Toll like receptor 6"	Q9Y2C9	4	38822897-38856817	"CD markers, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 11.8"	"Cell type enhanced"	"Detected in some"		"B-cells: 14.2;Hofbauer cells: 8.5;Kupffer cells: 7.6;Macrophages: 14.9;Microglial cells: 19.7;Mucus glandular cells: 6.6;Serous glandular cells: 7.1"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"neutrophil: 11.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 11.4"	"Low cancer specificity"	"Detected in many"			"Adipose subcutaneous - Macrophages, Skeletal muscle - Macrophages, Stomach - Macrophages"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA062733			Approved	"Endoplasmic reticulum"			NA	NA			"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 55: Lymphoma - Immune response"	"Cluster 74: Neutrophils - Degranulation"	3	"Endoplasmic reticulum"		"HPA062733: AB_2684853"	"unprognostic (1.79e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.52e-3)"	"unprognostic (3.04e-1)"		"unprognostic (2.81e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.92e-2)"	"unprognostic (4.19e-2)"		"unprognostic (1.28e-2)"	"unprognostic (6.26e-2)"	"potential prognostic unfavorable (3.87e-4)"		"unprognostic (4.01e-1)"	"unprognostic (1.55e-2)"	"unprognostic (9.01e-2)"	"unprognostic (4.02e-2)"	"unprognostic (4.49e-2)"			"unprognostic (4.21e-2)"	"potential prognostic unfavorable (4.13e-6)"			"unprognostic (1.89e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.68e-2)"		
TLR8	"CD288, hTLR8"	ENSG00000101916	"Toll like receptor 8"	Q9NR97	X	12906620-12923169	"CD markers, Disease related genes, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	Receptor	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lung: 10.3;lymphoid tissue: 16.3"	"Group enriched"	"Detected in some"	4	"Kupffer cells: 47.8;Macrophages: 21.5;monocytes: 51.0"	"Group enriched"	"Detected in some"	17	"central nervous system macrophage: 4.4;leukocyte: 3.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	73	"classical monocyte: 16.7;intermediate monocyte: 14.9;myeloid DC: 8.4;neutrophil: 27.6;non-classical monocyte: 15.7"	"Group enriched"	"Detected in many"	77	"dendritic cells: 8.4;granulocytes: 27.6;monocytes: 16.7"	"Not detected"	"Not detected"			"Adipose subcutaneous - Macrophages, Adrenal gland - Macrophages, Breast - Macrophages, Colon - Macrophages, Heart muscle - Macrophages, Kidney - Macrophages, Minor Salivary Gland - Macrophages, Pancreas - Macrophages, Pituitary gland - Macrophages, Prostate - Macrophages, Skin - Macrophages, Spleen - Neutrophils, Stomach - Macrophages, Thyroid gland - Macrophages"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA001608	Enhanced						NA	NA			"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 29: Monocytes - Innate immune response"	1			"HPA001608: AB_1080295"		"unprognostic (1.55e-1)"	"unprognostic (1.97e-2)"			"unprognostic (1.16e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.53e-2)"		"unprognostic (7.38e-3)"	"unprognostic (3.54e-1)"			"unprognostic (2.39e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.00e-1)"			"unprognostic (1.41e-1)"	"unprognostic (2.06e-1)"			"unprognostic (1.71e-1)"		"unprognostic (1.83e-1)"	"unprognostic (3.98e-2)"		
TLR9	CD289	ENSG00000239732	"Toll like receptor 9"	Q9NR96	3	52221080-52225645	"CD markers, FDA approved drug targets, Human disease related genes, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 5.9"	"Cell type enhanced"	"Detected in some"		"B-cells: 3.4;Plasma cells: 3.2"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"cerebral cortex: 10.3"	"Immune cell enriched"	"Detected in some"	7	"plasmacytoid DC: 167.1"	"Lineage enriched"	"Detected in many"	7	"dendritic cells: 167.1"	"Cancer enhanced"	"Detected in some"		"lymphoma: 16.6;Myeloma: 6.4"		"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"										NA	NA			"Cluster 44: Plasmacytoid DCs - Plasma membrane proteins"	"Cluster 16: Non-specific - Transcription"	"Cluster 15: Non-specific - Transcription"	"Cluster 55: Lymphoma - Immune response"	"Cluster 73: B-cells - B-cell function"	2						"unprognostic (2.51e-2)"			"unprognostic (3.30e-1)"										"unprognostic (8.91e-3)"				"unprognostic (1.04e-2)"						"unprognostic (7.34e-2)"		"unprognostic (1.46e-2)"			
TNFRSF10A	"Apo2, CD261, DR4, TRAILR-1, TRAILR1"	ENSG00000104689	"TNF receptor superfamily member 10a"	O00220	8	23190452-23225102	"Cancer-related genes, CD markers, Predicted membrane proteins"	Apoptosis	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 27.4"	"Group enriched"	"Detected in some"	8	"central nervous system macrophage: 19.2;endothelial cell: 53.1;leukocyte: 47.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Endothelial cells, Adipose visceral - Endothelial cells, Colon - Endothelial cells, Heart muscle - Endothelial cells, Pituitary gland - Endothelial cells, Skeletal muscle - Endothelial cells, Spleen - B-cells (Spleen)"									HPA054475	Approved						NA	NA			"Cluster 43: Non-specific - Transcription & Translation"	"Cluster 29: Squamous epithelium - Innate immune response"	"Cluster 47: Endothelial cells - Vasculature"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	20			"HPA054475: AB_2682500"	"unprognostic (3.64e-1)"	"unprognostic (1.47e-1)"	"unprognostic (9.51e-2)"	"unprognostic (4.24e-2)"	"unprognostic (7.36e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.95e-3)"	"unprognostic (7.32e-2)"	"unprognostic (9.03e-2)"	"validated prognostic favorable (2.74e-9)"	"validated prognostic favorable (1.65e-4)"	"potential prognostic favorable (1.49e-4)"	"unprognostic (2.82e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.08e-2)"	"unprognostic (6.01e-3)"	"unprognostic (2.37e-2)"	"unprognostic (2.03e-1)"	"unprognostic (7.82e-3)"	"potential prognostic unfavorable (2.42e-4)"	"unprognostic (5.95e-3)"	"unprognostic (1.44e-1)"	"unprognostic (6.93e-3)"	"unprognostic (8.63e-2)"	"unprognostic (2.36e-1)"	"unprognostic (7.40e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.25e-1)"
TNFRSF10B	"CD262, DR5, KILLER, TRAIL-R2, TRAILR2, TRICK2A, TRICKB"	ENSG00000120889	"TNF receptor superfamily member 10b"	O14763	8	23020133-23069031	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	Apoptosis	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"monocytes: 93.7"	"Cell type enhanced"	"Detected in many"		"central nervous system macrophage: 95.7;choroid plexus epithelial cell: 62.6;endothelial cell: 114.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Heart muscle - Endothelial cells, Minor Salivary Gland - Minor salivary glandular cells"									HPA023625	Approved						NA	NA			"Cluster 26: Monocytes - Plasma membrane proteins"	"Cluster 11: Liver - Plasma proteins"	"Cluster 12: Non-specific - Vasculature"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 29: Monocytes - Innate immune response"	18			"HPA023625: AB_1847860"	"unprognostic (5.59e-2)"	"unprognostic (3.36e-1)"	"potential prognostic favorable (4.26e-4)"	"unprognostic (2.01e-3)"	"unprognostic (4.24e-3)"	"unprognostic (1.31e-1)"	"unprognostic (8.81e-2)"	"potential prognostic unfavorable (1.12e-4)"	"unprognostic (2.07e-1)"	"unprognostic (5.12e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.87e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.08e-2)"	"unprognostic (4.23e-3)"	"unprognostic (4.12e-1)"	"unprognostic (5.84e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.54e-3)"	"unprognostic (2.53e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.65e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.19e-1)"
TNFRSF10C	"CD263, DcR1, LIT, TRAILR3, TRID"	ENSG00000173535	"TNF receptor superfamily member 10c"	O14798	8	23102921-23117445	"Cancer-related genes, CD markers, Predicted membrane proteins"	Apoptosis	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 20.8;lymphoid tissue: 23.1"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 2.8;Ionocytes: 3.7;Proximal enterocytes: 4.6;Secretory cells: 3.6;Serous glandular cells: 2.8"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in all"		"Thyroid Carcinoma (TCGA): 17.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"neutrophil: 3204.8"	"Lineage enriched"	"Detected in many"	120	"granulocytes: 3204.8"	"Low cancer specificity"	"Detected in many"			"Adipose visceral - Neutrophils, Heart muscle - Neutrophils, Lung - Neutrophil_2, Spleen - Neutrophils, Testis - Sertoli cells"									CAB025635	Enhanced						NA	NA		1200000	"Cluster 21: Neutrophils - Unknown function"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 47: Endothelial cells - Vasculature"	"Cluster 34: Testis cancer - Unknown function"	"Cluster 74: Neutrophils - Degranulation"	41			"CAB025635: "	"unprognostic (2.20e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.12e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.76e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.94e-2)"	"unprognostic (8.98e-2)"	"unprognostic (5.88e-3)"	"unprognostic (3.45e-3)"	"potential prognostic favorable (3.92e-5)"	"unprognostic (1.35e-2)"	"unprognostic (5.39e-2)"	"unprognostic (7.40e-2)"	"potential prognostic favorable (1.25e-4)"	"unprognostic (2.00e-1)"	"unprognostic (3.57e-3)"	"unprognostic (4.07e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.32e-1)"	"potential prognostic unfavorable (2.66e-4)"	"unprognostic (2.49e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.50e-2)"	"unprognostic (4.25e-2)"
TNFRSF10D	"CD264, DcR2, TRAILR4, TRUNDD"	ENSG00000173530	"TNF receptor superfamily member 10d"	Q9UBN6	8	23135588-23164027	"Cancer-related genes, CD markers, Predicted membrane proteins"	Apoptosis	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 102.7;Endothelial cells: 51.5;Gastric mucus-secreting cells: 70.7"	"Cell type enhanced"	"Detected in some"		"central nervous system macrophage: 53.2;endothelial cell: 106.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Pituitary gland - Endothelial cells"									HPA070971			Approved	"Plasma membrane,Actin filaments"			NA	NA			"Cluster 33: Non-specific - ATP binding"	"Cluster 11: Liver - Plasma proteins"	"Cluster 42: Choroid plexus - Mitochondria"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	21	"Plasma membrane, Actin filaments"		"HPA070971: AB_2686330"	"unprognostic (5.60e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.50e-2)"	"potential prognostic unfavorable (9.48e-4)"	"unprognostic (1.14e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.30e-3)"	"unprognostic (4.55e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.10e-2)"	"potential prognostic favorable (3.47e-4)"	"unprognostic (1.31e-3)"	"unprognostic (2.41e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.14e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.02e-3)"	"unprognostic (1.86e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.80e-3)"	"unprognostic (1.25e-3)"	"unprognostic (3.06e-2)"	"unprognostic (3.86e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.38e-1)"	"unprognostic (9.04e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.70e-1)"
TNFRSF11A	"CD265, FEO, LOH18CR1, ODFR, PDB2, RANK, TRANCE-R"	ENSG00000141655	"TNF receptor superfamily member 11a"	Q9Y6Q6	18	62325287-62391288	"CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Deafness, Disease variant, Osteopetrosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 29.4;salivary gland: 24.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 32.3;Enteroendocrine cells: 21.9;Lymphatic endothelial cells: 27.9;Paneth cells: 39.1;Proximal enterocytes: 23.4;Serous glandular cells: 36.3;Undifferentiated cells: 33.2"	"Cell type enhanced"	"Detected in many"		"central nervous system macrophage: 61.8"	"Cancer enhanced"	"Detected in many"		"Stomach Adenocarcinoma (TCGA): 15.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"NK-cell: 2.3"	"Lineage enriched"	"Detected in single"	8	"NK-cells: 2.3"	"Cancer enhanced"	"Detected in many"		"Gastric cancer: 9.7"	"Adipose subcutaneous - Macrophages, Adrenal gland - Macrophages, Kidney - Macrophages, Minor Salivary Gland - Minor salivary glandular cells, Pituitary gland - Corticotropes, Skeletal muscle - Macrophages, Stomach - Mitotic cells (Stomach), Testis - Spermatogonia, Thyroid gland - Fibroblasts"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB010391, HPA047976"	Approved		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"	Receptor	NA	NA		2800000	"Cluster 15: NK-cells - Unknown function"	"Cluster 45: Intestine - Digestion"	"Cluster 40: Astrocytes - Astrocyte-neuron interactions"	"Cluster 50: Lymphoma - Unknown function"	"Cluster 16: Intestinal goblet cells - Mucin production"	9	"Plasma membrane"	Cytosol	"CAB010391: AB_2205352, HPA047976: AB_2680227"	"unprognostic (2.06e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.43e-3)"	"unprognostic (1.98e-2)"	"unprognostic (1.26e-1)"	"unprognostic (7.99e-2)"		"unprognostic (3.58e-3)"	"unprognostic (3.19e-2)"			"potential prognostic unfavorable (6.59e-4)"	"potential prognostic unfavorable (8.41e-4)"	"unprognostic (1.87e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.65e-2)"	"unprognostic (2.56e-2)"		"unprognostic (1.84e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.13e-2)"	"potential prognostic unfavorable (2.37e-5)"	"unprognostic (4.96e-2)"	"unprognostic (9.92e-2)"	"unprognostic (8.84e-2)"		"unprognostic (1.47e-1)"
TNFRSF12A	"CD266, FN14, TweakR"	ENSG00000006327	"TNF receptor superfamily member 12A"	Q9NP84	16	3018445-3022383	"Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Angiogenesis, Apoptosis, Cell adhesion, Differentiation"	"Developmental protein, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 574.8;Basal respiratory cells: 577.5;Ductal cells: 809.1;Exocrine glandular cells: 535.5;Pancreatic endocrine cells: 706.4;Secretory cells: 888.2"	"Cell type enhanced"	"Detected in many"		"central nervous system macrophage: 10.9;lower rhombic lip: 10.7;vascular associated smooth muscle cell: 20.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"eosinophil: 140.0;neutrophil: 103.3"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 140.0"	"Low cancer specificity"	"Detected in all"			"Minor Salivary Gland - Minor salivary glandular cells, Pancreas - Ductal cells"					"Low region specificity"	"Detected in all"			HPA007853	Approved		Approved	"Plasma membrane,Cytosol"			NA	Yes		590000	"Cluster 36: Eosinophils - Protein ubiquitination"	"Cluster 68: Non-specific - Protein processing"	"Cluster 12: Non-specific - Vasculature"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 45: Non-specific - Mixed function"	7	"Plasma membrane, Cytosol"		"HPA007853: AB_1858463"	"unprognostic (9.13e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.30e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.68e-2)"	"potential prognostic unfavorable (3.13e-4)"	"potential prognostic unfavorable (2.63e-4)"	"unprognostic (7.19e-2)"	"unprognostic (1.25e-3)"	"potential prognostic unfavorable (7.22e-5)"	"unprognostic (2.44e-2)"	"unprognostic (4.27e-3)"	"unprognostic (6.70e-2)"	"unprognostic (3.40e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.70e-3)"	"unprognostic (8.21e-3)"	"unprognostic (2.26e-1)"	"unprognostic (4.46e-2)"	"unprognostic (3.16e-3)"	"unprognostic (3.11e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.16e-1)"	"potential prognostic favorable (4.95e-4)"	"unprognostic (1.77e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.83e-3)"	"unprognostic (3.35e-1)"
TNFRSF13B	"CD267, IGAD2, TACI"	ENSG00000240505	"TNF receptor superfamily member 13B"	O14836	17	16929816-16972118	"CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 18.4;lymphoid tissue: 32.2;skeletal muscle: 60.5"	"Group enriched"	"Detected in some"	39	"B-cells: 121.3;Plasma cells: 153.5"	"Cell type enriched"	"Detected in single"	5	"leukocyte: 2.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	41	"memory B-cell: 131.4;naive B-cell: 52.1"	"Lineage enriched"	"Detected in many"	59	"B-cells: 131.4"	"Group enriched"	"Detected in some"	6	"lymphoma: 69.1;Myeloma: 110.9"	"Adipose subcutaneous - Plasma cells, Breast - Plasma cells, Minor Salivary Gland - Plasma cells, Spleen - B-cells (Spleen), Stomach - Plasma cells, Thyroid gland - Plasma cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA030453	Uncertain						NA	NA			"Cluster 17: B-cells - Immunoglobulins"	"Cluster 19: Non-specific - Basic cellular processes"	"Cluster 6: Non-specific - Immune response"	"Cluster 55: Lymphoma - Immune response"	"Cluster 73: B-cells - B-cell function"	10			"HPA030453: AB_10601700"	"unprognostic (4.28e-1)"		"unprognostic (4.98e-2)"	"unprognostic (1.91e-2)"												"potential prognostic favorable (7.34e-4)"	"unprognostic (7.15e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.91e-1)"			"unprognostic (1.83e-1)"						"unprognostic (2.24e-1)"	"unprognostic (3.25e-1)"		
TNFRSF13C	"BAFFR, CD268"	ENSG00000159958	"TNF receptor superfamily member 13C"	Q96RJ3	22	41922032-41926806	"CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"intestine: 32.9;lymphoid tissue: 56.7"	"Cell type enriched"	"Detected in some"	12	"B-cells: 232.1"	"Cell type enriched"	"Detected in some"	13	"central nervous system macrophage: 72.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	39	"memory B-cell: 22.3;naive B-cell: 28.8"	"Lineage enriched"	"Detected in single"	44	"B-cells: 28.8"	"Group enriched"	"Detected in many"	5	"Leukemia: 10.0;lymphoma: 25.8"	"Heart muscle - Cardiomyocytes, Lung - B-cells (Lung), Spleen - B-cells (Spleen)"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA003246, CAB008380"	Enhanced						NA	NA			"Cluster 14: Non-specific - Unknown function"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 43: Hindbrain - Mixed function"	"Cluster 55: Lymphoma - Immune response"	"Cluster 73: B-cells - B-cell function"	2			"CAB008380: AB_590602, HPA003246: AB_1078264"	"unprognostic (3.84e-2)"	"unprognostic (3.61e-3)"	"unprognostic (7.12e-2)"	"potential prognostic favorable (1.81e-4)"	"unprognostic (1.31e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.37e-2)"	"potential prognostic favorable (1.54e-5)"	"unprognostic (6.82e-3)"							"unprognostic (1.20e-3)"	"unprognostic (1.35e-1)"	"unprognostic (6.08e-2)"	"unprognostic (7.03e-3)"	"unprognostic (2.29e-1)"		"unprognostic (9.67e-2)"				"unprognostic (2.49e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.31e-1)"		"unprognostic (1.17e-1)"
TNFRSF14	"ATAR, CD270, HVEA, HVEM, LIGHTR, TR2"	ENSG00000157873	"TNF receptor superfamily member 14"	Q92956	1	2555639-2565382	"Cancer-related genes, CD markers, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Host-virus interaction, Immunity, Innate immunity"	"Host cell receptor for virus entry, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"monocytes: 170.8;Proximal enterocytes: 210.6"	"Cell type enhanced"	"Detected in many"		"endothelial cell: 54.1;leukocyte: 56.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"skin cancer: 17.5"										"HPA006404, CAB026150, CAB030007, CAB080525, CAB080526"	Approved		Supported	"Plasma membrane,Cytosol"			NA	NA		110000	"Cluster 33: Non-specific - ATP binding"	"Cluster 47: Spleen - Immune response"	"Cluster 12: Non-specific - Vasculature"	"Cluster 9: Skin cancer - Melanin biosynthesis"	"Cluster 22: Proximal enterocytes - Digestion"	11	"Plasma membrane, Cytosol"		"CAB026150: , CAB030007: AB_2303380, CAB080525: , CAB080526: , HPA006404: AB_1851348"	"unprognostic (1.19e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.99e-3)"	"unprognostic (1.81e-2)"	"potential prognostic unfavorable (1.70e-4)"	"unprognostic (3.17e-2)"	"unprognostic (1.28e-1)"	"potential prognostic favorable (5.65e-6)"	"unprognostic (4.32e-3)"	"unprognostic (1.79e-1)"	"unprognostic (3.05e-1)"	"unprognostic (9.33e-2)"	"unprognostic (7.65e-2)"	"unprognostic (4.34e-2)"	"unprognostic (7.40e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.82e-3)"	"unprognostic (2.01e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.93e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.78e-1)"	"unprognostic (7.11e-3)"
TNFRSF17	"BCM, BCMA, CD269, TNFRSF13A"	ENSG00000048462	"TNF receptor superfamily member 17"	Q02223	16	11965210-11968068	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 28.2;lymphoid tissue: 46.5;stomach 1: 23.7"	"Cell type enriched"	"Detected in some"	15	"Plasma cells: 469.6"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	63	"memory B-cell: 125.4;naive B-cell: 109.1;plasmacytoid DC: 103.5"	"Group enriched"	"Detected in many"	64	"B-cells: 125.4;dendritic cells: 103.5"	"Cancer enriched"	"Detected in some"	9	"Myeloma: 608.0"	"Adipose visceral - Plasma cells, Breast - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Pancreas - Plasma cells, Prostate - Plasma cells, Stomach - Plasma cells, Testis - Early spermatids, Thyroid gland - Plasma cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA010569			Approved	"Golgi apparatus,Mitotic spindle"			Yes	NA		1200000	"Cluster 23: B-cells - Immunoglobulins"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 34: Non-specific - Mixed function"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 77: Plasma cells - Protein processing"	4	"Golgi apparatus"	"Mitotic spindle"	"HPA010569: AB_10602482"	"unprognostic (2.60e-1)"	"potential prognostic favorable (4.93e-6)"	"unprognostic (2.36e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.36e-2)"	"unprognostic (7.16e-2)"			"potential prognostic favorable (2.70e-6)"		"unprognostic (3.19e-3)"	"unprognostic (1.48e-1)"	"potential prognostic unfavorable (1.56e-4)"			"unprognostic (6.38e-3)"	"unprognostic (9.62e-3)"	"unprognostic (2.80e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.30e-2)"		"unprognostic (3.65e-1)"			"unprognostic (4.26e-3)"	"unprognostic (4.10e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.19e-1)"
TNFRSF18	"AITR, CD357, GITR"	ENSG00000186891	"TNF receptor superfamily member 18"	Q9Y5U5	1	1203508-1206592	"CD markers, Predicted membrane proteins, Predicted secreted proteins"	Apoptosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 37.5"	"Group enriched"	"Detected in many"	5	"Basal keratinocytes: 104.9;granulocytes: 35.5;Langerhans cells: 77.5;NK-cells: 77.0;Plasma cells: 92.5;Suprabasal keratinocytes: 76.6;T-cells: 73.0"	"Cell type enhanced"	"Detected in some"		"leukocyte: 9.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"NK-cell: 184.9;T-reg: 72.0"	"Group enriched"	"Detected in many"	11	"NK-cells: 184.9;T-cells: 72.0"	"Cancer enhanced"	"Detected in many"		"lymphoma: 36.8;Myeloma: 25.5"	"Minor Salivary Gland - Plasma cells, Skin - Keratinocyte (other), Stomach - Plasma cells"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	8	"basal ganglia: 1.2"	HPA008025	Approved				"Secreted to blood"	Receptor	NA	NA			"Cluster 1: T-cells - Unknown function"	"Cluster 13: Skin - Cornification"	"Cluster 37: Neurons - Mixed function"	"Cluster 59: Leukemia - T-cell receptor"	"Cluster 78: NK-cells & T-cells - Immune system & Transcription"	4			"HPA008025: AB_1849696"	"unprognostic (9.59e-2)"	"potential prognostic favorable (5.58e-4)"	"unprognostic (2.30e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.88e-1)"	"potential prognostic favorable (4.16e-5)"	"unprognostic (1.19e-3)"		"potential prognostic favorable (9.25e-5)"		"potential prognostic unfavorable (7.90e-6)"	"unprognostic (7.15e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.68e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.62e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.22e-3)"	"unprognostic (3.38e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.68e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.49e-1)"	"unprognostic (3.61e-2)"
TNFRSF1A	"CD120a, TNF-R, TNF-R-I, TNF-R55, TNFAR, TNFR1, TNFR60"	ENSG00000067182	"TNF receptor superfamily member 1A"	P19438	12	6328757-6342114	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Apoptosis, Host-virus interaction"	Receptor	"Amyloidosis, Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"central nervous system macrophage: 98.7;leukocyte: 78.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 454.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 116.0;granulocytes: 454.7;monocytes: 152.3"	"Low cancer specificity"	"Detected in all"			"Lung - Endothelial cells, Pituitary gland - Endothelial cells, Spleen - Fibroblast_1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004102, CAB010309"	Approved				"Secreted to blood"	Receptor	NA	NA	17700	650000	"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 41: Smooth muscle tissue - ECM organization"	"Cluster 39: Astrocytes - Mixed function"	"Cluster 7: Liver cancer - Metabolism"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	54			"CAB010309: AB_2206639, HPA004102: AB_1846232"	"unprognostic (1.10e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.45e-1)"	"unprognostic (7.41e-3)"	"unprognostic (2.64e-2)"	"unprognostic (5.28e-2)"	"unprognostic (4.83e-3)"	"potential prognostic unfavorable (1.94e-4)"	"unprognostic (2.80e-3)"	"unprognostic (1.03e-3)"	"unprognostic (5.66e-3)"	"unprognostic (3.12e-1)"	"unprognostic (5.44e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.09e-1)"	"potential prognostic unfavorable (1.81e-4)"	"unprognostic (1.10e-2)"	"unprognostic (5.05e-2)"	"potential prognostic unfavorable (7.43e-4)"	"unprognostic (1.10e-2)"	"unprognostic (4.00e-1)"	"unprognostic (1.85e-2)"	"potential prognostic unfavorable (5.97e-4)"	"unprognostic (3.29e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.87e-3)"	"unprognostic (3.77e-1)"	"unprognostic (4.75e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.45e-2)"	"unprognostic (4.70e-2)"
TNFRSF1B	"CD120b, p75, TNF-R-II, TNF-R75, TNFBR, TNFR2, TNFR80"	ENSG00000028137	"TNF receptor superfamily member 1B"	P20333	1	12166991-12209228	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	Apoptosis	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 66.5"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 328.8;Kupffer cells: 240.4;Langerhans cells: 352.6;Macrophages: 265.8;monocytes: 743.2;NK-cells: 332.9"	"Cell type enhanced"	"Detected in some"		"central nervous system macrophage: 150.7;endothelial cell: 76.7;leukocyte: 246.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 387.7"	"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"Leukemia: 29.3"	"Adrenal gland - Macrophages, Breast - Endothelial cells, Colon - Endothelial cells, Heart muscle - Endothelial cells, Skeletal muscle - Endothelial cells, Testis - Endothelial cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA004796	Approved				"Secreted to blood"	Receptor	NA	NA	3230000	6400000	"Cluster 37: Monocytes & Neutrophils - Innate immune response"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 12: Non-specific - Vasculature"	"Cluster 55: Lymphoma - Immune response"	"Cluster 29: Monocytes - Innate immune response"	21			"HPA004796: AB_1078436"	"unprognostic (1.97e-2)"	"unprognostic (2.79e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.94e-2)"	"unprognostic (2.34e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.25e-3)"	"unprognostic (2.81e-1)"	"potential prognostic favorable (1.36e-5)"	"unprognostic (5.14e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.70e-2)"	"unprognostic (9.59e-2)"	"unprognostic (4.79e-2)"	"unprognostic (5.96e-2)"	"unprognostic (7.85e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.72e-2)"	"unprognostic (8.84e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.22e-3)"	"unprognostic (2.64e-1)"	"unprognostic (9.56e-2)"
TNFRSF21	"CD358, DR6"	ENSG00000146072	"TNF receptor superfamily member 21"	O75509	6	47231532-47309905	"CD markers, Plasma proteins, Predicted membrane proteins"	"Adaptive immunity, Apoptosis, Host-virus interaction, Immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 109.7;urinary bladder: 142.7"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 129.4;dendritic cells: 182.3;Syncytiotrophoblasts: 154.2"	"Cell type enhanced"	"Detected in many"		"committed oligodendrocyte precursor: 280.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	35	"plasmacytoid DC: 69.3"	"Lineage enriched"	"Detected in single"	302	"dendritic cells: 69.3"	"Low cancer specificity"	"Detected in many"			"Prostate - Urothelial cells, Spleen - Macrophages, Testis - Early spermatids, Testis - Late spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006746, CAB009805"	Approved		Supported	"Plasma membrane,Cytosol"			NA	NA		1300000	"Cluster 44: Plasmacytoid DCs - Plasma membrane proteins"	"Cluster 34: Non-specific - Mixed function"	"Cluster 30: White matter - Myelination"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 45: Non-specific - Mixed function"	4	"Plasma membrane, Cytosol"		"CAB009805: AB_2206956, HPA006746: AB_1078701"	"unprognostic (1.06e-1)"	"unprognostic (7.93e-3)"	"unprognostic (3.92e-1)"	"unprognostic (5.90e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.89e-1)"	"unprognostic (6.99e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.92e-2)"	"potential prognostic favorable (1.79e-7)"	"unprognostic (4.11e-2)"	"unprognostic (7.09e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.16e-2)"	"unprognostic (8.33e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.88e-2)"	"unprognostic (2.58e-1)"	"potential prognostic unfavorable (1.66e-4)"	"unprognostic (2.27e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.48e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.04e-2)"
TNFRSF4	"ACT35, CD134, OX40, TXGP1L"	ENSG00000186827	"TNF receptor superfamily member 4"	P43489	1	1211326-1214153	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 10.0;lymphoid tissue: 13.0"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 100.7;Endothelial cells: 31.3;granulocytes: 70.3;Langerhans cells: 148.9;Lymphatic endothelial cells: 34.0;NK-cells: 29.8;Plasma cells: 51.6;T-cells: 38.6"	"Cell type enhanced"	"Detected in some"		"endothelial cell: 5.1;leukocyte: 5.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"memory CD4 T-cell: 25.6;T-reg: 31.0"	"Lineage enriched"	"Detected in many"	6	"T-cells: 31.0"	"Group enriched"	"Detected in some"	17	"Leukemia: 3.4;lymphoma: 10.7;thyroid cancer: 10.2"	"Minor Salivary Gland - Plasma cells"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			CAB016128	Enhanced						NA	NA			"Cluster 9: T-regs - Cell cycle regulation"	"Cluster 47: Spleen - Immune response"	"Cluster 15: Non-specific - Transcription"	"Cluster 59: Leukemia - T-cell receptor"	"Cluster 78: NK-cells & T-cells - Immune system & Transcription"	3			"CAB016128: AB_626897"	"unprognostic (3.49e-1)"	"unprognostic (6.73e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.92e-1)"	"unprognostic (3.37e-1)"		"potential prognostic favorable (2.18e-6)"	"unprognostic (3.35e-1)"	"unprognostic (5.06e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.27e-2)"	"potential prognostic unfavorable (3.99e-4)"	"unprognostic (2.45e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.50e-2)"	"unprognostic (6.67e-2)"	"unprognostic (4.31e-3)"	"unprognostic (1.46e-1)"	"unprognostic (7.79e-3)"	"unprognostic (2.40e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.87e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.45e-1)"
TNFRSF8	"CD30, D1S166E, KI-1"	ENSG00000120949	"TNF receptor superfamily member 8"	P28908	1	12063303-12144207	"Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 5.1"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 7.6;Kupffer cells: 4.8;Late spermatids: 10.1;Macrophages: 5.1;Mesothelial cells: 4.8;monocytes: 19.3"	"Cell type enhanced"	"Detected in some"		"leukocyte: 6.9;medium spiny neuron: 5.9"	"Cancer enriched"	"Detected in some"	10	"Testicular Germ Cell Tumor (TCGA): 11.6"	"Group enriched"	"Detected in some"	4	"basal ganglia: 4.8;thalamus: 1.5"	"Group enriched"	"Detected in many"	4	"intermediate monocyte: 59.4;non-classical monocyte: 97.0"	"Lineage enriched"	"Detected in many"	5	"monocytes: 97.0"	"Cancer enriched"	"Detected in some"	7	"lymphoma: 49.3"	"Breast - Endothelial cells, Colon - Endothelial cells, Minor Salivary Gland - Endothelial cells"	"Region enhanced"	"Detected in many"		"hypothalamus: 5.5"	"Low region specificity"	"Detected in all"			"CAB000016, HPA014823, HPA032081, HPA032082"	Approved		Supported	"Plasma membrane"			NA	NA		28000	"Cluster 37: Monocytes & Neutrophils - Innate immune response"	"Cluster 7: Adipose tissue - Mixed function"	"Cluster 33: Neurons - Mixed function"	"Cluster 21: Lymphoma - Adaptive immune response"	"Cluster 29: Monocytes - Innate immune response"	6	"Plasma membrane"		"CAB000016: AB_563546, HPA014823: , HPA032081: AB_2674141, HPA032082: AB_2674142"			"potential prognostic favorable (9.62e-4)"																	"unprognostic (1.65e-2)"									"unprognostic (6.89e-2)"		
TNFRSF9	"4-1BB, CD137, ILA"	ENSG00000049249	"TNF receptor superfamily member 9"	Q07011	1	7915871-7943165	"Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 9.6"	"Cell type enhanced"	"Detected in some"		"granulocytes: 63.6;Langerhans cells: 36.9;NK-cells: 13.4;T-cells: 25.7"	"Cell type enriched"	"Detected in single"	10	"leukocyte: 7.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"memory CD8 T-cell: 9.4;neutrophil: 8.6;NK-cell: 5.1;T-reg: 18.6"	"Group enriched"	"Detected in many"	5	"granulocytes: 8.6;NK-cells: 5.1;T-cells: 18.6"	"Low cancer specificity"	"Detected in many"				"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA071425			Approved	"Nucleoli,Plasma membrane"			NA	NA			"Cluster 33: Non-specific - ATP binding"	"Cluster 36: Lymphoid tissue - Cytokine signaling"	"Cluster 48: Non-specific - Mixed function"	"Cluster 21: Lymphoma - Adaptive immune response"	"Cluster 78: NK-cells & T-cells - Immune system & Transcription"	17	"Plasma membrane"	Nucleoli	"HPA071425: AB_2686394"	"unprognostic (5.30e-3)"	"unprognostic (1.75e-1)"	"unprognostic (8.66e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.31e-2)"		"unprognostic (3.89e-3)"	"unprognostic (2.50e-2)"		"unprognostic (6.95e-3)"	"unprognostic (4.28e-1)"	"unprognostic (1.20e-2)"			"unprognostic (3.32e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.00e-1)"	"unprognostic (8.82e-3)"		"unprognostic (1.47e-3)"	"unprognostic (1.76e-2)"		"unprognostic (2.84e-2)"	"unprognostic (3.98e-3)"	"unprognostic (2.58e-1)"	"unprognostic (6.10e-2)"	"unprognostic (2.76e-2)"		"unprognostic (1.00e-1)"
TNFSF10	"Apo-2L, CD253, TL2, TRAIL"	ENSG00000121858	"TNF superfamily member 10"	P50591	3	172505508-172523475	"Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	Apoptosis	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 385.4;Ductal cells: 709.4;Proximal tubular cells: 567.3"	"Cell type enriched"	"Detected in some"	5	"endothelial cell: 285.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 266.3;classical monocyte: 133.5;intermediate monocyte: 203.5;neutrophil: 257.9;non-classical monocyte: 214.1"	"Group enriched"	"Detected in all"	5	"granulocytes: 266.3;monocytes: 214.1"	"Group enriched"	"Detected in many"	4	"head and neck cancer: 121.7;Kidney cancer: 166.1"	"Adrenal gland - Adrenal cortex cells, Liver - Hepatocytes, Minor Salivary Gland - Minor salivary glandular cells"	"Low region specificity"	"Detected in all"							HPA054938	Uncertain				"Secreted to blood"	Cytokine	NA	NA	67400	12000	"Cluster 28: Neutrophils - Unknown function"	"Cluster 11: Liver - Plasma proteins"	"Cluster 8: Immune cells - Immune response"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 38: Proximal tubular cells - Transmembrane transport"	8			"HPA054938: AB_2682643"	"unprognostic (8.83e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.68e-3)"	"unprognostic (1.31e-3)"	"unprognostic (6.75e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.34e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.36e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.29e-2)"	"potential prognostic unfavorable (1.02e-4)"	"unprognostic (2.45e-1)"	"unprognostic (5.51e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.70e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.01e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.95e-2)"
TNFSF11	"CD254, ODF, OPGL, RANKL, TRANCE"	ENSG00000120659	"TNF superfamily member 11"	O14788	13	42562736-42608013	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Differentiation	"Cytokine, Developmental protein, Receptor"	"Cancer-related genes, Disease variant, FDA approved drug targets, Osteopetrosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"liver: 4.0;lymphoid tissue: 12.0"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 10.1;Ductal cells: 5.6;Early spermatids: 8.4;Late spermatids: 14.2;NK-cells: 3.9;Pancreatic endocrine cells: 3.4"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Pancreatic Adenocarcinoma (TCGA): 5.2"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in some"	8	"NK-cell: 9.9"	"Lineage enriched"	"Detected in many"	8	"NK-cells: 9.9"	"Cancer enhanced"	"Detected in some"		"Rhabdoid: 1.5;thyroid cancer: 1.7"	"Testis - Late spermatids"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB009193, HPA045142"	Enhanced				"Secreted to blood"	Cytokine	NA	NA	17200		"Cluster 15: NK-cells - Unknown function"	"Cluster 36: Lymphoid tissue - Cytokine signaling"	"Cluster 44: Non-specific - Mixed function"	"Cluster 55: Lymphoma - Immune response"	"Cluster 17: Breast glandular cells - Lactation"	4			"CAB009193: , HPA045142: AB_2679231"	"unprognostic (4.49e-2)"	"potential prognostic favorable (2.24e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.71e-2)"	"unprognostic (3.25e-2)"			"unprognostic (1.53e-1)"						"unprognostic (5.15e-2)"	"unprognostic (4.62e-3)"	"unprognostic (6.84e-2)"	"unprognostic (8.06e-2)"	"unprognostic (3.41e-2)"			"unprognostic (6.47e-3)"	"unprognostic (6.85e-2)"		"unprognostic (9.64e-2)"	"unprognostic (1.93e-1)"		"unprognostic (8.95e-2)"			
TNFSF13	"APRIL, CD256"	ENSG00000161955	"TNF superfamily member 13"	O75888	17	7558292-7561608	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Immunity	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 174.6;salivary gland: 143.4"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 4.7;Erythroid cells: 4.5;Gastric mucus-secreting cells: 10.6;Macrophages: 11.2;Mesothelial cells: 13.2;Schwann cells: 8.2"	"Cell type enhanced"	"Detected in some"		"astrocyte: 25.8;central nervous system macrophage: 18.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 384.4"	"Group enriched"	"Detected in all"	11	"dendritic cells: 249.2;granulocytes: 139.3;monocytes: 384.4"	"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Macrophages, Colon - Macrophages, Lung - Macrophages, Minor Salivary Gland - Minor salivary glandular cells, Skeletal muscle - Macrophages"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004863	Uncertain				"Secreted to blood"	Cytokine	NA	NA	6770000	450000	"Cluster 26: Monocytes - Plasma membrane proteins"	"Cluster 60: Choroid plexus - Transmembrane transport"	"Cluster 42: Choroid plexus - Mitochondria"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 49: Non-specific - Transcription"	1			"HPA004863: AB_1078187"	"unprognostic (9.30e-3)"	"unprognostic (5.99e-2)"	"unprognostic (9.89e-2)"	"unprognostic (7.55e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.83e-2)"	"potential prognostic unfavorable (1.31e-4)"	"unprognostic (8.44e-3)"	"unprognostic (2.70e-1)"	"unprognostic (3.32e-1)"	"potential prognostic favorable (7.92e-6)"	"unprognostic (2.09e-3)"	"potential prognostic favorable (2.28e-7)"	"unprognostic (4.80e-3)"	"unprognostic (8.92e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.53e-1)"	"unprognostic (6.48e-2)"	"unprognostic (7.39e-2)"	"unprognostic (2.81e-1)"	"unprognostic (6.23e-2)"	"unprognostic (7.41e-2)"	"unprognostic (4.52e-1)"	"unprognostic (4.22e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.25e-2)"	"unprognostic (3.40e-1)"	"unprognostic (3.12e-2)"
TNFSF13B	"BAFF, BLYS, CD257, TALL-1, TALL1, THANK, TNFSF20"	ENSG00000102524	"TNF superfamily member 13b"	Q9Y275	13	108251240-108308484	"Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Immunity	Cytokine	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 19.8;lymphoid tissue: 25.2"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 167.6;Kupffer cells: 106.6;Langerhans cells: 300.8;Macrophages: 143.4;monocytes: 542.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 509.3"	"Group enriched"	"Detected in all"	11	"dendritic cells: 207.0;granulocytes: 509.3;monocytes: 352.4"	"Cancer enriched"	"Detected in some"	10	"Leukemia: 21.6"		"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB009188, HPA030526"	Enhanced		Supported	"Vesicles,Plasma membrane,Focal adhesion sites"	"Secreted to blood"	Cytokine	NA	NA	393000	640000	"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 8: Immune cells - Immune response"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 29: Monocytes - Innate immune response"	26	"Plasma membrane"	"Vesicles, Focal adhesion sites"	"CAB009188: , HPA030526: "	"unprognostic (5.03e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.11e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.72e-2)"	"potential prognostic unfavorable (5.23e-4)"	"unprognostic (1.28e-1)"	"unprognostic (3.10e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.68e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.85e-2)"	"unprognostic (2.99e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.56e-2)"
TNFSF14	"CD258, HVEM-L, LIGHT, LTg"	ENSG00000125735	"TNF superfamily member 14"	O43557	19	6661253-6670588	"CD markers, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"adipose tissue: 28.0;liver: 105.3"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 22.2;Mesothelial cells: 45.1;NK-cells: 44.3;T-cells: 56.1"	"Cell type enriched"	"Detected in some"	24	"leukocyte: 28.9"	"Cancer enhanced"	"Detected in many"		"Liver Hepatocellular Carcinoma (TCGA): 7.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 199.9"	"Group enriched"	"Detected in all"	4	"granulocytes: 199.9;T-cells: 61.2"	"Cancer enhanced"	"Detected in some"		"Leukemia: 2.6;lymphoma: 3.6"		"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA012700	Uncertain		Approved	Vesicles	"Secreted to blood"	Cytokine	NA	NA	41000		"Cluster 21: Neutrophils - Unknown function"	"Cluster 83: Liver - Metabolism"	"Cluster 12: Non-specific - Vasculature"	"Cluster 55: Lymphoma - Immune response"	"Cluster 19: NK-cells - Adaptive immune response"	55	Vesicles		"HPA012700: AB_1852870"	"unprognostic (3.58e-2)"		"unprognostic (1.31e-2)"	"unprognostic (3.93e-2)"		"unprognostic (1.53e-2)"	"potential prognostic unfavorable (5.53e-4)"	"unprognostic (7.63e-3)"			"potential prognostic unfavorable (8.76e-9)"	"unprognostic (1.28e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.92e-2)"	"potential prognostic favorable (4.00e-5)"	"unprognostic (4.20e-1)"	"unprognostic (2.66e-1)"	"unprognostic (4.29e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.60e-3)"			"unprognostic (5.76e-2)"		"unprognostic (8.89e-2)"	"unprognostic (2.41e-1)"		"unprognostic (3.17e-2)"
TNFSF4	"CD252, gp34, OX-40L, TXGP1"	ENSG00000117586	"TNF superfamily member 4"	P23510	1	173183731-173207331	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins"		Cytokine	"Cancer-related genes, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Astrocytes: 8.1;Early spermatids: 4.6;Granulosa cells: 5.2;Inhibitory neurons: 5.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cancer enhanced"	"Detected in many"		"Brain cancer: 9.2"	"Testis - Sertoli cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA059579	Approved		Approved	Nucleoplasm,Vesicles			NA	NA			"Cluster 35: Neutrophils - Protein binding"	"Cluster 71: Thymus - Adaptive immune response"	"Cluster 37: Neurons - Mixed function"	"Cluster 48: Adipocytes & Endothelial cells - Angiogenesis"	"Cluster 57: Platelets - Hemostasis"	1	"Nucleoplasm, Vesicles"		"HPA059579: AB_2684071"	"unprognostic (1.79e-1)"	"unprognostic (1.85e-2)"	"unprognostic (8.41e-3)"	"unprognostic (1.07e-2)"	"unprognostic (5.44e-3)"	"unprognostic (4.49e-2)"	"unprognostic (4.40e-3)"	"unprognostic (3.14e-2)"	"unprognostic (1.23e-1)"		"unprognostic (1.08e-2)"	"unprognostic (1.67e-1)"	"potential prognostic unfavorable (5.81e-4)"	"potential prognostic unfavorable (9.31e-4)"	"unprognostic (1.99e-1)"	"unprognostic (7.86e-2)"	"potential prognostic unfavorable (8.24e-4)"	"unprognostic (1.96e-1)"	"unprognostic (2.76e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.48e-3)"	"unprognostic (1.36e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.79e-2)"	"potential prognostic favorable (2.10e-5)"	"unprognostic (1.71e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.56e-1)"
TNFSF8	"CD153, CD30LG"	ENSG00000106952	"TNF superfamily member 8"	P32971	9	114893343-114930595	"Cancer-related genes, CD markers, Predicted membrane proteins"		Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 18.5;lymphoid tissue: 26.2"	"Cell type enhanced"	"Detected in some"		"B-cells: 20.7;dendritic cells: 58.7;Hofbauer cells: 19.2;Kupffer cells: 18.6;Langerhans cells: 24.7;Macrophages: 25.4;Schwann cells: 30.4;T-cells: 70.0"	"Group enriched"	"Detected in some"	50	"central nervous system macrophage: 50.5;leukocyte: 56.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"lymphoma: 12.5;testis cancer: 21.5"	"Adipose visceral - Macrophages, Adrenal gland - Macrophages, Breast - Macrophages, Minor Salivary Gland - Macrophages, Skeletal muscle - Macrophages"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"										NA	NA			"Cluster 33: Non-specific - ATP binding"	"Cluster 71: Thymus - Adaptive immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 27: Breast cancer - Unknown function"	"Cluster 78: NK-cells & T-cells - Immune system & Transcription"	82				"unprognostic (1.36e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.13e-1)"			"unprognostic (1.94e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.78e-1)"			"unprognostic (7.53e-3)"	"unprognostic (2.70e-1)"	"unprognostic (1.38e-1)"		"unprognostic (3.62e-2)"	"unprognostic (1.25e-3)"	"unprognostic (7.12e-2)"	"unprognostic (1.22e-2)"	"unprognostic (8.12e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.26e-1)"			"unprognostic (5.72e-2)"		"unprognostic (5.12e-2)"	"unprognostic (4.79e-2)"	"unprognostic (8.15e-2)"	
TREM1	"CD354, TREM-1"	ENSG00000124731	"Triggering receptor expressed on myeloid cells 1"	Q9NP99	6	41267926-41286682	"CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 95.0;lung: 63.3;lymphoid tissue: 42.9"	"Group enriched"	"Detected in some"	4	"Hofbauer cells: 121.6;Macrophages: 117.6;monocytes: 389.2"	"Cell type enriched"	"Detected in some"	4	"leukocyte: 5.3"	"Cancer enhanced"	"Detected in many"		"Lung Adenocarcinoma (TCGA): 59.5"	"Region enhanced"	"Detected in many"		"cerebral cortex: 16.3"	"Immune cell enriched"	"Detected in many"	7	"neutrophil: 616.7"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 616.7"	"Cancer enhanced"	"Detected in some"		"testis cancer: 5.7"	"Adipose visceral - Neutrophils, Colon - Neutrophils, Spleen - Neutrophils, Stomach - Neutrophils, Thyroid gland - Neutrophils"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA005563, HPA053612"	Approved		Approved	"Golgi apparatus"	"Secreted to blood"	Receptor	NA	NA			"Cluster 21: Neutrophils - Unknown function"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 12: Non-specific - Vasculature"	"Cluster 71: Lymphoma - Inflammatory response"	"Cluster 58: Macrophages - Innate immune response"	4	"Golgi apparatus"		"HPA005563: AB_1858259, HPA053612: "	"unprognostic (1.07e-1)"	"unprognostic (5.10e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.49e-1)"	"potential prognostic unfavorable (6.48e-4)"	"unprognostic (4.71e-2)"	"unprognostic (3.69e-2)"		"potential prognostic unfavorable (1.01e-4)"	"unprognostic (8.96e-2)"	"unprognostic (2.16e-2)"	"potential prognostic unfavorable (2.51e-4)"	"unprognostic (4.42e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.33e-1)"	"potential prognostic unfavorable (7.14e-4)"	"unprognostic (1.27e-3)"	"unprognostic (3.78e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.10e-3)"	"unprognostic (5.53e-2)"		"unprognostic (1.21e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.30e-1)"	"unprognostic (6.43e-3)"	"unprognostic (1.35e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.40e-2)"
TSPAN7	"A15, CD231, DXS1692E, MRX58, MXS1, TALLA-1, TM4SF2"	ENSG00000156298	"Tetraspanin 7"	P41732	X	38561542-38688920	"CD markers, Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Host-virus interaction"		"Disease variant, Intellectual disability"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 480.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 260.7;Cone photoreceptor cells: 156.3;Endothelial cells: 163.0;Excitatory neurons: 208.4;Inhibitory neurons: 238.7;Oligodendrocyte precursor cells: 331.6"	"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"Glioblastoma Multiforme (TCGA): 288.7;Kidney Chromophobe (TCGA): 219.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Gallbladder cancer: 60.4;Neuroblastoma: 61.5"	"Adipose subcutaneous - Endothelial cells, Adipose visceral - Endothelial cells, Adrenal gland - Adrenal cortex cells, Breast - Endothelial cells, Colon - Endothelial cells, Heart muscle - Endothelial cells, Liver - Sinusoid Endothelial cells, Minor Salivary Gland - Endothelial cells, Prostate - Endothelial cells, Testis - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003140, CAB062566, CAB068245"	Enhanced						NA	NA				"Cluster 17: Neuronal - Synaptic function"	"Cluster 53: Neurons - Mixed function"	"Cluster 59: Leukemia - T-cell receptor"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	5			"CAB062566: AB_2665608, CAB068245: AB_2665609, HPA003140: AB_1078454"	"unprognostic (1.96e-2)"	"unprognostic (2.44e-2)"	"unprognostic (5.30e-2)"	"unprognostic (3.65e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.94e-1)"	"unprognostic (3.42e-3)"	"unprognostic (1.98e-3)"	"unprognostic (1.49e-1)"	"validated prognostic favorable (2.08e-11)"	"validated prognostic favorable (3.98e-6)"	"unprognostic (6.50e-3)"	"unprognostic (2.12e-3)"	"unprognostic (1.92e-3)"	"unprognostic (2.05e-3)"	"unprognostic (2.66e-2)"	"unprognostic (8.54e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.81e-1)"	"potential prognostic favorable (2.70e-4)"	"unprognostic (7.93e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.56e-1)"	"unprognostic (4.94e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.70e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.32e-2)"
VCAM1	CD106	ENSG00000162692	"Vascular cell adhesion molecule 1"	P19320	1	100719742-100739045	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"lymphoid tissue: 379.4"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 149.9;Endothelial cells: 74.9;Kupffer cells: 376.7;Proximal tubular cells: 167.1"	"Cell type enriched"	"Detected in some"	4	"endothelial cell: 135.6"	"Group enriched"	"Detected in all"	7	"Kidney Renal Clear Cell Carcinoma (TCGA): 293.6;Kidney Renal Papillary Cell Carcinoma (TCGA): 234.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Bladder cancer: 34.3;Kidney cancer: 63.3;thyroid cancer: 43.7"	"Spleen - Macrophages, Stomach - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000154, HPA034796, HPA069867"	Enhanced		Approved	"Cell Junctions"	"Secreted to blood"	"Cell adhesion"	NA	NA	624000000	890000000		"Cluster 47: Spleen - Immune response"	"Cluster 19: Astrocytes - Mixed function"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 38: Proximal tubular cells - Transmembrane transport"	10	"Cell Junctions"		"CAB000154: , HPA034796: AB_2674333, HPA069867: AB_2686215"	"unprognostic (6.75e-3)"	"unprognostic (2.69e-1)"	"unprognostic (3.12e-1)"	"unprognostic (2.24e-3)"	"unprognostic (2.44e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.03e-1)"	"potential prognostic favorable (2.57e-4)"	"unprognostic (1.37e-1)"	"potential prognostic favorable (1.86e-4)"	"unprognostic (3.86e-3)"	"unprognostic (1.11e-1)"	"unprognostic (5.00e-3)"	"unprognostic (7.31e-2)"	"unprognostic (8.79e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.78e-1)"	"unprognostic (7.14e-3)"	"unprognostic (8.97e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.94e-1)"	"unprognostic (6.42e-3)"	"unprognostic (1.43e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.42e-1)"
VPREB1	"CD179A, VpreB"	ENSG00000169575	"V-set pre-B cell surrogate light chain 1"	P12018	22	22244780-22245515	"CD markers, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	22	"bone marrow: 29.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"memory B-cell: 5.7;naive B-cell: 5.3"	"Lineage enriched"	"Detected in many"	5	"B-cells: 5.7"	"Cancer enriched"	"Detected in some"	4	"Leukemia: 204.5"	"Breast - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055886	Approved				"Intracellular and membrane"	"No annotated function"	NA	NA		28000	"Cluster 34: B-cells - Unknown function"	"Cluster 6: Bone marrow - Innate immune response"		"Cluster 35: RS4;11 - Unknown function"	"Cluster 19: NK-cells - Adaptive immune response"				"HPA055886: AB_2682956"																															
